cell_id,prompt,answer
ACH-000001,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
Drug 2: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 3: The drug is GSK2606414. The drug SMILES structure is CN1C=C(C2=C(N=CN=C21)N)C3=CC4=C(C=C3)N(CC4)C(=O)CC5=CC(=CC=C5)C(F)(F)F. Drug target is PERK. Drug target pathway is Metabolism.
The mutations of the cell line are NOTCH1, NOTCH3, PIK3R1, PPP2R1A, TP53, TSC2, WHSC1L1.
Best drug option: ?",KIN001-135
ACH-000002,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
Drug 2: The drug is FORETINIB. The drug SMILES structure is COC1=CC2=C(C=CN=C2C=C1OCCCN3CCOCC3)OC4=C(C=C(C=C4)NC(=O)C5(CC5)C(=O)NC6=CC=C(C=C6)F)F. Drug target is MET, KDR, TIE2, VEGFR3/FLT4, RON, PDGFR, FGFR1, EGFR. Drug target pathway is RTK signaling.
Drug 3: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are CDKN2A, CEBPA, KDM5C, NRAS, RPTOR.
Best drug option: ?",FORETINIB
ACH-000004,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is IMATINIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5. Drug target is ABL, KIT, PDGFR. Drug target pathway is Other, kinases.
Drug 2: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
Drug 3: The drug is KOBE2602. The drug SMILES structure is C1=CC(=CC=C1NC(=S)NNC2=C(C=C(C=C2[N+](=O)[O-])C(F)(F)F)[N+](=O)[O-])F. Drug target is RAS effector. Drug target pathway is RTK signaling.
The mutations of the cell line are FGFR3, POLE, TP53, ZNF703.
Best drug option: ?",WYE-125132
ACH-000007,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is BORTEZOMIB. The drug SMILES structure is B([C@H](CC(C)C)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O. Drug target is Proteasome. Drug target pathway is Protein stability and degradation.
Drug 2: The drug is KOBE2602. The drug SMILES structure is C1=CC(=CC=C1NC(=S)NNC2=C(C=C(C=C2[N+](=O)[O-])C(F)(F)F)[N+](=O)[O-])F. Drug target is RAS effector. Drug target pathway is RTK signaling.
Drug 3: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ALK, BRAF, KRAS, MET, MUTYH, NOTCH3, RAD54L, RAF1, SMARCA4, SOX9.
Best drug option: ?",BORTEZOMIB
ACH-000008,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 2: The drug is PF-4708671. The drug SMILES structure is CCC1=CN=CN=C1N2CCN(CC2)CC3=NC4=C(N3)C=C(C=C4)C(F)(F)F. Drug target is S6K1. Drug target pathway is PI3K/MTOR signaling.
Drug 3: The drug is AGI-5198. The drug SMILES structure is CC1=CC=CC=C1C(C(=O)NC2CCCCC2)N(C3=CC(=CC=C3)F)C(=O)CN4C=CN=C4C. Drug target is IDH1 (R132H). Drug target pathway is Metabolism.
The mutations of the cell line are BCOR, BRAF, IGF1R, MED12, RAD21, SDHA.
Best drug option: ?",KIN001-135
ACH-000009,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
Drug 2: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 3: The drug is AGI-5198. The drug SMILES structure is CC1=CC=CC=C1C(C(=O)NC2CCCCC2)N(C3=CC(=CC=C3)F)C(=O)CN4C=CN=C4C. Drug target is IDH1 (R132H). Drug target pathway is Metabolism.
The mutations of the cell line are ALK, APC, CTNNB1, EPHA3, ERBB3, ERG, JAK1, NFKBIA, PIK3C2B, ROS1, SMAD4, TP53, WHSC1.
Best drug option: ?",KIN001-135
ACH-000012,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is TIVOZANIB. The drug SMILES structure is CC1=CC(=NO1)NC(=O)NC2=C(C=C(C=C2)OC3=C4C=C(C(=CC4=NC=C3)OC)OC)Cl. Drug target is VEGFR1, VEGFR2, VEGFR3, PDGFR, KIT. Drug target pathway is RTK signaling.
Drug 2: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 3: The drug is JQ1-(+). The drug SMILES structure is CC1=C(SC2=C1C(=N[C@H](C3=NN=C(N32)C)CC(=O)OC(C)(C)C)C4=CC=C(C=C4)Cl)C. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are EGFR, FGF4, HNF1A, MYB, PTCH1, TP53, VEGFA.
Best drug option: ?",KIN001-135
ACH-000015,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is AVAGACESTAT. The drug SMILES structure is C1=CC(=CC=C1S(=O)(=O)N(CC2=C(C=C(C=C2)C3=NOC=N3)F)[C@H](CCC(F)(F)F)C(=O)N)Cl. Drug target is Amyloid beta20, Amyloid beta40. Drug target pathway is Other.
Drug 2: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 3: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are APC, ARID1A, INPP4B, MSH6, PIK3C2G, SMARCA4, TP53, ZNF217.
Best drug option: ?",KIN001-135
ACH-000018,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 2: The drug is CAY10566. The drug SMILES structure is CC1=NN=C(O1)C2=NN=C(C=C2)N3CCC(CC3)OC4=C(C=CC(=C4)F)Cl. Drug target is Stearoyl-CoA desaturase. Drug target pathway is Other.
Drug 3: The drug is LY2109761. The drug SMILES structure is C1CC2=C(C(=NN2C1)C3=CC=CC=N3)C4=C5C=CC(=CC5=NC=C4)OCCN6CCOCC6. Drug target is TGFB1. Drug target pathway is Other.
The mutations of the cell line are EP300, HRAS, KDM6A, SPEN, TP53.
Best drug option: ?",KIN001-135
ACH-000019,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
Drug 2: The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
Drug 3: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are EP300, ERBB4, GATA3, MAP3K13, NBN, PALB2, PAX5, PIK3CA.
Best drug option: ?",BRYOSTATIN-1
ACH-000020,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is YK-4-279. The drug SMILES structure is COC1=CC=C(C=C1)C(=O)CC2(C3=C(C=CC(=C3NC2=O)Cl)Cl)O. Drug target is RNA helicase A. Drug target pathway is Other.
Drug 2: The drug is ERK5-IN-1. The drug SMILES structure is CCOC1=C(C=CC(=C1)C(=O)N2CCC(CC2)N3CCN(CC3)C)NC4=NC=C5C(=N4)N(C6=CC=CC=C6C(=O)N5C)C7CCCC7. Drug target is ERK5, BET. Drug target pathway is Other.
Drug 3: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are JAK2, MLL2, NF1, QKI.
Best drug option: ?",KIN001-135
ACH-000023,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is IMATINIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5. Drug target is ABL, KIT, PDGFR. Drug target pathway is Other, kinases.
Drug 2: The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
Drug 3: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are ALOX12B, FAM123B, BCORL1, BRIP1, ERCC4, IRF2, KRAS, MRE11A, RNF43, TP53, TYRO3.
Best drug option: ?",KIN001-135
ACH-000024,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
Drug 2: The drug is ARA-G. The drug SMILES structure is C1=NC2=C(N1[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)N=C(NC2=O)N. Drug target is Anti-metabolite. Drug target pathway is Other.
Drug 3: The drug is GW-2580. The drug SMILES structure is COC1=CC=C(C=C1)COC2=C(C=C(C=C2)CC3=CN=C(N=C3N)N)OC. Drug target is CSF1R. Drug target pathway is RTK signaling.
The mutations of the cell line are CDKN2A, DIS3, FAM46C, FGFR3, GATA4, MLL2, MSH6, SMAD2, TP53.
Best drug option: ?",WYE-125132
ACH-000030,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is CAY10566. The drug SMILES structure is CC1=NN=C(O1)C2=NN=C(C=C2)N3CCC(CC3)OC4=C(C=CC(=C4)F)Cl. Drug target is Stearoyl-CoA desaturase. Drug target pathway is Other.
Drug 2: The drug is CETUXIMAB. The drug SMILES structure is CC1(C(=C)N(C2=CC=CC=C21)CCCCCC(=O)O)C. Drug target is EGFR. Drug target pathway is EGFR signaling.
Drug 3: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are ATM, CDKN2A, CIC, EGFR, MLL2, PBRM1, PIK3C2B, TP53.
Best drug option: ?",CAY10566
ACH-000035,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is LINSITINIB. The drug SMILES structure is CC1(CC(C1)C2=NC(=C3N2C=CN=C3N)C4=CC5=C(C=C4)C=CC(=N5)C6=CC=CC=C6)O. Drug target is IGF1R. Drug target pathway is IGF1R signaling.
Drug 2: The drug is YK-4-279. The drug SMILES structure is COC1=CC=C(C=C1)C(=O)CC2(C3=C(C=CC(=C3NC2=O)Cl)Cl)O. Drug target is RNA helicase A. Drug target pathway is Other.
Drug 3: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are APC, EGFR, ERG, MLL2, MED12, SMARCA4, TP53.
Best drug option: ?",KIN001-135
ACH-000038,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is AZD5363. The drug SMILES structure is O=C(C1(N)CCN(C2=C3C(NC=C3)=NC=N2)CC1)N[C@H](C4=CC=C(Cl)C=C4)CCO. Drug target is AKT1, AKT2, AKT3, ROCK2. Drug target pathway is Other, kinases.
Drug 2: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
Drug 3: The drug is IMATINIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5. Drug target is ABL, KIT, PDGFR. Drug target pathway is Other, kinases.
The mutations of the cell line are ATRX, BRCA2, RICTOR, SETD2.
Best drug option: ?",WYE-125132
ACH-000040,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 2: The drug is YK-4-279. The drug SMILES structure is COC1=CC=C(C=C1)C(=O)CC2(C3=C(C=CC(=C3NC2=O)Cl)Cl)O. Drug target is RNA helicase A. Drug target pathway is Other.
Drug 3: The drug is XMD13-2. The drug SMILES structure is O=C(C1CC1)NC2=NNC3=CC(C4=CC(C(NC5CC5)=O)=CC=C4)=CC=C32. Drug target is MRCKB. Drug target pathway is Cytoskeleton.
The mutations of the cell line are BARD1, CCND2, MTOR, PARK2, PTEN, TBX3, TP53.
Best drug option: ?",KIN001-135
ACH-000042,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is JQ1-(+). The drug SMILES structure is CC1=C(SC2=C1C(=N[C@H](C3=NN=C(N32)C)CC(=O)OC(C)(C)C)C4=CC=C(C=C4)Cl)C. Drug target is Unknown. Drug target pathway is Unknown.
Drug 2: The drug is PAZOPANIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC2=NC=CC(=N2)N(C)C3=CC4=NN(C(=C4C=C3)C)C)S(=O)(=O)N. Drug target is CSF1R, KIT,  PDGFRA, PDGFRB. Drug target pathway is RTK signaling.
Drug 3: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are ARID1A, CDKN2A, IDH1, KDR, KEL, KRAS, SF3B1, SMAD4, TP53.
Best drug option: ?",KIN001-135
ACH-000046,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is CAY10566. The drug SMILES structure is CC1=NN=C(O1)C2=NN=C(C=C2)N3CCC(CC3)OC4=C(C=CC(=C4)F)Cl. Drug target is Stearoyl-CoA desaturase. Drug target pathway is Other.
Drug 2: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 3: The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ATM, EPHB4, MPL, NF2, PBRM1, SMO.
Best drug option: ?",CAY10566
ACH-000048,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
Drug 2: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 3: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are CTNNB1, RICTOR, SF3B1, SMARCA4, SNCAIP, TP53.
Best drug option: ?",KIN001-135
ACH-000050,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 2: The drug is GSK2606414. The drug SMILES structure is CN1C=C(C2=C(N=CN=C21)N)C3=CC4=C(C=C3)N(CC4)C(=O)CC5=CC(=CC=C5)C(F)(F)F. Drug target is PERK. Drug target pathway is Metabolism.
Drug 3: The drug is AVAGACESTAT. The drug SMILES structure is C1=CC(=CC=C1S(=O)(=O)N(CC2=C(C=C(C=C2)C3=NOC=N3)F)[C@H](CCC(F)(F)F)C(=O)N)Cl. Drug target is Amyloid beta20, Amyloid beta40. Drug target pathway is Other.
The mutations of the cell line are ACVR1B, ATM, BCOR, BRCA2, BRIP1, FAM46C, FGFR4, KDM5A, MLL2, NRAS, PALB2, TBX3, XPO1.
Best drug option: ?",GSK2606414
ACH-000052,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
Drug 2: The drug is JNJ-38877605. The drug SMILES structure is CN1C=C(C=N1)C2=NN3C(=NN=C3C(C4=CC5=C(C=C4)N=CC=C5)(F)F)C=C2. Drug target is Unknown. Drug target pathway is Unknown.
Drug 3: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are BRAF, EED, MERTK, TP53.
Best drug option: ?",KIN001-135
ACH-000053,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is PF-4708671. The drug SMILES structure is CCC1=CN=CN=C1N2CCN(CC2)CC3=NC4=C(N3)C=C(C=C4)C(F)(F)F. Drug target is S6K1. Drug target pathway is PI3K/MTOR signaling.
Drug 2: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 3: The drug is AVAGACESTAT. The drug SMILES structure is C1=CC(=CC=C1S(=O)(=O)N(CC2=C(C=C(C=C2)C3=NOC=N3)F)[C@H](CCC(F)(F)F)C(=O)N)Cl. Drug target is Amyloid beta20, Amyloid beta40. Drug target pathway is Other.
The mutations of the cell line are ATR, DDR1, EPHB4, TP53.
Best drug option: ?",KIN001-135
ACH-000054,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is IMATINIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5. Drug target is ABL, KIT, PDGFR. Drug target pathway is Other, kinases.
Drug 2: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 3: The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are IDH1, NRAS, RAC1, RICTOR, RPTOR.
Best drug option: ?",IMATINIB
ACH-000055,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is YK-4-279. The drug SMILES structure is COC1=CC=C(C=C1)C(=O)CC2(C3=C(C=CC(=C3NC2=O)Cl)Cl)O. Drug target is RNA helicase A. Drug target pathway is Other.
Drug 2: The drug is FORETINIB. The drug SMILES structure is COC1=CC2=C(C=CN=C2C=C1OCCCN3CCOCC3)OC4=C(C=C(C=C4)NC(=O)C5(CC5)C(=O)NC6=CC=C(C=C6)F)F. Drug target is MET, KDR, TIE2, VEGFR3/FLT4, RON, PDGFR, FGFR1, EGFR. Drug target pathway is RTK signaling.
Drug 3: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ABL1, CIC, KIT, TP53.
Best drug option: ?",WYE-125132
ACH-000056,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is SARACATINIB. The drug SMILES structure is CN1CCN(CC1)CCOC2=CC(=C3C(=C2)N=CN=C3NC4=C(C=CC5=C4OCO5)Cl)OC6CCOCC6. Drug target is ABL, SRC. Drug target pathway is Other, kinases.
Drug 2: The drug is AVAGACESTAT. The drug SMILES structure is C1=CC(=CC=C1S(=O)(=O)N(CC2=C(C=C(C=C2)C3=NOC=N3)F)[C@H](CCC(F)(F)F)C(=O)N)Cl. Drug target is Amyloid beta20, Amyloid beta40. Drug target pathway is Other.
Drug 3: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are AXL, BCL2, BCR, BRCA2, CCND3, FLT1, GNA13, MED12, MYC, RAD51C.
Best drug option: ?",AVAGACESTAT
ACH-000058,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
Drug 2: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 3: The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are MED12, NF1, PIK3C2G, PRKAR1A, TP53.
Best drug option: ?",KIN001-135
ACH-000059,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is CAY10566. The drug SMILES structure is CC1=NN=C(O1)C2=NN=C(C=C2)N3CCC(CC3)OC4=C(C=CC(=C4)F)Cl. Drug target is Stearoyl-CoA desaturase. Drug target pathway is Other.
Drug 2: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 3: The drug is YK-4-279. The drug SMILES structure is COC1=CC=C(C=C1)C(=O)CC2(C3=C(C=CC(=C3NC2=O)Cl)Cl)O. Drug target is RNA helicase A. Drug target pathway is Other.
The mutations of the cell line are GNAS, IKZF1, INPP4B, KDM5C, MLL2, PRKCI, PTPRO, U2AF1.
Best drug option: ?",CAY10566
ACH-000060,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
Drug 2: The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
Drug 3: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are BRCA1, CHEK1, EP300, KRAS, MAP3K13, NF1, PBRM1, RNF43, SPEN, TGFBR2, TP53.
Best drug option: ?",YM-201636
ACH-000061,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is GW-2580. The drug SMILES structure is COC1=CC=C(C=C1)COC2=C(C=C(C=C2)CC3=CN=C(N=C3N)N)OC. Drug target is CSF1R. Drug target pathway is RTK signaling.
Drug 2: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
Drug 3: The drug is QS-11. The drug SMILES structure is C1CC2=C(C1)C=C(C=C2)OC3=NC(=C4C(=N3)N(C=N4)CC5=CC=C(C=C5)C6=CC=CC=C6)NC(CC7=CC=CC=C7)CO. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are CTNNB1, EPHA3, PDGFRB, SLC34A2, SPEN, TP53.
Best drug option: ?",QS-11
ACH-000062,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is LENALIDOMIDE. The drug SMILES structure is C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N. Drug target is CRBN. Drug target pathway is Protein stability and degradation.
Drug 2: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 3: The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are BRIP1, DOT1L, FGFR2, KEAP1, KEL, MSH2, PAX5, TP53.
Best drug option: ?",BRYOSTATIN-1
ACH-000065,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
Drug 2: The drug is PAZOPANIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC2=NC=CC(=N2)N(C)C3=CC4=NN(C(=C4C=C3)C)C)S(=O)(=O)N. Drug target is CSF1R, KIT,  PDGFRA, PDGFRB. Drug target pathway is RTK signaling.
Drug 3: The drug is IMATINIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5. Drug target is ABL, KIT, PDGFR. Drug target pathway is Other, kinases.
The mutations of the cell line are APC, ASXL1, CREBBP, DDR1, EZH2, IKZF1, NF1, POLD1, PTPN11, TET2.
Best drug option: ?",IMATINIB
ACH-000070,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is YK-4-279. The drug SMILES structure is COC1=CC=C(C=C1)C(=O)CC2(C3=C(C=CC(=C3NC2=O)Cl)Cl)O. Drug target is RNA helicase A. Drug target pathway is Other.
Drug 2: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 3: The drug is IMATINIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5. Drug target is ABL, KIT, PDGFR. Drug target pathway is Other, kinases.
The mutations of the cell line are CRKL, CYP17A1, EPHA3, FGF14, H3F3A, MLL2, NOTCH3, NRAS, NT5C2, POLE.
Best drug option: ?",IMATINIB
ACH-000072,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is REFAMETINIB. The drug SMILES structure is COC1=CC(=C(C(=C1NS(=O)(=O)C2(CC2)C[C@@H](CO)O)NC3=C(C=C(C=C3)I)F)F)F. Drug target is MEK1, MEK2. Drug target pathway is ERK MAPK signaling.
Drug 2: The drug is AZD4547. The drug SMILES structure is C[C@@H]1CN(C[C@@H](N1)C)C2=CC=C(C=C2)C(=O)NC3=NNC(=C3)CCC4=CC(=CC(=C4)OC)OC. Drug target is FGRF1, FGFR2, FGFR3. Drug target pathway is RTK signaling.
Drug 3: The drug is PI-103. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)O. Drug target is PI3Kalpha, DAPK3, CLK4, PIM3, HIPK2. Drug target pathway is Other, kinases.
The mutations of the cell line are ARID1A, EGFR, FGFR1, FLCN, FLT1, GSK3B, NT5C2, PPARG, RPTOR, TP53, WHSC1L1.
Best drug option: ?",REFAMETINIB
ACH-000073,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 2: The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
Drug 3: The drug is IMATINIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5. Drug target is ABL, KIT, PDGFR. Drug target pathway is Other, kinases.
The mutations of the cell line are ATM, BRCA2, KDM5A, MLL2, MDM4, MST1R, WHSC1.
Best drug option: ?",IMATINIB
ACH-000074,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is REFAMETINIB. The drug SMILES structure is COC1=CC(=C(C(=C1NS(=O)(=O)C2(CC2)C[C@@H](CO)O)NC3=C(C=C(C=C3)I)F)F)F. Drug target is MEK1, MEK2. Drug target pathway is ERK MAPK signaling.
Drug 2: The drug is FORETINIB. The drug SMILES structure is COC1=CC2=C(C=CN=C2C=C1OCCCN3CCOCC3)OC4=C(C=C(C=C4)NC(=O)C5(CC5)C(=O)NC6=CC=C(C=C6)F)F. Drug target is MET, KDR, TIE2, VEGFR3/FLT4, RON, PDGFR, FGFR1, EGFR. Drug target pathway is RTK signaling.
Drug 3: The drug is JQ1-(+). The drug SMILES structure is CC1=C(SC2=C1C(=N[C@H](C3=NN=C(N32)C)CC(=O)OC(C)(C)C)C4=CC=C(C=C4)Cl)C. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ASXL1, DOT1L, TP53.
Best drug option: ?",REFAMETINIB
ACH-000075,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 2: The drug is QS-11. The drug SMILES structure is C1CC2=C(C1)C=C(C=C2)OC3=NC(=C4C(=N3)N(C=N4)CC5=CC=C(C=C5)C6=CC=CC=C6)NC(CC7=CC=CC=C7)CO. Drug target is Unknown. Drug target pathway is Unknown.
Drug 3: The drug is LENALIDOMIDE. The drug SMILES structure is C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N. Drug target is CRBN. Drug target pathway is Protein stability and degradation.
The mutations of the cell line are ATRX, EPHA3, NF1, PTEN, RICTOR.
Best drug option: ?",KIN001-135
ACH-000081,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is XMD13-2. The drug SMILES structure is O=C(C1CC1)NC2=NNC3=CC(C4=CC(C(NC5CC5)=O)=CC=C4)=CC=C32. Drug target is MRCKB. Drug target pathway is Cytoskeleton.
Drug 2: The drug is IMATINIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5. Drug target is ABL, KIT, PDGFR. Drug target pathway is Other, kinases.
Drug 3: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are CBL, CSF1R, DDR2, EED, ERG, PTPN11, RPTOR.
Best drug option: ?",IMATINIB
ACH-000082,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
Drug 2: The drug is JNJ-38877605. The drug SMILES structure is CN1C=C(C=N1)C2=NN3C(=NN=C3C(C4=CC5=C(C=C4)N=CC=C5)(F)F)C=C2. Drug target is Unknown. Drug target pathway is Unknown.
Drug 3: The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ERCC4, TP53.
Best drug option: ?",BRYOSTATIN-1
ACH-000087,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
Drug 2: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 3: The drug is IMATINIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5. Drug target is ABL, KIT, PDGFR. Drug target pathway is Other, kinases.
The mutations of the cell line are APC, RICTOR, STAG2, TP53.
Best drug option: ?",IMATINIB
ACH-000090,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
Drug 2: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 3: The drug is QS-11. The drug SMILES structure is C1CC2=C(C1)C=C(C=C2)OC3=NC(=C4C(=N3)N(C=N4)CC5=CC=C(C=C5)C6=CC=CC=C6)NC(CC7=CC=CC=C7)CO. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are TP53, WHSC1.
Best drug option: ?",KIN001-135
ACH-000091,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is LENALIDOMIDE. The drug SMILES structure is C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N. Drug target is CRBN. Drug target pathway is Protein stability and degradation.
Drug 2: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 3: The drug is PAZOPANIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC2=NC=CC(=N2)N(C)C3=CC4=NN(C(=C4C=C3)C)C)S(=O)(=O)N. Drug target is CSF1R, KIT,  PDGFRA, PDGFRB. Drug target pathway is RTK signaling.
The mutations of the cell line are ALK, ARID1A, AXL, CREBBP, ETV6, GATA4, IRS2, MLL, KRAS, PIK3R1, PTEN, RICTOR, TP53, WHSC1L1.
Best drug option: ?",KIN001-135
ACH-000092,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is LINSITINIB. The drug SMILES structure is CC1(CC(C1)C2=NC(=C3N2C=CN=C3N)C4=CC5=C(C=C4)C=CC(=N5)C6=CC=CC=C6)O. Drug target is IGF1R. Drug target pathway is IGF1R signaling.
Drug 2: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 3: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ALK, AXIN1, BAP1, KEL, MPL, VEGFA, WHSC1L1.
Best drug option: ?",KIN001-135
ACH-000094,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is QS-11. The drug SMILES structure is C1CC2=C(C1)C=C(C=C2)OC3=NC(=C4C(=N3)N(C=N4)CC5=CC=C(C=C5)C6=CC=CC=C6)NC(CC7=CC=CC=C7)CO. Drug target is Unknown. Drug target pathway is Unknown.
Drug 2: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 3: The drug is AZD8931. The drug SMILES structure is CNC(=O)CN1CCC(CC1)OC2=C(C=C3C(=C2)C(=NC=N3)NC4=C(C(=CC=C4)Cl)F)OC. Drug target is EGFR, ERBB2, ERBB3. Drug target pathway is RTK signaling.
The mutations of the cell line are ATRX, CDKN2A, GNA13, KRAS, POLE, RNF43, TP53.
Best drug option: ?",KIN001-135
ACH-000096,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is YK-4-279. The drug SMILES structure is COC1=CC=C(C=C1)C(=O)CC2(C3=C(C=CC(=C3NC2=O)Cl)Cl)O. Drug target is RNA helicase A. Drug target pathway is Other.
Drug 2: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 3: The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are AXL, DDR1, TP53.
Best drug option: ?",KIN001-135
ACH-000098,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
Drug 2: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 3: The drug is CAY10566. The drug SMILES structure is CC1=NN=C(O1)C2=NN=C(C=C2)N3CCC(CC3)OC4=C(C=CC(=C4)F)Cl. Drug target is Stearoyl-CoA desaturase. Drug target pathway is Other.
The mutations of the cell line are BCOR, PIK3R1, SF3B1, SMARCA4, TP53, WHSC1L1.
Best drug option: ?",KIN001-135
ACH-000099,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is ARA-G. The drug SMILES structure is C1=NC2=C(N1[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)N=C(NC2=O)N. Drug target is Anti-metabolite. Drug target pathway is Other.
Drug 2: The drug is YK-4-279. The drug SMILES structure is COC1=CC=C(C=C1)C(=O)CC2(C3=C(C=CC(=C3NC2=O)Cl)Cl)O. Drug target is RNA helicase A. Drug target pathway is Other.
Drug 3: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ALK, BRCA2, DNMT3A, GATA3, MLL.
Best drug option: ?",WYE-125132
ACH-000100,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is JNJ-38877605. The drug SMILES structure is CN1C=C(C=N1)C2=NN3C(=NN=C3C(C4=CC5=C(C=C4)N=CC=C5)(F)F)C=C2. Drug target is Unknown. Drug target pathway is Unknown.
Drug 2: The drug is GW-2580. The drug SMILES structure is COC1=CC=C(C=C1)COC2=C(C=C(C=C2)CC3=CN=C(N=C3N)N)OC. Drug target is CSF1R. Drug target pathway is RTK signaling.
Drug 3: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are APC, NOTCH1, PARK2, PRKAR1A, TP53.
Best drug option: ?",WYE-125132
ACH-000101,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
Drug 2: The drug is EX-527. The drug SMILES structure is C1CC(C2=C(C1)C3=C(N2)C=CC(=C3)Cl)C(=O)N. Drug target is SIRT1. Drug target pathway is Chromatin histone acetylation.
Drug 3: The drug is IMATINIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5. Drug target is ABL, KIT, PDGFR. Drug target pathway is Other, kinases.
The mutations of the cell line are ATM, BRIP1, DAXX, EZH2, NOTCH1, NRAS, PTCH1, SF3B1, TP53.
Best drug option: ?",IMATINIB
ACH-000102,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 2: The drug is PF-4708671. The drug SMILES structure is CCC1=CN=CN=C1N2CCN(CC2)CC3=NC4=C(N3)C=C(C=C4)C(F)(F)F. Drug target is S6K1. Drug target pathway is PI3K/MTOR signaling.
Drug 3: The drug is FORETINIB. The drug SMILES structure is COC1=CC2=C(C=CN=C2C=C1OCCCN3CCOCC3)OC4=C(C=C(C=C4)NC(=O)C5(CC5)C(=O)NC6=CC=C(C=C6)F)F. Drug target is MET, KDR, TIE2, VEGFR3/FLT4, RON, PDGFR, FGFR1, EGFR. Drug target pathway is RTK signaling.
The mutations of the cell line are ATR, ERCC4, MLL, MED12, MERTK, NOTCH3, PIK3CB, PTEN, RB1, TP53.
Best drug option: ?",PF-4708671
ACH-000103,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 2: The drug is LENALIDOMIDE. The drug SMILES structure is C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N. Drug target is CRBN. Drug target pathway is Protein stability and degradation.
Drug 3: The drug is YK-4-279. The drug SMILES structure is COC1=CC=C(C=C1)C(=O)CC2(C3=C(C=CC(=C3NC2=O)Cl)Cl)O. Drug target is RNA helicase A. Drug target pathway is Other.
The mutations of the cell line are NOTCH1, PIK3C2G, RAF1, SRC, TP53.
Best drug option: ?",KIN001-135
ACH-000104,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is EX-527. The drug SMILES structure is C1CC(C2=C(C1)C3=C(N2)C=CC(=C3)Cl)C(=O)N. Drug target is SIRT1. Drug target pathway is Chromatin histone acetylation.
Drug 2: The drug is CPI-613. The drug SMILES structure is C1=CC=C(C=C1)CSCCC(CCCCC(=O)O)SCC2=CC=CC=C2. Drug target is Metabo, Mitochondria. Drug target pathway is Other.
Drug 3: The drug is PAC-1. The drug SMILES structure is C=CCC1=CC=CC(=CNNC(=O)CN2CCN(CC2)CC3=CC=CC=C3)C1=O. Drug target is Procaspase-3, Procaspase-7. Drug target pathway is Apoptosis regulation.
The mutations of the cell line are CDKN1B, DDR1, LYN, MYCN, TP53.
Best drug option: ?",CPI-613
ACH-000106,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is YK-4-279. The drug SMILES structure is COC1=CC=C(C=C1)C(=O)CC2(C3=C(C=CC(=C3NC2=O)Cl)Cl)O. Drug target is RNA helicase A. Drug target pathway is Other.
Drug 2: The drug is AVAGACESTAT. The drug SMILES structure is C1=CC(=CC=C1S(=O)(=O)N(CC2=C(C=C(C=C2)C3=NOC=N3)F)[C@H](CCC(F)(F)F)C(=O)N)Cl. Drug target is Amyloid beta20, Amyloid beta40. Drug target pathway is Other.
Drug 3: The drug is IMATINIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5. Drug target is ABL, KIT, PDGFR. Drug target pathway is Other, kinases.
The mutations of the cell line are PIK3C2G.
Best drug option: ?",IMATINIB
ACH-000108,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 2: The drug is LESTAURTINIB. The drug SMILES structure is C[C@@]12[C@](C[C@@H](O1)N3C4=CC=CC=C4C5=C6C(=C7C8=CC=CC=C8N2C7=C53)CNC6=O)(CO)O. Drug target is FLT3, JAK2, NTRK1, NTRK2, NTRK3. Drug target pathway is Other, kinases.
Drug 3: The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ARID1A, FLT3, GNAS, KRAS, SMAD4, SPEN, TP53.
Best drug option: ?",BRYOSTATIN-1
ACH-000111,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is CETUXIMAB. The drug SMILES structure is CC1(C(=C)N(C2=CC=CC=C21)CCCCCC(=O)O)C. Drug target is EGFR. Drug target pathway is EGFR signaling.
Drug 2: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
Drug 3: The drug is WIKI4. The drug SMILES structure is COC1=CC=C(C=C1)N2C(=NN=C2SCCCN3C(=O)C4=CC=CC5=C4C(=CC=C5)C3=O)C6=CC=NC=C6. Drug target is TNKS1, TNKS2. Drug target pathway is WNT signaling.
The mutations of the cell line are BAP1, BTK, CTNNA1, MDM2, NFKBIA, SPEN, TP53.
Best drug option: ?",WYE-125132
ACH-000112,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is CMK. The drug SMILES structure is CC1=CC=C(C=C1)C2=C(N(C3=NC=NC(=C23)N)CCCO)C(=O)CCl. Drug target is RSK2. Drug target pathway is Other, kinases.
Drug 2: The drug is KOBE2602. The drug SMILES structure is C1=CC(=CC=C1NC(=S)NNC2=C(C=C(C=C2[N+](=O)[O-])C(F)(F)F)[N+](=O)[O-])F. Drug target is RAS effector. Drug target pathway is RTK signaling.
Drug 3: The drug is GSK2578215A. The drug SMILES structure is C1=CC=C(C=C1)COC2=C(C=C(C=C2)C3=CC(=NC=C3)F)C(=O)NC4=CN=CC=C4. Drug target is LRRK2. Drug target pathway is Other, kinases.
The mutations of the cell line are ALK, BCORL1, BRAF, DNMT3A, ERBB4, FGF4, KIT, MLL2, MED12, NOTCH1, RAD51B, TET2.
Best drug option: ?",GSK2578215A
ACH-000113,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
Drug 2: The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
Drug 3: The drug is BORTEZOMIB. The drug SMILES structure is B([C@H](CC(C)C)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O. Drug target is Proteasome. Drug target pathway is Protein stability and degradation.
The mutations of the cell line are FANCA, FLCN, FLT3, MLL, SPEN.
Best drug option: ?",WYE-125132
ACH-000114,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 2: The drug is CAY10566. The drug SMILES structure is CC1=NN=C(O1)C2=NN=C(C=C2)N3CCC(CC3)OC4=C(C=CC(=C4)F)Cl. Drug target is Stearoyl-CoA desaturase. Drug target pathway is Other.
Drug 3: The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are FANCC, FGF23, GATA6, KRAS, TP53.
Best drug option: ?",KIN001-135
ACH-000115,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 2: The drug is FORETINIB. The drug SMILES structure is COC1=CC2=C(C=CN=C2C=C1OCCCN3CCOCC3)OC4=C(C=C(C=C4)NC(=O)C5(CC5)C(=O)NC6=CC=C(C=C6)F)F. Drug target is MET, KDR, TIE2, VEGFR3/FLT4, RON, PDGFR, FGFR1, EGFR. Drug target pathway is RTK signaling.
Drug 3: The drug is PAZOPANIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC2=NC=CC(=N2)N(C)C3=CC4=NN(C(=C4C=C3)C)C)S(=O)(=O)N. Drug target is CSF1R, KIT,  PDGFRA, PDGFRB. Drug target pathway is RTK signaling.
The mutations of the cell line are CCND1, IKBKE, MSH6, RICTOR, TP53.
Best drug option: ?",PAZOPANIB
ACH-000116,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is JQ1-(+). The drug SMILES structure is CC1=C(SC2=C1C(=N[C@H](C3=NN=C(N32)C)CC(=O)OC(C)(C)C)C4=CC=C(C=C4)Cl)C. Drug target is Unknown. Drug target pathway is Unknown.
Drug 2: The drug is PAZOPANIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC2=NC=CC(=N2)N(C)C3=CC4=NN(C(=C4C=C3)C)C)S(=O)(=O)N. Drug target is CSF1R, KIT,  PDGFRA, PDGFRB. Drug target pathway is RTK signaling.
Drug 3: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are KEAP1, MUTYH, NBN, TEK, TP53.
Best drug option: ?",KIN001-135
ACH-000117,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
Drug 2: The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
Drug 3: The drug is CAY10566. The drug SMILES structure is CC1=NN=C(O1)C2=NN=C(C=C2)N3CCC(CC3)OC4=C(C=CC(=C4)F)Cl. Drug target is Stearoyl-CoA desaturase. Drug target pathway is Other.
The mutations of the cell line are FAM123B, CIC, EZH2, MERTK, NF1, NOTCH2, PIK3C2B, PIK3CA, PTPRO, TP53, ZNF217.
Best drug option: ?",CAY10566
ACH-000118,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
Drug 2: The drug is YK-4-279. The drug SMILES structure is COC1=CC=C(C=C1)C(=O)CC2(C3=C(C=CC(=C3NC2=O)Cl)Cl)O. Drug target is RNA helicase A. Drug target pathway is Other.
Drug 3: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are BRCA2, IRF2, KRAS, MET, MSH2, MSH6, SETD2, SF3B1, TP53.
Best drug option: ?",KIN001-135
ACH-000120,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is JNJ-38877605. The drug SMILES structure is CN1C=C(C=N1)C2=NN3C(=NN=C3C(C4=CC5=C(C=C4)N=CC=C5)(F)F)C=C2. Drug target is Unknown. Drug target pathway is Unknown.
Drug 2: The drug is CMK. The drug SMILES structure is CC1=CC=C(C=C1)C2=C(N(C3=NC=NC(=C23)N)CCCO)C(=O)CCl. Drug target is RSK2. Drug target pathway is Other, kinases.
Drug 3: The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ALOX12B, FGF19, GRM3, NRAS, SOX9.
Best drug option: ?",CMK
ACH-000121,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
Drug 2: The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
Drug 3: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are BRAF, CIC, FGF6, FLCN, PRKAR1A, SPEN, TP53.
Best drug option: ?",BRYOSTATIN-1
ACH-000124,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is IMATINIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5. Drug target is ABL, KIT, PDGFR. Drug target pathway is Other, kinases.
Drug 2: The drug is EX-527. The drug SMILES structure is C1CC(C2=C(C1)C3=C(N2)C=CC(=C3)Cl)C(=O)N. Drug target is SIRT1. Drug target pathway is Chromatin histone acetylation.
Drug 3: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are ARID1A, ASXL1, ATRX, BCL2, CREBBP, CUL3, GNAS, MLL2, MERTK, NRAS, RICTOR, SDHA, WHSC1L1.
Best drug option: ?",KIN001-135
ACH-000129,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
Drug 2: The drug is JNJ-38877605. The drug SMILES structure is CN1C=C(C=N1)C2=NN3C(=NN=C3C(C4=CC5=C(C=C4)N=CC=C5)(F)F)C=C2. Drug target is Unknown. Drug target pathway is Unknown.
Drug 3: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are H3F3A, PIK3CA, PMS2, POLD1.
Best drug option: ?",WYE-125132
ACH-000132,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is BORTEZOMIB. The drug SMILES structure is B([C@H](CC(C)C)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O. Drug target is Proteasome. Drug target pathway is Protein stability and degradation.
Drug 2: The drug is FORETINIB. The drug SMILES structure is COC1=CC2=C(C=CN=C2C=C1OCCCN3CCOCC3)OC4=C(C=C(C=C4)NC(=O)C5(CC5)C(=O)NC6=CC=C(C=C6)F)F. Drug target is MET, KDR, TIE2, VEGFR3/FLT4, RON, PDGFR, FGFR1, EGFR. Drug target pathway is RTK signaling.
Drug 3: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are BRCA1, ERRFI1, NF1, NTRK2, STAG2, TP53.
Best drug option: ?",KIN001-135
ACH-000135,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is JNJ-38877605. The drug SMILES structure is CN1C=C(C=N1)C2=NN3C(=NN=C3C(C4=CC5=C(C=C4)N=CC=C5)(F)F)C=C2. Drug target is Unknown. Drug target pathway is Unknown.
Drug 2: The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
Drug 3: The drug is PANOBINOSTAT. The drug SMILES structure is CC1=C(C2=CC=CC=C2N1)CCNCC3=CC=C(C=C3)C=CC(=O)NO. Drug target is HDAC. Drug target pathway is Chromatin histone acetylation.
The mutations of the cell line are INPP4B, NRAS, TP53.
Best drug option: ?",PANOBINOSTAT
ACH-000136,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 2: The drug is IMATINIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5. Drug target is ABL, KIT, PDGFR. Drug target pathway is Other, kinases.
Drug 3: The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ASXL1, ATM, CREBBP, DAXX, RNF43, SRC.
Best drug option: ?",IMATINIB
ACH-000137,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 2: The drug is IMATINIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5. Drug target is ABL, KIT, PDGFR. Drug target pathway is Other, kinases.
Drug 3: The drug is YK-4-279. The drug SMILES structure is COC1=CC=C(C=C1)C(=O)CC2(C3=C(C=CC(=C3NC2=O)Cl)Cl)O. Drug target is RNA helicase A. Drug target pathway is Other.
The mutations of the cell line are APC, CTNNA1, GRM3, NF1, PBRM1, PTEN, TP53.
Best drug option: ?",KIN001-135
ACH-000138,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
Drug 2: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 3: The drug is CAY10566. The drug SMILES structure is CC1=NN=C(O1)C2=NN=C(C=C2)N3CCC(CC3)OC4=C(C=CC(=C4)F)Cl. Drug target is Stearoyl-CoA desaturase. Drug target pathway is Other.
The mutations of the cell line are KRAS, TP53.
Best drug option: ?",YM-201636
ACH-000144,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
Drug 2: The drug is ARA-G. The drug SMILES structure is C1=NC2=C(N1[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)N=C(NC2=O)N. Drug target is Anti-metabolite. Drug target pathway is Other.
Drug 3: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are BRCA2, CDH1, ERBB3, GNAS, RB1, SMARCA4, SPEN, TP53.
Best drug option: ?",WYE-125132
ACH-000145,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is GSK2606414. The drug SMILES structure is CN1C=C(C2=C(N=CN=C21)N)C3=CC4=C(C=C3)N(CC4)C(=O)CC5=CC(=CC=C5)C(F)(F)F. Drug target is PERK. Drug target pathway is Metabolism.
Drug 2: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
Drug 3: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are BCL2L1, BCOR, GNAS, NF1, TP53.
Best drug option: ?",KIN001-135
ACH-000146,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 2: The drug is IMATINIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5. Drug target is ABL, KIT, PDGFR. Drug target pathway is Other, kinases.
Drug 3: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ATM, FANCG, C17orf39, MSH3, NRAS, TP53, TSC1, TYRO3.
Best drug option: ?",IMATINIB
ACH-000149,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is CAY10566. The drug SMILES structure is CC1=NN=C(O1)C2=NN=C(C=C2)N3CCC(CC3)OC4=C(C=CC(=C4)F)Cl. Drug target is Stearoyl-CoA desaturase. Drug target pathway is Other.
Drug 2: The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
Drug 3: The drug is PANOBINOSTAT. The drug SMILES structure is CC1=C(C2=CC=CC=C2N1)CCNCC3=CC=C(C=C3)C=CC(=O)NO. Drug target is HDAC. Drug target pathway is Chromatin histone acetylation.
The mutations of the cell line are ALK, AXIN1, MPL, NRAS, RICTOR, SMARCA4.
Best drug option: ?",YM-201636
ACH-000151,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is IMATINIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5. Drug target is ABL, KIT, PDGFR. Drug target pathway is Other, kinases.
Drug 2: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 3: The drug is KOBE2602. The drug SMILES structure is C1=CC(=CC=C1NC(=S)NNC2=C(C=C(C=C2[N+](=O)[O-])C(F)(F)F)[N+](=O)[O-])F. Drug target is RAS effector. Drug target pathway is RTK signaling.
The mutations of the cell line are FAM123B, BCL2, BTG2, MLL2, MYC, SOCS1.
Best drug option: ?",IMATINIB
ACH-000153,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is CAY10566. The drug SMILES structure is CC1=NN=C(O1)C2=NN=C(C=C2)N3CCC(CC3)OC4=C(C=CC(=C4)F)Cl. Drug target is Stearoyl-CoA desaturase. Drug target pathway is Other.
Drug 2: The drug is AGI-5198. The drug SMILES structure is CC1=CC=CC=C1C(C(=O)NC2CCCCC2)N(C3=CC(=CC=C3)F)C(=O)CN4C=CN=C4C. Drug target is IDH1 (R132H). Drug target pathway is Metabolism.
Drug 3: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are NF2, NFKBIA, REL, SYK, TERT.
Best drug option: ?",KIN001-135
ACH-000155,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
Drug 2: The drug is PANOBINOSTAT. The drug SMILES structure is CC1=C(C2=CC=CC=C2N1)CCNCC3=CC=C(C=C3)C=CC(=O)NO. Drug target is HDAC. Drug target pathway is Chromatin histone acetylation.
Drug 3: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are FLCN, JAK2, JAK3, KRAS, NOTCH3, SOX9, TP53.
Best drug option: ?",BRYOSTATIN-1
ACH-000157,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is JNJ-38877605. The drug SMILES structure is CN1C=C(C=N1)C2=NN3C(=NN=C3C(C4=CC5=C(C=C4)N=CC=C5)(F)F)C=C2. Drug target is Unknown. Drug target pathway is Unknown.
Drug 2: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
Drug 3: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are ARID1A, BCOR, CCND3, ETV5, FLT1, KLHL6, MYC, MYD88, NF1, PBRM1, STAG2, TP53.
Best drug option: ?",WYE-125132
ACH-000159,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
Drug 2: The drug is NILOTINIB. The drug SMILES structure is CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)N3C=C(N=C3)C)C(F)(F)F)NC4=NC=CC(=N4)C5=CN=CC=C5. Drug target is ABL. Drug target pathway is ABL signaling.
Drug 3: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are APC, AR, FBXW7, PBRM1, PTEN, SDHB, VHL, WT1.
Best drug option: ?",KIN001-135
ACH-000161,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 2: The drug is LESTAURTINIB. The drug SMILES structure is C[C@@]12[C@](C[C@@H](O1)N3C4=CC=CC=C4C5=C6C(=C7C8=CC=CC=C8N2C7=C53)CNC6=O)(CO)O. Drug target is FLT3, JAK2, NTRK1, NTRK2, NTRK3. Drug target pathway is Other, kinases.
Drug 3: The drug is QL-VIII-58. The drug SMILES structure is NC1=NC=C(C=N1)C1=CC=C2N=CC3=C(N(C(=O)C=C3)C3=CC(Cl)=C(C=C3)N3CCNCC3)C2=C1. Drug target is MTOR, ATR. Drug target pathway is Other.
The mutations of the cell line are IDH1, MLL2, TEK.
Best drug option: ?",QL-VIII-58
ACH-000162,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is FORETINIB. The drug SMILES structure is COC1=CC2=C(C=CN=C2C=C1OCCCN3CCOCC3)OC4=C(C=C(C=C4)NC(=O)C5(CC5)C(=O)NC6=CC=C(C=C6)F)F. Drug target is MET, KDR, TIE2, VEGFR3/FLT4, RON, PDGFR, FGFR1, EGFR. Drug target pathway is RTK signaling.
Drug 2: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 3: The drug is IMATINIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5. Drug target is ABL, KIT, PDGFR. Drug target pathway is Other, kinases.
The mutations of the cell line are ARID1A, CCND3, DIS3, EPHA3, ID3, MYC, NRAS, TP53.
Best drug option: ?",KIN001-135
ACH-000168,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is IMATINIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5. Drug target is ABL, KIT, PDGFR. Drug target pathway is Other, kinases.
Drug 2: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
Drug 3: The drug is AVAGACESTAT. The drug SMILES structure is C1=CC(=CC=C1S(=O)(=O)N(CC2=C(C=C(C=C2)C3=NOC=N3)F)[C@H](CCC(F)(F)F)C(=O)N)Cl. Drug target is Amyloid beta20, Amyloid beta40. Drug target pathway is Other.
The mutations of the cell line are ASXL1, CDKN1B, CEBPA, CIC, EGFR, KDR, KRAS, TP53.
Best drug option: ?",WYE-125132
ACH-000171,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
Drug 2: The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
Drug 3: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are BRCA1, BRCA2, CSF3R, MKNK1, PARP3, TP53, VHL.
Best drug option: ?",KIN001-135
ACH-000174,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is GSK2606414. The drug SMILES structure is CN1C=C(C2=C(N=CN=C21)N)C3=CC4=C(C=C3)N(CC4)C(=O)CC5=CC(=CC=C5)C(F)(F)F. Drug target is PERK. Drug target pathway is Metabolism.
Drug 2: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
Drug 3: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are CREBBP, EP300, EPHA3, MLL2, KRAS, NF2, TP53.
Best drug option: ?",KIN001-135
ACH-000176,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 2: The drug is AVAGACESTAT. The drug SMILES structure is C1=CC(=CC=C1S(=O)(=O)N(CC2=C(C=C(C=C2)C3=NOC=N3)F)[C@H](CCC(F)(F)F)C(=O)N)Cl. Drug target is Amyloid beta20, Amyloid beta40. Drug target pathway is Other.
Drug 3: The drug is GSK2606414. The drug SMILES structure is CN1C=C(C2=C(N=CN=C21)N)C3=CC4=C(C=C3)N(CC4)C(=O)CC5=CC(=CC=C5)C(F)(F)F. Drug target is PERK. Drug target pathway is Metabolism.
The mutations of the cell line are FAM123B, EGFR, EP300, NF2, PIK3CA, TP53.
Best drug option: ?",KIN001-135
ACH-000178,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 2: The drug is PANOBINOSTAT. The drug SMILES structure is CC1=C(C2=CC=CC=C2N1)CCNCC3=CC=C(C=C3)C=CC(=O)NO. Drug target is HDAC. Drug target pathway is Chromatin histone acetylation.
Drug 3: The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are FAM123B, ARID1A, ATR, CARD11, CDKN2A, ERBB4, FANCG, FGF19, MLL, KRAS, MYD88.
Best drug option: ?",BRYOSTATIN-1
ACH-000181,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 2: The drug is JNJ-38877605. The drug SMILES structure is CN1C=C(C=N1)C2=NN3C(=NN=C3C(C4=CC5=C(C=C4)N=CC=C5)(F)F)C=C2. Drug target is Unknown. Drug target pathway is Unknown.
Drug 3: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ATR, FLCN, HRAS, NF1, RICTOR, SLC34A2.
Best drug option: ?",JNJ-38877605
ACH-000183,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is GW-2580. The drug SMILES structure is COC1=CC=C(C=C1)COC2=C(C=C(C=C2)CC3=CN=C(N=C3N)N)OC. Drug target is CSF1R. Drug target pathway is RTK signaling.
Drug 2: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
Drug 3: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are ARID1A, CALR, ERBB3, FANCA, IGF1R, KLHL6, NRAS, PIK3CA, RAF1, TP53.
Best drug option: ?",KIN001-135
ACH-000186,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 2: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
Drug 3: The drug is AZD8931. The drug SMILES structure is CNC(=O)CN1CCC(CC1)OC2=C(C=C3C(=C2)C(=NC=N3)NC4=C(C(=CC=C4)Cl)F)OC. Drug target is EGFR, ERBB2, ERBB3. Drug target pathway is RTK signaling.
The mutations of the cell line are ATRX, CD70, DOT1L, KDR, KRAS, PBRM1, PTEN, RBM10, TP53.
Best drug option: ?",WYE-125132
ACH-000187,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 2: The drug is AT13148. The drug SMILES structure is C1=CC(=CC=C1C2=CNN=C2)[C@@](CN)(C3=CC=C(C=C3)Cl)O. Drug target is AKT1. Drug target pathway is PI3K/MTOR signaling.
Drug 3: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ALK, RB1, SMARCA4, TP53.
Best drug option: ?",KIN001-135
ACH-000188,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is JNJ-38877605. The drug SMILES structure is CN1C=C(C=N1)C2=NN3C(=NN=C3C(C4=CC5=C(C=C4)N=CC=C5)(F)F)C=C2. Drug target is Unknown. Drug target pathway is Unknown.
Drug 2: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 3: The drug is PANOBINOSTAT. The drug SMILES structure is CC1=C(C2=CC=CC=C2N1)CCNCC3=CC=C(C=C3)C=CC(=O)NO. Drug target is HDAC. Drug target pathway is Chromatin histone acetylation.
The mutations of the cell line are FGF19, TP53.
Best drug option: ?",KIN001-135
ACH-000189,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is AZD5363. The drug SMILES structure is O=C(C1(N)CCN(C2=C3C(NC=C3)=NC=N2)CC1)N[C@H](C4=CC=C(Cl)C=C4)CCO. Drug target is AKT1, AKT2, AKT3, ROCK2. Drug target pathway is Other, kinases.
Drug 2: The drug is KB NB 142-70. The drug SMILES structure is C1CSC2=C(C(=O)N1)SC3=C2C=C(C=C3)O. Drug target is PKD. Drug target pathway is Other, kinases.
Drug 3: The drug is TPCA-1. The drug SMILES structure is C1=CC(=CC=C1C2=CC(=C(S2)NC(=O)N)C(=O)N)F. Drug target is IKK2. Drug target pathway is Other, kinases.
The mutations of the cell line are BRCA2, IRS2, NOTCH1, PIK3CB, POLD1, SMARCB1, SOX9, SPEN, VHL.
Best drug option: ?",TPCA-1
ACH-000190,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is QS-11. The drug SMILES structure is C1CC2=C(C1)C=C(C=C2)OC3=NC(=C4C(=N3)N(C=N4)CC5=CC=C(C=C5)C6=CC=CC=C6)NC(CC7=CC=CC=C7)CO. Drug target is Unknown. Drug target pathway is Unknown.
Drug 2: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
Drug 3: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are ABL1, BCR, CDH1, CREBBP, EP300, MLL2, MTAP, NRAS, POLE, PTCH1, RAF1, TP53.
Best drug option: ?",KIN001-135
ACH-000191,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
Drug 2: The drug is JW-7-24-1. The drug SMILES structure is COC1=CC(=CC(=C1)C2=CC3=C4C(=CN=C3C=C2)C=CC(=O)N4C5=CC(=C(C=C5)N6CCNCC6)C(F)(F)F)OC. Drug target is LCK. Drug target pathway is Other, kinases.
Drug 3: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are ALK, APC, ATM, BRAF, IDH1, TP53.
Best drug option: ?",JW-7-24-1
ACH-000192,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 2: The drug is JNJ-38877605. The drug SMILES structure is CN1C=C(C=N1)C2=NN3C(=NN=C3C(C4=CC5=C(C=C4)N=CC=C5)(F)F)C=C2. Drug target is Unknown. Drug target pathway is Unknown.
Drug 3: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are APC, ASXL1, FGFR2, PIK3CA, SLC34A2, TP53.
Best drug option: ?",KIN001-135
ACH-000193,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is SARACATINIB. The drug SMILES structure is CN1CCN(CC1)CCOC2=CC(=C3C(=C2)N=CN=C3NC4=C(C=CC5=C4OCO5)Cl)OC6CCOCC6. Drug target is ABL, SRC. Drug target pathway is Other, kinases.
Drug 2: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
Drug 3: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are AXL, DIS3, EED, INPP4B, KRAS, PALB2, TP53.
Best drug option: ?",WYE-125132
ACH-000196,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 2: The drug is FORETINIB. The drug SMILES structure is COC1=CC2=C(C=CN=C2C=C1OCCCN3CCOCC3)OC4=C(C=C(C=C4)NC(=O)C5(CC5)C(=O)NC6=CC=C(C=C6)F)F. Drug target is MET, KDR, TIE2, VEGFR3/FLT4, RON, PDGFR, FGFR1, EGFR. Drug target pathway is RTK signaling.
Drug 3: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are AXIN1, BRCA2, BRIP1, EMSY, DAXX, ETV5, MSH2, TP53, TSC1.
Best drug option: ?",FORETINIB
ACH-000197,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
Drug 2: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 3: The drug is PAZOPANIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC2=NC=CC(=N2)N(C)C3=CC4=NN(C(=C4C=C3)C)C)S(=O)(=O)N. Drug target is CSF1R, KIT,  PDGFRA, PDGFRB. Drug target pathway is RTK signaling.
The mutations of the cell line are AKT2, ATM, BRCA2, EZH2, NKX2-1, NOTCH3, NRAS, ROS1, TP53.
Best drug option: ?",KIN001-135
ACH-000198,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is PIK-93. The drug SMILES structure is CC1=C(SC(=N1)NC(=O)C)C2=CC(=C(C=C2)Cl)S(=O)(=O)NCCO. Drug target is PK3CG. Drug target pathway is PI3K/MTOR signaling.
Drug 2: The drug is FULVESTRANT. The drug SMILES structure is C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)[C@@H](CC4=C3C=CC(=C4)O)CCCCCCCCCS(=O)CCCC(C(F)(F)F)(F)F. Drug target is ESR1. Drug target pathway is Hormone-related.
Drug 3: The drug is ABT-737. The drug SMILES structure is CN(C)CC[C@H](CSC1=CC=CC=C1)NC2=C(C=C(C=C2)S(=O)(=O)NC(=O)C3=CC=C(C=C3)N4CCN(CC4)CC5=CC=CC=C5C6=CC=C(C=C6)Cl)[N+](=O)[O-]. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ARID1A, CDKN1B, CDKN2C, CREBBP, ESR1, KDM5C, MDM4, PDGFRA, PIK3CB, SMARCA4.
Best drug option: ?",PIK-93
ACH-000200,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KOBE2602. The drug SMILES structure is C1=CC(=CC=C1NC(=S)NNC2=C(C=C(C=C2[N+](=O)[O-])C(F)(F)F)[N+](=O)[O-])F. Drug target is RAS effector. Drug target pathway is RTK signaling.
Drug 2: The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
Drug 3: The drug is CAY10566. The drug SMILES structure is CC1=NN=C(O1)C2=NN=C(C=C2)N3CCC(CC3)OC4=C(C=CC(=C4)F)Cl. Drug target is Stearoyl-CoA desaturase. Drug target pathway is Other.
The mutations of the cell line are BRAF, IRF4, MLL, LTK, MLH1, NF2.
Best drug option: ?",CAY10566
ACH-000201,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 2: The drug is CAY10566. The drug SMILES structure is CC1=NN=C(O1)C2=NN=C(C=C2)N3CCC(CC3)OC4=C(C=CC(=C4)F)Cl. Drug target is Stearoyl-CoA desaturase. Drug target pathway is Other.
Drug 3: The drug is PF-4708671. The drug SMILES structure is CCC1=CN=CN=C1N2CCN(CC2)CC3=NC4=C(N3)C=C(C=C4)C(F)(F)F. Drug target is S6K1. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are NF1, PIK3CB, PPARG, SETD2, SMARCB1, WHSC1L1.
Best drug option: ?",PF-4708671
ACH-000204,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
Drug 2: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 3: The drug is IMATINIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5. Drug target is ABL, KIT, PDGFR. Drug target pathway is Other, kinases.
The mutations of the cell line are CASP8, CDKN2A, KDM6A, NBN, TP53.
Best drug option: ?",KIN001-135
ACH-000207,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is AVAGACESTAT. The drug SMILES structure is C1=CC(=CC=C1S(=O)(=O)N(CC2=C(C=C(C=C2)C3=NOC=N3)F)[C@H](CCC(F)(F)F)C(=O)N)Cl. Drug target is Amyloid beta20, Amyloid beta40. Drug target pathway is Other.
Drug 2: The drug is JNJ-38877605. The drug SMILES structure is CN1C=C(C=N1)C2=NN3C(=NN=C3C(C4=CC5=C(C=C4)N=CC=C5)(F)F)C=C2. Drug target is Unknown. Drug target pathway is Unknown.
Drug 3: The drug is YK-4-279. The drug SMILES structure is COC1=CC=C(C=C1)C(=O)CC2(C3=C(C=CC(=C3NC2=O)Cl)Cl)O. Drug target is RNA helicase A. Drug target pathway is Other.
The mutations of the cell line are CDKN2A, NKX2-1, PIK3CA, POLE, SPEN, TP53.
Best drug option: ?",JNJ-38877605
ACH-000210,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is GW-2580. The drug SMILES structure is COC1=CC=C(C=C1)COC2=C(C=C(C=C2)CC3=CN=C(N=C3N)N)OC. Drug target is CSF1R. Drug target pathway is RTK signaling.
Drug 2: The drug is FORETINIB. The drug SMILES structure is COC1=CC2=C(C=CN=C2C=C1OCCCN3CCOCC3)OC4=C(C=C(C=C4)NC(=O)C5(CC5)C(=O)NC6=CC=C(C=C6)F)F. Drug target is MET, KDR, TIE2, VEGFR3/FLT4, RON, PDGFR, FGFR1, EGFR. Drug target pathway is RTK signaling.
Drug 3: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ALOX12B, AR, BRCA2, CSF1R, MED12, MYD88, PIK3C2G.
Best drug option: ?",WYE-125132
ACH-000211,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is CAY10566. The drug SMILES structure is CC1=NN=C(O1)C2=NN=C(C=C2)N3CCC(CC3)OC4=C(C=CC(=C4)F)Cl. Drug target is Stearoyl-CoA desaturase. Drug target pathway is Other.
Drug 2: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 3: The drug is AVAGACESTAT. The drug SMILES structure is C1=CC(=CC=C1S(=O)(=O)N(CC2=C(C=C(C=C2)C3=NOC=N3)F)[C@H](CCC(F)(F)F)C(=O)N)Cl. Drug target is Amyloid beta20, Amyloid beta40. Drug target pathway is Other.
The mutations of the cell line are FGF14, JAK3, PIK3R1, QKI, RAD21, TERT, TP53.
Best drug option: ?",KIN001-135
ACH-000213,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
Drug 2: The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
Drug 3: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are BRD4, EMSY, MLL2, KRAS, MSH6, TP53.
Best drug option: ?",KIN001-135
ACH-000217,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is JNJ-38877605. The drug SMILES structure is CN1C=C(C=N1)C2=NN3C(=NN=C3C(C4=CC5=C(C=C4)N=CC=C5)(F)F)C=C2. Drug target is Unknown. Drug target pathway is Unknown.
Drug 2: The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
Drug 3: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are AXIN1, BCL2L1, CDKN1A, CEBPA, HGF, NF1, SGK1, TET2, TP53.
Best drug option: ?",BRYOSTATIN-1
ACH-000218,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
Drug 2: The drug is IMATINIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5. Drug target is ABL, KIT, PDGFR. Drug target pathway is Other, kinases.
Drug 3: The drug is XMD13-2. The drug SMILES structure is O=C(C1CC1)NC2=NNC3=CC(C4=CC(C(NC5CC5)=O)=CC=C4)=CC=C32. Drug target is MRCKB. Drug target pathway is Cytoskeleton.
The mutations of the cell line are ALOX12B, ASXL1, BCR, CCND2, CDK8, EZH2, FLT3, GNAS, KRAS, MST1R, MYC, RPTOR.
Best drug option: ?",XMD13-2
ACH-000219,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is JW-7-24-1. The drug SMILES structure is COC1=CC(=CC(=C1)C2=CC3=C4C(=CN=C3C=C2)C=CC(=O)N4C5=CC(=C(C=C5)N6CCNCC6)C(F)(F)F)OC. Drug target is LCK. Drug target pathway is Other, kinases.
Drug 2: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 3: The drug is JNJ-38877605. The drug SMILES structure is CN1C=C(C=N1)C2=NN3C(=NN=C3C(C4=CC5=C(C=C4)N=CC=C5)(F)F)C=C2. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are BRAF, CDKN2A, EP300, EPHB1, EZR, FGFR2, HGF, MSH3, MTOR, NF1, NOTCH3, SPEN.
Best drug option: ?",KIN001-135
ACH-000221,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
Drug 2: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
Drug 3: The drug is CAY10566. The drug SMILES structure is CC1=NN=C(O1)C2=NN=C(C=C2)N3CCC(CC3)OC4=C(C=CC(=C4)F)Cl. Drug target is Stearoyl-CoA desaturase. Drug target pathway is Other.
The mutations of the cell line are BRCA2, CTNNB1, DOT1L, ESR1, MYB, NTRK1, SDC4, TERT, TP53.
Best drug option: ?",CAY10566
ACH-000225,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is VINCRISTINE. The drug SMILES structure is CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O. Drug target is Unknown. Drug target pathway is Unknown.
Drug 2: The drug is BMS-536924. The drug SMILES structure is CC1=CC(=CC2=C1NC(=C3C(=CC=NC3=O)NC[C@H](C4=CC(=CC=C4)Cl)O)N2)N5CCOCC5. Drug target is IGF1R, IR. Drug target pathway is IGF1R signaling.
Drug 3: The drug is ACETALAX. The drug SMILES structure is CC(=O)OC1=CC=C(C=C1)C2(C3=CC=CC=C3NC2=O)C4=CC=C(C=C4)OC(=O)C. Drug target is Unknown. Drug target pathway is Unclassified.
The mutations of the cell line are CD22, FANCA, FGFR1, HGF, MERTK, MET, RICTOR, TP53, TSC2.
Best drug option: ?",ACETALAX
ACH-000226,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 2: The drug is YK-4-279. The drug SMILES structure is COC1=CC=C(C=C1)C(=O)CC2(C3=C(C=CC(=C3NC2=O)Cl)Cl)O. Drug target is RNA helicase A. Drug target pathway is Other.
Drug 3: The drug is AST-1306. The drug SMILES structure is C=CC(=O)NC1=CC2=C(C=C1)N=CN=C2NC3=CC(=C(C=C3)OCC4=CC(=CC=C4)F)Cl. Drug target is EGFR, ERBB4. Drug target pathway is RTK signaling.
The mutations of the cell line are FLT1, MLL2, PARK2.
Best drug option: ?",YK-4-279
ACH-000227,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
Drug 2: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 3: The drug is IMATINIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5. Drug target is ABL, KIT, PDGFR. Drug target pathway is Other, kinases.
The mutations of the cell line are BARD1, EWSR1, GNAS, MAP2K1, NF1, ROS1.
Best drug option: ?",IMATINIB
ACH-000228,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is AGI-5198. The drug SMILES structure is CC1=CC=CC=C1C(C(=O)NC2CCCCC2)N(C3=CC(=CC=C3)F)C(=O)CN4C=CN=C4C. Drug target is IDH1 (R132H). Drug target pathway is Metabolism.
Drug 2: The drug is JNJ-38877605. The drug SMILES structure is CN1C=C(C=N1)C2=NN3C(=NN=C3C(C4=CC5=C(C=C4)N=CC=C5)(F)F)C=C2. Drug target is Unknown. Drug target pathway is Unknown.
Drug 3: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are ERCC4, RAD54L, SMAD4, TP53.
Best drug option: ?",KIN001-135
ACH-000231,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
Drug 2: The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
Drug 3: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are CDKN2C, MLL2, LTK, MTOR, NF1, NPM1, PDGFRB, PTEN, ROS1, STK11, TP53.
Best drug option: ?",KIN001-135
ACH-000232,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is IMATINIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5. Drug target is ABL, KIT, PDGFR. Drug target pathway is Other, kinases.
Drug 2: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 3: The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are NF1, PTEN, SETD2, TP53.
Best drug option: ?",KIN001-135
ACH-000233,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is SARACATINIB. The drug SMILES structure is CN1CCN(CC1)CCOC2=CC(=C3C(=C2)N=CN=C3NC4=C(C=CC5=C4OCO5)Cl)OC6CCOCC6. Drug target is ABL, SRC. Drug target pathway is Other, kinases.
Drug 2: The drug is AVAGACESTAT. The drug SMILES structure is C1=CC(=CC=C1S(=O)(=O)N(CC2=C(C=C(C=C2)C3=NOC=N3)F)[C@H](CCC(F)(F)F)C(=O)N)Cl. Drug target is Amyloid beta20, Amyloid beta40. Drug target pathway is Other.
Drug 3: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are ATR, CREBBP, EPHA3, KDR, NUTM1, PDGFRA, RAC1, RICTOR, STAG2, TP53.
Best drug option: ?",SARACATINIB
ACH-000235,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 2: The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
Drug 3: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are APC, CDKN2A, MLL, KRAS, MSH6, NTRK3, PTPRO, RAD51C, TP53.
Best drug option: ?",KIN001-135
ACH-000236,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 2: The drug is ARA-G. The drug SMILES structure is C1=NC2=C(N1[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)N=C(NC2=O)N. Drug target is Anti-metabolite. Drug target pathway is Other.
Drug 3: The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are APC, BRAF, IRS2, JAK1, MAP2K4, PBRM1, PDK1, POLE, TP53, WHSC1.
Best drug option: ?",KIN001-135
ACH-000238,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 2: The drug is JNJ-38877605. The drug SMILES structure is CN1C=C(C=N1)C2=NN3C(=NN=C3C(C4=CC5=C(C=C4)N=CC=C5)(F)F)C=C2. Drug target is Unknown. Drug target pathway is Unknown.
Drug 3: The drug is AVAGACESTAT. The drug SMILES structure is C1=CC(=CC=C1S(=O)(=O)N(CC2=C(C=C(C=C2)C3=NOC=N3)F)[C@H](CCC(F)(F)F)C(=O)N)Cl. Drug target is Amyloid beta20, Amyloid beta40. Drug target pathway is Other.
The mutations of the cell line are CDKN2A, MLL2, NF1, TERT, TP53.
Best drug option: ?",KIN001-135
ACH-000242,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
Drug 2: The drug is PAZOPANIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC2=NC=CC(=N2)N(C)C3=CC4=NN(C(=C4C=C3)C)C)S(=O)(=O)N. Drug target is CSF1R, KIT,  PDGFRA, PDGFRB. Drug target pathway is RTK signaling.
Drug 3: The drug is GSK2606414. The drug SMILES structure is CN1C=C(C2=C(N=CN=C21)N)C3=CC4=C(C=C3)N(CC4)C(=O)CC5=CC(=CC=C5)C(F)(F)F. Drug target is PERK. Drug target pathway is Metabolism.
The mutations of the cell line are DNMT3A, MLL2, NOTCH3, PPARG, SPEN, TSC1.
Best drug option: ?",BRYOSTATIN-1
ACH-000243,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is YK-4-279. The drug SMILES structure is COC1=CC=C(C=C1)C(=O)CC2(C3=C(C=CC(=C3NC2=O)Cl)Cl)O. Drug target is RNA helicase A. Drug target pathway is Other.
Drug 2: The drug is TIPIFARNIB. The drug SMILES structure is CN1C=NC=C1[C@@](C2=CC=C(C=C2)Cl)(C3=CC4=C(C=C3)N(C(=O)C=C4C5=CC(=CC=C5)Cl)C)N. Drug target is Farnesyl-transferase (FNTA). Drug target pathway is Other.
Drug 3: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are ARFRP1, ERBB3, FANCA, KRAS, NOTCH3, SMAD4, TP53, WHSC1L1.
Best drug option: ?",KIN001-135
ACH-000244,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
Drug 2: The drug is CETUXIMAB. The drug SMILES structure is CC1(C(=C)N(C2=CC=CC=C21)CCCCCC(=O)O)C. Drug target is EGFR. Drug target pathway is EGFR signaling.
Drug 3: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are ASXL1, FGFR4, PIK3CA, PTEN, SNCAIP.
Best drug option: ?",KIN001-135
ACH-000245,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 2: The drug is AVAGACESTAT. The drug SMILES structure is C1=CC(=CC=C1S(=O)(=O)N(CC2=C(C=C(C=C2)C3=NOC=N3)F)[C@H](CCC(F)(F)F)C(=O)N)Cl. Drug target is Amyloid beta20, Amyloid beta40. Drug target pathway is Other.
Drug 3: The drug is SARACATINIB. The drug SMILES structure is CN1CCN(CC1)CCOC2=CC(=C3C(=C2)N=CN=C3NC4=C(C=CC5=C4OCO5)Cl)OC6CCOCC6. Drug target is ABL, SRC. Drug target pathway is Other, kinases.
The mutations of the cell line are ARID1A, BRIP1, GNA13, ID3, IGF1R, MLL2, MTOR, MYC, TP53, XRCC2.
Best drug option: ?",KIN001-135
ACH-000247,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is TIPIFARNIB. The drug SMILES structure is CN1C=NC=C1[C@@](C2=CC=C(C=C2)Cl)(C3=CC4=C(C=C3)N(C(=O)C=C4C5=CC(=CC=C5)Cl)C)N. Drug target is Farnesyl-transferase (FNTA). Drug target pathway is Other.
Drug 2: The drug is BORTEZOMIB. The drug SMILES structure is B([C@H](CC(C)C)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O. Drug target is Proteasome. Drug target pathway is Protein stability and degradation.
Drug 3: The drug is ARA-G. The drug SMILES structure is C1=NC2=C(N1[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)N=C(NC2=O)N. Drug target is Anti-metabolite. Drug target pathway is Other.
The mutations of the cell line are ARID1A, CDH1, CTNNB1, ETV5, MAP2K1, PTPRO, SPEN, TGFBR2, TP53.
Best drug option: ?",ARA-G
ACH-000248,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is LIMK1 INHIBITOR BMS4. The drug SMILES structure is CCNC(=O)NC1=NC=C(S1)C2=CC(=NC(=N2)C3=NC=CN=C3)C4=C(C=C(C=C4C)OC)C. Drug target is LIMK1. Drug target pathway is Cytoskeleton.
Drug 2: The drug is GDC-0068. The drug SMILES structure is CC1CC(C2=C1C(=NC=N2)N3CCN(CC3)C(=O)C(CNC(C)C)C4=CC=C(C=C4)Cl)O. Drug target is AKT1, AKT, AKT3. Drug target pathway is PI3K/MTOR signaling.
Drug 3: The drug is TIVOZANIB. The drug SMILES structure is CC1=CC(=NO1)NC(=O)NC2=C(C=C(C=C2)OC3=C4C=C(C(=CC4=NC=C3)OC)OC)Cl. Drug target is VEGFR1, VEGFR2, VEGFR3, PDGFR, KIT. Drug target pathway is RTK signaling.
The mutations of the cell line are AURKA, BCOR, BCR, EGFR, ERBB3, FGFR2, IKBKE, IKZF1, KIT, MLL2, MED12, MSH6, P2RY8, SMAD4, TIPARP, TP53.
Best drug option: ?",LIMK1 INHIBITOR BMS4
ACH-000249,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is METHOTREXATE. The drug SMILES structure is CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O. Drug target is Antimetabolite. Drug target pathway is DNA replication.
Drug 2: The drug is JW-7-24-1. The drug SMILES structure is COC1=CC(=CC(=C1)C2=CC3=C4C(=CN=C3C=C2)C=CC(=O)N4C5=CC(=C(C=C5)N6CCNCC6)C(F)(F)F)OC. Drug target is LCK. Drug target pathway is Other, kinases.
Drug 3: The drug is BORTEZOMIB. The drug SMILES structure is B([C@H](CC(C)C)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O. Drug target is Proteasome. Drug target pathway is Protein stability and degradation.
The mutations of the cell line are APC, EPHB1, ETV5, FBXW7, GNAS, KRAS, SMAD2, SPEN, TP53.
Best drug option: ?",BORTEZOMIB
ACH-000250,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is LY2109761. The drug SMILES structure is C1CC2=C(C(=NN2C1)C3=CC=CC=N3)C4=C5C=CC(=CC5=NC=C4)OCCN6CCOCC6. Drug target is TGFB1. Drug target pathway is Other.
Drug 2: The drug is YK-4-279. The drug SMILES structure is COC1=CC=C(C=C1)C(=O)CC2(C3=C(C=CC(=C3NC2=O)Cl)Cl)O. Drug target is RNA helicase A. Drug target pathway is Other.
Drug 3: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are BAP1, EMSY, CYP17A1, DDR1, MTOR, PBRM1, RICTOR, TP53, VHL.
Best drug option: ?",KIN001-135
ACH-000252,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is AZD5363. The drug SMILES structure is O=C(C1(N)CCN(C2=C3C(NC=C3)=NC=N2)CC1)N[C@H](C4=CC=C(Cl)C=C4)CCO. Drug target is AKT1, AKT2, AKT3, ROCK2. Drug target pathway is Other, kinases.
Drug 2: The drug is PAZOPANIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC2=NC=CC(=N2)N(C)C3=CC4=NN(C(=C4C=C3)C)C)S(=O)(=O)N. Drug target is CSF1R, KIT,  PDGFRA, PDGFRB. Drug target pathway is RTK signaling.
Drug 3: The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are CTCF, CXCR4, KRAS, NOTCH1, NOTCH3, RBM10, SDHA, SF3B1, SMO, TP53, WHSC1L1.
Best drug option: ?",YM-201636
ACH-000254,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is GW-2580. The drug SMILES structure is COC1=CC=C(C=C1)COC2=C(C=C(C=C2)CC3=CN=C(N=C3N)N)OC. Drug target is CSF1R. Drug target pathway is RTK signaling.
Drug 2: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
Drug 3: The drug is JNJ-38877605. The drug SMILES structure is CN1C=C(C=N1)C2=NN3C(=NN=C3C(C4=CC5=C(C=C4)N=CC=C5)(F)F)C=C2. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ARID1A, ATR, CDH1, ERG, SMAD2, TP53.
Best drug option: ?",JNJ-38877605
ACH-000257,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
Drug 2: The drug is QS-11. The drug SMILES structure is C1CC2=C(C1)C=C(C=C2)OC3=NC(=C4C(=N3)N(C=N4)CC5=CC=C(C=C5)C6=CC=CC=C6)NC(CC7=CC=CC=C7)CO. Drug target is Unknown. Drug target pathway is Unknown.
Drug 3: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are EPHB1, ERBB3, NRAS, SDHA, SMO, TP53.
Best drug option: ?",YM-201636
ACH-000258,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is BORTEZOMIB. The drug SMILES structure is B([C@H](CC(C)C)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O. Drug target is Proteasome. Drug target pathway is Protein stability and degradation.
Drug 2: The drug is IMATINIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5. Drug target is ABL, KIT, PDGFR. Drug target pathway is Other, kinases.
Drug 3: The drug is CMK. The drug SMILES structure is CC1=CC=C(C=C1)C2=C(N(C3=NC=NC(=C23)N)CCCO)C(=O)CCl. Drug target is RSK2. Drug target pathway is Other, kinases.
The mutations of the cell line are APC, AR, BRAF, IKBKE, SF3B1, STAG2, TYRO3.
Best drug option: ?",CMK
ACH-000259,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
Drug 2: The drug is AVAGACESTAT. The drug SMILES structure is C1=CC(=CC=C1S(=O)(=O)N(CC2=C(C=C(C=C2)C3=NOC=N3)F)[C@H](CCC(F)(F)F)C(=O)N)Cl. Drug target is Amyloid beta20, Amyloid beta40. Drug target pathway is Other.
Drug 3: The drug is IMATINIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5. Drug target is ABL, KIT, PDGFR. Drug target pathway is Other, kinases.
The mutations of the cell line are ALK, FAM123B, BCL2L2, BRIP1, CDK12, CDKN2A, ERBB4, NOTCH3, NUTM1, POLD1, SDHD, TIPARP, TP53.
Best drug option: ?",WYE-125132
ACH-000260,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 2: The drug is CMK. The drug SMILES structure is CC1=CC=C(C=C1)C2=C(N(C3=NC=NC(=C23)N)CCCO)C(=O)CCl. Drug target is RSK2. Drug target pathway is Other, kinases.
Drug 3: The drug is PAZOPANIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC2=NC=CC(=N2)N(C)C3=CC4=NN(C(=C4C=C3)C)C)S(=O)(=O)N. Drug target is CSF1R, KIT,  PDGFRA, PDGFRB. Drug target pathway is RTK signaling.
The mutations of the cell line are ATR, CIC, FBXW7, FLT3, NRAS, RB1.
Best drug option: ?",CMK
ACH-000264,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 2: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
Drug 3: The drug is WH-4-023. The drug SMILES structure is O=C(OC1=C(C)C=CC=C1C)N(C2=CC=C(OC)C=C2OC)C3=NC(NC4=CC=C(N5CCN(C)CC5)C=C4)=NC=C3. Drug target is SRC, LCK. Drug target pathway is Other, kinases.
The mutations of the cell line are BAP1, BRCA2, CSF1R, GATA6, GNAS, IGF1R, JAK1, MLL2, KRAS, MERTK, PARK2, TP53.
Best drug option: ?",KIN001-135
ACH-000265,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 2: The drug is GW-2580. The drug SMILES structure is COC1=CC=C(C=C1)COC2=C(C=C(C=C2)CC3=CN=C(N=C3N)N)OC. Drug target is CSF1R. Drug target pathway is RTK signaling.
Drug 3: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are CDH1, EZH2, KRAS, NUTM1, PRKCI.
Best drug option: ?",KIN001-135
ACH-000269,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is FORETINIB. The drug SMILES structure is COC1=CC2=C(C=CN=C2C=C1OCCCN3CCOCC3)OC4=C(C=C(C=C4)NC(=O)C5(CC5)C(=O)NC6=CC=C(C=C6)F)F. Drug target is MET, KDR, TIE2, VEGFR3/FLT4, RON, PDGFR, FGFR1, EGFR. Drug target pathway is RTK signaling.
Drug 2: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 3: The drug is IMATINIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5. Drug target is ABL, KIT, PDGFR. Drug target pathway is Other, kinases.
The mutations of the cell line are BCORL1, BRAF, KIT, MEF2B, MSH3, MYCN, PIK3C2G, SETD2.
Best drug option: ?",KIN001-135
ACH-000270,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 2: The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
Drug 3: The drug is AZD5363. The drug SMILES structure is O=C(C1(N)CCN(C2=C3C(NC=C3)=NC=N2)CC1)N[C@H](C4=CC=C(Cl)C=C4)CCO. Drug target is AKT1, AKT2, AKT3, ROCK2. Drug target pathway is Other, kinases.
The mutations of the cell line are ACVR1B, AKT3, ARID1A, CDKN2A, EZR, KDM6A, KRAS, PIK3CA, RICTOR, SMAD4, TP53.
Best drug option: ?",BRYOSTATIN-1
ACH-000271,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is PAZOPANIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC2=NC=CC(=N2)N(C)C3=CC4=NN(C(=C4C=C3)C)C)S(=O)(=O)N. Drug target is CSF1R, KIT,  PDGFRA, PDGFRB. Drug target pathway is RTK signaling.
Drug 2: The drug is EPZ004777. The drug SMILES structure is CC(C)N(CCCNC(=O)NC1=CC=C(C=C1)C(C)(C)C)C[C@@H]2[C@H]([C@H]([C@@H](O2)N3C=CC4=C(N=CN=C43)N)O)O. Drug target is DOT1L. Drug target pathway is Chromatin histone methylation.
Drug 3: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are CASP8, CCND3, CDK4, EP300, EZH2, KLHL6, KRAS, MYC, PTEN, TNFRSF14, TP53.
Best drug option: ?",PAZOPANIB
ACH-000276,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 2: The drug is CAY10566. The drug SMILES structure is CC1=NN=C(O1)C2=NN=C(C=C2)N3CCC(CC3)OC4=C(C=CC(=C4)F)Cl. Drug target is Stearoyl-CoA desaturase. Drug target pathway is Other.
Drug 3: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are BRCA2, EGFR, FGF14, PDGFRB, PIK3CA, SF3B1, TET2, TP53, TYRO3.
Best drug option: ?",CAY10566
ACH-000277,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is FORETINIB. The drug SMILES structure is COC1=CC2=C(C=CN=C2C=C1OCCCN3CCOCC3)OC4=C(C=C(C=C4)NC(=O)C5(CC5)C(=O)NC6=CC=C(C=C6)F)F. Drug target is MET, KDR, TIE2, VEGFR3/FLT4, RON, PDGFR, FGFR1, EGFR. Drug target pathway is RTK signaling.
Drug 2: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
Drug 3: The drug is LIMK1 INHIBITOR BMS4. The drug SMILES structure is CCNC(=O)NC1=NC=C(S1)C2=CC(=NC(=N2)C3=NC=CN=C3)C4=C(C=C(C=C4C)OC)C. Drug target is LIMK1. Drug target pathway is Cytoskeleton.
The mutations of the cell line are AXL, GNA11, HRAS, JAK3, MLL, RB1, TP53.
Best drug option: ?",FORETINIB
ACH-000281,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is AZD5363. The drug SMILES structure is O=C(C1(N)CCN(C2=C3C(NC=C3)=NC=N2)CC1)N[C@H](C4=CC=C(Cl)C=C4)CCO. Drug target is AKT1, AKT2, AKT3, ROCK2. Drug target pathway is Other, kinases.
Drug 2: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 3: The drug is SNX-2112. The drug SMILES structure is CC1(CC2=C(C(=O)C1)C(=NN2C3=CC(=C(C=C3)C(=O)N)NC4CCC(CC4)O)C(F)(F)F)C. Drug target is HSP90. Drug target pathway is Protein stability and degradation.
The mutations of the cell line are AKT1, ATR, KRAS, NTRK3, SMAD4, SRC, TP53, TSC2.
Best drug option: ?",KIN001-135
ACH-000282,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 2: The drug is PAZOPANIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC2=NC=CC(=N2)N(C)C3=CC4=NN(C(=C4C=C3)C)C)S(=O)(=O)N. Drug target is CSF1R, KIT,  PDGFRA, PDGFRB. Drug target pathway is RTK signaling.
Drug 3: The drug is EPZ004777. The drug SMILES structure is CC(C)N(CCCNC(=O)NC1=CC=C(C=C1)C(C)(C)C)C[C@@H]2[C@H]([C@H]([C@@H](O2)N3C=CC4=C(N=CN=C43)N)O)O. Drug target is DOT1L. Drug target pathway is Chromatin histone methylation.
The mutations of the cell line are ALK, FAM123B, BCOR, BRAF, CHEK2, CXCR4, EPHB1, KEAP1, KLHL6, MKNK1, MSH2, STK11, TP53.
Best drug option: ?",KIN001-135
ACH-000287,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 2: The drug is IMATINIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5. Drug target is ABL, KIT, PDGFR. Drug target pathway is Other, kinases.
Drug 3: The drug is KOBE2602. The drug SMILES structure is C1=CC(=CC=C1NC(=S)NNC2=C(C=C(C=C2[N+](=O)[O-])C(F)(F)F)[N+](=O)[O-])F. Drug target is RAS effector. Drug target pathway is RTK signaling.
The mutations of the cell line are EMSY, MLL2, KRAS, MYC, PAX5, TP53.
Best drug option: ?",KIN001-135
ACH-000288,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 2: The drug is LY2109761. The drug SMILES structure is C1CC2=C(C(=NN2C1)C3=CC=CC=N3)C4=C5C=CC(=CC5=NC=C4)OCCN6CCOCC6. Drug target is TGFB1. Drug target pathway is Other.
Drug 3: The drug is AVAGACESTAT. The drug SMILES structure is C1=CC(=CC=C1S(=O)(=O)N(CC2=C(C=C(C=C2)C3=NOC=N3)F)[C@H](CCC(F)(F)F)C(=O)N)Cl. Drug target is Amyloid beta20, Amyloid beta40. Drug target pathway is Other.
The mutations of the cell line are BCL2L1, FANCL, MUTYH, PTEN, TP53, ZNF703.
Best drug option: ?",KIN001-135
ACH-000290,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
Drug 2: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 3: The drug is IMATINIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5. Drug target is ABL, KIT, PDGFR. Drug target pathway is Other, kinases.
The mutations of the cell line are MLL2, MEN1, NOTCH1, PIK3C2G, RB1, SOCS1, TET2, TP53.
Best drug option: ?",KIN001-135
ACH-000291,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
Drug 2: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 3: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are BCOR, BCR, BRAF, CDKN2A, FGFR4, SMAD4, SPEN, TP53.
Best drug option: ?",KIN001-135
ACH-000292,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 2: The drug is VE-822. The drug SMILES structure is CC(C)S(=O)(=O)C1=CC=C(C=C1)C2=CN=C(C(=N2)C3=CC(=NO3)C4=CC=C(C=C4)CNC)N. Drug target is ATR. Drug target pathway is Genome integrity.
Drug 3: The drug is AVAGACESTAT. The drug SMILES structure is C1=CC(=CC=C1S(=O)(=O)N(CC2=C(C=C(C=C2)C3=NOC=N3)F)[C@H](CCC(F)(F)F)C(=O)N)Cl. Drug target is Amyloid beta20, Amyloid beta40. Drug target pathway is Other.
The mutations of the cell line are ATRX, AXL, KEL, MEF2B, PARK2, PBRM1, PIK3R1, RAD54L, RICTOR, SMARCA4, TP53.
Best drug option: ?",KIN001-135
ACH-000293,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is LIMK1 INHIBITOR BMS4. The drug SMILES structure is CCNC(=O)NC1=NC=C(S1)C2=CC(=NC(=N2)C3=NC=CN=C3)C4=C(C=C(C=C4C)OC)C. Drug target is LIMK1. Drug target pathway is Cytoskeleton.
Drug 2: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 3: The drug is AGI-5198. The drug SMILES structure is CC1=CC=CC=C1C(C(=O)NC2CCCCC2)N(C3=CC(=CC=C3)F)C(=O)CN4C=CN=C4C. Drug target is IDH1 (R132H). Drug target pathway is Metabolism.
The mutations of the cell line are ALK, ATM, FBXW7, GNAS, TP53.
Best drug option: ?",KIN001-135
ACH-000294,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
Drug 2: The drug is IMATINIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5. Drug target is ABL, KIT, PDGFR. Drug target pathway is Other, kinases.
Drug 3: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are ATM, EP300, FGFR3, KRAS, RAD51D, ROS1, SLC34A2, TEK, TP53.
Best drug option: ?",KIN001-135
ACH-000295,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 2: The drug is IMATINIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5. Drug target is ABL, KIT, PDGFR. Drug target pathway is Other, kinases.
Drug 3: The drug is PI-103. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)O. Drug target is PI3Kalpha, DAPK3, CLK4, PIM3, HIPK2. Drug target pathway is Other, kinases.
The mutations of the cell line are ASXL1, CD22, EP300, FLT1, GNAS, JAK1, MTOR, SETD2, TERT, TP53.
Best drug option: ?",KIN001-135
ACH-000298,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is ARA-G. The drug SMILES structure is C1=NC2=C(N1[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)N=C(NC2=O)N. Drug target is Anti-metabolite. Drug target pathway is Other.
Drug 2: The drug is JNJ-38877605. The drug SMILES structure is CN1C=C(C=N1)C2=NN3C(=NN=C3C(C4=CC5=C(C=C4)N=CC=C5)(F)F)C=C2. Drug target is Unknown. Drug target pathway is Unknown.
Drug 3: The drug is AZ960. The drug SMILES structure is CC1=CC(=NN1)NC2=C(C=C(C(=N2)N[C@@H](C)C3=CC=C(C=C3)F)C#N)F. Drug target is JAK2, JAK3. Drug target pathway is Other, kinases.
The mutations of the cell line are AKT2, CBL, EPHB1, ERBB4, ETV5, KDR, MLL2, NUTM1, PTCH1, RB1, SETD2, STK11, TP53.
Best drug option: ?",ARA-G
ACH-000301,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is REFAMETINIB. The drug SMILES structure is COC1=CC(=C(C(=C1NS(=O)(=O)C2(CC2)C[C@@H](CO)O)NC3=C(C=C(C=C3)I)F)F)F. Drug target is MEK1, MEK2. Drug target pathway is ERK MAPK signaling.
Drug 2: The drug is KB NB 142-70. The drug SMILES structure is C1CSC2=C(C(=O)N1)SC3=C2C=C(C=C3)O. Drug target is PKD. Drug target pathway is Other, kinases.
Drug 3: The drug is PI-103. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)O. Drug target is PI3Kalpha, DAPK3, CLK4, PIM3, HIPK2. Drug target pathway is Other, kinases.
The mutations of the cell line are NOTCH1, PIK3C2G, TP53.
Best drug option: ?",REFAMETINIB
ACH-000303,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 2: The drug is GSK2606414. The drug SMILES structure is CN1C=C(C2=C(N=CN=C21)N)C3=CC4=C(C=C3)N(CC4)C(=O)CC5=CC(=CC=C5)C(F)(F)F. Drug target is PERK. Drug target pathway is Metabolism.
Drug 3: The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ATRX, BRCA2, CDH1, CDKN2A, FGF6, IDH2, MSH6, NOTCH2, TP53.
Best drug option: ?",KIN001-135
ACH-000304,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
Drug 2: The drug is JNJ-38877605. The drug SMILES structure is CN1C=C(C=N1)C2=NN3C(=NN=C3C(C4=CC5=C(C=C4)N=CC=C5)(F)F)C=C2. Drug target is Unknown. Drug target pathway is Unknown.
Drug 3: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are ALOX12B, ATR, AURKB, BRAF, FGFR3, FLCN, GATA4, GRM3, HGF, PIK3R1, PRKCI, RPTOR, SMAD4.
Best drug option: ?",JNJ-38877605
ACH-000305,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is AVAGACESTAT. The drug SMILES structure is C1=CC(=CC=C1S(=O)(=O)N(CC2=C(C=C(C=C2)C3=NOC=N3)F)[C@H](CCC(F)(F)F)C(=O)N)Cl. Drug target is Amyloid beta20, Amyloid beta40. Drug target pathway is Other.
Drug 2: The drug is IMATINIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5. Drug target is ABL, KIT, PDGFR. Drug target pathway is Other, kinases.
Drug 3: The drug is GSK2606414. The drug SMILES structure is CN1C=C(C2=C(N=CN=C21)N)C3=CC4=C(C=C3)N(CC4)C(=O)CC5=CC(=CC=C5)C(F)(F)F. Drug target is PERK. Drug target pathway is Metabolism.
The mutations of the cell line are CREBBP, DOT1L, MLL, MAP3K1, TP53, TSC1.
Best drug option: ?",IMATINIB
ACH-000311,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is AVAGACESTAT. The drug SMILES structure is C1=CC(=CC=C1S(=O)(=O)N(CC2=C(C=C(C=C2)C3=NOC=N3)F)[C@H](CCC(F)(F)F)C(=O)N)Cl. Drug target is Amyloid beta20, Amyloid beta40. Drug target pathway is Other.
Drug 2: The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
Drug 3: The drug is LINIFANIB. The drug SMILES structure is CC1=CC(=C(C=C1)F)NC(=O)NC2=CC=C(C=C2)C3=C4C(=CC=C3)NN=C4N. Drug target is VEGFR1, VEGFR2, VEGFR3, CSF1R, FLT3, KIT. Drug target pathway is RTK signaling.
The mutations of the cell line are CDH1, CREBBP, FGFR4, GATA4, KEAP1, KRAS, MDM2, NUTM1, PARP1, PIK3C2G, STK11, TP53, TSC1.
Best drug option: ?",YM-201636
ACH-000315,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is YK-4-279. The drug SMILES structure is COC1=CC=C(C=C1)C(=O)CC2(C3=C(C=CC(=C3NC2=O)Cl)Cl)O. Drug target is RNA helicase A. Drug target pathway is Other.
Drug 2: The drug is XMD13-2. The drug SMILES structure is O=C(C1CC1)NC2=NNC3=CC(C4=CC(C(NC5CC5)=O)=CC=C4)=CC=C32. Drug target is MRCKB. Drug target pathway is Cytoskeleton.
Drug 3: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are ALK, ARID1A, BCL2, CARD11, CREBBP, EP300, EZH2, FAS, GNA13, GNAS, KIT, MLL2, MAP3K1, PTEN, TP53.
Best drug option: ?",KIN001-135
ACH-000318,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
Drug 2: The drug is PANOBINOSTAT. The drug SMILES structure is CC1=C(C2=CC=CC=C2N1)CCNCC3=CC=C(C=C3)C=CC(=O)NO. Drug target is HDAC. Drug target pathway is Chromatin histone acetylation.
Drug 3: The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ATRX, BCOR, CREBBP, EP300, GNAS, MLL2, PDK1, RARA, SF3B1, TP53, TSC2.
Best drug option: ?",PANOBINOSTAT
ACH-000319,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 2: The drug is ZG-10. The drug SMILES structure is O=C(C1=CC=C(NC(C=CCN(C)C)=O)C=C1)NC2=CC(NC3=NC(C4=CC=CN=C4)=CC=N3)=CC=C2. Drug target is JNK1. Drug target pathway is JNK and p38 signaling.
Drug 3: The drug is PAZOPANIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC2=NC=CC(=N2)N(C)C3=CC4=NN(C(=C4C=C3)C)C)S(=O)(=O)N. Drug target is CSF1R, KIT,  PDGFRA, PDGFRB. Drug target pathway is RTK signaling.
The mutations of the cell line are APC, KDM6A, KEAP1, NF2, RAD51D, RAD54L, RB1.
Best drug option: ?",KIN001-135
ACH-000322,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
Drug 2: The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
Drug 3: The drug is JNJ-38877605. The drug SMILES structure is CN1C=C(C=N1)C2=NN3C(=NN=C3C(C4=CC5=C(C=C4)N=CC=C5)(F)F)C=C2. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ATM, BCL2L1, BRAF, CREBBP, FANCA, KEL, PDGFRA, PIK3C2G, RAF1, STAT3.
Best drug option: ?",WYE-125132
ACH-000323,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is IMATINIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5. Drug target is ABL, KIT, PDGFR. Drug target pathway is Other, kinases.
Drug 2: The drug is YK-4-279. The drug SMILES structure is COC1=CC=C(C=C1)C(=O)CC2(C3=C(C=CC(=C3NC2=O)Cl)Cl)O. Drug target is RNA helicase A. Drug target pathway is Other.
Drug 3: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are BCR, BRIP1, DAXX, PTEN, RB1, STAG2, TP53.
Best drug option: ?",KIN001-135
ACH-000326,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KOBE2602. The drug SMILES structure is C1=CC(=CC=C1NC(=S)NNC2=C(C=C(C=C2[N+](=O)[O-])C(F)(F)F)[N+](=O)[O-])F. Drug target is RAS effector. Drug target pathway is RTK signaling.
Drug 2: The drug is REFAMETINIB. The drug SMILES structure is COC1=CC(=C(C(=C1NS(=O)(=O)C2(CC2)C[C@@H](CO)O)NC3=C(C=C(C=C3)I)F)F)F. Drug target is MEK1, MEK2. Drug target pathway is ERK MAPK signaling.
Drug 3: The drug is PI-103. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)O. Drug target is PI3Kalpha, DAPK3, CLK4, PIM3, HIPK2. Drug target pathway is Other, kinases.
The mutations of the cell line are BCOR, EPHA3, IKZF1, MLL2, NTRK2, PARK2, TP53.
Best drug option: ?",REFAMETINIB
ACH-000327,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is CETUXIMAB. The drug SMILES structure is CC1(C(=C)N(C2=CC=CC=C21)CCCCCC(=O)O)C. Drug target is EGFR. Drug target pathway is EGFR signaling.
Drug 2: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
Drug 3: The drug is AVAGACESTAT. The drug SMILES structure is C1=CC(=CC=C1S(=O)(=O)N(CC2=C(C=C(C=C2)C3=NOC=N3)F)[C@H](CCC(F)(F)F)C(=O)N)Cl. Drug target is Amyloid beta20, Amyloid beta40. Drug target pathway is Other.
The mutations of the cell line are ATM, BRAF, DOT1L, ERRFI1, FANCA, FANCG, PTCH1, STK11.
Best drug option: ?",WYE-125132
ACH-000329,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is CETUXIMAB. The drug SMILES structure is CC1(C(=C)N(C2=CC=CC=C21)CCCCCC(=O)O)C. Drug target is EGFR. Drug target pathway is EGFR signaling.
Drug 2: The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
Drug 3: The drug is XMD13-2. The drug SMILES structure is O=C(C1CC1)NC2=NNC3=CC(C4=CC(C(NC5CC5)=O)=CC=C4)=CC=C32. Drug target is MRCKB. Drug target pathway is Cytoskeleton.
The mutations of the cell line are ARID1A, ATRX, BCORL1, BRAF, CDKN1A, PTEN, PTPN11, SNCAIP, ZNF217.
Best drug option: ?",YM-201636
ACH-000330,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is CAY10566. The drug SMILES structure is CC1=NN=C(O1)C2=NN=C(C=C2)N3CCC(CC3)OC4=C(C=CC(=C4)F)Cl. Drug target is Stearoyl-CoA desaturase. Drug target pathway is Other.
Drug 2: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 3: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ATM, FGFR2, MLL2, PIK3CA, PTPN11, ROS1, SDHA, SOX9, TP53.
Best drug option: ?",CAY10566
ACH-000332,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is LENALIDOMIDE. The drug SMILES structure is C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N. Drug target is CRBN. Drug target pathway is Protein stability and degradation.
Drug 2: The drug is IMATINIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5. Drug target is ABL, KIT, PDGFR. Drug target pathway is Other, kinases.
Drug 3: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are BCR, CREBBP, EP300, MLL2, KRAS, MAF, ROS1, SMAD4, TP53, WHSC1L1.
Best drug option: ?",KIN001-135
ACH-000334,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 2: The drug is YK-4-279. The drug SMILES structure is COC1=CC=C(C=C1)C(=O)CC2(C3=C(C=CC(=C3NC2=O)Cl)Cl)O. Drug target is RNA helicase A. Drug target pathway is Other.
Drug 3: The drug is PAZOPANIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC2=NC=CC(=N2)N(C)C3=CC4=NN(C(=C4C=C3)C)C)S(=O)(=O)N. Drug target is CSF1R, KIT,  PDGFRA, PDGFRB. Drug target pathway is RTK signaling.
The mutations of the cell line are BCL2, BCR, EZH2, GNA13, KDM5C, MLL2, MEF2B, NOTCH1, STAG2, TP53.
Best drug option: ?",YK-4-279
ACH-000335,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is AZD8931. The drug SMILES structure is CNC(=O)CN1CCC(CC1)OC2=C(C=C3C(=C2)C(=NC=N3)NC4=C(C(=CC=C4)Cl)F)OC. Drug target is EGFR, ERBB2, ERBB3. Drug target pathway is RTK signaling.
Drug 2: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
Drug 3: The drug is GW-2580. The drug SMILES structure is COC1=CC=C(C=C1)COC2=C(C=C(C=C2)CC3=CN=C(N=C3N)N)OC. Drug target is CSF1R. Drug target pathway is RTK signaling.
The mutations of the cell line are ATR, FBXW7, FGFR2, IRS2, KDR, MLL2, POLE.
Best drug option: ?",WYE-125132
ACH-000336,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 2: The drug is GSK2606414. The drug SMILES structure is CN1C=C(C2=C(N=CN=C21)N)C3=CC4=C(C=C3)N(CC4)C(=O)CC5=CC(=CC=C5)C(F)(F)F. Drug target is PERK. Drug target pathway is Metabolism.
Drug 3: The drug is AVAGACESTAT. The drug SMILES structure is C1=CC(=CC=C1S(=O)(=O)N(CC2=C(C=C(C=C2)C3=NOC=N3)F)[C@H](CCC(F)(F)F)C(=O)N)Cl. Drug target is Amyloid beta20, Amyloid beta40. Drug target pathway is Other.
The mutations of the cell line are DNMT3A, NPM1, NRAS, SMO, WHSC1L1.
Best drug option: ?",AVAGACESTAT
ACH-000337,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
Drug 2: The drug is SNX-2112. The drug SMILES structure is CC1(CC2=C(C(=O)C1)C(=NN2C3=CC(=C(C=C3)C(=O)N)NC4CCC(CC4)O)C(F)(F)F)C. Drug target is HSP90. Drug target pathway is Protein stability and degradation.
Drug 3: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are CDH1, FANCA, NF1, PDCD1, ROS1, TP53.
Best drug option: ?",YM-201636
ACH-000341,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is AZ960. The drug SMILES structure is CC1=CC(=NN1)NC2=C(C=C(C(=N2)N[C@@H](C)C3=CC=C(C=C3)F)C#N)F. Drug target is JAK2, JAK3. Drug target pathway is Other, kinases.
Drug 2: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
Drug 3: The drug is JNJ-38877605. The drug SMILES structure is CN1C=C(C=N1)C2=NN3C(=NN=C3C(C4=CC5=C(C=C4)N=CC=C5)(F)F)C=C2. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are NOTCH2, SMARCA4, TP53.
Best drug option: ?",JNJ-38877605
ACH-000343,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is CAY10566. The drug SMILES structure is CC1=NN=C(O1)C2=NN=C(C=C2)N3CCC(CC3)OC4=C(C=CC(=C4)F)Cl. Drug target is Stearoyl-CoA desaturase. Drug target pathway is Other.
Drug 2: The drug is AZD5363. The drug SMILES structure is O=C(C1(N)CCN(C2=C3C(NC=C3)=NC=N2)CC1)N[C@H](C4=CC=C(Cl)C=C4)CCO. Drug target is AKT1, AKT2, AKT3, ROCK2. Drug target pathway is Other, kinases.
Drug 3: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are ATM, BCOR, CXCR4, FGF10, MSH2, MTOR, RET, SLC34A2, SMARCA4, TP53, U2AF1.
Best drug option: ?",KIN001-135
ACH-000345,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is DABRAFENIB. The drug SMILES structure is CC(C)(C)C1=NC(=C(S1)C2=NC(=NC=C2)N)C3=C(C(=CC=C3)NS(=O)(=O)C4=C(C=CC=C4F)F)F. Drug target is BRAF. Drug target pathway is ERK MAPK signaling.
Drug 2: The drug is PIPERLONGUMINE. The drug SMILES structure is COC1=CC(=CC(=C1OC)OC)C=CC(=O)N2CCC=CC2=O. Drug target is Induces reactive oxygen species. Drug target pathway is Other.
Drug 3: The drug is ETOPOSIDE. The drug SMILES structure is C[C@@H]1OC[C@@H]2[C@@H](O1)[C@@H]([C@H]([C@@H](O2)O[C@H]3[C@H]4COC(=O)[C@@H]4[C@@H](C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O. Drug target is TOP2. Drug target pathway is DNA replication.
The mutations of the cell line are ALK, MSH6, TNFAIP3.
Best drug option: ?",ETOPOSIDE
ACH-000347,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is IMATINIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5. Drug target is ABL, KIT, PDGFR. Drug target pathway is Other, kinases.
Drug 2: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 3: The drug is PAZOPANIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC2=NC=CC(=N2)N(C)C3=CC4=NN(C(=C4C=C3)C)C)S(=O)(=O)N. Drug target is CSF1R, KIT,  PDGFRA, PDGFRB. Drug target pathway is RTK signaling.
The mutations of the cell line are APC, ATM, ERRFI1, KRAS, MTOR, PAX5, SMO, TET2, TP53.
Best drug option: ?",KIN001-135
ACH-000348,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is JNJ-38877605. The drug SMILES structure is CN1C=C(C=N1)C2=NN3C(=NN=C3C(C4=CC5=C(C=C4)N=CC=C5)(F)F)C=C2. Drug target is Unknown. Drug target pathway is Unknown.
Drug 2: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
Drug 3: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are BRAF, BRIP1, CDKN2A, JAK3, MET, POLE, RET, TP53.
Best drug option: ?",KIN001-135
ACH-000350,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is AGI-5198. The drug SMILES structure is CC1=CC=CC=C1C(C(=O)NC2CCCCC2)N(C3=CC(=CC=C3)F)C(=O)CN4C=CN=C4C. Drug target is IDH1 (R132H). Drug target pathway is Metabolism.
Drug 2: The drug is ARA-G. The drug SMILES structure is C1=NC2=C(N1[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)N=C(NC2=O)N. Drug target is Anti-metabolite. Drug target pathway is Other.
Drug 3: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are APC, EPHB1, ERBB3, MLL2, KRAS, MAP3K13, MRE11A, MTOR, MYCL1, NUTM1, SDHA, WHSC1L1.
Best drug option: ?",KIN001-135
ACH-000351,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 2: The drug is JNJ-38877605. The drug SMILES structure is CN1C=C(C=N1)C2=NN3C(=NN=C3C(C4=CC5=C(C=C4)N=CC=C5)(F)F)C=C2. Drug target is Unknown. Drug target pathway is Unknown.
Drug 3: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are BRIP1, CD22, FBXW7, NKX2-1, NOTCH3, PAX5, PIK3CA, TP53.
Best drug option: ?",KIN001-135
ACH-000352,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is AZD5363. The drug SMILES structure is O=C(C1(N)CCN(C2=C3C(NC=C3)=NC=N2)CC1)N[C@H](C4=CC=C(Cl)C=C4)CCO. Drug target is AKT1, AKT2, AKT3, ROCK2. Drug target pathway is Other, kinases.
Drug 2: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 3: The drug is ARA-G. The drug SMILES structure is C1=NC2=C(N1[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)N=C(NC2=O)N. Drug target is Anti-metabolite. Drug target pathway is Other.
The mutations of the cell line are AR, CIC, MST1R, SMAD4, SPEN, TSC2.
Best drug option: ?",KIN001-135
ACH-000354,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
Drug 2: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 3: The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ATM, BRCA2, FANCA, FANCG, GNAS, IKZF1, KRAS, MAP2K4, MERTK, MST1R, RAD54L, SF3B1, SMAD4, TP53.
Best drug option: ?",YM-201636
ACH-000355,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 2: The drug is SARACATINIB. The drug SMILES structure is CN1CCN(CC1)CCOC2=CC(=C3C(=C2)N=CN=C3NC4=C(C=CC5=C4OCO5)Cl)OC6CCOCC6. Drug target is ABL, SRC. Drug target pathway is Other, kinases.
Drug 3: The drug is AVAGACESTAT. The drug SMILES structure is C1=CC(=CC=C1S(=O)(=O)N(CC2=C(C=C(C=C2)C3=NOC=N3)F)[C@H](CCC(F)(F)F)C(=O)N)Cl. Drug target is Amyloid beta20, Amyloid beta40. Drug target pathway is Other.
The mutations of the cell line are CDH1, DDR1, MAP2K2, NF1, NOTCH1, NTRK1, RB1, SDHC, TP53, ZNF217.
Best drug option: ?",KIN001-135
ACH-000356,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is CAY10566. The drug SMILES structure is CC1=NN=C(O1)C2=NN=C(C=C2)N3CCC(CC3)OC4=C(C=CC(=C4)F)Cl. Drug target is Stearoyl-CoA desaturase. Drug target pathway is Other.
Drug 2: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 3: The drug is ABT-737. The drug SMILES structure is CN(C)CC[C@H](CSC1=CC=CC=C1)NC2=C(C=C(C=C2)S(=O)(=O)NC(=O)C3=CC=C(C=C3)N4CCN(CC4)CC5=CC=CC=C5C6=CC=C(C=C6)Cl)[N+](=O)[O-]. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are BCOR, BRCA1, CDH1, EGFR, FANCA, POLD1, TP53.
Best drug option: ?",CAY10566
ACH-000357,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is LINSITINIB. The drug SMILES structure is CC1(CC(C1)C2=NC(=C3N2C=CN=C3N)C4=CC5=C(C=C4)C=CC(=N5)C6=CC=CC=C6)O. Drug target is IGF1R. Drug target pathway is IGF1R signaling.
Drug 2: The drug is PACLITAXEL. The drug SMILES structure is CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@](C3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C. Drug target is TTK and microtubules. Drug target pathway is Unclassified.
Drug 3: The drug is IMATINIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5. Drug target is ABL, KIT, PDGFR. Drug target pathway is Other, kinases.
The mutations of the cell line are ATR, ATRX, BAP1, BCORL1, BRAF, BRCA1, CHEK2, FGF19, C17orf39, MLL2, TP53, VHL.
Best drug option: ?",IMATINIB
ACH-000358,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
Drug 2: The drug is AZD8931. The drug SMILES structure is CNC(=O)CN1CCC(CC1)OC2=C(C=C3C(=C2)C(=NC=N3)NC4=C(C(=CC=C4)Cl)F)OC. Drug target is EGFR, ERBB2, ERBB3. Drug target pathway is RTK signaling.
Drug 3: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are ATM, AURKB, MAP2K4, MYC, NTRK2, PIK3CA, PMS2, RB1, ROS1, SMARCB1, SPEN, TP53, WHSC1L1.
Best drug option: ?",KIN001-135
ACH-000359,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is GW-2580. The drug SMILES structure is COC1=CC=C(C=C1)COC2=C(C=C(C=C2)CC3=CN=C(N=C3N)N)OC. Drug target is CSF1R. Drug target pathway is RTK signaling.
Drug 2: The drug is AVAGACESTAT. The drug SMILES structure is C1=CC(=CC=C1S(=O)(=O)N(CC2=C(C=C(C=C2)C3=NOC=N3)F)[C@H](CCC(F)(F)F)C(=O)N)Cl. Drug target is Amyloid beta20, Amyloid beta40. Drug target pathway is Other.
Drug 3: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are ATRX, PRDM1, RPTOR.
Best drug option: ?",KIN001-135
ACH-000360,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is PYRIMETHAMINE. The drug SMILES structure is CCC1=C(C(=NC(=N1)N)N)C2=CC=C(C=C2)Cl. Drug target is Dihydrofolate reductase (DHFR). Drug target pathway is Other.
Drug 2: The drug is DASATINIB. The drug SMILES structure is CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)N4CCN(CC4)CCO)C. Drug target is ABL, SRC, Ephrins, PDGFR, KIT. Drug target pathway is RTK signaling.
Drug 3: The drug is LINIFANIB. The drug SMILES structure is CC1=CC(=C(C=C1)F)NC(=O)NC2=CC=C(C=C2)C3=C4C(=CC=C3)NN=C4N. Drug target is VEGFR1, VEGFR2, VEGFR3, CSF1R, FLT3, KIT. Drug target pathway is RTK signaling.
The mutations of the cell line are BRAF, CREBBP, MEF2B, MET, NOTCH3, PALB2, PIK3CA, SPOP, TP53, U2AF1.
Best drug option: ?",DASATINIB
ACH-000361,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 2: The drug is CAY10566. The drug SMILES structure is CC1=NN=C(O1)C2=NN=C(C=C2)N3CCC(CC3)OC4=C(C=CC(=C4)F)Cl. Drug target is Stearoyl-CoA desaturase. Drug target pathway is Other.
Drug 3: The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are BRAF, NF2, SMARCA4.
Best drug option: ?",KIN001-135
ACH-000362,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is YK-4-279. The drug SMILES structure is COC1=CC=C(C=C1)C(=O)CC2(C3=C(C=CC(=C3NC2=O)Cl)Cl)O. Drug target is RNA helicase A. Drug target pathway is Other.
Drug 2: The drug is LINSITINIB. The drug SMILES structure is CC1(CC(C1)C2=NC(=C3N2C=CN=C3N)C4=CC5=C(C=C4)C=CC(=N5)C6=CC=CC=C6)O. Drug target is IGF1R. Drug target pathway is IGF1R signaling.
Drug 3: The drug is ABT-737. The drug SMILES structure is CN(C)CC[C@H](CSC1=CC=CC=C1)NC2=C(C=C(C=C2)S(=O)(=O)NC(=O)C3=CC=C(C=C3)N4CCN(CC4)CC5=CC=CC=C5C6=CC=C(C=C6)Cl)[N+](=O)[O-]. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are BRCA2, CBL, MLL, MLH1, MSH2, MTOR, NF1, PIK3C2G.
Best drug option: ?",YK-4-279
ACH-000363,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is WZ3105. The drug SMILES structure is CC(C)N1C=NC2=C1N=C(N=C2NC3=CC(=CC=C3)NC(=O)C=C)NC4CCC(CC4)N(C)C. Drug target is SRC, ROCK2, NTRK2, FLT3, IRAK1, others. Drug target pathway is Other.
Drug 2: The drug is ERK5-IN-1. The drug SMILES structure is CCOC1=C(C=CC(=C1)C(=O)N2CCC(CC2)N3CCN(CC3)C)NC4=NC=C5C(=N4)N(C6=CC=CC=C6C(=O)N5C)C7CCCC7. Drug target is ERK5, BET. Drug target pathway is Other.
Drug 3: The drug is AVAGACESTAT. The drug SMILES structure is C1=CC(=CC=C1S(=O)(=O)N(CC2=C(C=C(C=C2)C3=NOC=N3)F)[C@H](CCC(F)(F)F)C(=O)N)Cl. Drug target is Amyloid beta20, Amyloid beta40. Drug target pathway is Other.
The mutations of the cell line are CALR, DOT1L, TP53, TSC2.
Best drug option: ?",ERK5-IN-1
ACH-000364,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is GW-2580. The drug SMILES structure is COC1=CC=C(C=C1)COC2=C(C=C(C=C2)CC3=CN=C(N=C3N)N)OC. Drug target is CSF1R. Drug target pathway is RTK signaling.
Drug 2: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
Drug 3: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are CTNNB1, H3F3A, PPARG, RICTOR, SLC34A2, TET2.
Best drug option: ?",KIN001-135
ACH-000365,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is PANOBINOSTAT. The drug SMILES structure is CC1=C(C2=CC=CC=C2N1)CCNCC3=CC=C(C=C3)C=CC(=O)NO. Drug target is HDAC. Drug target pathway is Chromatin histone acetylation.
Drug 2: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 3: The drug is CYCLOPHOSPHAMIDE. The drug SMILES structure is C1CNP(=O)(OC1)N(CCCl)CCCl. Drug target is Alkylating agent. Drug target pathway is DNA replication.
The mutations of the cell line are AXIN1, BCL2, EZH2, MEF2B, PBRM1, PIK3CB, TNFRSF14, TP53, TYRO3, XPO1.
Best drug option: ?",KIN001-135
ACH-000366,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is AVAGACESTAT. The drug SMILES structure is C1=CC(=CC=C1S(=O)(=O)N(CC2=C(C=C(C=C2)C3=NOC=N3)F)[C@H](CCC(F)(F)F)C(=O)N)Cl. Drug target is Amyloid beta20, Amyloid beta40. Drug target pathway is Other.
Drug 2: The drug is GSK650394. The drug SMILES structure is C1CCC(C1)C2=C(C=CC(=C2)C3=CNC4=NC=C(C=C34)C5=CC=CC=C5)C(=O)O. Drug target is SGK2, SGK3. Drug target pathway is Other, kinases.
Drug 3: The drug is AZ960. The drug SMILES structure is CC1=CC(=NN1)NC2=C(C=C(C(=N2)N[C@@H](C)C3=CC=C(C=C3)F)C#N)F. Drug target is JAK2, JAK3. Drug target pathway is Other, kinases.
The mutations of the cell line are EMSY, EP300, FANCC, C17orf39, IGF1R, LYN, MAP3K13, PIK3C2G, PMS2, RB1, TET2, TP53.
Best drug option: ?",AZ960
ACH-000367,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
Drug 2: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
Drug 3: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are APC, EGFR, PBRM1, TERT, XPO1.
Best drug option: ?",WYE-125132
ACH-000372,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is EX-527. The drug SMILES structure is C1CC(C2=C(C1)C3=C(N2)C=CC(=C3)Cl)C(=O)N. Drug target is SIRT1. Drug target pathway is Chromatin histone acetylation.
Drug 2: The drug is AVAGACESTAT. The drug SMILES structure is C1=CC(=CC=C1S(=O)(=O)N(CC2=C(C=C(C=C2)C3=NOC=N3)F)[C@H](CCC(F)(F)F)C(=O)N)Cl. Drug target is Amyloid beta20, Amyloid beta40. Drug target pathway is Other.
Drug 3: The drug is IMATINIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5. Drug target is ABL, KIT, PDGFR. Drug target pathway is Other, kinases.
The mutations of the cell line are APC, BRAF, EPHA3, FBXW7, MLL2, NFE2L2, NOTCH1, NRAS, PTEN, SMAD4, TP53, WHSC1L1.
Best drug option: ?",IMATINIB
ACH-000373,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is IMATINIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5. Drug target is ABL, KIT, PDGFR. Drug target pathway is Other, kinases.
Drug 2: The drug is BORTEZOMIB. The drug SMILES structure is B([C@H](CC(C)C)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O. Drug target is Proteasome. Drug target pathway is Protein stability and degradation.
Drug 3: The drug is SARACATINIB. The drug SMILES structure is CN1CCN(CC1)CCOC2=CC(=C3C(=C2)N=CN=C3NC4=C(C=CC5=C4OCO5)Cl)OC6CCOCC6. Drug target is ABL, SRC. Drug target pathway is Other, kinases.
The mutations of the cell line are ASXL1, BCOR, BCORL1, EZH2, FBXW7, KRAS, PARP2, SPEN, TET2, TP53, WT1.
Best drug option: ?",SARACATINIB
ACH-000374,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is IMATINIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5. Drug target is ABL, KIT, PDGFR. Drug target pathway is Other, kinases.
Drug 2: The drug is JQ1-(+). The drug SMILES structure is CC1=C(SC2=C1C(=N[C@H](C3=NN=C(N32)C)CC(=O)OC(C)(C)C)C4=CC=C(C=C4)Cl)C. Drug target is Unknown. Drug target pathway is Unknown.
Drug 3: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are FGFR2, NOTCH2, SMARCA4, TP53.
Best drug option: ?",WYE-125132
ACH-000375,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is CAY10566. The drug SMILES structure is CC1=NN=C(O1)C2=NN=C(C=C2)N3CCC(CC3)OC4=C(C=CC(=C4)F)Cl. Drug target is Stearoyl-CoA desaturase. Drug target pathway is Other.
Drug 2: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 3: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ERCC4, MED12, NF1, NOTCH1, RNF43.
Best drug option: ?",KIN001-135
ACH-000376,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is CAY10566. The drug SMILES structure is CC1=NN=C(O1)C2=NN=C(C=C2)N3CCC(CC3)OC4=C(C=CC(=C4)F)Cl. Drug target is Stearoyl-CoA desaturase. Drug target pathway is Other.
Drug 2: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 3: The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are BCOR, FANCA, JUN, KEL, MAP3K1, NOTCH3, PTEN, TP53.
Best drug option: ?",YM-201636
ACH-000378,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 2: The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
Drug 3: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are FGFR2, GNA11, KEAP1, KEL, KRAS, STK11, TNFAIP3, TP53.
Best drug option: ?",KIN001-135
ACH-000379,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is TIVOZANIB. The drug SMILES structure is CC1=CC(=NO1)NC(=O)NC2=C(C=C(C=C2)OC3=C4C=C(C(=CC4=NC=C3)OC)OC)Cl. Drug target is VEGFR1, VEGFR2, VEGFR3, PDGFR, KIT. Drug target pathway is RTK signaling.
Drug 2: The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
Drug 3: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are ATR, CDC73, EPHB1, ERBB2, KDM5A, MSH6, NTRK3, PARK2, PTEN, TNFAIP3, TP53.
Best drug option: ?",YM-201636
ACH-000380,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is AVAGACESTAT. The drug SMILES structure is C1=CC(=CC=C1S(=O)(=O)N(CC2=C(C=C(C=C2)C3=NOC=N3)F)[C@H](CCC(F)(F)F)C(=O)N)Cl. Drug target is Amyloid beta20, Amyloid beta40. Drug target pathway is Other.
Drug 2: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
Drug 3: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are CDKN2C, EPHA3, ERBB2, KDM5A, LYN, MERTK, RAD21, TP53.
Best drug option: ?",KIN001-135
ACH-000381,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is PYRIDOSTATIN. The drug SMILES structure is C1=CC=C2C(=C1)C(=CC(=N2)NC(=O)C3=CC(=CC(=N3)C(=O)NC4=NC5=CC=CC=C5C(=C4)OCCN)OCCN)OCCN. Drug target is G-quadruplex stabiliser. Drug target pathway is DNA replication.
Drug 2: The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
Drug 3: The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are APC, ATR, BCOR, CIC, KDM5A, KEL, MLL, KRAS, PIK3C2B, PIK3CA, RET, SMAD4, TP53.
Best drug option: ?",YM-201636
ACH-000384,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is YK-4-279. The drug SMILES structure is COC1=CC=C(C=C1)C(=O)CC2(C3=C(C=CC(=C3NC2=O)Cl)Cl)O. Drug target is RNA helicase A. Drug target pathway is Other.
Drug 2: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 3: The drug is JNJ-38877605. The drug SMILES structure is CN1C=C(C=N1)C2=NN3C(=NN=C3C(C4=CC5=C(C=C4)N=CC=C5)(F)F)C=C2. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are BRIP1, CDH1, CREBBP, FGFR3.
Best drug option: ?",KIN001-135
ACH-000386,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is CAY10566. The drug SMILES structure is CC1=NN=C(O1)C2=NN=C(C=C2)N3CCC(CC3)OC4=C(C=CC(=C4)F)Cl. Drug target is Stearoyl-CoA desaturase. Drug target pathway is Other.
Drug 2: The drug is IMATINIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5. Drug target is ABL, KIT, PDGFR. Drug target pathway is Other, kinases.
Drug 3: The drug is QS-11. The drug SMILES structure is C1CC2=C(C1)C=C(C=C2)OC3=NC(=C4C(=N3)N(C=N4)CC5=CC=C(C=C5)C6=CC=CC=C6)NC(CC7=CC=CC=C7)CO. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are DIS3, DOT1L, EZR, FGFR1, JUN, MSH6, NOTCH1, NOTCH2, PARK2, TP53.
Best drug option: ?",IMATINIB
ACH-000389,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is AVAGACESTAT. The drug SMILES structure is C1=CC(=CC=C1S(=O)(=O)N(CC2=C(C=C(C=C2)C3=NOC=N3)F)[C@H](CCC(F)(F)F)C(=O)N)Cl. Drug target is Amyloid beta20, Amyloid beta40. Drug target pathway is Other.
Drug 2: The drug is YK-4-279. The drug SMILES structure is COC1=CC=C(C=C1)C(=O)CC2(C3=C(C=CC(=C3NC2=O)Cl)Cl)O. Drug target is RNA helicase A. Drug target pathway is Other.
Drug 3: The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are EPHA3, FGFR4, PARP3, POLE, PTEN, SUFU, TMPRSS2, WT1.
Best drug option: ?",YM-201636
ACH-000391,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 2: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
Drug 3: The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ATRX, AURKA, CDKN2A, NF1, PDK1, PIK3R1, RAD21, TP53, WHSC1L1, XPO1.
Best drug option: ?",WYE-125132
ACH-000392,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is LIMK1 INHIBITOR BMS4. The drug SMILES structure is CCNC(=O)NC1=NC=C(S1)C2=CC(=NC(=N2)C3=NC=CN=C3)C4=C(C=C(C=C4C)OC)C. Drug target is LIMK1. Drug target pathway is Cytoskeleton.
Drug 2: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
Drug 3: The drug is TIVOZANIB. The drug SMILES structure is CC1=CC(=NO1)NC(=O)NC2=C(C=C(C=C2)OC3=C4C=C(C(=CC4=NC=C3)OC)OC)Cl. Drug target is VEGFR1, VEGFR2, VEGFR3, PDGFR, KIT. Drug target pathway is RTK signaling.
The mutations of the cell line are AXL, CDKN1A, CDKN2A, DNMT3A, ERG, MSH6, RPTOR, TP53.
Best drug option: ?",LIMK1 INHIBITOR BMS4
ACH-000394,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is IMATINIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5. Drug target is ABL, KIT, PDGFR. Drug target pathway is Other, kinases.
Drug 2: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 3: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ATR, ATRX, CDH1, CUL3, FANCL, MLL2, PIK3CB, PTEN, RB1, SLC34A2.
Best drug option: ?",KIN001-135
ACH-000395,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
Drug 2: The drug is XMD13-2. The drug SMILES structure is O=C(C1CC1)NC2=NNC3=CC(C4=CC(C(NC5CC5)=O)=CC=C4)=CC=C32. Drug target is MRCKB. Drug target pathway is Cytoskeleton.
Drug 3: The drug is QS-11. The drug SMILES structure is C1CC2=C(C1)C=C(C=C2)OC3=NC(=C4C(=N3)N(C=N4)CC5=CC=C(C=C5)C6=CC=CC=C6)NC(CC7=CC=CC=C7)CO. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ACVR1B, AKT1, ATM, BRD4, CARD11, CDKN2A, CREBBP, KEL, MLL2, MDM4, NTRK3, PIK3C2B, PMS2, POLE, TP53.
Best drug option: ?",BRYOSTATIN-1
ACH-000399,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is PAZOPANIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC2=NC=CC(=N2)N(C)C3=CC4=NN(C(=C4C=C3)C)C)S(=O)(=O)N. Drug target is CSF1R, KIT,  PDGFRA, PDGFRB. Drug target pathway is RTK signaling.
Drug 2: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
Drug 3: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are ACVR1B, ASXL1, CDK12, FGF12, MLL2, PBRM1, PMS2, PTCH1, RB1, TP53.
Best drug option: ?",KIN001-135
ACH-000400,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is BORTEZOMIB. The drug SMILES structure is B([C@H](CC(C)C)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O. Drug target is Proteasome. Drug target pathway is Protein stability and degradation.
Drug 2: The drug is CAY10566. The drug SMILES structure is CC1=NN=C(O1)C2=NN=C(C=C2)N3CCC(CC3)OC4=C(C=CC(=C4)F)Cl. Drug target is Stearoyl-CoA desaturase. Drug target pathway is Other.
Drug 3: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are APC, EED, EP300, ERBB4, FLCN, GNAS, GSK3B, KLHL6, KRAS, MST1R, RET, RPTOR.
Best drug option: ?",CAY10566
ACH-000401,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is IMATINIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5. Drug target is ABL, KIT, PDGFR. Drug target pathway is Other, kinases.
Drug 2: The drug is CCT007093. The drug SMILES structure is C1CC(=CC2=CC=CS2)C(=O)C1=CC3=CC=CS3. Drug target is PPM1D. Drug target pathway is Cell cycle.
Drug 3: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are BRAF, BRCA2, CDK4, IGF1R, ROS1, SPEN, TP53, WHSC1.
Best drug option: ?",WYE-125132
ACH-000403,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 2: The drug is KRAS (G12C) INHIBITOR-12. The drug SMILES structure is C=CC(=O)N1CCN(CC1)C(=O)CNC2=CC(=C(C=C2O)Cl)I. Drug target is KRAS (G12C). Drug target pathway is ERK MAPK signaling.
Drug 3: The drug is CPI-613. The drug SMILES structure is C1=CC=C(C=C1)CSCCC(CCCCC(=O)O)SCC2=CC=CC=C2. Drug target is Metabo, Mitochondria. Drug target pathway is Other.
The mutations of the cell line are APC, ATM, BRCA2, DIS3, ETV6, KRAS, SF3B1, TP53.
Best drug option: ?",KIN001-135
ACH-000408,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is GSK2606414. The drug SMILES structure is CN1C=C(C2=C(N=CN=C21)N)C3=CC4=C(C=C3)N(CC4)C(=O)CC5=CC(=CC=C5)C(F)(F)F. Drug target is PERK. Drug target pathway is Metabolism.
Drug 2: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
Drug 3: The drug is GW-2580. The drug SMILES structure is COC1=CC=C(C=C1)COC2=C(C=C(C=C2)CC3=CN=C(N=C3N)N)OC. Drug target is CSF1R. Drug target pathway is RTK signaling.
The mutations of the cell line are ALK, APC, BCORL1, EP300, MLL, MED12, MET, PIK3CA, TP53.
Best drug option: ?",WYE-125132
ACH-000410,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is LINIFANIB. The drug SMILES structure is CC1=CC(=C(C=C1)F)NC(=O)NC2=CC=C(C=C2)C3=C4C(=CC=C3)NN=C4N. Drug target is VEGFR1, VEGFR2, VEGFR3, CSF1R, FLT3, KIT. Drug target pathway is RTK signaling.
Drug 2: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
Drug 3: The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are BARD1, FGF12, FLT3, MLL2, MDM2, MLH1, MSH6, NUTM1, RB1, RSPO2, SF3B1, SPEN, WHSC1.
Best drug option: ?",LINIFANIB
ACH-000411,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
Drug 2: The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
Drug 3: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are BAP1, TSC2, VHL.
Best drug option: ?",YM-201636
ACH-000414,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is LESTAURTINIB. The drug SMILES structure is C[C@@]12[C@](C[C@@H](O1)N3C4=CC=CC=C4C5=C6C(=C7C8=CC=CC=C8N2C7=C53)CNC6=O)(CO)O. Drug target is FLT3, JAK2, NTRK1, NTRK2, NTRK3. Drug target pathway is Other, kinases.
Drug 2: The drug is CAY10566. The drug SMILES structure is CC1=NN=C(O1)C2=NN=C(C=C2)N3CCC(CC3)OC4=C(C=CC(=C4)F)Cl. Drug target is Stearoyl-CoA desaturase. Drug target pathway is Other.
Drug 3: The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are FAM123B, ATR, CEBPA, FBXW7, GATA4, HGF, KEAP1, KRAS, MAP3K1, NBN, NTRK1, PRKAR1A, RBM10, STK11, TBX3, TIPARP, TNFAIP3, WHSC1L1.
Best drug option: ?",LESTAURTINIB
ACH-000416,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is IMATINIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5. Drug target is ABL, KIT, PDGFR. Drug target pathway is Other, kinases.
Drug 2: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 3: The drug is SB-505124. The drug SMILES structure is CC1=NC(=CC=C1)C2=C(N=C(N2)C(C)(C)C)C3=CC4=C(C=C3)OCO4. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ARID1A, KDR, KEAP1, MED12, MET, SMARCA4, STK11, TP53.
Best drug option: ?",KIN001-135
ACH-000417,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is PFI-1. The drug SMILES structure is CN1CC2=C(C=CC(=C2)NS(=O)(=O)C3=CC=CC=C3OC)NC1=O. Drug target is BRD4. Drug target pathway is Chromatin other.
Drug 2: The drug is LINIFANIB. The drug SMILES structure is CC1=CC(=C(C=C1)F)NC(=O)NC2=CC=C(C=C2)C3=C4C(=CC=C3)NN=C4N. Drug target is VEGFR1, VEGFR2, VEGFR3, CSF1R, FLT3, KIT. Drug target pathway is RTK signaling.
Drug 3: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are ATM, CREBBP, DAXX, KRAS, MKNK1, MSH3, RSPO2, SMAD4, SNCAIP.
Best drug option: ?",LINIFANIB
ACH-000420,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
Drug 2: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 3: The drug is QS-11. The drug SMILES structure is C1CC2=C(C1)C=C(C=C2)OC3=NC(=C4C(=N3)N(C=N4)CC5=CC=C(C=C5)C6=CC=CC=C6)NC(CC7=CC=CC=C7)CO. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ALK, ARID1A, AXIN1, HNF1A, HSD3B1, NTRK1, PTEN, TP53.
Best drug option: ?",WYE-125132
ACH-000422,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 2: The drug is GW-2580. The drug SMILES structure is COC1=CC=C(C=C1)COC2=C(C=C(C=C2)CC3=CN=C(N=C3N)N)OC. Drug target is CSF1R. Drug target pathway is RTK signaling.
Drug 3: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ASXL1, ATR, AXL, CDKN2C, CIC, DDR1, KEAP1, KEL, MAP3K13, MITF, MSH6, NBN, RPTOR, TIPARP, TP53.
Best drug option: ?",WYE-125132
ACH-000423,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is PANOBINOSTAT. The drug SMILES structure is CC1=C(C2=CC=CC=C2N1)CCNCC3=CC=C(C=C3)C=CC(=O)NO. Drug target is HDAC. Drug target pathway is Chromatin histone acetylation.
Drug 2: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
Drug 3: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are APC, BRAF, MLL, MEN1, PDK1, TP53.
Best drug option: ?",PANOBINOSTAT
ACH-000424,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is AVAGACESTAT. The drug SMILES structure is C1=CC(=CC=C1S(=O)(=O)N(CC2=C(C=C(C=C2)C3=NOC=N3)F)[C@H](CCC(F)(F)F)C(=O)N)Cl. Drug target is Amyloid beta20, Amyloid beta40. Drug target pathway is Other.
Drug 2: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 3: The drug is IMATINIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5. Drug target is ABL, KIT, PDGFR. Drug target pathway is Other, kinases.
The mutations of the cell line are EGFR, ERBB4, MLL2, NF1, PIK3C2G, SF3B1, SMARCB1, SOCS1, TP53.
Best drug option: ?",KIN001-135
ACH-000425,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is JW-7-24-1. The drug SMILES structure is COC1=CC(=CC(=C1)C2=CC3=C4C(=CN=C3C=C2)C=CC(=O)N4C5=CC(=C(C=C5)N6CCNCC6)C(F)(F)F)OC. Drug target is LCK. Drug target pathway is Other, kinases.
Drug 2: The drug is TIPIFARNIB. The drug SMILES structure is CN1C=NC=C1[C@@](C2=CC=C(C=C2)Cl)(C3=CC4=C(C=C3)N(C(=O)C=C4C5=CC(=CC=C5)Cl)C)N. Drug target is Farnesyl-transferase (FNTA). Drug target pathway is Other.
Drug 3: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are BRAF, BRCA1, FANCG, FGF4, IKZF1, MRE11A, NUTM1, POLE, PTEN, ROS1.
Best drug option: ?",JW-7-24-1
ACH-000427,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 2: The drug is DASATINIB. The drug SMILES structure is CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)N4CCN(CC4)CCO)C. Drug target is ABL, SRC, Ephrins, PDGFR, KIT. Drug target pathway is RTK signaling.
Drug 3: The drug is SINULARIN. The drug SMILES structure is CC1=CCCC(C2CC(CCC3(C(O3)CC1)C)C(=C)C(=O)O2)(C)O. Drug target is Unknown. Drug target pathway is Unclassified.
The mutations of the cell line are ERBB2, ERRFI1, GATA3, MLL2, MSH6, NTRK3, SPOP, TP53.
Best drug option: ?",DASATINIB
ACH-000428,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is PANOBINOSTAT. The drug SMILES structure is CC1=C(C2=CC=CC=C2N1)CCNCC3=CC=C(C=C3)C=CC(=O)NO. Drug target is HDAC. Drug target pathway is Chromatin histone acetylation.
Drug 2: The drug is KOBE2602. The drug SMILES structure is C1=CC(=CC=C1NC(=S)NNC2=C(C=C(C=C2[N+](=O)[O-])C(F)(F)F)[N+](=O)[O-])F. Drug target is RAS effector. Drug target pathway is RTK signaling.
Drug 3: The drug is CAY10566. The drug SMILES structure is CC1=NN=C(O1)C2=NN=C(C=C2)N3CCC(CC3)OC4=C(C=CC(=C4)F)Cl. Drug target is Stearoyl-CoA desaturase. Drug target pathway is Other.
The mutations of the cell line are APC, JAK2, MLL2, MAP3K13, RSPO2, SF3B1, SMARCA4.
Best drug option: ?",PANOBINOSTAT
ACH-000429,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KB NB 142-70. The drug SMILES structure is C1CSC2=C(C(=O)N1)SC3=C2C=C(C=C3)O. Drug target is PKD. Drug target pathway is Other, kinases.
Drug 2: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 3: The drug is TIPIFARNIB. The drug SMILES structure is CN1C=NC=C1[C@@](C2=CC=C(C=C2)Cl)(C3=CC4=C(C=C3)N(C(=O)C=C4C5=CC(=CC=C5)Cl)C)N. Drug target is Farnesyl-transferase (FNTA). Drug target pathway is Other.
The mutations of the cell line are CDKN2B, DOT1L, EPHA3, MSH6, NOTCH3, PBRM1, RARA, RET, RNF43, SETD2, SMAD2, TP53, VHL.
Best drug option: ?",KB NB 142-70
ACH-000430,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
Drug 2: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 3: The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ARID1A, ATRX, DDR1, DOT1L, EPHA3, ERCC4, KDM5A, MSH3, MSH6, NPM1, NRAS, PIK3C2B, TP53.
Best drug option: ?",KIN001-135
ACH-000431,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is CYTARABINE. The drug SMILES structure is C1=CN(C(=O)N=C1N)[C@H]2[C@H]([C@@H]([C@H](O2)CO)O)O. Drug target is Antimetabolite. Drug target pathway is Other.
Drug 2: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 3: The drug is IMATINIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5. Drug target is ABL, KIT, PDGFR. Drug target pathway is Other, kinases.
The mutations of the cell line are AKT2, CREBBP, MAP3K13, RB1, TET2, TP53.
Best drug option: ?",KIN001-135
ACH-000433,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is PARTHENOLIDE. The drug SMILES structure is CC1=CCCC2(C(O2)C3C(CC1)C(=C)C(=O)O3)C. Drug target is HDAC1. Drug target pathway is Chromatin histone acetylation.
Drug 2: The drug is CAY10566. The drug SMILES structure is CC1=NN=C(O1)C2=NN=C(C=C2)N3CCC(CC3)OC4=C(C=CC(=C4)F)Cl. Drug target is Stearoyl-CoA desaturase. Drug target pathway is Other.
Drug 3: The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are CIC, MET, PTCH1, RB1, SETD2.
Best drug option: ?",YM-201636
ACH-000434,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 2: The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
Drug 3: The drug is AVAGACESTAT. The drug SMILES structure is C1=CC(=CC=C1S(=O)(=O)N(CC2=C(C=C(C=C2)C3=NOC=N3)F)[C@H](CCC(F)(F)F)C(=O)N)Cl. Drug target is Amyloid beta20, Amyloid beta40. Drug target pathway is Other.
The mutations of the cell line are ABL1, CDKN2A, EPHA3, GATA6, HGF, HRAS, KEAP1, MYD88, RARA, STK11, TP53.
Best drug option: ?",BRYOSTATIN-1
ACH-000437,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is YK-4-279. The drug SMILES structure is COC1=CC=C(C=C1)C(=O)CC2(C3=C(C=CC(=C3NC2=O)Cl)Cl)O. Drug target is RNA helicase A. Drug target pathway is Other.
Drug 2: The drug is AGI-5198. The drug SMILES structure is CC1=CC=CC=C1C(C(=O)NC2CCCCC2)N(C3=CC(=CC=C3)F)C(=O)CN4C=CN=C4C. Drug target is IDH1 (R132H). Drug target pathway is Metabolism.
Drug 3: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are ARID1A, CREBBP, IDH2, MRE11A, MSH3, MYD88, NRAS, ROS1, SUFU, TET2, TP53.
Best drug option: ?",KIN001-135
ACH-000439,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is ARA-G. The drug SMILES structure is C1=NC2=C(N1[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)N=C(NC2=O)N. Drug target is Anti-metabolite. Drug target pathway is Other.
Drug 2: The drug is MIRIN. The drug SMILES structure is C1=CC(=CC=C1C=C2C(=O)N=C(S2)N)O. Drug target is MRE11. Drug target pathway is Genome integrity.
Drug 3: The drug is ERK5-IN-1. The drug SMILES structure is CCOC1=C(C=CC(=C1)C(=O)N2CCC(CC2)N3CCN(CC3)C)NC4=NC=C5C(=N4)N(C6=CC=CC=C6C(=O)N5C)C7CCCC7. Drug target is ERK5, BET. Drug target pathway is Other.
The mutations of the cell line are ERBB3, FLT3, NRAS, PTCH1, RARA, WT1.
Best drug option: ?",ERK5-IN-1
ACH-000440,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is IMATINIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5. Drug target is ABL, KIT, PDGFR. Drug target pathway is Other, kinases.
Drug 2: The drug is PAZOPANIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC2=NC=CC(=N2)N(C)C3=CC4=NN(C(=C4C=C3)C)C)S(=O)(=O)N. Drug target is CSF1R, KIT,  PDGFRA, PDGFRB. Drug target pathway is RTK signaling.
Drug 3: The drug is EPZ004777. The drug SMILES structure is CC(C)N(CCCNC(=O)NC1=CC=C(C=C1)C(C)(C)C)C[C@@H]2[C@H]([C@H]([C@@H](O2)N3C=CC4=C(N=CN=C43)N)O)O. Drug target is DOT1L. Drug target pathway is Chromatin histone methylation.
The mutations of the cell line are ABL1, HGF, ID3, MYC, RET, TP53, TSC1.
Best drug option: ?",IMATINIB
ACH-000441,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is GSK2606414. The drug SMILES structure is CN1C=C(C2=C(N=CN=C21)N)C3=CC4=C(C=C3)N(CC4)C(=O)CC5=CC(=CC=C5)C(F)(F)F. Drug target is PERK. Drug target pathway is Metabolism.
Drug 2: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
Drug 3: The drug is JW-7-24-1. The drug SMILES structure is COC1=CC(=CC(=C1)C2=CC3=C4C(=CN=C3C=C2)C=CC(=O)N4C5=CC(=C(C=C5)N6CCNCC6)C(F)(F)F)OC. Drug target is LCK. Drug target pathway is Other, kinases.
The mutations of the cell line are ABL1, BRAF, CDKN2C, EWSR1, IRS2, RNF43.
Best drug option: ?",JW-7-24-1
ACH-000442,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is GW-2580. The drug SMILES structure is COC1=CC=C(C=C1)COC2=C(C=C(C=C2)CC3=CN=C(N=C3N)N)OC. Drug target is CSF1R. Drug target pathway is RTK signaling.
Drug 2: The drug is YK-4-279. The drug SMILES structure is COC1=CC=C(C=C1)C(=O)CC2(C3=C(C=CC(=C3NC2=O)Cl)Cl)O. Drug target is RNA helicase A. Drug target pathway is Other.
Drug 3: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are CUL3, MAP3K1, NF1, NFE2L2, PIK3CA, WHSC1.
Best drug option: ?",YK-4-279
ACH-000443,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is JQ1-(+). The drug SMILES structure is CC1=C(SC2=C1C(=N[C@H](C3=NN=C(N32)C)CC(=O)OC(C)(C)C)C4=CC=C(C=C4)Cl)C. Drug target is Unknown. Drug target pathway is Unknown.
Drug 2: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 3: The drug is PAZOPANIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC2=NC=CC(=N2)N(C)C3=CC4=NN(C(=C4C=C3)C)C)S(=O)(=O)N. Drug target is CSF1R, KIT,  PDGFRA, PDGFRB. Drug target pathway is RTK signaling.
The mutations of the cell line are ATM, ATR, DNMT3A, FH, GATA4, KDM5C, ROS1, SMAD4, TET2, TP53, TSC2.
Best drug option: ?",KIN001-135
ACH-000447,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
Drug 2: The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
Drug 3: The drug is Z-LLNLE-CHO. The drug SMILES structure is CCCCC(C=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)OCC1=CC=CC=C1. Drug target is gamma-secretase. Drug target pathway is Other.
The mutations of the cell line are CD74, EED, NFE2L2, PDGFRA, RAD21, RB1, RET, TP53, WHSC1L1.
Best drug option: ?",YM-201636
ACH-000448,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
Drug 2: The drug is METHOTREXATE. The drug SMILES structure is CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O. Drug target is Antimetabolite. Drug target pathway is DNA replication.
Drug 3: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are ATM, BRAF, BTK, CDK6, DNMT3A, EPHA3, EPHB1, FUBP1, MDM2, NOTCH1, NOTCH3, RET, STK11.
Best drug option: ?",KIN001-135
ACH-000449,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 2: The drug is GSK2606414. The drug SMILES structure is CN1C=C(C2=C(N=CN=C21)N)C3=CC4=C(C=C3)N(CC4)C(=O)CC5=CC(=CC=C5)C(F)(F)F. Drug target is PERK. Drug target pathway is Metabolism.
Drug 3: The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are AKT1, ARID1A, GNAS, HGF, NFE2L2, PIK3R1, POLE, PTEN, RAF1, TET2, TSC1.
Best drug option: ?",KIN001-135
ACH-000450,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is JW-7-24-1. The drug SMILES structure is COC1=CC(=CC(=C1)C2=CC3=C4C(=CN=C3C=C2)C=CC(=O)N4C5=CC(=C(C=C5)N6CCNCC6)C(F)(F)F)OC. Drug target is LCK. Drug target pathway is Other, kinases.
Drug 2: The drug is NU-7441. The drug SMILES structure is C1COCCN1C2=CC(=O)C3=C(O2)C(=CC=C3)C4=CC=CC5=C4SC6=CC=CC=C56. Drug target is Unknown. Drug target pathway is Unknown.
Drug 3: The drug is BORTEZOMIB. The drug SMILES structure is B([C@H](CC(C)C)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O. Drug target is Proteasome. Drug target pathway is Protein stability and degradation.
The mutations of the cell line are ASXL1, BRAF, EMSY, EWSR1, MLL, MLL2, MAP2K4, MAP3K13, PTEN, ROS1, SNCAIP, TERT.
Best drug option: ?",NU-7441
ACH-000451,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is XMD13-2. The drug SMILES structure is O=C(C1CC1)NC2=NNC3=CC(C4=CC(C(NC5CC5)=O)=CC=C4)=CC=C32. Drug target is MRCKB. Drug target pathway is Cytoskeleton.
Drug 2: The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
Drug 3: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are CSF1R, CUL4A, EZR, FLT1, GRM3, MLL, MAP2K4, SMARCA4, TGFBR2, TP53.
Best drug option: ?",KIN001-135
ACH-000452,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is AZD5363. The drug SMILES structure is O=C(C1(N)CCN(C2=C3C(NC=C3)=NC=N2)CC1)N[C@H](C4=CC=C(Cl)C=C4)CCO. Drug target is AKT1, AKT2, AKT3, ROCK2. Drug target pathway is Other, kinases.
Drug 2: The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
Drug 3: The drug is IMATINIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5. Drug target is ABL, KIT, PDGFR. Drug target pathway is Other, kinases.
The mutations of the cell line are BRIP1, CREBBP, DDR1, FH, MET, NOTCH1, SF3B1, TP53.
Best drug option: ?",IMATINIB
ACH-000456,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is JNJ-38877605. The drug SMILES structure is CN1C=C(C=N1)C2=NN3C(=NN=C3C(C4=CC5=C(C=C4)N=CC=C5)(F)F)C=C2. Drug target is Unknown. Drug target pathway is Unknown.
Drug 2: The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
Drug 3: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are APC, BRAF, BTK, CSF3R, DIS3, DOT1L, EPHA3, FANCA, JAK3, REL, SDHA, TP53.
Best drug option: ?",WYE-125132
ACH-000457,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is CAY10566. The drug SMILES structure is CC1=NN=C(O1)C2=NN=C(C=C2)N3CCC(CC3)OC4=C(C=CC(=C4)F)Cl. Drug target is Stearoyl-CoA desaturase. Drug target pathway is Other.
Drug 2: The drug is YK-4-279. The drug SMILES structure is COC1=CC=C(C=C1)C(=O)CC2(C3=C(C=CC(=C3NC2=O)Cl)Cl)O. Drug target is RNA helicase A. Drug target pathway is Other.
Drug 3: The drug is VINBLASTINE. The drug SMILES structure is CC[C@@]1(C[C@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O. Drug target is Microtubule destabiliser. Drug target pathway is Mitosis.
The mutations of the cell line are CDK8, FBXW7, SMARCA4.
Best drug option: ?",CAY10566
ACH-000463,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
Drug 2: The drug is PANOBINOSTAT. The drug SMILES structure is CC1=C(C2=CC=CC=C2N1)CCNCC3=CC=C(C=C3)C=CC(=O)NO. Drug target is HDAC. Drug target pathway is Chromatin histone acetylation.
Drug 3: The drug is Z-LLNLE-CHO. The drug SMILES structure is CCCCC(C=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)OCC1=CC=CC=C1. Drug target is gamma-secretase. Drug target pathway is Other.
The mutations of the cell line are ARID1A, CUL3, KDR, KEAP1, KRAS, MAP2K1, NBN, NOTCH3, NUTM1, PARK2, PIK3CA, PPP2R1A, PTCH1, RAD21, RPTOR, STK11, ZNF217.
Best drug option: ?",YM-201636
ACH-000464,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 2: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
Drug 3: The drug is ARA-G. The drug SMILES structure is C1=NC2=C(N1[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)N=C(NC2=O)N. Drug target is Anti-metabolite. Drug target pathway is Other.
The mutations of the cell line are ETV5, IRS2, NOTCH3, PTEN, TP53.
Best drug option: ?",KIN001-135
ACH-000465,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is BORTEZOMIB. The drug SMILES structure is B([C@H](CC(C)C)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O. Drug target is Proteasome. Drug target pathway is Protein stability and degradation.
Drug 2: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 3: The drug is PILARALISIB. The drug SMILES structure is CC(C)(C(=O)NC1=CC(=CC=C1)S(=O)(=O)NC2=NC3=CC=CC=C3N=C2NC4=C(C=CC(=C4)OC)Cl)N. Drug target is PI3K. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ARID1A, BRAF, BRCA2, CTNNB1, EPHB4, GNAS, HGF, MEN1, RAD52.
Best drug option: ?",KIN001-135
ACH-000469,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
Drug 2: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 3: The drug is AVAGACESTAT. The drug SMILES structure is C1=CC(=CC=C1S(=O)(=O)N(CC2=C(C=C(C=C2)C3=NOC=N3)F)[C@H](CCC(F)(F)F)C(=O)N)Cl. Drug target is Amyloid beta20, Amyloid beta40. Drug target pathway is Other.
The mutations of the cell line are CREBBP, HSD3B1, LTK, PIK3CA, TP53, TSC1.
Best drug option: ?",AVAGACESTAT
ACH-000470,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is BORTEZOMIB. The drug SMILES structure is B([C@H](CC(C)C)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O. Drug target is Proteasome. Drug target pathway is Protein stability and degradation.
Drug 2: The drug is YK-4-279. The drug SMILES structure is COC1=CC=C(C=C1)C(=O)CC2(C3=C(C=CC(=C3NC2=O)Cl)Cl)O. Drug target is RNA helicase A. Drug target pathway is Other.
Drug 3: The drug is CMK. The drug SMILES structure is CC1=CC=C(C=C1)C2=C(N(C3=NC=NC(=C23)N)CCCO)C(=O)CCl. Drug target is RSK2. Drug target pathway is Other, kinases.
The mutations of the cell line are AKT3, APC, ATRX, BCORL1, EPHB1, FBXW7, FLT1, KRAS, MLH1, MPL, ROS1, SDHA, SMAD4, SOX9, TBX3, TP53.
Best drug option: ?",CMK
ACH-000472,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
Drug 2: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 3: The drug is AVAGACESTAT. The drug SMILES structure is C1=CC(=CC=C1S(=O)(=O)N(CC2=C(C=C(C=C2)C3=NOC=N3)F)[C@H](CCC(F)(F)F)C(=O)N)Cl. Drug target is Amyloid beta20, Amyloid beta40. Drug target pathway is Other.
The mutations of the cell line are ATM, BRIP1, CASP8, CD70, CDKN1A, CDKN2A, CREBBP, CTNNB1, DDR1, KDM5A, KDM6A, KDR, KEAP1, MLL, MED12, MSH3, NOTCH2, PIK3CA, RAC1, RAD54L, TET2, TP53.
Best drug option: ?",KIN001-135
ACH-000473,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
Drug 2: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 3: The drug is AVAGACESTAT. The drug SMILES structure is C1=CC(=CC=C1S(=O)(=O)N(CC2=C(C=C(C=C2)C3=NOC=N3)F)[C@H](CCC(F)(F)F)C(=O)N)Cl. Drug target is Amyloid beta20, Amyloid beta40. Drug target pathway is Other.
The mutations of the cell line are ALK, CDKN1A, ETV5, FLCN, KDM6A, MYC, NF1, PIK3CA, TP53.
Best drug option: ?",AVAGACESTAT
ACH-000475,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is LY2109761. The drug SMILES structure is C1CC2=C(C(=NN2C1)C3=CC=CC=N3)C4=C5C=CC(=CC5=NC=C4)OCCN6CCOCC6. Drug target is TGFB1. Drug target pathway is Other.
Drug 2: The drug is T-0901317. The drug SMILES structure is C1=CC=C(C=C1)S(=O)(=O)N(CC(F)(F)F)C2=CC=C(C=C2)C(C(F)(F)F)(C(F)(F)F)O. Drug target is Unknown. Drug target pathway is Unknown.
Drug 3: The drug is LESTAURTINIB. The drug SMILES structure is C[C@@]12[C@](C[C@@H](O1)N3C4=CC=CC=C4C5=C6C(=C7C8=CC=CC=C8N2C7=C53)CNC6=O)(CO)O. Drug target is FLT3, JAK2, NTRK1, NTRK2, NTRK3. Drug target pathway is Other, kinases.
The mutations of the cell line are AXIN1, BTG1, EP300, FLT3, KEAP1, MLL, MLL2, TP53.
Best drug option: ?",LESTAURTINIB
ACH-000476,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is GW-2580. The drug SMILES structure is COC1=CC=C(C=C1)COC2=C(C=C(C=C2)CC3=CN=C(N=C3N)N)OC. Drug target is CSF1R. Drug target pathway is RTK signaling.
Drug 2: The drug is JNJ-38877605. The drug SMILES structure is CN1C=C(C=N1)C2=NN3C(=NN=C3C(C4=CC5=C(C=C4)N=CC=C5)(F)F)C=C2. Drug target is Unknown. Drug target pathway is Unknown.
Drug 3: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are AR, BCR, EPHA3, POLD1, SPEN, TP53.
Best drug option: ?",WYE-125132
ACH-000478,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
Drug 2: The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
Drug 3: The drug is JNJ-38877605. The drug SMILES structure is CN1C=C(C=N1)C2=NN3C(=NN=C3C(C4=CC5=C(C=C4)N=CC=C5)(F)F)C=C2. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are FANCC, HGF, NOTCH1, NRAS, RET, TP53.
Best drug option: ?",JNJ-38877605
ACH-000480,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
Drug 2: The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
Drug 3: The drug is GW-2580. The drug SMILES structure is COC1=CC=C(C=C1)COC2=C(C=C(C=C2)CC3=CN=C(N=C3N)N)OC. Drug target is CSF1R. Drug target pathway is RTK signaling.
The mutations of the cell line are FAM123B, FANCC, MLL2, NOTCH1, PIK3C2G, ROS1, SYK, TP53.
Best drug option: ?",BRYOSTATIN-1
ACH-000481,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is CAY10566. The drug SMILES structure is CC1=NN=C(O1)C2=NN=C(C=C2)N3CCC(CC3)OC4=C(C=CC(=C4)F)Cl. Drug target is Stearoyl-CoA desaturase. Drug target pathway is Other.
Drug 2: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 3: The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ATR, BCORL1, EP300, KEAP1, TP53.
Best drug option: ?",YM-201636
ACH-000483,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
Drug 2: The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
Drug 3: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are ERCC4, GNAS, IRS2, MLL2, MDM2, PARK2, ROS1, TP53, U2AF1.
Best drug option: ?",WYE-125132
ACH-000484,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is PANOBINOSTAT. The drug SMILES structure is CC1=C(C2=CC=CC=C2N1)CCNCC3=CC=C(C=C3)C=CC(=O)NO. Drug target is HDAC. Drug target pathway is Chromatin histone acetylation.
Drug 2: The drug is SNX-2112. The drug SMILES structure is CC1(CC2=C(C(=O)C1)C(=NN2C3=CC(=C(C=C3)C(=O)N)NC4CCC(CC4)O)C(F)(F)F)C. Drug target is HSP90. Drug target pathway is Protein stability and degradation.
Drug 3: The drug is KOBE2602. The drug SMILES structure is C1=CC(=CC=C1NC(=S)NNC2=C(C=C(C=C2[N+](=O)[O-])C(F)(F)F)[N+](=O)[O-])F. Drug target is RAS effector. Drug target pathway is RTK signaling.
The mutations of the cell line are BAP1, PIK3C2G, RICTOR, SETD2, SMARCA4, TGFBR2, TP53, VHL.
Best drug option: ?",PANOBINOSTAT
ACH-000486,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is YK-4-279. The drug SMILES structure is COC1=CC=C(C=C1)C(=O)CC2(C3=C(C=CC(=C3NC2=O)Cl)Cl)O. Drug target is RNA helicase A. Drug target pathway is Other.
Drug 2: The drug is IMATINIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5. Drug target is ABL, KIT, PDGFR. Drug target pathway is Other, kinases.
Drug 3: The drug is GSK2606414. The drug SMILES structure is CN1C=C(C2=C(N=CN=C21)N)C3=CC4=C(C=C3)N(CC4)C(=O)CC5=CC(=CC=C5)C(F)(F)F. Drug target is PERK. Drug target pathway is Metabolism.
The mutations of the cell line are AKT1, ARID1A, BCL6, EP300, KDM6A, MLL2, MSH3, NRAS, POLE, TERT.
Best drug option: ?",IMATINIB
ACH-000488,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is LINIFANIB. The drug SMILES structure is CC1=CC(=C(C=C1)F)NC(=O)NC2=CC=C(C=C2)C3=C4C(=CC=C3)NN=C4N. Drug target is VEGFR1, VEGFR2, VEGFR3, CSF1R, FLT3, KIT. Drug target pathway is RTK signaling.
Drug 2: The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
Drug 3: The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ASXL1, ATM, EMSY, FBXW7, GRM3, HGF, MAP2K2, NF1, NFE2L2, NOTCH1, NOTCH2, SDHA, TP53, TSC2.
Best drug option: ?",LINIFANIB
ACH-000489,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 2: The drug is PAZOPANIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC2=NC=CC(=N2)N(C)C3=CC4=NN(C(=C4C=C3)C)C)S(=O)(=O)N. Drug target is CSF1R, KIT,  PDGFRA, PDGFRB. Drug target pathway is RTK signaling.
Drug 3: The drug is ZG-10. The drug SMILES structure is O=C(C1=CC=C(NC(C=CCN(C)C)=O)C=C1)NC2=CC(NC3=NC(C4=CC=CN=C4)=CC=N3)=CC=C2. Drug target is JNK1. Drug target pathway is JNK and p38 signaling.
The mutations of the cell line are APC, ASXL1, BCOR, CREBBP, ERCC4, FBXW7, GABRA6, H3F3A, IRF2, JAK1, KRAS, NBN, PMS2, PPP2R1A, SOX9, TP53, ZNF703.
Best drug option: ?",KIN001-135
ACH-000491,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is QL-X-138. The drug SMILES structure is CC1=C(C=C(C=C1)N2C(=O)C=CC3=CN=C4C=CC(=CC4=C32)C5=CNN=C5)NC(=O)C=C. Drug target is BTK. Drug target pathway is Other, kinases.
Drug 2: The drug is LINIFANIB. The drug SMILES structure is CC1=CC(=C(C=C1)F)NC(=O)NC2=CC=C(C=C2)C3=C4C(=CC=C3)NN=C4N. Drug target is VEGFR1, VEGFR2, VEGFR3, CSF1R, FLT3, KIT. Drug target pathway is RTK signaling.
Drug 3: The drug is IMATINIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5. Drug target is ABL, KIT, PDGFR. Drug target pathway is Other, kinases.
The mutations of the cell line are ATR, CIC, EPHB4, KRAS, MED12, MLH1, RAD52, RNF43, SPEN, TP53, TSC2.
Best drug option: ?",IMATINIB
ACH-000493,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
Drug 2: The drug is GW-2580. The drug SMILES structure is COC1=CC=C(C=C1)COC2=C(C=C(C=C2)CC3=CN=C(N=C3N)N)OC. Drug target is CSF1R. Drug target pathway is RTK signaling.
Drug 3: The drug is JNJ-38877605. The drug SMILES structure is CN1C=C(C=N1)C2=NN3C(=NN=C3C(C4=CC5=C(C=C4)N=CC=C5)(F)F)C=C2. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ARID1A, AURKA, AXIN1, FANCA, FLT1, KEAP1, PRDM1, RNF43, TP53, TYRO3.
Best drug option: ?",WYE-125132
ACH-000496,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is AVAGACESTAT. The drug SMILES structure is C1=CC(=CC=C1S(=O)(=O)N(CC2=C(C=C(C=C2)C3=NOC=N3)F)[C@H](CCC(F)(F)F)C(=O)N)Cl. Drug target is Amyloid beta20, Amyloid beta40. Drug target pathway is Other.
Drug 2: The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
Drug 3: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are CDKN2A, ERBB3, GATA3, KDM6A, KEAP1, KRAS, MLH1, MTOR, PDGFRA, TP53.
Best drug option: ?",AVAGACESTAT
ACH-000501,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is GSK2606414. The drug SMILES structure is CN1C=C(C2=C(N=CN=C21)N)C3=CC4=C(C=C3)N(CC4)C(=O)CC5=CC(=CC=C5)C(F)(F)F. Drug target is PERK. Drug target pathway is Metabolism.
Drug 2: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 3: The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are APC, ATRX, BCORL1, BRD4, KRAS, SMAD4, TP53.
Best drug option: ?",KIN001-135
ACH-000504,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is LENALIDOMIDE. The drug SMILES structure is C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N. Drug target is CRBN. Drug target pathway is Protein stability and degradation.
Drug 2: The drug is GSK2606414. The drug SMILES structure is CN1C=C(C2=C(N=CN=C21)N)C3=CC4=C(C=C3)N(CC4)C(=O)CC5=CC(=CC=C5)C(F)(F)F. Drug target is PERK. Drug target pathway is Metabolism.
Drug 3: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are CREBBP, EP300, FANCC, NT5C2, PIK3R1, RAD54L, RB1, TP53.
Best drug option: ?",GSK2606414
ACH-000505,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is GSK2606414. The drug SMILES structure is CN1C=C(C2=C(N=CN=C21)N)C3=CC4=C(C=C3)N(CC4)C(=O)CC5=CC(=CC=C5)C(F)(F)F. Drug target is PERK. Drug target pathway is Metabolism.
Drug 2: The drug is METHOTREXATE. The drug SMILES structure is CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O. Drug target is Antimetabolite. Drug target pathway is DNA replication.
Drug 3: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are ATM, ETV6, FGFR2, IRF4, KRAS, NOTCH1, TP53, TSC1.
Best drug option: ?",KIN001-135
ACH-000506,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is ARA-G. The drug SMILES structure is C1=NC2=C(N1[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)N=C(NC2=O)N. Drug target is Anti-metabolite. Drug target pathway is Other.
Drug 2: The drug is IMATINIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5. Drug target is ABL, KIT, PDGFR. Drug target pathway is Other, kinases.
Drug 3: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are BRIP1, FGFR4, FLT1, H3F3A, IRF4, MLL2, PIK3CB, POLE, PRKCI, PTPN11, RB1, TBX3, TP53.
Best drug option: ?",IMATINIB
ACH-000514,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is IMATINIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5. Drug target is ABL, KIT, PDGFR. Drug target pathway is Other, kinases.
Drug 2: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 3: The drug is PAZOPANIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC2=NC=CC(=N2)N(C)C3=CC4=NN(C(=C4C=C3)C)C)S(=O)(=O)N. Drug target is CSF1R, KIT,  PDGFRA, PDGFRB. Drug target pathway is RTK signaling.
The mutations of the cell line are BRIP1, CTNNB1, ERBB4, ETV5, GATA6, JUN, KDR, NTRK3, RET, SDHA, SMARCA4, TP53, WHSC1.
Best drug option: ?",IMATINIB
ACH-000515,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 2: The drug is ARA-G. The drug SMILES structure is C1=NC2=C(N1[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)N=C(NC2=O)N. Drug target is Anti-metabolite. Drug target pathway is Other.
Drug 3: The drug is PAZOPANIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC2=NC=CC(=N2)N(C)C3=CC4=NN(C(=C4C=C3)C)C)S(=O)(=O)N. Drug target is CSF1R, KIT,  PDGFRA, PDGFRB. Drug target pathway is RTK signaling.
The mutations of the cell line are CREBBP, EGFR, NOTCH3, POLE, PTEN, RB1, RET, SMO, TP53, ZNF217.
Best drug option: ?",KIN001-135
ACH-000516,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is AVAGACESTAT. The drug SMILES structure is C1=CC(=CC=C1S(=O)(=O)N(CC2=C(C=C(C=C2)C3=NOC=N3)F)[C@H](CCC(F)(F)F)C(=O)N)Cl. Drug target is Amyloid beta20, Amyloid beta40. Drug target pathway is Other.
Drug 2: The drug is CETUXIMAB. The drug SMILES structure is CC1(C(=C)N(C2=CC=CC=C21)CCCCCC(=O)O)C. Drug target is EGFR. Drug target pathway is EGFR signaling.
Drug 3: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ATM, EZH2, FAM46C, NBN, SDHA, SPEN, TIPARP, TP53, ZNF217.
Best drug option: ?",WYE-125132
ACH-000518,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is AVAGACESTAT. The drug SMILES structure is C1=CC(=CC=C1S(=O)(=O)N(CC2=C(C=C(C=C2)C3=NOC=N3)F)[C@H](CCC(F)(F)F)C(=O)N)Cl. Drug target is Amyloid beta20, Amyloid beta40. Drug target pathway is Other.
Drug 2: The drug is JNJ-38877605. The drug SMILES structure is CN1C=C(C=N1)C2=NN3C(=NN=C3C(C4=CC5=C(C=C4)N=CC=C5)(F)F)C=C2. Drug target is Unknown. Drug target pathway is Unknown.
Drug 3: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are APC, CASP8, CDKN2A, EP300, ERG, MED12, MSH3, NF2, PIK3CA, SMAD4, TP53, TYRO3.
Best drug option: ?",JNJ-38877605
ACH-000522,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 2: The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
Drug 3: The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ATM, AURKA, CCNE1, CDH1, ERBB3, KDM6A, MLL2, KRAS, MSH3, MUTYH, SMARCA4, STAG2, TP53.
Best drug option: ?",KIN001-135
ACH-000524,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 2: The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
Drug 3: The drug is GSK2606414. The drug SMILES structure is CN1C=C(C2=C(N=CN=C21)N)C3=CC4=C(C=C3)N(CC4)C(=O)CC5=CC(=CC=C5)C(F)(F)F. Drug target is PERK. Drug target pathway is Metabolism.
The mutations of the cell line are ATM, BRCA2, EP300, FLT1, GNAS, HGF, LTK, NOTCH1, NPM1, SMAD4, TP53.
Best drug option: ?",BRYOSTATIN-1
ACH-000525,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 2: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
Drug 3: The drug is EX-527. The drug SMILES structure is C1CC(C2=C(C1)C3=C(N2)C=CC(=C3)Cl)C(=O)N. Drug target is SIRT1. Drug target pathway is Chromatin histone acetylation.
The mutations of the cell line are ATR, BCORL1, CTCF, FLT1, HNF1A, MLL2, NTRK3, P2RY8, RB1, RPTOR, TNFAIP3, TP53.
Best drug option: ?",KIN001-135
ACH-000527,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
Drug 2: The drug is XMD13-2. The drug SMILES structure is O=C(C1CC1)NC2=NNC3=CC(C4=CC(C(NC5CC5)=O)=CC=C4)=CC=C32. Drug target is MRCKB. Drug target pathway is Cytoskeleton.
Drug 3: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are APC, ARID1A, ATRX, BRD4, MRE11A, NOTCH1, PIK3CA, PPP2R1A, STAT3, TBX3.
Best drug option: ?",KIN001-135
ACH-000528,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is LY2109761. The drug SMILES structure is C1CC2=C(C(=NN2C1)C3=CC=CC=N3)C4=C5C=CC(=CC5=NC=C4)OCCN6CCOCC6. Drug target is TGFB1. Drug target pathway is Other.
Drug 2: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 3: The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ALK, FLT3, GATA4, KDM5A, MSH3, NF1, PARP3, POLE, RNF43, TP53.
Best drug option: ?",KIN001-135
ACH-000530,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is QS-11. The drug SMILES structure is C1CC2=C(C1)C=C(C=C2)OC3=NC(=C4C(=N3)N(C=N4)CC5=CC=C(C=C5)C6=CC=CC=C6)NC(CC7=CC=CC=C7)CO. Drug target is Unknown. Drug target pathway is Unknown.
Drug 2: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 3: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are AKT1, AXL, CIC, GNAS, HGF, INPP4B, MSH2, QKI, ROS1, SMARCA4, SNCAIP, TP53, XPO1.
Best drug option: ?",KIN001-135
ACH-000532,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 2: The drug is ARA-G. The drug SMILES structure is C1=NC2=C(N1[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)N=C(NC2=O)N. Drug target is Anti-metabolite. Drug target pathway is Other.
Drug 3: The drug is PAZOPANIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC2=NC=CC(=N2)N(C)C3=CC4=NN(C(=C4C=C3)C)C)S(=O)(=O)N. Drug target is CSF1R, KIT,  PDGFRA, PDGFRB. Drug target pathway is RTK signaling.
The mutations of the cell line are APC, ASXL1, ATM, AXIN1, CDH1, KRAS, PBRM1, PIK3R1, TBX3, TP53.
Best drug option: ?",KIN001-135
ACH-000534,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is PD-184352. The drug SMILES structure is C1CC1CONC(=O)C2=C(C(=C(C=C2)F)F)NC3=C(C=C(C=C3)I)Cl. Drug target is MEK1, MEK2. Drug target pathway is ERK MAPK signaling.
Drug 2: The drug is IPA-3. The drug SMILES structure is C1=CC=C2C(=C1)C=CC(=C2SSC3=C(C=CC4=CC=CC=C43)O)O. Drug target is PAK1. Drug target pathway is Cytoskeleton.
Drug 3: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are BCL2, CREBBP, ERBB4, EZH2, FGFR4, FLT3, GNA13, TNFRSF14, TP53.
Best drug option: ?",IPA-3
ACH-000535,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is GW-2580. The drug SMILES structure is COC1=CC=C(C=C1)COC2=C(C=C(C=C2)CC3=CN=C(N=C3N)N)OC. Drug target is CSF1R. Drug target pathway is RTK signaling.
Drug 2: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 3: The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are BRAF, EP300, RNF43, TP53.
Best drug option: ?",KIN001-135
ACH-000536,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 2: The drug is FORETINIB. The drug SMILES structure is COC1=CC2=C(C=CN=C2C=C1OCCCN3CCOCC3)OC4=C(C=C(C=C4)NC(=O)C5(CC5)C(=O)NC6=CC=C(C=C6)F)F. Drug target is MET, KDR, TIE2, VEGFR3/FLT4, RON, PDGFR, FGFR1, EGFR. Drug target pathway is RTK signaling.
Drug 3: The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are CDKN2C, DNMT3A, DOT1L, KDR, MAP3K13, PIK3CA, POLD1, RARA, RB1, ROS1, SPEN, TBX3, TP53, WHSC1.
Best drug option: ?",KIN001-135
ACH-000538,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 2: The drug is LY2109761. The drug SMILES structure is C1CC2=C(C(=NN2C1)C3=CC=CC=N3)C4=C5C=CC(=CC5=NC=C4)OCCN6CCOCC6. Drug target is TGFB1. Drug target pathway is Other.
Drug 3: The drug is KOBE2602. The drug SMILES structure is C1=CC(=CC=C1NC(=S)NNC2=C(C=C(C=C2[N+](=O)[O-])C(F)(F)F)[N+](=O)[O-])F. Drug target is RAS effector. Drug target pathway is RTK signaling.
The mutations of the cell line are BRCA2, CTNNB1, GRM3, PIK3C2G, SMARCA4, WT1.
Best drug option: ?",KIN001-135
ACH-000544,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
Drug 2: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 3: The drug is GSK2606414. The drug SMILES structure is CN1C=C(C2=C(N=CN=C21)N)C3=CC4=C(C=C3)N(CC4)C(=O)CC5=CC(=CC=C5)C(F)(F)F. Drug target is PERK. Drug target pathway is Metabolism.
The mutations of the cell line are ARID1A, AXL, CIC, FUBP1, MLL, MAP2K2, NFE2L2, NOTCH1, TP53.
Best drug option: ?",BRYOSTATIN-1
ACH-000546,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is DACINOSTAT. The drug SMILES structure is C1=CC=C2C(=C1)C(=CN2)CCN(CCO)CC3=CC=C(C=C3)C=CC(=O)NO. Drug target is HDAC1. Drug target pathway is Chromatin histone acetylation.
Drug 2: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 3: The drug is GSK2606414. The drug SMILES structure is CN1C=C(C2=C(N=CN=C21)N)C3=CC4=C(C=C3)N(CC4)C(=O)CC5=CC(=CC=C5)C(F)(F)F. Drug target is PERK. Drug target pathway is Metabolism.
The mutations of the cell line are ATM, CCND1, CCND2, CD22, CD74, CDC73, CDKN2A, CTNNB1, DIS3, KDM5C, MKNK1, MLH1, NOTCH2, PIK3CA, PTEN, SETD2, TP53.
Best drug option: ?",KIN001-135
ACH-000547,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 2: The drug is FORETINIB. The drug SMILES structure is COC1=CC2=C(C=CN=C2C=C1OCCCN3CCOCC3)OC4=C(C=C(C=C4)NC(=O)C5(CC5)C(=O)NC6=CC=C(C=C6)F)F. Drug target is MET, KDR, TIE2, VEGFR3/FLT4, RON, PDGFR, FGFR1, EGFR. Drug target pathway is RTK signaling.
Drug 3: The drug is YK-4-279. The drug SMILES structure is COC1=CC=C(C=C1)C(=O)CC2(C3=C(C=CC(=C3NC2=O)Cl)Cl)O. Drug target is RNA helicase A. Drug target pathway is Other.
The mutations of the cell line are ARID1A, NRAS, PIK3CA.
Best drug option: ?",KIN001-135
ACH-000548,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 2: The drug is JNJ-38877605. The drug SMILES structure is CN1C=C(C=N1)C2=NN3C(=NN=C3C(C4=CC5=C(C=C4)N=CC=C5)(F)F)C=C2. Drug target is Unknown. Drug target pathway is Unknown.
Drug 3: The drug is PANOBINOSTAT. The drug SMILES structure is CC1=C(C2=CC=CC=C2N1)CCNCC3=CC=C(C=C3)C=CC(=O)NO. Drug target is HDAC. Drug target pathway is Chromatin histone acetylation.
The mutations of the cell line are ATRX, BRAF, CDKN2A, CHEK2, NTRK2, POLE, ROS1, TP53, XRCC2.
Best drug option: ?",PANOBINOSTAT
ACH-000551,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 2: The drug is KB NB 142-70. The drug SMILES structure is C1CSC2=C(C(=O)N1)SC3=C2C=C(C=C3)O. Drug target is PKD. Drug target pathway is Other, kinases.
Drug 3: The drug is PI-103. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)O. Drug target is PI3Kalpha, DAPK3, CLK4, PIM3, HIPK2. Drug target pathway is Other, kinases.
The mutations of the cell line are AKT3, ASXL1, CARD11, CBL, CIC, ERBB3, NFE2L2, NOTCH1, PDGFRA, ROS1, TP53, WHSC1.
Best drug option: ?",KIN001-135
ACH-000552,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is AVAGACESTAT. The drug SMILES structure is C1=CC(=CC=C1S(=O)(=O)N(CC2=C(C=C(C=C2)C3=NOC=N3)F)[C@H](CCC(F)(F)F)C(=O)N)Cl. Drug target is Amyloid beta20, Amyloid beta40. Drug target pathway is Other.
Drug 2: The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
Drug 3: The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ALK, APC, BCR, BRAF, CASP8, EPHB1, EPHB4, ETV6, FGF4, IRS2, MST1R, PIK3CA, SDHA, SMAD4, SNCAIP, SPEN, TP53.
Best drug option: ?",YM-201636
ACH-000554,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
Drug 2: The drug is AZD8931. The drug SMILES structure is CNC(=O)CN1CCC(CC1)OC2=C(C=C3C(=C2)C(=NC=N3)NC4=C(C(=CC=C4)Cl)F)OC. Drug target is EGFR, ERBB2, ERBB3. Drug target pathway is RTK signaling.
Drug 3: The drug is GW-2580. The drug SMILES structure is COC1=CC=C(C=C1)COC2=C(C=C(C=C2)CC3=CN=C(N=C3N)N)OC. Drug target is CSF1R. Drug target pathway is RTK signaling.
The mutations of the cell line are MLL, NUTM1, PIK3CA, SOX9, TBX3, TGFBR2, TP53, WHSC1L1.
Best drug option: ?",WYE-125132
ACH-000555,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is GSK2606414. The drug SMILES structure is CN1C=C(C2=C(N=CN=C21)N)C3=CC4=C(C=C3)N(CC4)C(=O)CC5=CC(=CC=C5)C(F)(F)F. Drug target is PERK. Drug target pathway is Metabolism.
Drug 2: The drug is KB NB 142-70. The drug SMILES structure is C1CSC2=C(C(=O)N1)SC3=C2C=C(C=C3)O. Drug target is PKD. Drug target pathway is Other, kinases.
Drug 3: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are ALK, APC, CUL3, FGFR2, MLL, PIK3C2G, PIK3CB, SETD2, SMARCA4, TMPRSS2, VHL.
Best drug option: ?",GSK2606414
ACH-000556,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 2: The drug is JNJ-38877605. The drug SMILES structure is CN1C=C(C=N1)C2=NN3C(=NN=C3C(C4=CC5=C(C=C4)N=CC=C5)(F)F)C=C2. Drug target is Unknown. Drug target pathway is Unknown.
Drug 3: The drug is IMATINIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5. Drug target is ABL, KIT, PDGFR. Drug target pathway is Other, kinases.
The mutations of the cell line are BCL2, CASP8, MLL.
Best drug option: ?",IMATINIB
ACH-000558,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is YK-4-279. The drug SMILES structure is COC1=CC=C(C=C1)C(=O)CC2(C3=C(C=CC(=C3NC2=O)Cl)Cl)O. Drug target is RNA helicase A. Drug target pathway is Other.
Drug 2: The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
Drug 3: The drug is IMATINIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5. Drug target is ABL, KIT, PDGFR. Drug target pathway is Other, kinases.
The mutations of the cell line are ETV4, PTCH1, RB1.
Best drug option: ?",BRYOSTATIN-1
ACH-000559,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is ARA-G. The drug SMILES structure is C1=NC2=C(N1[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)N=C(NC2=O)N. Drug target is Anti-metabolite. Drug target pathway is Other.
Drug 2: The drug is PAZOPANIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC2=NC=CC(=N2)N(C)C3=CC4=NN(C(=C4C=C3)C)C)S(=O)(=O)N. Drug target is CSF1R, KIT,  PDGFRA, PDGFRB. Drug target pathway is RTK signaling.
Drug 3: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are ALK, APC, AR, ATR, BRIP1, CDK12, CIC, EP300, ERBB4, FGF3, FLT3, MLL, PPP2R2A, TP53.
Best drug option: ?",KIN001-135
ACH-000560,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 2: The drug is ACY-1215. The drug SMILES structure is C1=CC=C(C=C1)N(C2=CC=CC=C2)C3=NC=C(C=N3)C(=O)NCCCCCCC(=O)NO. Drug target is HDAC6. Drug target pathway is Chromatin histone acetylation.
Drug 3: The drug is JNJ-38877605. The drug SMILES structure is CN1C=C(C=N1)C2=NN3C(=NN=C3C(C4=CC5=C(C=C4)N=CC=C5)(F)F)C=C2. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are APC, AR, CDK6, ERBB2, HSD3B1, PARP3, RB1, RNF43, ZNF217, ZNF703.
Best drug option: ?",KIN001-135
ACH-000562,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
Drug 2: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 3: The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ALK, CDKN2A, GNAS, KDM6A, MLL, MCL1, MRE11A, MYC, NOTCH3, PALB2, PPP2R2A, SMO, SPEN, TP53, U2AF1.
Best drug option: ?",WYE-125132
ACH-000563,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is ABT-737. The drug SMILES structure is CN(C)CC[C@H](CSC1=CC=CC=C1)NC2=C(C=C(C=C2)S(=O)(=O)NC(=O)C3=CC=C(C=C3)N4CCN(CC4)CC5=CC=CC=C5C6=CC=C(C=C6)Cl)[N+](=O)[O-]. Drug target is Unknown. Drug target pathway is Unknown.
Drug 2: The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
Drug 3: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are ATM, BCL6, BRCA2, CCND1, CREBBP, ERCC4, GRM3, NFE2L2, PALB2, SOX9, TET2, TP53, XPO1.
Best drug option: ?",ABT-737
ACH-000565,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
Drug 2: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 3: The drug is CAY10566. The drug SMILES structure is CC1=NN=C(O1)C2=NN=C(C=C2)N3CCC(CC3)OC4=C(C=CC(=C4)F)Cl. Drug target is Stearoyl-CoA desaturase. Drug target pathway is Other.
The mutations of the cell line are APC, AR, BCORL1, BRD4, EP300, EPHB1, FANCA, FBXW7, KRAS, MRE11A, RBM10, SMAD4, TP53.
Best drug option: ?",KIN001-135
ACH-000566,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
Drug 2: The drug is PYRIDOSTATIN. The drug SMILES structure is C1=CC=C2C(=C1)C(=CC(=N2)NC(=O)C3=CC(=CC(=N3)C(=O)NC4=NC5=CC=CC=C5C(=C4)OCCN)OCCN)OCCN. Drug target is G-quadruplex stabiliser. Drug target pathway is DNA replication.
Drug 3: The drug is AGI-5198. The drug SMILES structure is CC1=CC=CC=C1C(C(=O)NC2CCCCC2)N(C3=CC(=CC=C3)F)C(=O)CN4C=CN=C4C. Drug target is IDH1 (R132H). Drug target pathway is Metabolism.
The mutations of the cell line are ACVR1B, CD74, GATA6, RARA, TP53, WHSC1L1.
Best drug option: ?",BRYOSTATIN-1
ACH-000567,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
Drug 2: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 3: The drug is AVAGACESTAT. The drug SMILES structure is C1=CC(=CC=C1S(=O)(=O)N(CC2=C(C=C(C=C2)C3=NOC=N3)F)[C@H](CCC(F)(F)F)C(=O)N)Cl. Drug target is Amyloid beta20, Amyloid beta40. Drug target pathway is Other.
The mutations of the cell line are ARID1A, CCND3, CXCR4, ID3, MTOR, MYC, PDCD1LG2, RICTOR, TP53, TSC2.
Best drug option: ?",KIN001-135
ACH-000568,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 2: The drug is PAZOPANIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC2=NC=CC(=N2)N(C)C3=CC4=NN(C(=C4C=C3)C)C)S(=O)(=O)N. Drug target is CSF1R, KIT,  PDGFRA, PDGFRB. Drug target pathway is RTK signaling.
Drug 3: The drug is FORETINIB. The drug SMILES structure is COC1=CC2=C(C=CN=C2C=C1OCCCN3CCOCC3)OC4=C(C=C(C=C4)NC(=O)C5(CC5)C(=O)NC6=CC=C(C=C6)F)F. Drug target is MET, KDR, TIE2, VEGFR3/FLT4, RON, PDGFR, FGFR1, EGFR. Drug target pathway is RTK signaling.
The mutations of the cell line are ARID1A, BRD4, EMSY, CARD11, CDH1, CDKN2B, CHEK2, MST1R, NOTCH3, WHSC1L1, ZNF703.
Best drug option: ?",FORETINIB
ACH-000569,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is LENALIDOMIDE. The drug SMILES structure is C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N. Drug target is CRBN. Drug target pathway is Protein stability and degradation.
Drug 2: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 3: The drug is KB NB 142-70. The drug SMILES structure is C1CSC2=C(C(=O)N1)SC3=C2C=C(C=C3)O. Drug target is PKD. Drug target pathway is Other, kinases.
The mutations of the cell line are BAP1, ID3, SMARCA4.
Best drug option: ?",KIN001-135
ACH-000570,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KOBE2602. The drug SMILES structure is C1=CC(=CC=C1NC(=S)NNC2=C(C=C(C=C2[N+](=O)[O-])C(F)(F)F)[N+](=O)[O-])F. Drug target is RAS effector. Drug target pathway is RTK signaling.
Drug 2: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
Drug 3: The drug is PANOBINOSTAT. The drug SMILES structure is CC1=C(C2=CC=CC=C2N1)CCNCC3=CC=C(C=C3)C=CC(=O)NO. Drug target is HDAC. Drug target pathway is Chromatin histone acetylation.
The mutations of the cell line are ATRX, EPHA3, ERBB3, FGFR1, MLH1, MYCL1, NF1, PIK3CA, PTEN, STAG2, TP53.
Best drug option: ?",KOBE2602
ACH-000571,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is AVAGACESTAT. The drug SMILES structure is C1=CC(=CC=C1S(=O)(=O)N(CC2=C(C=C(C=C2)C3=NOC=N3)F)[C@H](CCC(F)(F)F)C(=O)N)Cl. Drug target is Amyloid beta20, Amyloid beta40. Drug target pathway is Other.
Drug 2: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 3: The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are CTNNB1, KEL, NOTCH3, PARK2, POLD1, PRKCI, PTEN, SETD2, TP53.
Best drug option: ?",AVAGACESTAT
ACH-000572,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is CAY10566. The drug SMILES structure is CC1=NN=C(O1)C2=NN=C(C=C2)N3CCC(CC3)OC4=C(C=CC(=C4)F)Cl. Drug target is Stearoyl-CoA desaturase. Drug target pathway is Other.
Drug 2: The drug is GW-2580. The drug SMILES structure is COC1=CC=C(C=C1)COC2=C(C=C(C=C2)CC3=CN=C(N=C3N)N)OC. Drug target is CSF1R. Drug target pathway is RTK signaling.
Drug 3: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ALK, FAM123B, BRAF, CD79A, KEL, PIK3C2G, STK11.
Best drug option: ?",WYE-125132
ACH-000573,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 2: The drug is TIPIFARNIB. The drug SMILES structure is CN1C=NC=C1[C@@](C2=CC=C(C=C2)Cl)(C3=CC4=C(C=C3)N(C(=O)C=C4C5=CC(=CC=C5)Cl)C)N. Drug target is Farnesyl-transferase (FNTA). Drug target pathway is Other.
Drug 3: The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ABL1, BRAF, BRCA1, BTK, CBL, EPHA3, EZH2, KDM6A, NOTCH2, PIK3C2B, TMPRSS2, TP53.
Best drug option: ?",KIN001-135
ACH-000574,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 2: The drug is AZD5363. The drug SMILES structure is O=C(C1(N)CCN(C2=C3C(NC=C3)=NC=N2)CC1)N[C@H](C4=CC=C(Cl)C=C4)CCO. Drug target is AKT1, AKT2, AKT3, ROCK2. Drug target pathway is Other, kinases.
Drug 3: The drug is ARA-G. The drug SMILES structure is C1=NC2=C(N1[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)N=C(NC2=O)N. Drug target is Anti-metabolite. Drug target pathway is Other.
The mutations of the cell line are AR, BCORL1, CREBBP, PDK1, SPOP, TP53.
Best drug option: ?",KIN001-135
ACH-000577,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is JNJ-38877605. The drug SMILES structure is CN1C=C(C=N1)C2=NN3C(=NN=C3C(C4=CC5=C(C=C4)N=CC=C5)(F)F)C=C2. Drug target is Unknown. Drug target pathway is Unknown.
Drug 2: The drug is GW-2580. The drug SMILES structure is COC1=CC=C(C=C1)COC2=C(C=C(C=C2)CC3=CN=C(N=C3N)N)OC. Drug target is CSF1R. Drug target pathway is RTK signaling.
Drug 3: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ATM, BRCA2, CDKN2A, CTNNA1, DOT1L, PARK2, PARP2, ROS1, TP53, XPO1.
Best drug option: ?",WYE-125132
ACH-000579,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 2: The drug is WH-4-023. The drug SMILES structure is O=C(OC1=C(C)C=CC=C1C)N(C2=CC=C(OC)C=C2OC)C3=NC(NC4=CC=C(N5CCN(C)CC5)C=C4)=NC=C3. Drug target is SRC, LCK. Drug target pathway is Other, kinases.
Drug 3: The drug is JW-7-24-1. The drug SMILES structure is COC1=CC(=CC(=C1)C2=CC3=C4C(=CN=C3C=C2)C=CC(=O)N4C5=CC(=C(C=C5)N6CCNCC6)C(F)(F)F)OC. Drug target is LCK. Drug target pathway is Other, kinases.
The mutations of the cell line are ABL1, BARD1, BRAF, BRCA2, CDKN2A, KDR, KEL, MLL2, NTRK1, RNF43.
Best drug option: ?",KIN001-135
ACH-000580,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is TIPIFARNIB. The drug SMILES structure is CN1C=NC=C1[C@@](C2=CC=C(C=C2)Cl)(C3=CC4=C(C=C3)N(C(=O)C=C4C5=CC(=CC=C5)Cl)C)N. Drug target is Farnesyl-transferase (FNTA). Drug target pathway is Other.
Drug 2: The drug is JW-7-24-1. The drug SMILES structure is COC1=CC(=CC(=C1)C2=CC3=C4C(=CN=C3C=C2)C=CC(=O)N4C5=CC(=C(C=C5)N6CCNCC6)C(F)(F)F)OC. Drug target is LCK. Drug target pathway is Other, kinases.
Drug 3: The drug is T-0901317. The drug SMILES structure is C1=CC=C(C=C1)S(=O)(=O)N(CC(F)(F)F)C2=CC=C(C=C2)C(C(F)(F)F)(C(F)(F)F)O. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ABL1, ALK, AXIN1, BRAF, CD22, CDKN2A, CHEK2, IDH1, MLL, MTOR, PIK3CB, PRDM1, ROS1.
Best drug option: ?",TIPIFARNIB
ACH-000581,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 2: The drug is CETUXIMAB. The drug SMILES structure is CC1(C(=C)N(C2=CC=CC=C21)CCCCCC(=O)O)C. Drug target is EGFR. Drug target pathway is EGFR signaling.
Drug 3: The drug is YK-4-279. The drug SMILES structure is COC1=CC=C(C=C1)C(=O)CC2(C3=C(C=CC(=C3NC2=O)Cl)Cl)O. Drug target is RNA helicase A. Drug target pathway is Other.
The mutations of the cell line are BRAF, CIC, CTCF, FANCA, FH, GNAS, HSD3B1, KRAS, MSH6, TP53.
Best drug option: ?",YK-4-279
ACH-000583,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 2: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
Drug 3: The drug is IMATINIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5. Drug target is ABL, KIT, PDGFR. Drug target pathway is Other, kinases.
The mutations of the cell line are AKT2, BCL6, CCND3, CXCR4, FGFR4, GNA13, ID3, JAK2, MET, PTEN, RAD54L, SMARCA4, SPOP, TP53.
Best drug option: ?",KIN001-135
ACH-000584,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
Drug 2: The drug is LY2109761. The drug SMILES structure is C1CC2=C(C(=NN2C1)C3=CC=CC=N3)C4=C5C=CC(=CC5=NC=C4)OCCN6CCOCC6. Drug target is TGFB1. Drug target pathway is Other.
Drug 3: The drug is FORETINIB. The drug SMILES structure is COC1=CC2=C(C=CN=C2C=C1OCCCN3CCOCC3)OC4=C(C=C(C=C4)NC(=O)C5(CC5)C(=O)NC6=CC=C(C=C6)F)F. Drug target is MET, KDR, TIE2, VEGFR3/FLT4, RON, PDGFR, FGFR1, EGFR. Drug target pathway is RTK signaling.
The mutations of the cell line are ATM, ATRX, BCOR, BRCA1, CSF3R, CUL3, GNA13, IRS2, MST1R, MYC, POLD1, SETD2, TP53.
Best drug option: ?",WYE-125132
ACH-000585,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is GSK2606414. The drug SMILES structure is CN1C=C(C2=C(N=CN=C21)N)C3=CC4=C(C=C3)N(CC4)C(=O)CC5=CC(=CC=C5)C(F)(F)F. Drug target is PERK. Drug target pathway is Metabolism.
Drug 2: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
Drug 3: The drug is FORETINIB. The drug SMILES structure is COC1=CC2=C(C=CN=C2C=C1OCCCN3CCOCC3)OC4=C(C=C(C=C4)NC(=O)C5(CC5)C(=O)NC6=CC=C(C=C6)F)F. Drug target is MET, KDR, TIE2, VEGFR3/FLT4, RON, PDGFR, FGFR1, EGFR. Drug target pathway is RTK signaling.
The mutations of the cell line are CREBBP, EPHA3, IRF4, MLL2, NF1, RICTOR, SMARCA4, TP53.
Best drug option: ?",WYE-125132
ACH-000587,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
Drug 2: The drug is QL-VIII-58. The drug SMILES structure is NC1=NC=C(C=N1)C1=CC=C2N=CC3=C(N(C(=O)C=C3)C3=CC(Cl)=C(C=C3)N3CCNCC3)C2=C1. Drug target is MTOR, ATR. Drug target pathway is Other.
Drug 3: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are APC, CDKN2A, EGFR, IGF1R, PARK2, PBRM1, PIK3CA, RBM10, TP53, TSC2.
Best drug option: ?",KIN001-135
ACH-000589,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 2: The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
Drug 3: The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are BCORL1, MLL2, MAP2K1, NBN, NTRK3, POLE, RBM10, TP53.
Best drug option: ?",KIN001-135
ACH-000595,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 2: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
Drug 3: The drug is IMATINIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5. Drug target is ABL, KIT, PDGFR. Drug target pathway is Other, kinases.
The mutations of the cell line are BCOR, CIC, EED, ERBB2, FANCC, FLT1, H3F3A, JAK3, PARP1, PTPN11, RAD21, TP53.
Best drug option: ?",KIN001-135
ACH-000596,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 2: The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
Drug 3: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are BCORL1, BCR, DOT1L, ERBB4, FANCA, FGF12, FGFR4, GABRA6, IRS2, KRAS, MAP3K13, P2RY8, POLE, TP53.
Best drug option: ?",KIN001-135
ACH-000599,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
Drug 2: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 3: The drug is XMD13-2. The drug SMILES structure is O=C(C1CC1)NC2=NNC3=CC(C4=CC(C(NC5CC5)=O)=CC=C4)=CC=C32. Drug target is MRCKB. Drug target pathway is Cytoskeleton.
The mutations of the cell line are APC, ATR, EMSY, EP300, EPHA3, FH, IGF1R, KRAS, NUTM1, PBRM1, RBM10, SPOP, STAT3, TP53.
Best drug option: ?",KIN001-135
ACH-000601,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
Drug 2: The drug is CAY10566. The drug SMILES structure is CC1=NN=C(O1)C2=NN=C(C=C2)N3CCC(CC3)OC4=C(C=CC(=C4)F)Cl. Drug target is Stearoyl-CoA desaturase. Drug target pathway is Other.
Drug 3: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are AR, ARID1A, BCR, ERRFI1, KRAS, MLH1, PALB2, TBX3, TP53.
Best drug option: ?",CAY10566
ACH-000603,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is GW-2580. The drug SMILES structure is COC1=CC=C(C=C1)COC2=C(C=C(C=C2)CC3=CN=C(N=C3N)N)OC. Drug target is CSF1R. Drug target pathway is RTK signaling.
Drug 2: The drug is LESTAURTINIB. The drug SMILES structure is C[C@@]12[C@](C[C@@H](O1)N3C4=CC=CC=C4C5=C6C(=C7C8=CC=CC=C8N2C7=C53)CNC6=O)(CO)O. Drug target is FLT3, JAK2, NTRK1, NTRK2, NTRK3. Drug target pathway is Other, kinases.
Drug 3: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ATRX, FOXL2, KEAP1, MAP3K13, NF2, PIK3CA, SETD2, SRC, TET2, TP53.
Best drug option: ?",WYE-125132
ACH-000605,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
Drug 2: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
Drug 3: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are FAM123B, AR, ATRX, CARD11, EPHB1, FGFR3, GATA3, HGF, HNF1A, KDM5A, MLL2, NFE2L2, PIK3C2G, PIK3R1, POLE, SDHA, SPEN, TERT, TP53.
Best drug option: ?",WYE-125132
ACH-000607,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is FORETINIB. The drug SMILES structure is COC1=CC2=C(C=CN=C2C=C1OCCCN3CCOCC3)OC4=C(C=C(C=C4)NC(=O)C5(CC5)C(=O)NC6=CC=C(C=C6)F)F. Drug target is MET, KDR, TIE2, VEGFR3/FLT4, RON, PDGFR, FGFR1, EGFR. Drug target pathway is RTK signaling.
Drug 2: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 3: The drug is PF-4708671. The drug SMILES structure is CCC1=CN=CN=C1N2CCN(CC2)CC3=NC4=C(N3)C=C(C=C4)C(F)(F)F. Drug target is S6K1. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are BRD4, BRIP1, CASP8, KEL, MTOR, NOTCH3, ROS1, TET2.
Best drug option: ?",KIN001-135
ACH-000609,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is IMATINIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5. Drug target is ABL, KIT, PDGFR. Drug target pathway is Other, kinases.
Drug 2: The drug is LY2109761. The drug SMILES structure is C1CC2=C(C(=NN2C1)C3=CC=CC=N3)C4=C5C=CC(=CC5=NC=C4)OCCN6CCOCC6. Drug target is TGFB1. Drug target pathway is Other.
Drug 3: The drug is KOBE2602. The drug SMILES structure is C1=CC(=CC=C1NC(=S)NNC2=C(C=C(C=C2[N+](=O)[O-])C(F)(F)F)[N+](=O)[O-])F. Drug target is RAS effector. Drug target pathway is RTK signaling.
The mutations of the cell line are ALK, ARID1A, ATR, CARD11, GNA11, JAK3, LTK, POLE, PTCH1, PTEN.
Best drug option: ?",IMATINIB
ACH-000610,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is PAZOPANIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC2=NC=CC(=N2)N(C)C3=CC4=NN(C(=C4C=C3)C)C)S(=O)(=O)N. Drug target is CSF1R, KIT,  PDGFRA, PDGFRB. Drug target pathway is RTK signaling.
Drug 2: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 3: The drug is JQ1-(+). The drug SMILES structure is CC1=C(SC2=C1C(=N[C@H](C3=NN=C(N32)C)CC(=O)OC(C)(C)C)C4=CC=C(C=C4)Cl)C. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are BRAF, CTCF, DNMT3A, HGF, KDM5C, NOTCH1, NTRK3, PDGFRA, PDGFRB, RB1, ROS1, TIPARP, TP53.
Best drug option: ?",KIN001-135
ACH-000611,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
Drug 2: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 3: The drug is SL 0101-1. The drug SMILES structure is CC1C(C(C(C(O1)OC2=C(OC3=CC(=CC(=C3C2=O)O)O)C4=CC=C(C=C4)O)O)OC(=O)C)OC(=O)C. Drug target is RSK, AURKB, PIM1, PIM3. Drug target pathway is Other, kinases.
The mutations of the cell line are ARID1A, ASXL1, BCL2, CREBBP, EP300, ERBB4, EZH2, GNA13, MLL2, MST1R, MYD88, PIK3R1, SDC4, TP53, WHSC1.
Best drug option: ?",WYE-125132
ACH-000613,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
Drug 2: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
Drug 3: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are EP300, EPHB4, FUBP1, IDH1, MED12, NF1, POLD1, SLC34A2, TP53.
Best drug option: ?",KIN001-135
ACH-000614,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is PANOBINOSTAT. The drug SMILES structure is CC1=C(C2=CC=CC=C2N1)CCNCC3=CC=C(C=C3)C=CC(=O)NO. Drug target is HDAC. Drug target pathway is Chromatin histone acetylation.
Drug 2: The drug is JNJ-38877605. The drug SMILES structure is CN1C=C(C=N1)C2=NN3C(=NN=C3C(C4=CC5=C(C=C4)N=CC=C5)(F)F)C=C2. Drug target is Unknown. Drug target pathway is Unknown.
Drug 3: The drug is GW-2580. The drug SMILES structure is COC1=CC=C(C=C1)COC2=C(C=C(C=C2)CC3=CN=C(N=C3N)N)OC. Drug target is CSF1R. Drug target pathway is RTK signaling.
The mutations of the cell line are ARID1A, BRAF, BRCA2, BTK, ERBB4, IRS2, NOTCH1, NOTCH3, PIK3R1, TP53.
Best drug option: ?",PANOBINOSTAT
ACH-000615,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is GSK1059615. The drug SMILES structure is C1=CC2=NC=CC(=C2C=C1C=C3C(=O)NC(=O)S3)C4=CC=NC=C4. Drug target is PI3K. Drug target pathway is PI3K/MTOR signaling.
Drug 2: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 3: The drug is BORTEZOMIB. The drug SMILES structure is B([C@H](CC(C)C)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O. Drug target is Proteasome. Drug target pathway is Protein stability and degradation.
The mutations of the cell line are ARID1A, BRAF, CDK4, CHEK2, DIS3, EGFR, HDAC1, JAK2, JAK3, MLL, PTEN, SF3B1, TP53.
Best drug option: ?",KIN001-135
ACH-000616,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 2: The drug is SB-505124. The drug SMILES structure is CC1=NC(=CC=C1)C2=C(N=C(N2)C(C)(C)C)C3=CC4=C(C=C3)OCO4. Drug target is Unknown. Drug target pathway is Unknown.
Drug 3: The drug is QS-11. The drug SMILES structure is C1CC2=C(C1)C=C(C=C2)OC3=NC(=C4C(=N3)N(C=N4)CC5=CC=C(C=C5)C6=CC=CC=C6)NC(CC7=CC=CC=C7)CO. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are APC, ARID1A, BRCA1, DAXX, FANCG, KDR, MED12, MET, RPTOR, SMO, TP53, WHSC1L1.
Best drug option: ?",KIN001-135
ACH-000617,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
Drug 2: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 3: The drug is FORETINIB. The drug SMILES structure is COC1=CC2=C(C=CN=C2C=C1OCCCN3CCOCC3)OC4=C(C=C(C=C4)NC(=O)C5(CC5)C(=O)NC6=CC=C(C=C6)F)F. Drug target is MET, KDR, TIE2, VEGFR3/FLT4, RON, PDGFR, FGFR1, EGFR. Drug target pathway is RTK signaling.
The mutations of the cell line are ASXL1, ATM, BRCA2, CDKN2A, DOT1L, EP300, EPHB4, NOTCH1, PIK3CB, POLE, SPOP, TP53.
Best drug option: ?",KIN001-135
ACH-000619,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is JNJ-38877605. The drug SMILES structure is CN1C=C(C=N1)C2=NN3C(=NN=C3C(C4=CC5=C(C=C4)N=CC=C5)(F)F)C=C2. Drug target is Unknown. Drug target pathway is Unknown.
Drug 2: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 3: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are BCR, BRD4, CD22, GABRA6, KEAP1, NOTCH2, PALB2, ROS1, RSPO2, TP53.
Best drug option: ?",KIN001-135
ACH-000620,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is JNJ-38877605. The drug SMILES structure is CN1C=C(C=N1)C2=NN3C(=NN=C3C(C4=CC5=C(C=C4)N=CC=C5)(F)F)C=C2. Drug target is Unknown. Drug target pathway is Unknown.
Drug 2: The drug is ARA-G. The drug SMILES structure is C1=NC2=C(N1[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)N=C(NC2=O)N. Drug target is Anti-metabolite. Drug target pathway is Other.
Drug 3: The drug is PAZOPANIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC2=NC=CC(=N2)N(C)C3=CC4=NN(C(=C4C=C3)C)C)S(=O)(=O)N. Drug target is CSF1R, KIT,  PDGFRA, PDGFRB. Drug target pathway is RTK signaling.
The mutations of the cell line are APC, BRIP1, CALR, CIC, CREBBP, EPHB4, GNAS, MEF2B, NOTCH1, PIK3C2G, ROS1, SNCAIP, TET2.
Best drug option: ?",PAZOPANIB
ACH-000621,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 2: The drug is AZD5363. The drug SMILES structure is O=C(C1(N)CCN(C2=C3C(NC=C3)=NC=N2)CC1)N[C@H](C4=CC=C(Cl)C=C4)CCO. Drug target is AKT1, AKT2, AKT3, ROCK2. Drug target pathway is Other, kinases.
Drug 3: The drug is FORETINIB. The drug SMILES structure is COC1=CC2=C(C=CN=C2C=C1OCCCN3CCOCC3)OC4=C(C=C(C=C4)NC(=O)C5(CC5)C(=O)NC6=CC=C(C=C6)F)F. Drug target is MET, KDR, TIE2, VEGFR3/FLT4, RON, PDGFR, FGFR1, EGFR. Drug target pathway is RTK signaling.
The mutations of the cell line are BAP1, MED12, MLH1, MSH6, NF1, PARK2, PDGFRB, PIK3C2B, RAC1, SPEN, TP53, TYRO3.
Best drug option: ?",KIN001-135
ACH-000622,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
Drug 2: The drug is GDC-0941. The drug SMILES structure is CS(=O)(=O)N1CCN(CC1)CC2=CC3=C(S2)C(=NC(=N3)C4=C5C=NNC5=CC=C4)N6CCOCC6. Drug target is PI3K (class 1). Drug target pathway is PI3K/MTOR signaling.
Drug 3: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are ATR, BRIP1, CSF1R, EPHA3, FGF23, H3F3A, MLL, MAP3K1, MRE11A, RET, SETD2, SMARCA4, SPEN, TP53.
Best drug option: ?",KIN001-135
ACH-000624,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is CAY10566. The drug SMILES structure is CC1=NN=C(O1)C2=NN=C(C=C2)N3CCC(CC3)OC4=C(C=CC(=C4)F)Cl. Drug target is Stearoyl-CoA desaturase. Drug target pathway is Other.
Drug 2: The drug is AVAGACESTAT. The drug SMILES structure is C1=CC(=CC=C1S(=O)(=O)N(CC2=C(C=C(C=C2)C3=NOC=N3)F)[C@H](CCC(F)(F)F)C(=O)N)Cl. Drug target is Amyloid beta20, Amyloid beta40. Drug target pathway is Other.
Drug 3: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are INPP4B, MSH6, PDGFRB, SF3B1, TP53.
Best drug option: ?",CAY10566
ACH-000625,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is JNJ-38877605. The drug SMILES structure is CN1C=C(C=N1)C2=NN3C(=NN=C3C(C4=CC5=C(C=C4)N=CC=C5)(F)F)C=C2. Drug target is Unknown. Drug target pathway is Unknown.
Drug 2: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
Drug 3: The drug is GW-2580. The drug SMILES structure is COC1=CC=C(C=C1)COC2=C(C=C(C=C2)CC3=CN=C(N=C3N)N)OC. Drug target is CSF1R. Drug target pathway is RTK signaling.
The mutations of the cell line are AXIN1, CDKN2A, RB1.
Best drug option: ?",WYE-125132
ACH-000626,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 2: The drug is AVAGACESTAT. The drug SMILES structure is C1=CC(=CC=C1S(=O)(=O)N(CC2=C(C=C(C=C2)C3=NOC=N3)F)[C@H](CCC(F)(F)F)C(=O)N)Cl. Drug target is Amyloid beta20, Amyloid beta40. Drug target pathway is Other.
Drug 3: The drug is BX-912. The drug SMILES structure is C1CCN(C1)C(=O)NC2=CC=CC(=C2)NC3=NC=C(C(=N3)NCCC4=CN=CN4)Br. Drug target is PDK1 (PDPK1). Drug target pathway is Metabolism.
The mutations of the cell line are BRAF, FLCN, MED12, MSH6, RB1, SF3B1, TP53.
Best drug option: ?",KIN001-135
ACH-000627,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 2: The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
Drug 3: The drug is CAY10566. The drug SMILES structure is CC1=NN=C(O1)C2=NN=C(C=C2)N3CCC(CC3)OC4=C(C=CC(=C4)F)Cl. Drug target is Stearoyl-CoA desaturase. Drug target pathway is Other.
The mutations of the cell line are ATM, BCORL1, CDK12, EPHA3, EPHB1, KDR, NF1, NF2, SETD2, TP53.
Best drug option: ?",KIN001-135
ACH-000628,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
Drug 2: The drug is AZD8931. The drug SMILES structure is CNC(=O)CN1CCC(CC1)OC2=C(C=C3C(=C2)C(=NC=N3)NC4=C(C(=CC=C4)Cl)F)OC. Drug target is EGFR, ERBB2, ERBB3. Drug target pathway is RTK signaling.
Drug 3: The drug is PF-4708671. The drug SMILES structure is CCC1=CN=CN=C1N2CCN(CC2)CC3=NC4=C(N3)C=C(C=C4)C(F)(F)F. Drug target is S6K1. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are BRIP1, CBFB, DOT1L, MLL2, MEN1, MET, MSH2, PIK3CA, RB1, RNF43, TGFBR2, TP53.
Best drug option: ?",WYE-125132
ACH-000631,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is CAY10566. The drug SMILES structure is CC1=NN=C(O1)C2=NN=C(C=C2)N3CCC(CC3)OC4=C(C=CC(=C4)F)Cl. Drug target is Stearoyl-CoA desaturase. Drug target pathway is Other.
Drug 2: The drug is Z-LLNLE-CHO. The drug SMILES structure is CCCCC(C=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)OCC1=CC=CC=C1. Drug target is gamma-secretase. Drug target pathway is Other.
Drug 3: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are ATM, AXIN1, CBL, INPP4B, JAK3, NF1, SDHD, SF3B1.
Best drug option: ?",KIN001-135
ACH-000633,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is PANOBINOSTAT. The drug SMILES structure is CC1=C(C2=CC=CC=C2N1)CCNCC3=CC=C(C=C3)C=CC(=O)NO. Drug target is HDAC. Drug target pathway is Chromatin histone acetylation.
Drug 2: The drug is JNJ-38877605. The drug SMILES structure is CN1C=C(C=N1)C2=NN3C(=NN=C3C(C4=CC5=C(C=C4)N=CC=C5)(F)F)C=C2. Drug target is Unknown. Drug target pathway is Unknown.
Drug 3: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are APC, EWSR1, FGF6, NOTCH3, SETD2, TP53, WHSC1L1.
Best drug option: ?",KIN001-135
ACH-000636,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
Drug 2: The drug is FORETINIB. The drug SMILES structure is COC1=CC2=C(C=CN=C2C=C1OCCCN3CCOCC3)OC4=C(C=C(C=C4)NC(=O)C5(CC5)C(=O)NC6=CC=C(C=C6)F)F. Drug target is MET, KDR, TIE2, VEGFR3/FLT4, RON, PDGFR, FGFR1, EGFR. Drug target pathway is RTK signaling.
Drug 3: The drug is KRAS (G12C) INHIBITOR-12. The drug SMILES structure is C=CC(=O)N1CCN(CC1)C(=O)CNC2=CC(=C(C=C2O)Cl)I. Drug target is KRAS (G12C). Drug target pathway is ERK MAPK signaling.
The mutations of the cell line are ATRX, BCOR, CREBBP, DOT1L, ETV4, FBXW7, HRAS, NOTCH3, PPARG, PTEN, SOX2, TET2, TP53, TSC2, WHSC1, WT1.
Best drug option: ?",WYE-125132
ACH-000637,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is CETUXIMAB. The drug SMILES structure is CC1(C(=C)N(C2=CC=CC=C21)CCCCCC(=O)O)C. Drug target is EGFR. Drug target pathway is EGFR signaling.
Drug 2: The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
Drug 3: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are CDKN1B, CEBPA, ERG, FAS, FH, KDM5A, NFE2L2, NOTCH2, POLD1, TP53, TSC2.
Best drug option: ?",BRYOSTATIN-1
ACH-000639,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is PAZOPANIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC2=NC=CC(=N2)N(C)C3=CC4=NN(C(=C4C=C3)C)C)S(=O)(=O)N. Drug target is CSF1R, KIT,  PDGFRA, PDGFRB. Drug target pathway is RTK signaling.
Drug 2: The drug is QS-11. The drug SMILES structure is C1CC2=C(C1)C=C(C=C2)OC3=NC(=C4C(=N3)N(C=N4)CC5=CC=C(C=C5)C6=CC=CC=C6)NC(CC7=CC=CC=C7)CO. Drug target is Unknown. Drug target pathway is Unknown.
Drug 3: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are ARAF, BAP1, CREBBP, KIT, MLL2, NOTCH2, NOTCH3, PDGFRA, PIK3CB, PTPN11, PTPRO, RARA, ROS1, TEK, TP53.
Best drug option: ?",KIN001-135
ACH-000640,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is LINSITINIB. The drug SMILES structure is CC1(CC(C1)C2=NC(=C3N2C=CN=C3N)C4=CC5=C(C=C4)C=CC(=N5)C6=CC=CC=C6)O. Drug target is IGF1R. Drug target pathway is IGF1R signaling.
Drug 2: The drug is LY2109761. The drug SMILES structure is C1CC2=C(C(=NN2C1)C3=CC=CC=N3)C4=C5C=CC(=CC5=NC=C4)OCCN6CCOCC6. Drug target is TGFB1. Drug target pathway is Other.
Drug 3: The drug is LENALIDOMIDE. The drug SMILES structure is C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N. Drug target is CRBN. Drug target pathway is Protein stability and degradation.
The mutations of the cell line are BRAF, CREBBP, DOT1L, ERBB4, FLCN, ID3, NF1, PMS2, PRDM1, TYRO3.
Best drug option: ?",LY2109761
ACH-000641,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is PANOBINOSTAT. The drug SMILES structure is CC1=C(C2=CC=CC=C2N1)CCNCC3=CC=C(C=C3)C=CC(=O)NO. Drug target is HDAC. Drug target pathway is Chromatin histone acetylation.
Drug 2: The drug is IMATINIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5. Drug target is ABL, KIT, PDGFR. Drug target pathway is Other, kinases.
Drug 3: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are BRCA2, CSF3R, EPHA3, GATA4, GATA6, RAC1, TP53.
Best drug option: ?",IMATINIB
ACH-000643,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is VX-11E. The drug SMILES structure is CC1=CN=C(NC2=C(Cl)C=C(F)C=C2)N=C1C3=CNC(C(N[C@@H](C4=CC(Cl)=CC=C4)CO)=O)=C3. Drug target is ERK2. Drug target pathway is ERK MAPK signaling.
Drug 2: The drug is YK-4-279. The drug SMILES structure is COC1=CC=C(C=C1)C(=O)CC2(C3=C(C=CC(=C3NC2=O)Cl)Cl)O. Drug target is RNA helicase A. Drug target pathway is Other.
Drug 3: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are CDH1, DDR1, FGF19, KDM6A, MST1R, SPEN, TERT, TP53.
Best drug option: ?",YK-4-279
ACH-000644,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is NU-7441. The drug SMILES structure is C1COCCN1C2=CC(=O)C3=C(O2)C(=CC=C3)C4=CC=CC5=C4SC6=CC=CC=C56. Drug target is Unknown. Drug target pathway is Unknown.
Drug 2: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 3: The drug is WH-4-023. The drug SMILES structure is O=C(OC1=C(C)C=CC=C1C)N(C2=CC=C(OC)C=C2OC)C3=NC(NC4=CC=C(N5CCN(C)CC5)C=C4)=NC=C3. Drug target is SRC, LCK. Drug target pathway is Other, kinases.
The mutations of the cell line are BRAF, CDKN2A, EPHB4, ETV5, FAM46C, NOTCH2, RAD51B, SF3B1, TET2, ZNF217.
Best drug option: ?",KIN001-135
ACH-000647,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is YK-4-279. The drug SMILES structure is COC1=CC=C(C=C1)C(=O)CC2(C3=C(C=CC(=C3NC2=O)Cl)Cl)O. Drug target is RNA helicase A. Drug target pathway is Other.
Drug 2: The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
Drug 3: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are BRAF, CREBBP, DIS3, EPHA3, ETV5, H3F3A, MLL2, MTAP, NOTCH1, NOTCH3, PIK3C2G, RB1, SDHA, SMAD4, TP53.
Best drug option: ?",KIN001-135
ACH-000648,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is CAY10566. The drug SMILES structure is CC1=NN=C(O1)C2=NN=C(C=C2)N3CCC(CC3)OC4=C(C=CC(=C4)F)Cl. Drug target is Stearoyl-CoA desaturase. Drug target pathway is Other.
Drug 2: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 3: The drug is ARA-G. The drug SMILES structure is C1=NC2=C(N1[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)N=C(NC2=O)N. Drug target is Anti-metabolite. Drug target pathway is Other.
The mutations of the cell line are ATM, BAP1, BRCA2, GATA6, MSH3, NTRK3, RAC1, RSPO2, TGFBR2, VHL.
Best drug option: ?",KIN001-135
ACH-000649,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
Drug 2: The drug is PYRIDOSTATIN. The drug SMILES structure is C1=CC=C2C(=C1)C(=CC(=N2)NC(=O)C3=CC(=CC(=N3)C(=O)NC4=NC5=CC=CC=C5C(=C4)OCCN)OCCN)OCCN. Drug target is G-quadruplex stabiliser. Drug target pathway is DNA replication.
Drug 3: The drug is CAY10566. The drug SMILES structure is CC1=NN=C(O1)C2=NN=C(C=C2)N3CCC(CC3)OC4=C(C=CC(=C4)F)Cl. Drug target is Stearoyl-CoA desaturase. Drug target pathway is Other.
The mutations of the cell line are ALOX12B, ASXL1, ATM, CIC, ETV5, FLT1, KEL, MLL, MDM2, NOTCH3, POLE, PTEN, TP53, VHL, ZNF703.
Best drug option: ?",BRYOSTATIN-1
ACH-000650,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is JW-7-24-1. The drug SMILES structure is COC1=CC(=CC(=C1)C2=CC3=C4C(=CN=C3C=C2)C=CC(=O)N4C5=CC(=C(C=C5)N6CCNCC6)C(F)(F)F)OC. Drug target is LCK. Drug target pathway is Other, kinases.
Drug 2: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
Drug 3: The drug is EPOTHILONE-B. The drug SMILES structure is CC1CCCC2(C(O2)CC(OC(=O)CC(C(C(=O)C(C1O)C)(C)C)O)C(=CC3=CSC(=N3)C)C)C. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are AURKB, BRAF, CD22, DIS3, FGF10, FLT1, MEN1, PIK3C2G, TP53.
Best drug option: ?",JW-7-24-1
ACH-000651,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
Drug 2: The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
Drug 3: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are FAM123B, APC, ATRX, CCND2, EP300, KDM5C, KRAS, PBRM1, PPP2R2A, SF3B1, TP53.
Best drug option: ?",KIN001-135
ACH-000652,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 2: The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
Drug 3: The drug is GW-2580. The drug SMILES structure is COC1=CC=C(C=C1)COC2=C(C=C(C=C2)CC3=CN=C(N=C3N)N)OC. Drug target is CSF1R. Drug target pathway is RTK signaling.
The mutations of the cell line are ARID1A, BTG1, CDKN2A, EPHB1, HSD3B1, KRAS, MET, MYCL1, NTRK1, NTRK2, PDGFRA, SPEN, TP53, TSC1.
Best drug option: ?",GW-2580
ACH-000653,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 2: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
Drug 3: The drug is IMATINIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5. Drug target is ABL, KIT, PDGFR. Drug target pathway is Other, kinases.
The mutations of the cell line are CTCF, CTNNB1, EZH2, FANCA, GATA6, HGF, IRF4, NRAS, PARP1, TIPARP.
Best drug option: ?",KIN001-135
ACH-000654,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 2: The drug is YK-4-279. The drug SMILES structure is COC1=CC=C(C=C1)C(=O)CC2(C3=C(C=CC(=C3NC2=O)Cl)Cl)O. Drug target is RNA helicase A. Drug target pathway is Other.
Drug 3: The drug is IMATINIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5. Drug target is ABL, KIT, PDGFR. Drug target pathway is Other, kinases.
The mutations of the cell line are ARFRP1, ATRX, BRD4, CSF1R, CTNNA1, ERBB2, EWSR1, FANCG, FAS, GNA13, MYC, NOTCH1, PIK3C2G, POLD1, RICTOR, SPEN, TP53.
Best drug option: ?",KIN001-135
ACH-000655,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
Drug 2: The drug is IMATINIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5. Drug target is ABL, KIT, PDGFR. Drug target pathway is Other, kinases.
Drug 3: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are FAM123B, DNMT3A, EGFR, MLL2, MUTYH, TP53.
Best drug option: ?",KIN001-135
ACH-000656,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is PAZOPANIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC2=NC=CC(=N2)N(C)C3=CC4=NN(C(=C4C=C3)C)C)S(=O)(=O)N. Drug target is CSF1R, KIT,  PDGFRA, PDGFRB. Drug target pathway is RTK signaling.
Drug 2: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 3: The drug is FORETINIB. The drug SMILES structure is COC1=CC2=C(C=CN=C2C=C1OCCCN3CCOCC3)OC4=C(C=C(C=C4)NC(=O)C5(CC5)C(=O)NC6=CC=C(C=C6)F)F. Drug target is MET, KDR, TIE2, VEGFR3/FLT4, RON, PDGFR, FGFR1, EGFR. Drug target pathway is RTK signaling.
The mutations of the cell line are BCL2L2, BRAF, CALR, CREBBP, EP300, FAS, MLL2, MAP3K1, MST1R, MYC, NOTCH3, SGK1, TET2, TP53.
Best drug option: ?",KIN001-135
ACH-000660,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 2: The drug is SARACATINIB. The drug SMILES structure is CN1CCN(CC1)CCOC2=CC(=C3C(=C2)N=CN=C3NC4=C(C=CC5=C4OCO5)Cl)OC6CCOCC6. Drug target is ABL, SRC. Drug target pathway is Other, kinases.
Drug 3: The drug is AVAGACESTAT. The drug SMILES structure is C1=CC(=CC=C1S(=O)(=O)N(CC2=C(C=C(C=C2)C3=NOC=N3)F)[C@H](CCC(F)(F)F)C(=O)N)Cl. Drug target is Amyloid beta20, Amyloid beta40. Drug target pathway is Other.
The mutations of the cell line are ARID1A, BCL2L1, BTG2, EMSY, FANCA, GNA13, GNAS, MAP2K1, MCL1, MYC, PTEN, SOCS1, TET2.
Best drug option: ?",AVAGACESTAT
ACH-000662,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is IMATINIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5. Drug target is ABL, KIT, PDGFR. Drug target pathway is Other, kinases.
Drug 2: The drug is CAY10566. The drug SMILES structure is CC1=NN=C(O1)C2=NN=C(C=C2)N3CCC(CC3)OC4=C(C=CC(=C4)F)Cl. Drug target is Stearoyl-CoA desaturase. Drug target pathway is Other.
Drug 3: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are ALK, AURKB, CDKN2A, CIC, ETV5, GATA6, IRS2, MLL2, KRAS, MLH1, MTOR, NTRK1, PIK3CA, RICTOR, ROS1, SMARCA4.
Best drug option: ?",CAY10566
ACH-000664,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 2: The drug is KOBE2602. The drug SMILES structure is C1=CC(=CC=C1NC(=S)NNC2=C(C=C(C=C2[N+](=O)[O-])C(F)(F)F)[N+](=O)[O-])F. Drug target is RAS effector. Drug target pathway is RTK signaling.
Drug 3: The drug is AST-1306. The drug SMILES structure is C=CC(=O)NC1=CC2=C(C=C1)N=CN=C2NC3=CC(=C(C=C3)OCC4=CC(=CC=C4)F)Cl. Drug target is EGFR, ERBB4. Drug target pathway is RTK signaling.
The mutations of the cell line are CREBBP, DNMT3A, FLT1, KDM6A, KLHL6, MLL2, MPL, NTRK3, PIK3C2B, PIM1, SLC34A2, TP53.
Best drug option: ?",KIN001-135
ACH-000665,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
Drug 2: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 3: The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are EGFR, ERBB4, RET, TP53.
Best drug option: ?",BRYOSTATIN-1
ACH-000666,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 2: The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
Drug 3: The drug is NILOTINIB. The drug SMILES structure is CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)N3C=C(N=C3)C)C(F)(F)F)NC4=NC=CC(=N4)C5=CN=CC=C5. Drug target is ABL. Drug target pathway is ABL signaling.
The mutations of the cell line are ALK, ARAF, BCOR, BRCA2, EGFR, ERG, FH, FOXL2, GNA13, INPP4B, KEAP1, KRAS, RET, STK11, TNFRSF14, TP53, WHSC1, ZNF217.
Best drug option: ?",KIN001-135
ACH-000667,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
Drug 2: The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
Drug 3: The drug is CAY10566. The drug SMILES structure is CC1=NN=C(O1)C2=NN=C(C=C2)N3CCC(CC3)OC4=C(C=CC(=C4)F)Cl. Drug target is Stearoyl-CoA desaturase. Drug target pathway is Other.
The mutations of the cell line are AXIN1, CIC, EP300, GABRA6, KEAP1, KRAS, MED12, MITF, MKNK1, NKX2-1, NOTCH1, NTRK3, RB1, STK11, TP53.
Best drug option: ?",BRYOSTATIN-1
ACH-000668,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
Drug 2: The drug is PF-4708671. The drug SMILES structure is CCC1=CN=CN=C1N2CCN(CC2)CC3=NC4=C(N3)C=C(C=C4)C(F)(F)F. Drug target is S6K1. Drug target pathway is PI3K/MTOR signaling.
Drug 3: The drug is AT13148. The drug SMILES structure is C1=CC(=CC=C1C2=CNN=C2)[C@@](CN)(C3=CC=C(C=C3)Cl)O. Drug target is AKT1. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are CDKN2B, CSF1R, FLT1, IRS2, PTEN, RB1, SNCAIP, SOX9, TP53.
Best drug option: ?",WYE-125132
ACH-000669,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is YK-4-279. The drug SMILES structure is COC1=CC=C(C=C1)C(=O)CC2(C3=C(C=CC(=C3NC2=O)Cl)Cl)O. Drug target is RNA helicase A. Drug target pathway is Other.
Drug 2: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 3: The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are AKT2, ALK, ATR, BTG2, EPHB1, EPHB4, GNAS, IRF4, KDR, KIT, MLL2, KRAS, MYC, NTRK3, NUTM1, PPP2R1A, TP53.
Best drug option: ?",KIN001-135
ACH-000670,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 2: The drug is AVAGACESTAT. The drug SMILES structure is C1=CC(=CC=C1S(=O)(=O)N(CC2=C(C=C(C=C2)C3=NOC=N3)F)[C@H](CCC(F)(F)F)C(=O)N)Cl. Drug target is Amyloid beta20, Amyloid beta40. Drug target pathway is Other.
Drug 3: The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ALK, BCORL1, CDKN2A, EPHA3, FGFR2, MLL2, MAF, MST1R, MYB, NTRK3, SMARCA4, TP53, TSC2.
Best drug option: ?",KIN001-135
ACH-000672,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 2: The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
Drug 3: The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are BCORL1, BRCA2, CDKN2A, FGF4, FUBP1, GNAQ, KDR, KRAS, MED12, NTRK2, RARA, SPEN, TP53, XPO1.
Best drug option: ?",KIN001-135
ACH-000674,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
Drug 2: The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
Drug 3: The drug is AS601245. The drug SMILES structure is C1=CC=C2C(=C1)N=C(S2)C(C#N)C3=NC(=NC=C3)NCCC4=CN=CC=C4. Drug target is JNK1, JNK2, JNK2. Drug target pathway is JNK and p38 signaling.
The mutations of the cell line are BCR, BRCA1, CDH1, FUBP1, HNF1A, JAK3, NF1, NT5C2, PIK3C2G.
Best drug option: ?",BRYOSTATIN-1
ACH-000675,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 2: The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
Drug 3: The drug is CAY10566. The drug SMILES structure is CC1=NN=C(O1)C2=NN=C(C=C2)N3CCC(CC3)OC4=C(C=CC(=C4)F)Cl. Drug target is Stearoyl-CoA desaturase. Drug target pathway is Other.
The mutations of the cell line are ASXL1, ATM, CCNE1, DDR1, EPHA3, EPHB1, ERBB4, GRM3, INPP4B, IRS2, MLL2, KRAS, MSH2, NF1, NTRK3, P2RY8, RB1, SLC34A2, STK11, TP53.
Best drug option: ?",KIN001-135
ACH-000677,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is CAY10566. The drug SMILES structure is CC1=NN=C(O1)C2=NN=C(C=C2)N3CCC(CC3)OC4=C(C=CC(=C4)F)Cl. Drug target is Stearoyl-CoA desaturase. Drug target pathway is Other.
Drug 2: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 3: The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are CTNNB1, GABRA6, C17orf39, HGF, KRAS, MST1R, PIK3CA, REL, SMARCB1, SPEN.
Best drug option: ?",CAY10566
ACH-000678,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is YK-4-279. The drug SMILES structure is COC1=CC=C(C=C1)C(=O)CC2(C3=C(C=CC(=C3NC2=O)Cl)Cl)O. Drug target is RNA helicase A. Drug target pathway is Other.
Drug 2: The drug is GSK2606414. The drug SMILES structure is CN1C=C(C2=C(N=CN=C21)N)C3=CC4=C(C=C3)N(CC4)C(=O)CC5=CC(=CC=C5)C(F)(F)F. Drug target is PERK. Drug target pathway is Metabolism.
Drug 3: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are AR, ATRX, BRCA1, EGFR, ERBB4, FGFR4, IRS2, NOTCH1, NOTCH3, TP53.
Best drug option: ?",KIN001-135
ACH-000679,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is LIMK1 INHIBITOR BMS4. The drug SMILES structure is CCNC(=O)NC1=NC=C(S1)C2=CC(=NC(=N2)C3=NC=CN=C3)C4=C(C=C(C=C4C)OC)C. Drug target is LIMK1. Drug target pathway is Cytoskeleton.
Drug 2: The drug is FORETINIB. The drug SMILES structure is COC1=CC2=C(C=CN=C2C=C1OCCCN3CCOCC3)OC4=C(C=C(C=C4)NC(=O)C5(CC5)C(=O)NC6=CC=C(C=C6)F)F. Drug target is MET, KDR, TIE2, VEGFR3/FLT4, RON, PDGFR, FGFR1, EGFR. Drug target pathway is RTK signaling.
Drug 3: The drug is TIVOZANIB. The drug SMILES structure is CC1=CC(=NO1)NC(=O)NC2=C(C=C(C=C2)OC3=C4C=C(C(=CC4=NC=C3)OC)OC)Cl. Drug target is VEGFR1, VEGFR2, VEGFR3, PDGFR, KIT. Drug target pathway is RTK signaling.
The mutations of the cell line are CDH1, CUL3, FAM46C, GRM3, JAK2, MSH6, NUTM1, SDC4, SDHD, SMAD2, STAT3, TP53.
Best drug option: ?",TIVOZANIB
ACH-000680,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KRAS (G12C) INHIBITOR-12. The drug SMILES structure is C=CC(=O)N1CCN(CC1)C(=O)CNC2=CC(=C(C=C2O)Cl)I. Drug target is KRAS (G12C). Drug target pathway is ERK MAPK signaling.
Drug 2: The drug is PAZOPANIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC2=NC=CC(=N2)N(C)C3=CC4=NN(C(=C4C=C3)C)C)S(=O)(=O)N. Drug target is CSF1R, KIT,  PDGFRA, PDGFRB. Drug target pathway is RTK signaling.
Drug 3: The drug is LINIFANIB. The drug SMILES structure is CC1=CC(=C(C=C1)F)NC(=O)NC2=CC=C(C=C2)C3=C4C(=CC=C3)NN=C4N. Drug target is VEGFR1, VEGFR2, VEGFR3, CSF1R, FLT3, KIT. Drug target pathway is RTK signaling.
The mutations of the cell line are ALOX12B, APC, ARID1A, ATM, BCR, CD79B, EP300, EPHA3, MLL2, KRAS, MED12, PARP1, PDGFRB, PIK3CA, SMAD4, TP53.
Best drug option: ?",KRAS (G12C) INHIBITOR-12
ACH-000681,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is T-0901317. The drug SMILES structure is C1=CC=C(C=C1)S(=O)(=O)N(CC(F)(F)F)C2=CC=C(C=C2)C(C(F)(F)F)(C(F)(F)F)O. Drug target is Unknown. Drug target pathway is Unknown.
Drug 2: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 3: The drug is AVAGACESTAT. The drug SMILES structure is C1=CC(=CC=C1S(=O)(=O)N(CC2=C(C=C(C=C2)C3=NOC=N3)F)[C@H](CCC(F)(F)F)C(=O)N)Cl. Drug target is Amyloid beta20, Amyloid beta40. Drug target pathway is Other.
The mutations of the cell line are ATR, CARD11, CTNNA1, FH, FLT3, GRM3, KEAP1, KRAS, NT5C2, POLD1, SMARCA4, STK11, SUFU.
Best drug option: ?",KIN001-135
ACH-000684,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is AGI-5198. The drug SMILES structure is CC1=CC=CC=C1C(C(=O)NC2CCCCC2)N(C3=CC(=CC=C3)F)C(=O)CN4C=CN=C4C. Drug target is IDH1 (R132H). Drug target pathway is Metabolism.
Drug 2: The drug is PAZOPANIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC2=NC=CC(=N2)N(C)C3=CC4=NN(C(=C4C=C3)C)C)S(=O)(=O)N. Drug target is CSF1R, KIT,  PDGFRA, PDGFRB. Drug target pathway is RTK signaling.
Drug 3: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are CCNE1, ERRFI1, IKBKE, KDR, LTK, MYCL1, PBRM1, PDGFRA, ROS1, SMARCB1, VHL.
Best drug option: ?",KIN001-135
ACH-000688,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is GSK2606414. The drug SMILES structure is CN1C=C(C2=C(N=CN=C21)N)C3=CC4=C(C=C3)N(CC4)C(=O)CC5=CC(=CC=C5)C(F)(F)F. Drug target is PERK. Drug target pathway is Metabolism.
Drug 2: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 3: The drug is PAZOPANIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC2=NC=CC(=N2)N(C)C3=CC4=NN(C(=C4C=C3)C)C)S(=O)(=O)N. Drug target is CSF1R, KIT,  PDGFRA, PDGFRB. Drug target pathway is RTK signaling.
The mutations of the cell line are CDKN1A, EPHA3, FBXW7, KRAS, MSH6, PIK3CA, RB1, SMARCA4, TP53.
Best drug option: ?",KIN001-135
ACH-000689,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
Drug 2: The drug is AZD8931. The drug SMILES structure is CNC(=O)CN1CCC(CC1)OC2=C(C=C3C(=C2)C(=NC=N3)NC4=C(C(=CC=C4)Cl)F)OC. Drug target is EGFR, ERBB2, ERBB3. Drug target pathway is RTK signaling.
Drug 3: The drug is JNJ-38877605. The drug SMILES structure is CN1C=C(C=N1)C2=NN3C(=NN=C3C(C4=CC5=C(C=C4)N=CC=C5)(F)F)C=C2. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are CEBPA, CUL3, HGF, SETD2.
Best drug option: ?",WYE-125132
ACH-000691,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 2: The drug is AVAGACESTAT. The drug SMILES structure is C1=CC(=CC=C1S(=O)(=O)N(CC2=C(C=C(C=C2)C3=NOC=N3)F)[C@H](CCC(F)(F)F)C(=O)N)Cl. Drug target is Amyloid beta20, Amyloid beta40. Drug target pathway is Other.
Drug 3: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are BRCA1, CDKN2B, CHEK1, MLL, MLL2, NOTCH1, NOTCH2, POLE, TP53.
Best drug option: ?",KIN001-135
ACH-000693,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 2: The drug is AVAGACESTAT. The drug SMILES structure is C1=CC(=CC=C1S(=O)(=O)N(CC2=C(C=C(C=C2)C3=NOC=N3)F)[C@H](CCC(F)(F)F)C(=O)N)Cl. Drug target is Amyloid beta20, Amyloid beta40. Drug target pathway is Other.
Drug 3: The drug is IMATINIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5. Drug target is ABL, KIT, PDGFR. Drug target pathway is Other, kinases.
The mutations of the cell line are BRAF, BTK, CBL, ERCC4, FGF6, FLCN, KDM6A, KEAP1, MED12, NFE2L2, NOTCH1, PIK3C2G, PPP2R1A, PRKAR1A, TP53.
Best drug option: ?",AVAGACESTAT
ACH-000694,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is AVAGACESTAT. The drug SMILES structure is C1=CC(=CC=C1S(=O)(=O)N(CC2=C(C=C(C=C2)C3=NOC=N3)F)[C@H](CCC(F)(F)F)C(=O)N)Cl. Drug target is Amyloid beta20, Amyloid beta40. Drug target pathway is Other.
Drug 2: The drug is FR-180204. The drug SMILES structure is C1=CC=C(C=C1)C2=NN3C=CC=CC3=C2C4=CC5=C(NN=C5N=N4)N. Drug target is ERK1, ERK2. Drug target pathway is ERK MAPK signaling.
Drug 3: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are ATM, BRCA2, CHEK2, DDR2, ERBB3, FGFR4, MLL2, PAX5, PIM1, RPTOR, SDHD, SETD2, SMARCB1, SNCAIP, TET2, TP53.
Best drug option: ?",FR-180204
ACH-000696,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is CAY10566. The drug SMILES structure is CC1=NN=C(O1)C2=NN=C(C=C2)N3CCC(CC3)OC4=C(C=CC(=C4)F)Cl. Drug target is Stearoyl-CoA desaturase. Drug target pathway is Other.
Drug 2: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 3: The drug is IMATINIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5. Drug target is ABL, KIT, PDGFR. Drug target pathway is Other, kinases.
The mutations of the cell line are FAM123B, APC, ATM, AXL, CREBBP, CTNNB1, EP300, ERBB2, KRAS, MSH6, NOTCH1, PPARG, TBX3, TEK, TP53.
Best drug option: ?",CAY10566
ACH-000697,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is IMATINIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5. Drug target is ABL, KIT, PDGFR. Drug target pathway is Other, kinases.
Drug 2: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
Drug 3: The drug is YK-4-279. The drug SMILES structure is COC1=CC=C(C=C1)C(=O)CC2(C3=C(C=CC(=C3NC2=O)Cl)Cl)O. Drug target is RNA helicase A. Drug target pathway is Other.
The mutations of the cell line are ARID1A, ATR, BAP1, BTG2, CDK12, FGFR4, ID3, IRF4, KDM5C, MLL, MSH2, MYC, NTRK1, NTRK2, PARK2, PIK3CB, ROS1, SPEN, WT1.
Best drug option: ?",YK-4-279
ACH-000698,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is MIRIN. The drug SMILES structure is C1=CC(=CC=C1C=C2C(=O)N=C(S2)N)O. Drug target is MRE11. Drug target pathway is Genome integrity.
Drug 2: The drug is SB-505124. The drug SMILES structure is CC1=NC(=CC=C1)C2=C(N=C(N2)C(C)(C)C)C3=CC4=C(C=C3)OCO4. Drug target is Unknown. Drug target pathway is Unknown.
Drug 3: The drug is TIPIFARNIB. The drug SMILES structure is CN1C=NC=C1[C@@](C2=CC=C(C=C2)Cl)(C3=CC4=C(C=C3)N(C(=O)C=C4C5=CC(=CC=C5)Cl)C)N. Drug target is Farnesyl-transferase (FNTA). Drug target pathway is Other.
The mutations of the cell line are AXL, CUL3, EED, GATA6, KDR, MLL2, MET, NTRK2, RAD21, SMARCA4, STAG2, STK11, TET2, TNFAIP3, TP53, TSC2.
Best drug option: ?",MIRIN
ACH-000699,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
Drug 2: The drug is TIPIFARNIB. The drug SMILES structure is CN1C=NC=C1[C@@](C2=CC=C(C=C2)Cl)(C3=CC4=C(C=C3)N(C(=O)C=C4C5=CC(=CC=C5)Cl)C)N. Drug target is Farnesyl-transferase (FNTA). Drug target pathway is Other.
Drug 3: The drug is CAY10566. The drug SMILES structure is CC1=NN=C(O1)C2=NN=C(C=C2)N3CCC(CC3)OC4=C(C=CC(=C4)F)Cl. Drug target is Stearoyl-CoA desaturase. Drug target pathway is Other.
The mutations of the cell line are ATRX, BRCA1, BRCA2, CIC, CREBBP, FGFR1, MSH6, PDGFRB, TP53.
Best drug option: ?",CAY10566
ACH-000702,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 2: The drug is ARA-G. The drug SMILES structure is C1=NC2=C(N1[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)N=C(NC2=O)N. Drug target is Anti-metabolite. Drug target pathway is Other.
Drug 3: The drug is SU-11274. The drug SMILES structure is CC1=C(NC(=C1C(=O)N2CCN(CC2)C)C)C=C3C4=C(C=CC(=C4)S(=O)(=O)N(C)C5=CC(=CC=C5)Cl)NC3=O. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ATM, ATRX, BTG1, CDK4, DOT1L, EPHB4, ERBB3, FAS, GNA13, JAK2, KLHL6, MLL2, LTK, MTOR, P2RY8, POLE, SOCS1, TNFAIP3, TYRO3, XPO1, ZNF217.
Best drug option: ?",KIN001-135
ACH-000703,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is CISPLATIN. The drug SMILES structure is N.N.Cl[Pt]Cl. Drug target is DNA crosslinker. Drug target pathway is DNA replication.
Drug 2: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 3: The drug is IMATINIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5. Drug target is ABL, KIT, PDGFR. Drug target pathway is Other, kinases.
The mutations of the cell line are APC, CHEK1, IKZF1, MLL, MST1R, NOTCH1, PAX5, PIK3C2B, PTEN, PTPRO, RB1, ROS1, TP53.
Best drug option: ?",KIN001-135
ACH-000704,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
Drug 2: The drug is CAY10566. The drug SMILES structure is CC1=NN=C(O1)C2=NN=C(C=C2)N3CCC(CC3)OC4=C(C=CC(=C4)F)Cl. Drug target is Stearoyl-CoA desaturase. Drug target pathway is Other.
Drug 3: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ARID1A, AXL, BRIP1, EPHB1, KDM6A, KLHL6, PIK3CA.
Best drug option: ?",YM-201636
ACH-000706,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
Drug 2: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 3: The drug is GSK2606414. The drug SMILES structure is CN1C=C(C2=C(N=CN=C21)N)C3=CC4=C(C=C3)N(CC4)C(=O)CC5=CC(=CC=C5)C(F)(F)F. Drug target is PERK. Drug target pathway is Metabolism.
The mutations of the cell line are CXCR4, DNMT3A, FGFR3, KEL, MYC, PDGFRA, PIK3C2G, ROS1, SMARCA4, STK11, TET2, TP53, VHL.
Best drug option: ?",KIN001-135
ACH-000711,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is SELUMETINIB. The drug SMILES structure is CN1C=NC2=C1C=C(C(=C2F)NC3=C(C=C(C=C3)Br)Cl)C(=O)NOCCO. Drug target is MEK1, MEK2. Drug target pathway is ERK MAPK signaling.
Drug 2: The drug is AVAGACESTAT. The drug SMILES structure is C1=CC(=CC=C1S(=O)(=O)N(CC2=C(C=C(C=C2)C3=NOC=N3)F)[C@H](CCC(F)(F)F)C(=O)N)Cl. Drug target is Amyloid beta20, Amyloid beta40. Drug target pathway is Other.
Drug 3: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are ARID1A, CUL4A, MAF, PIK3CA, TP53.
Best drug option: ?",AVAGACESTAT
ACH-000713,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
Drug 2: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 3: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ACVR1B, ATM, BCORL1, EGFR, MYCN, PDK1, SF3B1, TP53.
Best drug option: ?",KIN001-135
ACH-000714,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 2: The drug is IMATINIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5. Drug target is ABL, KIT, PDGFR. Drug target pathway is Other, kinases.
Drug 3: The drug is GSK591. The drug SMILES structure is C1CC(C1)NC2=NC=CC(=C2)C(=O)NC[C@@H](CN3CCC4=CC=CC=C4C3)O. Drug target is PMRT5. Drug target pathway is Chromatin histone methylation.
The mutations of the cell line are APC, CCNE1, DDR1, FGFR3, INPP4B, MAF, NOTCH3, PDCD1LG2, RAD21.
Best drug option: ?",KIN001-135
ACH-000716,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
Drug 2: The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
Drug 3: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are BARD1, DAXX, FGF12, MLL2, NRAS, TP53.
Best drug option: ?",BRYOSTATIN-1
ACH-000717,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is AZ960. The drug SMILES structure is CC1=CC(=NN1)NC2=C(C=C(C(=N2)N[C@@H](C)C3=CC=C(C=C3)F)C#N)F. Drug target is JAK2, JAK3. Drug target pathway is Other, kinases.
Drug 2: The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
Drug 3: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are ASXL1, ATM, BTK, FGF19, INPP4B, JAK2, MLL2, MAP2K2, PTPN11, RPTOR, SPEN, TP53.
Best drug option: ?",KIN001-135
ACH-000718,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is BORTEZOMIB. The drug SMILES structure is B([C@H](CC(C)C)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O. Drug target is Proteasome. Drug target pathway is Protein stability and degradation.
Drug 2: The drug is GSK2606414. The drug SMILES structure is CN1C=C(C2=C(N=CN=C21)N)C3=CC4=C(C=C3)N(CC4)C(=O)CC5=CC(=CC=C5)C(F)(F)F. Drug target is PERK. Drug target pathway is Metabolism.
Drug 3: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are AXL, CARD11, EGFR, ERBB4, KRAS, NTRK1, PARP3, POLE, PTPRO, RBM10, TEK, TP53, WT1.
Best drug option: ?",BORTEZOMIB
ACH-000719,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is QS-11. The drug SMILES structure is C1CC2=C(C1)C=C(C=C2)OC3=NC(=C4C(=N3)N(C=N4)CC5=CC=C(C=C5)C6=CC=CC=C6)NC(CC7=CC=CC=C7)CO. Drug target is Unknown. Drug target pathway is Unknown.
Drug 2: The drug is CAY10566. The drug SMILES structure is CC1=NN=C(O1)C2=NN=C(C=C2)N3CCC(CC3)OC4=C(C=CC(=C4)F)Cl. Drug target is Stearoyl-CoA desaturase. Drug target pathway is Other.
Drug 3: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are FANCL, KDR, MLH1, NOTCH3, RAD54L, SF3B1.
Best drug option: ?",CAY10566
ACH-000720,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 2: The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
Drug 3: The drug is YK-4-279. The drug SMILES structure is COC1=CC=C(C=C1)C(=O)CC2(C3=C(C=CC(=C3NC2=O)Cl)Cl)O. Drug target is RNA helicase A. Drug target pathway is Other.
The mutations of the cell line are ARID1A, CDKN1B, FUBP1, HGF, KDR, MRE11A, NOTCH3, PIK3CA, PMS2, POLE, SMARCA4, TET2, TP53.
Best drug option: ?",KIN001-135
ACH-000722,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is VE-822. The drug SMILES structure is CC(C)S(=O)(=O)C1=CC=C(C=C1)C2=CN=C(C(=N2)C3=CC(=NO3)C4=CC=C(C=C4)CNC)N. Drug target is ATR. Drug target pathway is Genome integrity.
Drug 2: The drug is ARA-G. The drug SMILES structure is C1=NC2=C(N1[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)N=C(NC2=O)N. Drug target is Anti-metabolite. Drug target pathway is Other.
Drug 3: The drug is GSK2606414. The drug SMILES structure is CN1C=C(C2=C(N=CN=C21)N)C3=CC4=C(C=C3)N(CC4)C(=O)CC5=CC(=CC=C5)C(F)(F)F. Drug target is PERK. Drug target pathway is Metabolism.
The mutations of the cell line are ALK, BRIP1, EPHB1, ERBB4, ETV6, FANCL, INPP4B, LYN, MAP2K1, PALB2, POLE, RICTOR, SOX9, TP53, TSC2, WHSC1L1.
Best drug option: ?",ARA-G
ACH-000724,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
Drug 2: The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
Drug 3: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are ARID1A, ASXL1, CDKN1A, JAK2, MRE11A, RB1, REL, TP53.
Best drug option: ?",KIN001-135
ACH-000729,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is ERK5-IN-1. The drug SMILES structure is CCOC1=C(C=CC(=C1)C(=O)N2CCC(CC2)N3CCN(CC3)C)NC4=NC=C5C(=N4)N(C6=CC=CC=C6C(=O)N5C)C7CCCC7. Drug target is ERK5, BET. Drug target pathway is Other.
Drug 2: The drug is AGI-5198. The drug SMILES structure is CC1=CC=CC=C1C(C(=O)NC2CCCCC2)N(C3=CC(=CC=C3)F)C(=O)CN4C=CN=C4C. Drug target is IDH1 (R132H). Drug target pathway is Metabolism.
Drug 3: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are AR, ATR, EMSY, CHEK2, CREBBP, MLL, MCL1, POLD1, PTPRO, RB1, ROS1, TP53.
Best drug option: ?",KIN001-135
ACH-000730,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
Drug 2: The drug is GW-2580. The drug SMILES structure is COC1=CC=C(C=C1)COC2=C(C=C(C=C2)CC3=CN=C(N=C3N)N)OC. Drug target is CSF1R. Drug target pathway is RTK signaling.
Drug 3: The drug is JNJ-38877605. The drug SMILES structure is CN1C=C(C=N1)C2=NN3C(=NN=C3C(C4=CC5=C(C=C4)N=CC=C5)(F)F)C=C2. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are APC, BRAF, IRS2, KDR, MLL2, NTRK2, PIK3CB, PTPRO, RICTOR, SETD2, SMARCA4, TET2, WHSC1.
Best drug option: ?",WYE-125132
ACH-000733,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
Drug 2: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 3: The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are FAM123B, ATM, ATR, BRCA1, CDK12, FAS, MLL2, MED12, MET, MITF, NF1, PDCD1, PIM1, SDHC, SF3B1, SUFU, TP53.
Best drug option: ?",KIN001-135
ACH-000738,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is FLUDARABINE. The drug SMILES structure is C1=NC2=C(N=C(N=C2N1[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)F)N. Drug target is Antimetabolite. Drug target pathway is DNA replication.
Drug 2: The drug is IMATINIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5. Drug target is ABL, KIT, PDGFR. Drug target pathway is Other, kinases.
Drug 3: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are CDKN2C, CIC, CREBBP, ERBB4, MLH1, MST1R, NF1, NOTCH1, REL, TP53.
Best drug option: ?",IMATINIB
ACH-000744,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is LIMK1 INHIBITOR BMS4. The drug SMILES structure is CCNC(=O)NC1=NC=C(S1)C2=CC(=NC(=N2)C3=NC=CN=C3)C4=C(C=C(C=C4C)OC)C. Drug target is LIMK1. Drug target pathway is Cytoskeleton.
Drug 2: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
Drug 3: The drug is GDC-0068. The drug SMILES structure is CC1CC(C2=C1C(=NC=N2)N3CCN(CC3)C(=O)C(CNC(C)C)C4=CC=C(C=C4)Cl)O. Drug target is AKT1, AKT, AKT3. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are FGFR2, FUBP1, IKZF1, KDM5A, KDR, KEAP1, MUTYH, PARP1, POLD1, SETD2, SF3B1, STK11, TMPRSS2, TP53.
Best drug option: ?",WYE-125132
ACH-000747,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 2: The drug is CETUXIMAB. The drug SMILES structure is CC1(C(=C)N(C2=CC=CC=C21)CCCCCC(=O)O)C. Drug target is EGFR. Drug target pathway is EGFR signaling.
Drug 3: The drug is CAY10566. The drug SMILES structure is CC1=NN=C(O1)C2=NN=C(C=C2)N3CCC(CC3)OC4=C(C=CC(=C4)F)Cl. Drug target is Stearoyl-CoA desaturase. Drug target pathway is Other.
The mutations of the cell line are ATM, BRCA1, CDKN2A, CREBBP, EP300, KEL, PIK3C2G, REL, SF3B1, SMARCA4, TP53.
Best drug option: ?",KIN001-135
ACH-000748,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 2: The drug is PANOBINOSTAT. The drug SMILES structure is CC1=C(C2=CC=CC=C2N1)CCNCC3=CC=C(C=C3)C=CC(=O)NO. Drug target is HDAC. Drug target pathway is Chromatin histone acetylation.
Drug 3: The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ATR, ATRX, EP300, ERBB3, FLT1, KEL, MLL, MLL2, KRAS, MDM2, MUTYH, NOTCH3, NRAS, RAD21, TP53.
Best drug option: ?",YM-201636
ACH-000749,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
Drug 2: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 3: The drug is AVAGACESTAT. The drug SMILES structure is C1=CC(=CC=C1S(=O)(=O)N(CC2=C(C=C(C=C2)C3=NOC=N3)F)[C@H](CCC(F)(F)F)C(=O)N)Cl. Drug target is Amyloid beta20, Amyloid beta40. Drug target pathway is Other.
The mutations of the cell line are ATM, BRCA1, EZH2, MLL2, MET, PTEN, RB1, SLC34A2, TERT, TP53.
Best drug option: ?",KIN001-135
ACH-000752,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is ZG-10. The drug SMILES structure is O=C(C1=CC=C(NC(C=CCN(C)C)=O)C=C1)NC2=CC(NC3=NC(C4=CC=CN=C4)=CC=N3)=CC=C2. Drug target is JNK1. Drug target pathway is JNK and p38 signaling.
Drug 2: The drug is PAZOPANIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC2=NC=CC(=N2)N(C)C3=CC4=NN(C(=C4C=C3)C)C)S(=O)(=O)N. Drug target is CSF1R, KIT,  PDGFRA, PDGFRB. Drug target pathway is RTK signaling.
Drug 3: The drug is EPZ004777. The drug SMILES structure is CC(C)N(CCCNC(=O)NC1=CC=C(C=C1)C(C)(C)C)C[C@@H]2[C@H]([C@H]([C@@H](O2)N3C=CC4=C(N=CN=C43)N)O)O. Drug target is DOT1L. Drug target pathway is Chromatin histone methylation.
The mutations of the cell line are ARID1A, CIC, FLT1, HGF, IGF1R, JAK2, MLL2, MED12, NOTCH3, PIK3C2B, PPARG, PTEN, RB1, TP53, WHSC1L1.
Best drug option: ?",PAZOPANIB
ACH-000754,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 2: The drug is IMATINIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5. Drug target is ABL, KIT, PDGFR. Drug target pathway is Other, kinases.
Drug 3: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are AXIN1, BCL2L1, BCL6, EZH2, IRF4, MYB, MYD88, NFKBIA, P2RY8, PIK3C2G, RAD51C, RPTOR, SMARCA4, SOCS1.
Best drug option: ?",IMATINIB
ACH-000755,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is FORETINIB. The drug SMILES structure is COC1=CC2=C(C=CN=C2C=C1OCCCN3CCOCC3)OC4=C(C=C(C=C4)NC(=O)C5(CC5)C(=O)NC6=CC=C(C=C6)F)F. Drug target is MET, KDR, TIE2, VEGFR3/FLT4, RON, PDGFR, FGFR1, EGFR. Drug target pathway is RTK signaling.
Drug 2: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 3: The drug is VE-822. The drug SMILES structure is CC(C)S(=O)(=O)C1=CC=C(C=C1)C2=CN=C(C(=N2)C3=CC(=NO3)C4=CC=C(C=C4)CNC)N. Drug target is ATR. Drug target pathway is Genome integrity.
The mutations of the cell line are BCORL1, BRAF, CIC, EP300, KDM5A, MLL, MET, MRE11A, MSH2, SMARCA4, TEK.
Best drug option: ?",KIN001-135
ACH-000756,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
Drug 2: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 3: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ABL1, ATR, ATRX, CREBBP, CUL4A, EP300, EPHB4, MDM4, MYC, PDCD1LG2, PIK3R1, RB1, TP53.
Best drug option: ?",KIN001-135
ACH-000757,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is CAY10566. The drug SMILES structure is CC1=NN=C(O1)C2=NN=C(C=C2)N3CCC(CC3)OC4=C(C=CC(=C4)F)Cl. Drug target is Stearoyl-CoA desaturase. Drug target pathway is Other.
Drug 2: The drug is IMATINIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5. Drug target is ABL, KIT, PDGFR. Drug target pathway is Other, kinases.
Drug 3: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are BCOR, CTNNB1, GABRA6, KRAS, MSH2, POLE, RBM10, SDHA, SMO, TYRO3.
Best drug option: ?",CAY10566
ACH-000759,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is LIMK1 INHIBITOR BMS4. The drug SMILES structure is CCNC(=O)NC1=NC=C(S1)C2=CC(=NC(=N2)C3=NC=CN=C3)C4=C(C=C(C=C4C)OC)C. Drug target is LIMK1. Drug target pathway is Cytoskeleton.
Drug 2: The drug is TIVOZANIB. The drug SMILES structure is CC1=CC(=NO1)NC(=O)NC2=C(C=C(C=C2)OC3=C4C=C(C(=CC4=NC=C3)OC)OC)Cl. Drug target is VEGFR1, VEGFR2, VEGFR3, PDGFR, KIT. Drug target pathway is RTK signaling.
Drug 3: The drug is GDC-0068. The drug SMILES structure is CC1CC(C2=C1C(=NC=N2)N3CCN(CC3)C(=O)C(CNC(C)C)C4=CC=C(C=C4)Cl)O. Drug target is AKT1, AKT, AKT3. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ARID1A, CDKN2B, FANCA, NF1, PIK3C2B, XPO1.
Best drug option: ?",TIVOZANIB
ACH-000763,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is SARACATINIB. The drug SMILES structure is CN1CCN(CC1)CCOC2=CC(=C3C(=C2)N=CN=C3NC4=C(C=CC5=C4OCO5)Cl)OC6CCOCC6. Drug target is ABL, SRC. Drug target pathway is Other, kinases.
Drug 2: The drug is AVAGACESTAT. The drug SMILES structure is C1=CC(=CC=C1S(=O)(=O)N(CC2=C(C=C(C=C2)C3=NOC=N3)F)[C@H](CCC(F)(F)F)C(=O)N)Cl. Drug target is Amyloid beta20, Amyloid beta40. Drug target pathway is Other.
Drug 3: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are CIC, EGFR, FAM46C, KRAS, MAF, MITF, PRKCI, RICTOR, WHSC1.
Best drug option: ?",KIN001-135
ACH-000766,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KRAS (G12C) INHIBITOR-12. The drug SMILES structure is C=CC(=O)N1CCN(CC1)C(=O)CNC2=CC(=C(C=C2O)Cl)I. Drug target is KRAS (G12C). Drug target pathway is ERK MAPK signaling.
Drug 2: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
Drug 3: The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are BARD1, BRCA2, BRIP1, EP300, ERG, FBXW7, FH, KEAP1, MAP3K1, NOTCH3, SPOP, TP53, ZNF217.
Best drug option: ?",WYE-125132
ACH-000767,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 2: The drug is AVAGACESTAT. The drug SMILES structure is C1=CC(=CC=C1S(=O)(=O)N(CC2=C(C=C(C=C2)C3=NOC=N3)F)[C@H](CCC(F)(F)F)C(=O)N)Cl. Drug target is Amyloid beta20, Amyloid beta40. Drug target pathway is Other.
Drug 3: The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are AR, ATRX, BRD4, DDR1, EPHA3, GATA6, GNAS, KDM5A, NOTCH1, P2RY8, PBRM1, PIK3C2B, PIK3C2G, POLE, RAD21, RB1, ROS1, TP53, WHSC1L1.
Best drug option: ?",YM-201636
ACH-000768,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is CAY10566. The drug SMILES structure is CC1=NN=C(O1)C2=NN=C(C=C2)N3CCC(CC3)OC4=C(C=CC(=C4)F)Cl. Drug target is Stearoyl-CoA desaturase. Drug target pathway is Other.
Drug 2: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 3: The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ATM, BRAF, CD79A, EPHA3, EPHB4, GRM3, MLL, KRAS, MSH3, MST1R, MYCL1, NF1, NF2, NOTCH3, P2RY8, PBRM1, PDGFRA, TP53, ZNF703.
Best drug option: ?",KIN001-135
ACH-000769,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
Drug 2: The drug is AVAGACESTAT. The drug SMILES structure is C1=CC(=CC=C1S(=O)(=O)N(CC2=C(C=C(C=C2)C3=NOC=N3)F)[C@H](CCC(F)(F)F)C(=O)N)Cl. Drug target is Amyloid beta20, Amyloid beta40. Drug target pathway is Other.
Drug 3: The drug is CETUXIMAB. The drug SMILES structure is CC1(C(=C)N(C2=CC=CC=C21)CCCCCC(=O)O)C. Drug target is EGFR. Drug target pathway is EGFR signaling.
The mutations of the cell line are APC, CDKN2A, CRKL, FANCA, MLL2, NFE2L2, PDGFRB, PRDM1, SPEN, TP53.
Best drug option: ?",AVAGACESTAT
ACH-000770,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is MG-132. The drug SMILES structure is CC(C)C[C@@H](C=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)OCC1=CC=CC=C1. Drug target is Proteasome, CAPN1. Drug target pathway is Protein stability and degradation.
Drug 2: The drug is IRINOTECAN. The drug SMILES structure is CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)[C@@]4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7. Drug target is TOP1. Drug target pathway is DNA replication.
Drug 3: The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ARID1A, ATRX, BCORL1, CD70, CREBBP, DOT1L, EP300, ETV6, ID3, IRF4, MLL, MAP3K1, MITF, NRAS, PDCD1LG2, PIK3C2G, PMS2, PTEN, PTPRO, QKI, RAD21, RAD51B, RB1, RPTOR, SPEN, TP53.
Best drug option: ?",IRINOTECAN
ACH-000772,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is AT13148. The drug SMILES structure is C1=CC(=CC=C1C2=CNN=C2)[C@@](CN)(C3=CC=C(C=C3)Cl)O. Drug target is AKT1. Drug target pathway is PI3K/MTOR signaling.
Drug 2: The drug is AGI-5198. The drug SMILES structure is CC1=CC=CC=C1C(C(=O)NC2CCCCC2)N(C3=CC(=CC=C3)F)C(=O)CN4C=CN=C4C. Drug target is IDH1 (R132H). Drug target pathway is Metabolism.
Drug 3: The drug is PAC-1. The drug SMILES structure is C=CCC1=CC=CC(=CNNC(=O)CN2CCN(CC2)CC3=CC=CC=C3)C1=O. Drug target is Procaspase-3, Procaspase-7. Drug target pathway is Apoptosis regulation.
The mutations of the cell line are ATRX, CIC, DOT1L, MLL2, WHSC1L1, ZNF217.
Best drug option: ?",PAC-1
ACH-000775,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is LINIFANIB. The drug SMILES structure is CC1=CC(=C(C=C1)F)NC(=O)NC2=CC=C(C=C2)C3=C4C(=CC=C3)NN=C4N. Drug target is VEGFR1, VEGFR2, VEGFR3, CSF1R, FLT3, KIT. Drug target pathway is RTK signaling.
Drug 2: The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
Drug 3: The drug is AZD5363. The drug SMILES structure is O=C(C1(N)CCN(C2=C3C(NC=C3)=NC=N2)CC1)N[C@H](C4=CC=C(Cl)C=C4)CCO. Drug target is AKT1, AKT2, AKT3, ROCK2. Drug target pathway is Other, kinases.
The mutations of the cell line are ARAF, BCOR, BRCA1, BRD4, CDC73, EPHA3, ERBB4, HGF, IDH2, KDM5A, KRAS, NTRK3, STK11, TP53.
Best drug option: ?",YM-201636
ACH-000776,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is GSK2606414. The drug SMILES structure is CN1C=C(C2=C(N=CN=C21)N)C3=CC4=C(C=C3)N(CC4)C(=O)CC5=CC(=CC=C5)C(F)(F)F. Drug target is PERK. Drug target pathway is Metabolism.
Drug 2: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 3: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ACVR1B, APC, AR, BTK, ERCC4, FLT1, JAK1, MYCL1, NOTCH3, NRAS, POLD1, TEK, TERT.
Best drug option: ?",KIN001-135
ACH-000778,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
Drug 2: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 3: The drug is PF-4708671. The drug SMILES structure is CCC1=CN=CN=C1N2CCN(CC2)CC3=NC4=C(N3)C=C(C=C4)C(F)(F)F. Drug target is S6K1. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ABL1, CASP8, CDKN2A, MLL2, MAP2K1, NOTCH1, PPP2R1A, SETD2, SMAD4, SRC, TP53.
Best drug option: ?",PF-4708671
ACH-000780,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is ARA-G. The drug SMILES structure is C1=NC2=C(N1[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)N=C(NC2=O)N. Drug target is Anti-metabolite. Drug target pathway is Other.
Drug 2: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
Drug 3: The drug is VENETOCLAX. The drug SMILES structure is CC1(CCC(=C(C1)C2=CC=C(C=C2)Cl)CN3CCN(CC3)C4=CC(=C(C=C4)C(=O)NS(=O)(=O)C5=CC(=C(C=C5)NCC6CCOCC6)[N+](=O)[O-])OC7=CN=C8C(=C7)C=CN8)C. Drug target is BCL2. Drug target pathway is Apoptosis regulation.
The mutations of the cell line are ALOX12B, CCND1, CREBBP, EP300, EPHA3, EPHB1, EZR, FGF12, GRM3, MLL2, PDGFRA, PIK3C2G, PIK3CB, POLD1, RAD21, RB1, RET, ROS1, SETD2, TP53.
Best drug option: ?",WYE-125132
ACH-000781,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
Drug 2: The drug is CAY10566. The drug SMILES structure is CC1=NN=C(O1)C2=NN=C(C=C2)N3CCC(CC3)OC4=C(C=CC(=C4)F)Cl. Drug target is Stearoyl-CoA desaturase. Drug target pathway is Other.
Drug 3: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are AKT2, APC, CD22, CD79B, ERBB4, FGFR2, FUBP1, KDR, KEAP1, MERTK, MST1R, PDGFRB, PTEN, SMARCA4, SOX9, TP53, WHSC1.
Best drug option: ?",KIN001-135
ACH-000783,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 2: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
Drug 3: The drug is GW-2580. The drug SMILES structure is COC1=CC=C(C=C1)COC2=C(C=C(C=C2)CC3=CN=C(N=C3N)N)OC. Drug target is CSF1R. Drug target pathway is RTK signaling.
The mutations of the cell line are BRD4, CDH1, EP300, FGFR4, C17orf39, HSD3B1, MAP3K1, NTRK1, NTRK2, PTCH1, PTEN, RARA, TP53, VHL, WHSC1L1.
Best drug option: ?",KIN001-135
ACH-000784,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
Drug 2: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
Drug 3: The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ARAF, ARID1A, ASXL1, BCL2L1, CDKN1B, EGFR, ESR1, FH, GATA3, JAK2, KIT, MAP2K2, NFE2L2, PIK3CA, PTPRO, RET, RICTOR, TP53.
Best drug option: ?",BRYOSTATIN-1
ACH-000786,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
Drug 2: The drug is YK-4-279. The drug SMILES structure is COC1=CC=C(C=C1)C(=O)CC2(C3=C(C=CC(=C3NC2=O)Cl)Cl)O. Drug target is RNA helicase A. Drug target pathway is Other.
Drug 3: The drug is PAZOPANIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC2=NC=CC(=N2)N(C)C3=CC4=NN(C(=C4C=C3)C)C)S(=O)(=O)N. Drug target is CSF1R, KIT,  PDGFRA, PDGFRB. Drug target pathway is RTK signaling.
The mutations of the cell line are ALK, APC, AR, ARAF, ARID1A, ASXL1, ATM, ATR, ATRX, BCOR, BCORL1, BRCA2, BRD4, EMSY, CBL, CDK12, CDK8, CHEK2, CREBBP, CTCF, CTNNA1, EPHA3, EPHB1, ETV5, EWSR1, FANCA, FGF12, FGF14, FGF6, FGFR2, FLCN, FLT3, GATA3, HGF, ID3, IGF1R, IKZF1, INPP4B, JUN, KDM5A, KDM5C, KDM6A, KIT, MLL, MLL2, KRAS, MAF, MCL1, MDM4, MED12, MITF, MYCL1, NF1, NFKBIA, PARK2, PDK1, PIK3C2B, PRKCI, PTCH1, RAF1, RB1, RBM10, RET, RNF43, ROS1, SMAD2, SOCS1, SOX2, SPEN, STAG2, TIPARP, TP53, WHSC1L1, XPO1.
Best drug option: ?",PAZOPANIB
ACH-000787,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 2: The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
Drug 3: The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ATM, CDKN2A, CTNNB1, DDR2, KEAP1, NF1, NUTM1, PPARG, RAD21, SPEN, STAG2, TP53.
Best drug option: ?",BRYOSTATIN-1
ACH-000788,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 2: The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
Drug 3: The drug is AVAGACESTAT. The drug SMILES structure is C1=CC(=CC=C1S(=O)(=O)N(CC2=C(C=C(C=C2)C3=NOC=N3)F)[C@H](CCC(F)(F)F)C(=O)N)Cl. Drug target is Amyloid beta20, Amyloid beta40. Drug target pathway is Other.
The mutations of the cell line are ATR, BCOR, BRAF, CTCF, DIS3, GABRA6, MLL2, MAF, MAP2K1, PTEN, RB1, SF3B1, STK11, SYK, TET2, TP53.
Best drug option: ?",KIN001-135
ACH-000789,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is ARA-G. The drug SMILES structure is C1=NC2=C(N1[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)N=C(NC2=O)N. Drug target is Anti-metabolite. Drug target pathway is Other.
Drug 2: The drug is PAZOPANIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC2=NC=CC(=N2)N(C)C3=CC4=NN(C(=C4C=C3)C)C)S(=O)(=O)N. Drug target is CSF1R, KIT,  PDGFRA, PDGFRB. Drug target pathway is RTK signaling.
Drug 3: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are ARID1A, ATM, CARD11, CSF1R, DDR2, FGFR4, IGF1R, IKZF1, NTRK3, STK11, TP53, WHSC1L1.
Best drug option: ?",KIN001-135
ACH-000790,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is AVAGACESTAT. The drug SMILES structure is C1=CC(=CC=C1S(=O)(=O)N(CC2=C(C=C(C=C2)C3=NOC=N3)F)[C@H](CCC(F)(F)F)C(=O)N)Cl. Drug target is Amyloid beta20, Amyloid beta40. Drug target pathway is Other.
Drug 2: The drug is SB-505124. The drug SMILES structure is CC1=NC(=CC=C1)C2=C(N=C(N2)C(C)(C)C)C3=CC4=C(C=C3)OCO4. Drug target is Unknown. Drug target pathway is Unknown.
Drug 3: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are ABL1, ARID1A, AXIN1, DAXX, DDR1, EGFR, ERBB4, EZH2, FGFR1, FUBP1, HGF, INPP4B, KEAP1, KEL, MLL2, KRAS, MAF, PDGFRA, RAC1, TP53.
Best drug option: ?",AVAGACESTAT
ACH-000792,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is YK-4-279. The drug SMILES structure is COC1=CC=C(C=C1)C(=O)CC2(C3=C(C=CC(=C3NC2=O)Cl)Cl)O. Drug target is RNA helicase A. Drug target pathway is Other.
Drug 2: The drug is CAY10566. The drug SMILES structure is CC1=NN=C(O1)C2=NN=C(C=C2)N3CCC(CC3)OC4=C(C=CC(=C4)F)Cl. Drug target is Stearoyl-CoA desaturase. Drug target pathway is Other.
Drug 3: The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are EPHA3, KEL, LTK, PBRM1, PIK3CA, PRKCI, TP53.
Best drug option: ?",CAY10566
ACH-000793,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 2: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
Drug 3: The drug is VOXTALISIB. The drug SMILES structure is CCN1C2=NC(=NC(=C2C=C(C1=O)C3=CC=NN3)C)N. Drug target is PI3K (class 1), DNAPK, MTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are AR, ATM, BRCA2, CARD11, CDH1, DDR2, DOT1L, FLT1, GATA3, MLL, MLL2, MLH1, MSH3, NOTCH1, PIK3C2G, POLD1, PTCH1.
Best drug option: ?",KIN001-135
ACH-000794,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is CETUXIMAB. The drug SMILES structure is CC1(C(=C)N(C2=CC=CC=C21)CCCCCC(=O)O)C. Drug target is EGFR. Drug target pathway is EGFR signaling.
Drug 2: The drug is SARACATINIB. The drug SMILES structure is CN1CCN(CC1)CCOC2=CC(=C3C(=C2)N=CN=C3NC4=C(C=CC5=C4OCO5)Cl)OC6CCOCC6. Drug target is ABL, SRC. Drug target pathway is Other, kinases.
Drug 3: The drug is AVAGACESTAT. The drug SMILES structure is C1=CC(=CC=C1S(=O)(=O)N(CC2=C(C=C(C=C2)C3=NOC=N3)F)[C@H](CCC(F)(F)F)C(=O)N)Cl. Drug target is Amyloid beta20, Amyloid beta40. Drug target pathway is Other.
The mutations of the cell line are CREBBP, EP300, MEF2B, MEN1, PIK3CB, PTPN11, TP53, XPO1, ZNF703.
Best drug option: ?",AVAGACESTAT
ACH-000798,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is SARACATINIB. The drug SMILES structure is CN1CCN(CC1)CCOC2=CC(=C3C(=C2)N=CN=C3NC4=C(C=CC5=C4OCO5)Cl)OC6CCOCC6. Drug target is ABL, SRC. Drug target pathway is Other, kinases.
Drug 2: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 3: The drug is YK-4-279. The drug SMILES structure is COC1=CC=C(C=C1)C(=O)CC2(C3=C(C=CC(=C3NC2=O)Cl)Cl)O. Drug target is RNA helicase A. Drug target pathway is Other.
The mutations of the cell line are FAM123B, APC, FLCN, KRAS, MAP3K13, MSH2, PIK3CA, RAD51B, SOX9, TP53.
Best drug option: ?",KIN001-135
ACH-000800,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is AVAGACESTAT. The drug SMILES structure is C1=CC(=CC=C1S(=O)(=O)N(CC2=C(C=C(C=C2)C3=NOC=N3)F)[C@H](CCC(F)(F)F)C(=O)N)Cl. Drug target is Amyloid beta20, Amyloid beta40. Drug target pathway is Other.
Drug 2: The drug is SARACATINIB. The drug SMILES structure is CN1CCN(CC1)CCOC2=CC(=C3C(=C2)N=CN=C3NC4=C(C=CC5=C4OCO5)Cl)OC6CCOCC6. Drug target is ABL, SRC. Drug target pathway is Other, kinases.
Drug 3: The drug is IMATINIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5. Drug target is ABL, KIT, PDGFR. Drug target pathway is Other, kinases.
The mutations of the cell line are ATRX, CALR, CDKN1B, FBXW7, IGF1R, MLL2, MTOR, NBN, NF1, NOTCH2, NOTCH3, PBRM1, PDCD1, PDGFRA, PIK3C2B, PTCH1, PTPRO, RB1, SMARCA4, SOX9, TP53, ZNF217.
Best drug option: ?",IMATINIB
ACH-000803,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is CAY10566. The drug SMILES structure is CC1=NN=C(O1)C2=NN=C(C=C2)N3CCC(CC3)OC4=C(C=CC(=C4)F)Cl. Drug target is Stearoyl-CoA desaturase. Drug target pathway is Other.
Drug 2: The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
Drug 3: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are AKT2, BRIP1, EMSY, CARD11, CDK6, EPHA3, FLT3, IKZF1, KDM6A, KRAS, PDGFRA, RAD54L, RB1, TP53, TSC2.
Best drug option: ?",CAY10566
ACH-000804,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is ETOPOSIDE. The drug SMILES structure is C[C@@H]1OC[C@@H]2[C@@H](O1)[C@@H]([C@H]([C@@H](O2)O[C@H]3[C@H]4COC(=O)[C@@H]4[C@@H](C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O. Drug target is TOP2. Drug target pathway is DNA replication.
Drug 2: The drug is JNJ-38877605. The drug SMILES structure is CN1C=C(C=N1)C2=NN3C(=NN=C3C(C4=CC5=C(C=C4)N=CC=C5)(F)F)C=C2. Drug target is Unknown. Drug target pathway is Unknown.
Drug 3: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ATR, AXL, BRAF, CTNNA1, DOT1L, KDM5A, MLL, MLL2, MAP3K13, NTRK2, PIK3R1, PPP2R1A, SMAD4, SPOP, TMPRSS2, TSC2, TYRO3.
Best drug option: ?",WYE-125132
ACH-000805,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
Drug 2: The drug is JW-7-24-1. The drug SMILES structure is COC1=CC(=CC(=C1)C2=CC3=C4C(=CN=C3C=C2)C=CC(=O)N4C5=CC(=C(C=C5)N6CCNCC6)C(F)(F)F)OC. Drug target is LCK. Drug target pathway is Other, kinases.
Drug 3: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are ATM, BCOR, BRAF, BRCA2, CALR, CSF3R, DDR1, EGFR, ERBB4, ERG, EZH2, FGFR2, GABRA6, NOTCH2, NTRK2, PPP2R2A, PTPN11, PTPRO, SPEN.
Best drug option: ?",KIN001-135
ACH-000806,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is SARACATINIB. The drug SMILES structure is CN1CCN(CC1)CCOC2=CC(=C3C(=C2)N=CN=C3NC4=C(C=CC5=C4OCO5)Cl)OC6CCOCC6. Drug target is ABL, SRC. Drug target pathway is Other, kinases.
Drug 2: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 3: The drug is AVAGACESTAT. The drug SMILES structure is C1=CC(=CC=C1S(=O)(=O)N(CC2=C(C=C(C=C2)C3=NOC=N3)F)[C@H](CCC(F)(F)F)C(=O)N)Cl. Drug target is Amyloid beta20, Amyloid beta40. Drug target pathway is Other.
The mutations of the cell line are ABL1, CIC, CREBBP, EGFR, ERG, MLL2, MAP3K1, MTOR, PRDM1, SF3B1, SPEN, TEK.
Best drug option: ?",KIN001-135
ACH-000809,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 2: The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
Drug 3: The drug is LESTAURTINIB. The drug SMILES structure is C[C@@]12[C@](C[C@@H](O1)N3C4=CC=CC=C4C5=C6C(=C7C8=CC=CC=C8N2C7=C53)CNC6=O)(CO)O. Drug target is FLT3, JAK2, NTRK1, NTRK2, NTRK3. Drug target pathway is Other, kinases.
The mutations of the cell line are ABL1, APC, ATM, ATR, BCR, CBL, CSF1R, FGF10, FH, FLT3, GNAS, MLL2, KRAS, MDM4, MTOR, PALB2, SETD2, SMARCA4, TET2, TP53, WHSC1L1.
Best drug option: ?",BRYOSTATIN-1
ACH-000810,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 2: The drug is PANOBINOSTAT. The drug SMILES structure is CC1=C(C2=CC=CC=C2N1)CCNCC3=CC=C(C=C3)C=CC(=O)NO. Drug target is HDAC. Drug target pathway is Chromatin histone acetylation.
Drug 3: The drug is BORTEZOMIB. The drug SMILES structure is B([C@H](CC(C)C)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O. Drug target is Proteasome. Drug target pathway is Protein stability and degradation.
The mutations of the cell line are ALK, APC, BRAF, CDKN2A, EZH2, MERTK, NOTCH3, NRAS, SPEN, TP53.
Best drug option: ?",KIN001-135
ACH-000811,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is PF-4708671. The drug SMILES structure is CCC1=CN=CN=C1N2CCN(CC2)CC3=NC4=C(N3)C=C(C=C4)C(F)(F)F. Drug target is S6K1. Drug target pathway is PI3K/MTOR signaling.
Drug 2: The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
Drug 3: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are APC, ARID1A, ATM, EMSY, CIC, EP300, FBXW7, FGFR2, FLT3, NF1, NKX2-1, NOTCH2, PIK3CA, PIM1, POLD1, ROS1, RPTOR, STAG2, TP53.
Best drug option: ?",BRYOSTATIN-1
ACH-000812,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is NU-7441. The drug SMILES structure is C1COCCN1C2=CC(=O)C3=C(O2)C(=CC=C3)C4=CC=CC5=C4SC6=CC=CC=C56. Drug target is Unknown. Drug target pathway is Unknown.
Drug 2: The drug is JNJ-38877605. The drug SMILES structure is CN1C=C(C=N1)C2=NN3C(=NN=C3C(C4=CC5=C(C=C4)N=CC=C5)(F)F)C=C2. Drug target is Unknown. Drug target pathway is Unknown.
Drug 3: The drug is BORTEZOMIB. The drug SMILES structure is B([C@H](CC(C)C)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O. Drug target is Proteasome. Drug target pathway is Protein stability and degradation.
The mutations of the cell line are AKT2, ATRX, BCORL1, BRAF, BRCA2, CARD11, CDKN1B, CDKN2A, CTNNB1, EP300, FGF23, KLHL6, MERTK, NF1, PIK3C2G, ROS1, TIPARP, TP53.
Best drug option: ?",JNJ-38877605
ACH-000814,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
Drug 2: The drug is FORETINIB. The drug SMILES structure is COC1=CC2=C(C=CN=C2C=C1OCCCN3CCOCC3)OC4=C(C=C(C=C4)NC(=O)C5(CC5)C(=O)NC6=CC=C(C=C6)F)F. Drug target is MET, KDR, TIE2, VEGFR3/FLT4, RON, PDGFR, FGFR1, EGFR. Drug target pathway is RTK signaling.
Drug 3: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are FAM123B, ATRX, BCOR, BRAF, CARD11, CDKN2A, CTNNA1, FANCL, IDH1, MTAP, ROS1, RSPO2, SF3B1, SNCAIP.
Best drug option: ?",KIN001-135
ACH-000816,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is AVAGACESTAT. The drug SMILES structure is C1=CC(=CC=C1S(=O)(=O)N(CC2=C(C=C(C=C2)C3=NOC=N3)F)[C@H](CCC(F)(F)F)C(=O)N)Cl. Drug target is Amyloid beta20, Amyloid beta40. Drug target pathway is Other.
Drug 2: The drug is EX-527. The drug SMILES structure is C1CC(C2=C(C1)C3=C(N2)C=CC(=C3)Cl)C(=O)N. Drug target is SIRT1. Drug target pathway is Chromatin histone acetylation.
Drug 3: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are ATM, ATR, CCNE1, CDC73, CDK4, EP300, MLL, LYN, PRKCI, PTPRO, RB1, RSPO2, TP53.
Best drug option: ?",KIN001-135
ACH-000817,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is YK-4-279. The drug SMILES structure is COC1=CC=C(C=C1)C(=O)CC2(C3=C(C=CC(=C3NC2=O)Cl)Cl)O. Drug target is RNA helicase A. Drug target pathway is Other.
Drug 2: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 3: The drug is AVAGACESTAT. The drug SMILES structure is C1=CC(=CC=C1S(=O)(=O)N(CC2=C(C=C(C=C2)C3=NOC=N3)F)[C@H](CCC(F)(F)F)C(=O)N)Cl. Drug target is Amyloid beta20, Amyloid beta40. Drug target pathway is Other.
The mutations of the cell line are BARD1, CCND2, CDH1, CIC, EGFR, ERBB4, INPP4B, JAK1, JAK3, KDM6A, MLL2, KRAS, MUTYH, NOTCH1, RPTOR, SPEN, TEK, TP53, U2AF1.
Best drug option: ?",AVAGACESTAT
ACH-000821,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
Drug 2: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
Drug 3: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are ARID1A, AXL, BARD1, BCL6, EWSR1, FUBP1, MLL, MSH3, MYD88, PIK3C2B, RAC1, SETD2, TET2, TIPARP, TP53.
Best drug option: ?",KIN001-135
ACH-000822,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is NIRAPARIB. The drug SMILES structure is C1C[C@H](CNC1)C2=CC=C(C=C2)N3C=C4C=CC=C(C4=N3)C(=O)N. Drug target is PARP1, PARP2. Drug target pathway is Genome integrity.
Drug 2: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
Drug 3: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are ATM, ATR, BRAF, CHEK1, JAK3, MLL2, MERTK, NFKBIA, PARK2, PARP1, PRKCI, TNFRSF14.
Best drug option: ?",WYE-125132
ACH-000823,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 2: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
Drug 3: The drug is YK-4-279. The drug SMILES structure is COC1=CC=C(C=C1)C(=O)CC2(C3=C(C=CC(=C3NC2=O)Cl)Cl)O. Drug target is RNA helicase A. Drug target pathway is Other.
The mutations of the cell line are BRCA1, CSF1R, DDR1, DOT1L, EPHB1, ERCC4, ETV5, ETV6, FGF23, FLT1, GATA6, HGF, IKBKE, JAK3, KEL, KIT, PALB2, PIK3C2G, POLE, SF3B1, SMARCA4, SPEN, TP53, TSC2.
Best drug option: ?",WYE-125132
ACH-000824,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
Drug 2: The drug is KOBE2602. The drug SMILES structure is C1=CC(=CC=C1NC(=S)NNC2=C(C=C(C=C2[N+](=O)[O-])C(F)(F)F)[N+](=O)[O-])F. Drug target is RAS effector. Drug target pathway is RTK signaling.
Drug 3: The drug is PANOBINOSTAT. The drug SMILES structure is CC1=C(C2=CC=CC=C2N1)CCNCC3=CC=C(C=C3)C=CC(=O)NO. Drug target is HDAC. Drug target pathway is Chromatin histone acetylation.
The mutations of the cell line are ATR, BCL6, BRCA2, CDH1, CIC, CTNNA1, CXCR4, EGFR, EP300, ERCC4, FANCA, FLT3, FUBP1, HGF, KIT, MLL2, MAP3K13, MST1R, MTOR, PIK3CA, ROS1, TP53.
Best drug option: ?",KOBE2602
ACH-000825,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
Drug 2: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 3: The drug is AZD5363. The drug SMILES structure is O=C(C1(N)CCN(C2=C3C(NC=C3)=NC=N2)CC1)N[C@H](C4=CC=C(Cl)C=C4)CCO. Drug target is AKT1, AKT2, AKT3, ROCK2. Drug target pathway is Other, kinases.
The mutations of the cell line are BCORL1, BRIP1, CARD11, CDK12, CSF3R, GNAS, KDM5A, MTAP, NF1, PDK1, PTPN11, SF3B1, TBX3, TP53.
Best drug option: ?",KIN001-135
ACH-000826,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
Drug 2: The drug is PANOBINOSTAT. The drug SMILES structure is CC1=C(C2=CC=CC=C2N1)CCNCC3=CC=C(C=C3)C=CC(=O)NO. Drug target is HDAC. Drug target pathway is Chromatin histone acetylation.
Drug 3: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are ACVR1B, FAM123B, AR, BRAF, CDKN2A, CYP17A1, DOT1L, FGF3, FGFR2, GRM3, GSK3B, MLL, MYCN, NTRK3, PRKCI, RB1, SF3B1, SMARCA4, SPEN, TBX3, TMPRSS2, TP53, WHSC1L1.
Best drug option: ?",KIN001-135
ACH-000827,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
Drug 2: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 3: The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ARID1A, AURKA, BRAF, BRD4, CDK4, KDM5A, KEL, MLL2, PIK3C2G, PTEN, RICTOR, SNCAIP.
Best drug option: ?",KIN001-135
ACH-000830,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is ARA-G. The drug SMILES structure is C1=NC2=C(N1[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)N=C(NC2=O)N. Drug target is Anti-metabolite. Drug target pathway is Other.
Drug 2: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 3: The drug is IMATINIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5. Drug target is ABL, KIT, PDGFR. Drug target pathway is Other, kinases.
The mutations of the cell line are AR, ARID1A, CCNE1, ERBB3, FBXW7, JAK3, KDM6A, MLL2, NOTCH1, RAD21, REL, SGK1, TP53, WT1.
Best drug option: ?",KIN001-135
ACH-000832,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is AVAGACESTAT. The drug SMILES structure is C1=CC(=CC=C1S(=O)(=O)N(CC2=C(C=C(C=C2)C3=NOC=N3)F)[C@H](CCC(F)(F)F)C(=O)N)Cl. Drug target is Amyloid beta20, Amyloid beta40. Drug target pathway is Other.
Drug 2: The drug is IMATINIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5. Drug target is ABL, KIT, PDGFR. Drug target pathway is Other, kinases.
Drug 3: The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ABL1, APC, ATRX, CASP8, CDKN1A, CDKN2A, CREBBP, DIS3, ESR1, FGF23, HGF, KDM6A, MSH3, NOTCH1, NRAS, ROS1, SMAD4, SPEN, TERT, TP53.
Best drug option: ?",IMATINIB
ACH-000835,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 2: The drug is GW-2580. The drug SMILES structure is COC1=CC=C(C=C1)COC2=C(C=C(C=C2)CC3=CN=C(N=C3N)N)OC. Drug target is CSF1R. Drug target pathway is RTK signaling.
Drug 3: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are BRAF, CASP8, CDKN2A, CREBBP, CSF1R, FAS, FLT1, GATA6, JAK3, KDR, KEL, MLL, MLL2, NOTCH3, NTRK3, PAX5, PDGFRA, PDGFRB, PTEN, ROS1, SMO, TP53.
Best drug option: ?",WYE-125132
ACH-000838,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is AVAGACESTAT. The drug SMILES structure is C1=CC(=CC=C1S(=O)(=O)N(CC2=C(C=C(C=C2)C3=NOC=N3)F)[C@H](CCC(F)(F)F)C(=O)N)Cl. Drug target is Amyloid beta20, Amyloid beta40. Drug target pathway is Other.
Drug 2: The drug is YK-4-279. The drug SMILES structure is COC1=CC=C(C=C1)C(=O)CC2(C3=C(C=CC(=C3NC2=O)Cl)Cl)O. Drug target is RNA helicase A. Drug target pathway is Other.
Drug 3: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are ALOX12B, ARAF, ATM, ATR, CD274, EGFR, FGF3, KRAS, MAP2K2, PIK3C2G, SLC34A2, SPEN, STAT3, TET2.
Best drug option: ?",KIN001-135
ACH-000840,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is LY2109761. The drug SMILES structure is C1CC2=C(C(=NN2C1)C3=CC=CC=N3)C4=C5C=CC(=CC5=NC=C4)OCCN6CCOCC6. Drug target is TGFB1. Drug target pathway is Other.
Drug 2: The drug is GSK2606414. The drug SMILES structure is CN1C=C(C2=C(N=CN=C21)N)C3=CC4=C(C=C3)N(CC4)C(=O)CC5=CC(=CC=C5)C(F)(F)F. Drug target is PERK. Drug target pathway is Metabolism.
Drug 3: The drug is IMATINIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5. Drug target is ABL, KIT, PDGFR. Drug target pathway is Other, kinases.
The mutations of the cell line are AR, ATM, CIC, DDR2, FLCN, KDM5A, KEL, NOTCH1, NOTCH2, PIK3R1, SMARCA4, TNFRSF14, TP53, XPO1.
Best drug option: ?",GSK2606414
ACH-000841,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 2: The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
Drug 3: The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ALK, ATM, ATR, BRAF, CREBBP, FGF14, IGF1R, KLHL6, MYC, NRAS, NTRK3, RAF1, RB1, SPEN, STAT3, TP53.
Best drug option: ?",YM-201636
ACH-000843,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is YK-4-279. The drug SMILES structure is COC1=CC=C(C=C1)C(=O)CC2(C3=C(C=CC(=C3NC2=O)Cl)Cl)O. Drug target is RNA helicase A. Drug target pathway is Other.
Drug 2: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 3: The drug is AVAGACESTAT. The drug SMILES structure is C1=CC(=CC=C1S(=O)(=O)N(CC2=C(C=C(C=C2)C3=NOC=N3)F)[C@H](CCC(F)(F)F)C(=O)N)Cl. Drug target is Amyloid beta20, Amyloid beta40. Drug target pathway is Other.
The mutations of the cell line are ABL1, ATM, CARD11, CDH1, CDKN2A, CREBBP, DAXX, DIS3, DOT1L, ERCC4, FLT1, GABRA6, HNF1A, JAK2, KDM5A, KEL, RET, TP53.
Best drug option: ?",AVAGACESTAT
ACH-000846,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
Drug 2: The drug is T-0901317. The drug SMILES structure is C1=CC=C(C=C1)S(=O)(=O)N(CC(F)(F)F)C2=CC=C(C=C2)C(C(F)(F)F)(C(F)(F)F)O. Drug target is Unknown. Drug target pathway is Unknown.
Drug 3: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are ATR, BRCA2, CDKN2A, CXCR4, EPHB4, ERBB3, FANCL, FLCN, KDM6A, MITF, P2RY8, RAF1, REL, ROS1, RPTOR, TP53, VHL.
Best drug option: ?",KIN001-135
ACH-000847,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is IMATINIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5. Drug target is ABL, KIT, PDGFR. Drug target pathway is Other, kinases.
Drug 2: The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
Drug 3: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are APC, ATM, ATR, BRCA2, CD22, CDK12, EP300, ERBB4, FANCA, GNA13, IRF4, JAK1, MED12, MET, PIK3CA, PRDM1, SMAD4, SMARCA4, TP53, TSC2.
Best drug option: ?",IMATINIB
ACH-000848,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is AGI-5198. The drug SMILES structure is CC1=CC=CC=C1C(C(=O)NC2CCCCC2)N(C3=CC(=CC=C3)F)C(=O)CN4C=CN=C4C. Drug target is IDH1 (R132H). Drug target pathway is Metabolism.
Drug 2: The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
Drug 3: The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ATR, AXIN1, BCR, BRCA1, EMSY, CD274, DNMT3A, EPHB4, EZR, FLT3, GRM3, MSH6, NOTCH1, PTCH1, PTPRO, ROS1, TNFAIP3, TP53.
Best drug option: ?",YM-201636
ACH-000849,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
Drug 2: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 3: The drug is FORETINIB. The drug SMILES structure is COC1=CC2=C(C=CN=C2C=C1OCCCN3CCOCC3)OC4=C(C=C(C=C4)NC(=O)C5(CC5)C(=O)NC6=CC=C(C=C6)F)F. Drug target is MET, KDR, TIE2, VEGFR3/FLT4, RON, PDGFR, FGFR1, EGFR. Drug target pathway is RTK signaling.
The mutations of the cell line are BCOR, BRCA2, ERBB2, ERG, FANCA, MLL, NOTCH1, PTEN, SDC4, TP53.
Best drug option: ?",FORETINIB
ACH-000852,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 2: The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
Drug 3: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ALK, BCL2, CCND1, CCND2, GRM3, KEAP1, LTK, NF1, NTRK3, PDGFRA, RAD54L, RBM10, SMARCA4, STK11, TP53.
Best drug option: ?",KIN001-135
ACH-000853,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is FORETINIB. The drug SMILES structure is COC1=CC2=C(C=CN=C2C=C1OCCCN3CCOCC3)OC4=C(C=C(C=C4)NC(=O)C5(CC5)C(=O)NC6=CC=C(C=C6)F)F. Drug target is MET, KDR, TIE2, VEGFR3/FLT4, RON, PDGFR, FGFR1, EGFR. Drug target pathway is RTK signaling.
Drug 2: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
Drug 3: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are ATR, ATRX, BRCA2, BRIP1, CALR, CDKN2A, CSF3R, DOT1L, FANCC, FLCN, GNAS, JAK3, KEAP1, MERTK, MYB, NOTCH3, NTRK2, PIK3C2B, PTPN11, ROS1, SMARCA4, TET2, TP53.
Best drug option: ?",KIN001-135
ACH-000855,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 2: The drug is CAY10566. The drug SMILES structure is CC1=NN=C(O1)C2=NN=C(C=C2)N3CCC(CC3)OC4=C(C=CC(=C4)F)Cl. Drug target is Stearoyl-CoA desaturase. Drug target pathway is Other.
Drug 3: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ATM, ATR, CASP8, ERBB3, FAS, FLT1, FUBP1, IKZF1, NF1, NOTCH1, NTRK1, P2RY8, PDGFRA, POLE, PRKCI, RAC1, SMAD4, SMARCA4, TIPARP, TP53, WHSC1.
Best drug option: ?",KIN001-135
ACH-000856,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is CAY10566. The drug SMILES structure is CC1=NN=C(O1)C2=NN=C(C=C2)N3CCC(CC3)OC4=C(C=CC(=C4)F)Cl. Drug target is Stearoyl-CoA desaturase. Drug target pathway is Other.
Drug 2: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 3: The drug is IMATINIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5. Drug target is ABL, KIT, PDGFR. Drug target pathway is Other, kinases.
The mutations of the cell line are ALK, ARID1A, ATRX, BCOR, BCORL1, BRCA2, CARD11, CCNE1, CHEK1, CREBBP, FBXW7, FGF19, FGFR3, GNAS, JAK1, MLL, MLL2, MAP2K4, NTRK3, PIK3CA, PTCH1, PTEN, RAC1, RAF1, SMARCA4, TNFRSF14.
Best drug option: ?",CAY10566
ACH-000857,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is CAY10566. The drug SMILES structure is CC1=NN=C(O1)C2=NN=C(C=C2)N3CCC(CC3)OC4=C(C=CC(=C4)F)Cl. Drug target is Stearoyl-CoA desaturase. Drug target pathway is Other.
Drug 2: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 3: The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are BRCA2, CIC, ERBB4, JAK3, RB1, TP53.
Best drug option: ?",CAY10566
ACH-000858,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is YK-4-279. The drug SMILES structure is COC1=CC=C(C=C1)C(=O)CC2(C3=C(C=CC(=C3NC2=O)Cl)Cl)O. Drug target is RNA helicase A. Drug target pathway is Other.
Drug 2: The drug is LY2109761. The drug SMILES structure is C1CC2=C(C(=NN2C1)C3=CC=CC=N3)C4=C5C=CC(=CC5=NC=C4)OCCN6CCOCC6. Drug target is TGFB1. Drug target pathway is Other.
Drug 3: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are CDKN2A, DOT1L, ESR1, HRAS, MLL, MYB, STAG2, TP53.
Best drug option: ?",KIN001-135
ACH-000859,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is GSK2606414. The drug SMILES structure is CN1C=C(C2=C(N=CN=C21)N)C3=CC4=C(C=C3)N(CC4)C(=O)CC5=CC(=CC=C5)C(F)(F)F. Drug target is PERK. Drug target pathway is Metabolism.
Drug 2: The drug is FORETINIB. The drug SMILES structure is COC1=CC2=C(C=CN=C2C=C1OCCCN3CCOCC3)OC4=C(C=C(C=C4)NC(=O)C5(CC5)C(=O)NC6=CC=C(C=C6)F)F. Drug target is MET, KDR, TIE2, VEGFR3/FLT4, RON, PDGFR, FGFR1, EGFR. Drug target pathway is RTK signaling.
Drug 3: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are APC, BRCA1, ERRFI1, NOTCH1, PIK3CA, ROS1, TP53.
Best drug option: ?",WYE-125132
ACH-000860,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 2: The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
Drug 3: The drug is CAY10566. The drug SMILES structure is CC1=NN=C(O1)C2=NN=C(C=C2)N3CCC(CC3)OC4=C(C=CC(=C4)F)Cl. Drug target is Stearoyl-CoA desaturase. Drug target pathway is Other.
The mutations of the cell line are ASXL1, CARD11, CD22, CTNNB1, FANCC, FGFR1, FGFR3, GNAQ, JAK2, KDM5A, KEL, KRAS, MED12, MEF2B, MRE11A, MSH3, MUTYH, RAD51D, RARA, RPTOR, SF3B1, TBX3.
Best drug option: ?",KIN001-135
ACH-000861,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
Drug 2: The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
Drug 3: The drug is CAY10566. The drug SMILES structure is CC1=NN=C(O1)C2=NN=C(C=C2)N3CCC(CC3)OC4=C(C=CC(=C4)F)Cl. Drug target is Stearoyl-CoA desaturase. Drug target pathway is Other.
The mutations of the cell line are AR, BARD1, CTNNA1, DOT1L, EPHA3, GNAS, KRAS, MYB, PDGFRB, POLE, RAF1, SDHA, STAT3, TP53.
Best drug option: ?",BRYOSTATIN-1
ACH-000863,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
Drug 2: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 3: The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are BRAF, CD22, FGFR1, KEL, MLL, MLL2, PTPN11, ROS1, TSC1, TSC2, WHSC1.
Best drug option: ?",KIN001-135
ACH-000866,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is IMATINIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5. Drug target is ABL, KIT, PDGFR. Drug target pathway is Other, kinases.
Drug 2: The drug is JNJ-38877605. The drug SMILES structure is CN1C=C(C=N1)C2=NN3C(=NN=C3C(C4=CC5=C(C=C4)N=CC=C5)(F)F)C=C2. Drug target is Unknown. Drug target pathway is Unknown.
Drug 3: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ARID1A, ASXL1, ATR, BCOR, BCORL1, CDK8, CREBBP, CSF3R, CTCF, CUL4A, ETV5, GATA3, GATA6, MLL2, MED12, NOTCH1, NRAS, PIK3CA, PTEN, RAD21, RB1, SETD2, TP53, ZNF217.
Best drug option: ?",WYE-125132
ACH-000867,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 2: The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
Drug 3: The drug is IMATINIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5. Drug target is ABL, KIT, PDGFR. Drug target pathway is Other, kinases.
The mutations of the cell line are ARID1A, BRIP1, CIC, CTNNA1, GATA4, GATA6, GNAS, IGF1R, JUN, MLL, MAF, MSH6, MYB, NTRK3, PDGFRB, PRKCI, RAF1, RB1, SPEN, STK11, TP53, TSC2.
Best drug option: ?",KIN001-135
ACH-000869,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is PF-4708671. The drug SMILES structure is CCC1=CN=CN=C1N2CCN(CC2)CC3=NC4=C(N3)C=C(C=C4)C(F)(F)F. Drug target is S6K1. Drug target pathway is PI3K/MTOR signaling.
Drug 2: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 3: The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ATM, EMSY, CEBPA, CSF1R, DNMT3A, EGFR, EPHB1, EPHB4, ERBB4, ETV5, FLT3, IRS2, KDM5A, MLL2, MTOR, NFE2L2, NOTCH3, PDGFRA, POLE, PTPRO, RAD21, RICTOR, SMARCA4, TP53, WHSC1L1.
Best drug option: ?",KIN001-135
ACH-000871,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is ARA-G. The drug SMILES structure is C1=NC2=C(N1[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)N=C(NC2=O)N. Drug target is Anti-metabolite. Drug target pathway is Other.
Drug 2: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 3: The drug is PAZOPANIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC2=NC=CC(=N2)N(C)C3=CC4=NN(C(=C4C=C3)C)C)S(=O)(=O)N. Drug target is CSF1R, KIT,  PDGFRA, PDGFRB. Drug target pathway is RTK signaling.
The mutations of the cell line are FAM123B, APC, BARD1, BCORL1, DOT1L, ERBB4, FGF12, GNA13, INPP4B, MLL2, LTK, MLH1, MPL, MSH6, NF1, NKX2-1, PDK1, QKI, RB1, RNF43, SDHA, SMAD4, SOX9, TNFAIP3, TP53, XPO1.
Best drug option: ?",KIN001-135
ACH-000874,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is CAY10566. The drug SMILES structure is CC1=NN=C(O1)C2=NN=C(C=C2)N3CCC(CC3)OC4=C(C=CC(=C4)F)Cl. Drug target is Stearoyl-CoA desaturase. Drug target pathway is Other.
Drug 2: The drug is IMATINIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5. Drug target is ABL, KIT, PDGFR. Drug target pathway is Other, kinases.
Drug 3: The drug is EX-527. The drug SMILES structure is C1CC(C2=C(C1)C3=C(N2)C=CC(=C3)Cl)C(=O)N. Drug target is SIRT1. Drug target pathway is Chromatin histone acetylation.
The mutations of the cell line are FAM123B, ARID1A, BCL2L1, CDK12, CIC, CRKL, GSK3B, HGF, MLL, MED12, NOTCH3, NTRK2, PBRM1, PMS2, PTCH1, RAD54L, SMARCA4, WHSC1, XPO1.
Best drug option: ?",IMATINIB
ACH-000875,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 2: The drug is FORETINIB. The drug SMILES structure is COC1=CC2=C(C=CN=C2C=C1OCCCN3CCOCC3)OC4=C(C=C(C=C4)NC(=O)C5(CC5)C(=O)NC6=CC=C(C=C6)F)F. Drug target is MET, KDR, TIE2, VEGFR3/FLT4, RON, PDGFR, FGFR1, EGFR. Drug target pathway is RTK signaling.
Drug 3: The drug is GSK2606414. The drug SMILES structure is CN1C=C(C2=C(N=CN=C21)N)C3=CC4=C(C=C3)N(CC4)C(=O)CC5=CC(=CC=C5)C(F)(F)F. Drug target is PERK. Drug target pathway is Metabolism.
The mutations of the cell line are ATRX, BCORL1, BRCA1, CARD11, CDK8, CXCR4, EP300, EWSR1, FGFR4, FLT1, KDR, KLHL6, KRAS, NBN, NF1, NOTCH3, NRAS, RBM10, RET, TP53, TSC1.
Best drug option: ?",KIN001-135
ACH-000878,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
Drug 2: The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
Drug 3: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are APC, EMSY, CTNNB1, EP300, ERBB4, FGF14, FGF23, GATA4, KEAP1, MLL2, MET, NOTCH1, NRAS, RB1, SMARCA4, SNCAIP, TBX3, TP53.
Best drug option: ?",KIN001-135
ACH-000879,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is IMATINIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5. Drug target is ABL, KIT, PDGFR. Drug target pathway is Other, kinases.
Drug 2: The drug is LENALIDOMIDE. The drug SMILES structure is C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N. Drug target is CRBN. Drug target pathway is Protein stability and degradation.
Drug 3: The drug is GSK2606414. The drug SMILES structure is CN1C=C(C2=C(N=CN=C21)N)C3=CC4=C(C=C3)N(CC4)C(=O)CC5=CC(=CC=C5)C(F)(F)F. Drug target is PERK. Drug target pathway is Metabolism.
The mutations of the cell line are ALOX12B, FAM123B, APC, ARID1A, BCORL1, BRCA2, CHEK2, CIC, CTCF, CTNNA1, EP300, ERBB3, FGF19, FGFR2, GABRA6, IGF1R, JAK1, KDM6A, MLL2, MAP3K1, MDM2, MSH6, MTOR, NTRK1, PARP3, PDCD1, PIK3CA, PRDM1, PTEN, PTPN11, REL, RNF43, SRC, TP53.
Best drug option: ?",LENALIDOMIDE
ACH-000880,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is JNJ-38877605. The drug SMILES structure is CN1C=C(C=N1)C2=NN3C(=NN=C3C(C4=CC5=C(C=C4)N=CC=C5)(F)F)C=C2. Drug target is Unknown. Drug target pathway is Unknown.
Drug 2: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 3: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are AR, ATRX, CASP8, CD22, CDH1, CEBPA, CIC, CTNNB1, EP300, FGFR4, GNAS, KRAS, MDM2, MSH3, MUTYH, NF1, PIK3CA, RBM10, TET2, U2AF1, WT1, ZNF217.
Best drug option: ?",JNJ-38877605
ACH-000881,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is CAY10566. The drug SMILES structure is CC1=NN=C(O1)C2=NN=C(C=C2)N3CCC(CC3)OC4=C(C=CC(=C4)F)Cl. Drug target is Stearoyl-CoA desaturase. Drug target pathway is Other.
Drug 2: The drug is SNX-2112. The drug SMILES structure is CC1(CC2=C(C(=O)C1)C(=NN2C3=CC(=C(C=C3)C(=O)N)NC4CCC(CC4)O)C(F)(F)F)C. Drug target is HSP90. Drug target pathway is Protein stability and degradation.
Drug 3: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are APC, BARD1, BRCA2, BRD4, BTK, CREBBP, CSF3R, DDR1, HRAS, MLL2, MERTK, MLH1, MYB, MYCN, NF1, NRAS, NTRK1, PARK2, PDGFRA, PDGFRB, PTPRO, RARA, RBM10, RET, RNF43, SNCAIP, TET2.
Best drug option: ?",WYE-125132
ACH-000882,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 2: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
Drug 3: The drug is JNJ-38877605. The drug SMILES structure is CN1C=C(C=N1)C2=NN3C(=NN=C3C(C4=CC5=C(C=C4)N=CC=C5)(F)F)C=C2. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ARID1A, BRAF, ERBB4, EZH2, FANCA, FLT3, GNAS, KEL, MAP2K2, MAP2K4, MLH1, MST1R, NFE2L2, NTRK1, PIK3C2G, RAC1, ROS1.
Best drug option: ?",WYE-125132
ACH-000883,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is PANOBINOSTAT. The drug SMILES structure is CC1=C(C2=CC=CC=C2N1)CCNCC3=CC=C(C=C3)C=CC(=O)NO. Drug target is HDAC. Drug target pathway is Chromatin histone acetylation.
Drug 2: The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
Drug 3: The drug is CAY10566. The drug SMILES structure is CC1=NN=C(O1)C2=NN=C(C=C2)N3CCC(CC3)OC4=C(C=CC(=C4)F)Cl. Drug target is Stearoyl-CoA desaturase. Drug target pathway is Other.
The mutations of the cell line are CIC, DDR1, DDR2, GNAS, GRM3, HNF1A, KLHL6, MLL2, MCL1, MITF, MSH2, NF1, NTRK3, PPARG, PTEN, RB1, TP53.
Best drug option: ?",YM-201636
ACH-000885,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 2: The drug is GSK2606414. The drug SMILES structure is CN1C=C(C2=C(N=CN=C21)N)C3=CC4=C(C=C3)N(CC4)C(=O)CC5=CC(=CC=C5)C(F)(F)F. Drug target is PERK. Drug target pathway is Metabolism.
Drug 3: The drug is T-0901317. The drug SMILES structure is C1=CC=C(C=C1)S(=O)(=O)N(CC(F)(F)F)C2=CC=C(C=C2)C(C(F)(F)F)(C(F)(F)F)O. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ALOX12B, ARID1A, AXIN1, BCOR, CCND1, CD274, CD79A, CTNNB1, ERBB3, FANCC, FGFR3, GATA6, IRF4, IRS2, JAK1, KDM5A, MLL2, KRAS, MEN1, NBN, NF1, NOTCH1, PDGFRB, PIK3CA, PIK3CB, PRKCI, PTCH1, PTEN, RNF43, SLC34A2, SMO, SNCAIP, SOCS1, STK11, TNFAIP3, TYRO3, ZNF217.
Best drug option: ?",KIN001-135
ACH-000886,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
Drug 2: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 3: The drug is AGI-5198. The drug SMILES structure is CC1=CC=CC=C1C(C(=O)NC2CCCCC2)N(C3=CC(=CC=C3)F)C(=O)CN4C=CN=C4C. Drug target is IDH1 (R132H). Drug target pathway is Metabolism.
The mutations of the cell line are CREBBP, FANCL, FGFR2, FGFR3, GABRA6, MLL2, KRAS, NOTCH2, NTRK2, PIK3C2B, RAD21, RAD51D, SOX9, TBX3, TP53, XPO1.
Best drug option: ?",AGI-5198
ACH-000888,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is AZD8931. The drug SMILES structure is CNC(=O)CN1CCC(CC1)OC2=C(C=C3C(=C2)C(=NC=N3)NC4=C(C(=CC=C4)Cl)F)OC. Drug target is EGFR, ERBB2, ERBB3. Drug target pathway is RTK signaling.
Drug 2: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 3: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ALK, APC, ARID1A, BTG1, CD79A, CDK8, CUL3, DIS3, DNMT3A, EGFR, EPHB1, ERBB2, ERBB4, GATA4, GRM3, JAK1, MAP3K13, NBN, NOTCH2, NOTCH3, NTRK2, NTRK3, NUTM1, PBRM1, PDGFRA, PDGFRB, RICTOR, SMARCA4, TP53, TSC1.
Best drug option: ?",KIN001-135
ACH-000890,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 2: The drug is CAY10566. The drug SMILES structure is CC1=NN=C(O1)C2=NN=C(C=C2)N3CCC(CC3)OC4=C(C=CC(=C4)F)Cl. Drug target is Stearoyl-CoA desaturase. Drug target pathway is Other.
Drug 3: The drug is LESTAURTINIB. The drug SMILES structure is C[C@@]12[C@](C[C@@H](O1)N3C4=CC=CC=C4C5=C6C(=C7C8=CC=CC=C8N2C7=C53)CNC6=O)(CO)O. Drug target is FLT3, JAK2, NTRK1, NTRK2, NTRK3. Drug target pathway is Other, kinases.
The mutations of the cell line are ATRX, BCORL1, BRAF, BRCA1, BRIP1, CARD11, ERBB2, ESR1, FLT1, GNAS, JAK3, KLHL6, MED12, MRE11A, MYC, NBN, NRAS, PMS2, PRKCI, RAD51B, ROS1, SMARCA4, SOX2, STAG2, TP53.
Best drug option: ?",KIN001-135
ACH-000892,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 2: The drug is LY2109761. The drug SMILES structure is C1CC2=C(C(=NN2C1)C3=CC=CC=N3)C4=C5C=CC(=CC5=NC=C4)OCCN6CCOCC6. Drug target is TGFB1. Drug target pathway is Other.
Drug 3: The drug is LENALIDOMIDE. The drug SMILES structure is C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N. Drug target is CRBN. Drug target pathway is Protein stability and degradation.
The mutations of the cell line are ARID1A, BCOR, BRCA1, CBL, ERBB2, ERRFI1, ETV5, JAK1, MLL2, MAP2K4, NTRK3, PBRM1, PIK3CA, RAD54L, RET, STK11.
Best drug option: ?",KIN001-135
ACH-000893,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
Drug 2: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 3: The drug is AVAGACESTAT. The drug SMILES structure is C1=CC(=CC=C1S(=O)(=O)N(CC2=C(C=C(C=C2)C3=NOC=N3)F)[C@H](CCC(F)(F)F)C(=O)N)Cl. Drug target is Amyloid beta20, Amyloid beta40. Drug target pathway is Other.
The mutations of the cell line are ALK, BCORL1, BRAF, CREBBP, DAXX, EPHB1, KDM6A, KEL, LTK, MEF2B, NF1, NOTCH1, PRKAR1A, TIPARP, TP53, TSC2, ZNF217.
Best drug option: ?",KIN001-135
ACH-000894,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
Drug 2: The drug is JW-7-24-1. The drug SMILES structure is COC1=CC(=CC(=C1)C2=CC3=C4C(=CN=C3C=C2)C=CC(=O)N4C5=CC(=C(C=C5)N6CCNCC6)C(F)(F)F)OC. Drug target is LCK. Drug target pathway is Other, kinases.
Drug 3: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are ARID1A, BRCA2, ERBB4, FGFR1, GATA4, MET, NKX2-1, NTRK3, POLE, TP53.
Best drug option: ?",KIN001-135
ACH-000895,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is BX-795. The drug SMILES structure is C1CCN(C1)C(=O)NC2=CC=CC(=C2)NC3=NC=C(C(=N3)NCCCNC(=O)C4=CC=CS4)I. Drug target is TBK1, PDK1 (PDPK1), IKK, AURKB, AURKC. Drug target pathway is Other, kinases.
Drug 2: The drug is BORTEZOMIB. The drug SMILES structure is B([C@H](CC(C)C)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O. Drug target is Proteasome. Drug target pathway is Protein stability and degradation.
Drug 3: The drug is METHOTREXATE. The drug SMILES structure is CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O. Drug target is Antimetabolite. Drug target pathway is DNA replication.
The mutations of the cell line are FAM123B, APC, ARAF, ATM, ATRX, BRAF, BRCA2, CARD11, CDKN2B, CREBBP, CTCF, DDR1, DIS3, ETV5, ETV6, EWSR1, FGFR3, GNA13, HDAC1, HNF1A, MLL2, MAF, MAP2K4, MLH1, MSH3, NOTCH3, NUTM1, P2RY8, PARP1, PDCD1, PIK3C2B, PIK3R1, POLD1, PPP2R1A, RET, RICTOR, SETD2, SMAD2, SOX9, TGFBR2, TP53, TSC1, TYRO3, VEGFA.
Best drug option: ?",BORTEZOMIB
ACH-000896,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
Drug 2: The drug is PF-4708671. The drug SMILES structure is CCC1=CN=CN=C1N2CCN(CC2)CC3=NC4=C(N3)C=C(C=C4)C(F)(F)F. Drug target is S6K1. Drug target pathway is PI3K/MTOR signaling.
Drug 3: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are AR, ATM, BRD4, CDKN1A, EP300, FLT1, KDM6A, MDM4, MST1R, NF2, PBRM1, PIK3C2G, RB1, TP53.
Best drug option: ?",KIN001-135
ACH-000900,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 2: The drug is YK-4-279. The drug SMILES structure is COC1=CC=C(C=C1)C(=O)CC2(C3=C(C=CC(=C3NC2=O)Cl)Cl)O. Drug target is RNA helicase A. Drug target pathway is Other.
Drug 3: The drug is IMATINIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5. Drug target is ABL, KIT, PDGFR. Drug target pathway is Other, kinases.
The mutations of the cell line are ALK, ASXL1, ATM, BARD1, BCR, BRIP1, CCNE1, CRKL, CSF1R, DDR2, DNMT3A, DOT1L, FGFR2, FLT3, INPP4B, IRF2, KDM5A, KEAP1, MLL2, KRAS, MSH3, NBN, NOTCH1, PDCD1, PDGFRA, PDK1, PMS2, RET, SDHA, SMARCA4, STK11, TP53, ZNF703.
Best drug option: ?",KIN001-135
ACH-000902,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 2: The drug is FORETINIB. The drug SMILES structure is COC1=CC2=C(C=CN=C2C=C1OCCCN3CCOCC3)OC4=C(C=C(C=C4)NC(=O)C5(CC5)C(=O)NC6=CC=C(C=C6)F)F. Drug target is MET, KDR, TIE2, VEGFR3/FLT4, RON, PDGFR, FGFR1, EGFR. Drug target pathway is RTK signaling.
Drug 3: The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ALOX12B, FAM123B, BCORL1, BRD4, BTK, CDH1, CDKN2A, ERBB4, GRM3, MAP2K1, MEF2B, PIK3CA, PTEN, RAF1, SMARCA4, TBX3, TIPARP, TP53, ZNF217.
Best drug option: ?",FORETINIB
ACH-000903,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 2: The drug is AZ960. The drug SMILES structure is CC1=CC(=NN1)NC2=C(C=C(C(=N2)N[C@@H](C)C3=CC=C(C=C3)F)C#N)F. Drug target is JAK2, JAK3. Drug target pathway is Other, kinases.
Drug 3: The drug is SB-505124. The drug SMILES structure is CC1=NC(=CC=C1)C2=C(N=C(N2)C(C)(C)C)C3=CC4=C(C=C3)OCO4. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ALK, AR, CCNE1, CDK6, CTNNA1, CXCR4, EGFR, EPHB4, ERBB2, ERBB4, ERCC4, FAM46C, FANCA, GNAS, KDR, MSH6, MST1R, NF1, NOTCH3, NTRK1, NTRK2, PIK3C2B, PTEN, RB1, SMAD2, STAG2, TEK, TP53.
Best drug option: ?",KIN001-135
ACH-000905,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
Drug 2: The drug is CAY10566. The drug SMILES structure is CC1=NN=C(O1)C2=NN=C(C=C2)N3CCC(CC3)OC4=C(C=CC(=C4)F)Cl. Drug target is Stearoyl-CoA desaturase. Drug target pathway is Other.
Drug 3: The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ATM, BRD4, CDKN2C, ERBB2, FANCA, HGF, KDM5A, MLL2, MAPK1, MITF, NF2, RB1, SDHC, TET2, TNFAIP3, TP53.
Best drug option: ?",CAY10566
ACH-000906,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is EPZ004777. The drug SMILES structure is CC(C)N(CCCNC(=O)NC1=CC=C(C=C1)C(C)(C)C)C[C@@H]2[C@H]([C@H]([C@@H](O2)N3C=CC4=C(N=CN=C43)N)O)O. Drug target is DOT1L. Drug target pathway is Chromatin histone methylation.
Drug 2: The drug is PAZOPANIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC2=NC=CC(=N2)N(C)C3=CC4=NN(C(=C4C=C3)C)C)S(=O)(=O)N. Drug target is CSF1R, KIT,  PDGFRA, PDGFRB. Drug target pathway is RTK signaling.
Drug 3: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are FAM123B, AR, ASXL1, ATRX, BRAF, CARD11, CD22, CDK4, FGFR4, JAK1, MLL2, MAP2K1, NOTCH3, PIK3C2G, SPEN, TEK, TP53, VEGFA.
Best drug option: ?",PAZOPANIB
ACH-000910,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is FORETINIB. The drug SMILES structure is COC1=CC2=C(C=CN=C2C=C1OCCCN3CCOCC3)OC4=C(C=C(C=C4)NC(=O)C5(CC5)C(=O)NC6=CC=C(C=C6)F)F. Drug target is MET, KDR, TIE2, VEGFR3/FLT4, RON, PDGFR, FGFR1, EGFR. Drug target pathway is RTK signaling.
Drug 2: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
Drug 3: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are AR, ATM, BRD4, CDH1, CIC, EPHB1, FGFR4, FLT1, LTK, MKNK1, NKX2-1, PAX5, PIK3C2G, PIK3CA, PMS2, PTEN, SLC34A2, TET2, WHSC1L1.
Best drug option: ?",WYE-125132
ACH-000911,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 2: The drug is AVAGACESTAT. The drug SMILES structure is C1=CC(=CC=C1S(=O)(=O)N(CC2=C(C=C(C=C2)C3=NOC=N3)F)[C@H](CCC(F)(F)F)C(=O)N)Cl. Drug target is Amyloid beta20, Amyloid beta40. Drug target pathway is Other.
Drug 3: The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ARAF, ARID1A, ASXL1, CDK4, CDKN2C, DAXX, DDR1, EP300, EPHA3, ERBB3, ERRFI1, EZH2, GRM3, HGF, HSD3B1, IRS2, MLL2, LTK, MAP3K1, NF2, NKX2-1, NOTCH1, NTRK2, PBRM1, POLE, QKI, RPTOR, SMAD2, SPEN, TET2, TP53, TSC2, WHSC1L1.
Best drug option: ?",YM-201636
ACH-000913,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is PF-4708671. The drug SMILES structure is CCC1=CN=CN=C1N2CCN(CC2)CC3=NC4=C(N3)C=C(C=C4)C(F)(F)F. Drug target is S6K1. Drug target pathway is PI3K/MTOR signaling.
Drug 2: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 3: The drug is CAY10566. The drug SMILES structure is CC1=NN=C(O1)C2=NN=C(C=C2)N3CCC(CC3)OC4=C(C=CC(=C4)F)Cl. Drug target is Stearoyl-CoA desaturase. Drug target pathway is Other.
The mutations of the cell line are FAM123B, ATM, CREBBP, DAXX, EP300, EPHA3, EZH2, FANCC, FBXW7, FGF3, FGFR2, GABRA6, KDM6A, MLL2, MAP3K1, NF1, NUTM1, PBRM1, PDGFRB, PIK3C2G, PIK3CA, POLE, PRKCI, PTEN, RARA, RB1, RBM10, RPTOR, SDHA, SF3B1, TP53, WHSC1, XPO1.
Best drug option: ?",KIN001-135
ACH-000914,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 2: The drug is IMATINIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5. Drug target is ABL, KIT, PDGFR. Drug target pathway is Other, kinases.
Drug 3: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ABL1, APC, ASXL1, ATRX, BCOR, BCORL1, BRCA1, BRCA2, CIC, DDR2, EED, EP300, ERBB4, ERRFI1, ETV6, FANCA, GNAS, HDAC1, HNF1A, KDM5A, KDM6A, MLL2, MAF, MAP3K1, MCL1, MSH2, MSH6, MTOR, MYCN, NFE2L2, NFKBIA, NOTCH1, NOTCH3, NT5C2, NTRK2, PALB2, PARK2, PARP2, PDCD1, PDGFRA, RAD51, RAD51C, RB1, SLC34A2, SMARCA4, SPEN, STAT3, TET2, TP53.
Best drug option: ?",KIN001-135
ACH-000915,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
Drug 2: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 3: The drug is BORTEZOMIB. The drug SMILES structure is B([C@H](CC(C)C)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O. Drug target is Proteasome. Drug target pathway is Protein stability and degradation.
The mutations of the cell line are ATM, CARD11, CDK8, CDKN2A, DAXX, FLT3, FOXL2, GATA3, GNA11, IRF4, KEL, MLL2, NOTCH3, NRAS, PTPRO, SLC34A2, SMARCB1, SPEN, TP53, WHSC1L1.
Best drug option: ?",KIN001-135
ACH-000916,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is AZD8931. The drug SMILES structure is CNC(=O)CN1CCC(CC1)OC2=C(C=C3C(=C2)C(=NC=N3)NC4=C(C(=CC=C4)Cl)F)OC. Drug target is EGFR, ERBB2, ERBB3. Drug target pathway is RTK signaling.
Drug 2: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 3: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ASXL1, BCR, BRIP1, CIC, DIS3, ERBB3, EZH2, FBXW7, GABRA6, GNAS, JAK2, JAK3, KDR, KEAP1, KIT, KLHL6, MLL2, KRAS, LTK, MCL1, MKNK1, MLH1, MRE11A, MUTYH, NRAS, PIK3R1, PRKCI, PTPN11, RNF43, SMARCA4, STK11, TET2, TP53.
Best drug option: ?",WYE-125132
ACH-000917,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is AVAGACESTAT. The drug SMILES structure is C1=CC(=CC=C1S(=O)(=O)N(CC2=C(C=C(C=C2)C3=NOC=N3)F)[C@H](CCC(F)(F)F)C(=O)N)Cl. Drug target is Amyloid beta20, Amyloid beta40. Drug target pathway is Other.
Drug 2: The drug is LIMK1 INHIBITOR BMS4. The drug SMILES structure is CCNC(=O)NC1=NC=C(S1)C2=CC(=NC(=N2)C3=NC=CN=C3)C4=C(C=C(C=C4C)OC)C. Drug target is LIMK1. Drug target pathway is Cytoskeleton.
Drug 3: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are BRCA2, CHEK1, CSF1R, CUL4A, DDR1, DDR2, DOT1L, ERCC4, FGF12, IKBKE, MERTK, NTRK3, PDGFRA, POLE, PTCH1, PTEN, SF3B1, STK11, TGFBR2, TP53, TSC2.
Best drug option: ?",AVAGACESTAT
ACH-000918,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is YK-4-279. The drug SMILES structure is COC1=CC=C(C=C1)C(=O)CC2(C3=C(C=CC(=C3NC2=O)Cl)Cl)O. Drug target is RNA helicase A. Drug target pathway is Other.
Drug 2: The drug is IMATINIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5. Drug target is ABL, KIT, PDGFR. Drug target pathway is Other, kinases.
Drug 3: The drug is AVAGACESTAT. The drug SMILES structure is C1=CC(=CC=C1S(=O)(=O)N(CC2=C(C=C(C=C2)C3=NOC=N3)F)[C@H](CCC(F)(F)F)C(=O)N)Cl. Drug target is Amyloid beta20, Amyloid beta40. Drug target pathway is Other.
The mutations of the cell line are ALK, APC, BCL6, BCORL1, BRIP1, CARD11, CCND1, CDK8, CIC, CREBBP, EPHB1, ERBB2, EZR, GNAS, H3F3A, HDAC1, IGF1R, IRS2, KDR, MLL, MAP2K1, MSH2, MTOR, NOTCH2, PAX5, PIK3CA, PMS2, PRKAR1A, PTEN, RAD54L, RBM10, SMAD4, SOX9, SPEN, SRC, TP53, WHSC1L1, WT1.
Best drug option: ?",YK-4-279
ACH-000919,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
Drug 2: The drug is JNJ-38877605. The drug SMILES structure is CN1C=C(C=N1)C2=NN3C(=NN=C3C(C4=CC5=C(C=C4)N=CC=C5)(F)F)C=C2. Drug target is Unknown. Drug target pathway is Unknown.
Drug 3: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ABL1, AKT3, ARID1A, AXIN1, BARD1, BCOR, CARD11, CDH1, CEBPA, EP300, FBXW7, FGFR1, FUBP1, GATA6, GNAS, IDH2, KDM5C, MLL2, MAP3K13, MSH3, NBN, NUTM1, PARP2, PDCD1, PIK3C2B, PIK3CA, POLD1, QKI, RAD21, RAF1, ROS1, SETD2, SLC34A2, SMAD4, SOX2, SPEN, TERT, TNFAIP3, TSC1.
Best drug option: ?",JNJ-38877605
ACH-000920,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is YK-4-279. The drug SMILES structure is COC1=CC=C(C=C1)C(=O)CC2(C3=C(C=CC(=C3NC2=O)Cl)Cl)O. Drug target is RNA helicase A. Drug target pathway is Other.
Drug 2: The drug is ARA-G. The drug SMILES structure is C1=NC2=C(N1[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)N=C(NC2=O)N. Drug target is Anti-metabolite. Drug target pathway is Other.
Drug 3: The drug is REFAMETINIB. The drug SMILES structure is COC1=CC(=C(C(=C1NS(=O)(=O)C2(CC2)C[C@@H](CO)O)NC3=C(C=C(C=C3)I)F)F)F. Drug target is MEK1, MEK2. Drug target pathway is ERK MAPK signaling.
The mutations of the cell line are ALK, FAM123B, ARID1A, ATR, BARD1, BRIP1, EMSY, CBFB, CD22, CREBBP, CTCF, CTNNB1, DNMT3A, EP300, EPHA3, ERBB4, ESR1, ETV4, EWSR1, FANCA, FBXW7, FGF12, FGF14, FGFR3, FLT1, GATA3, GNA11, H3F3A, HDAC1, HNF1A, IKBKE, KDM5A, KEAP1, KEL, MLL, MLL2, MAP2K2, MPL, MST1R, MTOR, MYB, NBN, NOTCH3, NTRK1, PALB2, PDK1, PMS2, POLD1, PTEN, RBM10, RNF43, RPTOR, SDHA, SLC34A2, SMARCA4, SPEN, STAG2, TP53, WHSC1, ZNF703.
Best drug option: ?",REFAMETINIB
ACH-000922,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is ARA-G. The drug SMILES structure is C1=NC2=C(N1[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)N=C(NC2=O)N. Drug target is Anti-metabolite. Drug target pathway is Other.
Drug 2: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
Drug 3: The drug is IMATINIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5. Drug target is ABL, KIT, PDGFR. Drug target pathway is Other, kinases.
The mutations of the cell line are ACVR1B, BARD1, CALR, CSF1R, DOT1L, EGFR, ERBB3, EZH2, FGFR2, FGFR4, FLT1, GNAS, HRAS, IGF1R, INPP4B, KDM5C, KEL, KRAS, MSH6, NOTCH1, PAX5, PRDM1, ROS1, SETD2, SOX9, SRC, STAT3, TGFBR2, TMPRSS2, VEGFA, WHSC1.
Best drug option: ?",IMATINIB
ACH-000924,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is LESTAURTINIB. The drug SMILES structure is C[C@@]12[C@](C[C@@H](O1)N3C4=CC=CC=C4C5=C6C(=C7C8=CC=CC=C8N2C7=C53)CNC6=O)(CO)O. Drug target is FLT3, JAK2, NTRK1, NTRK2, NTRK3. Drug target pathway is Other, kinases.
Drug 2: The drug is AZD5363. The drug SMILES structure is O=C(C1(N)CCN(C2=C3C(NC=C3)=NC=N2)CC1)N[C@H](C4=CC=C(Cl)C=C4)CCO. Drug target is AKT1, AKT2, AKT3, ROCK2. Drug target pathway is Other, kinases.
Drug 3: The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ARID1A, ATM, BRCA1, EMSY, CD22, CD70, CYP17A1, EGFR, EPHA3, ERBB4, ESR1, EZH2, FBXW7, FGFR3, FLT3, GNA13, GRM3, HGF, KDR, KEAP1, KEL, MAP3K13, NT5C2, NTRK3, NUTM1, PDGFRA, PIK3C2G, POLE, RB1, RNF43, TEK, TET2, TP53.
Best drug option: ?",YM-201636
ACH-000926,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is LINIFANIB. The drug SMILES structure is CC1=CC(=C(C=C1)F)NC(=O)NC2=CC=C(C=C2)C3=C4C(=CC=C3)NN=C4N. Drug target is VEGFR1, VEGFR2, VEGFR3, CSF1R, FLT3, KIT. Drug target pathway is RTK signaling.
Drug 2: The drug is AVAGACESTAT. The drug SMILES structure is C1=CC(=CC=C1S(=O)(=O)N(CC2=C(C=C(C=C2)C3=NOC=N3)F)[C@H](CCC(F)(F)F)C(=O)N)Cl. Drug target is Amyloid beta20, Amyloid beta40. Drug target pathway is Other.
Drug 3: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are APC, ASXL1, ATRX, AURKA, BCL6, BCOR, BRAF, CARD11, CASP8, CTNNB1, DNMT3A, EPHA3, FANCG, FGF4, IRS2, JAK1, KLHL6, MAP3K1, MAP3K13, MKNK1, NF1, NTRK3, PARK2, ROS1, SLC34A2, TP53.
Best drug option: ?",LINIFANIB
ACH-000927,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is GDC-0068. The drug SMILES structure is CC1CC(C2=C1C(=NC=N2)N3CCN(CC3)C(=O)C(CNC(C)C)C4=CC=C(C=C4)Cl)O. Drug target is AKT1, AKT, AKT3. Drug target pathway is PI3K/MTOR signaling.
Drug 2: The drug is LIMK1 INHIBITOR BMS4. The drug SMILES structure is CCNC(=O)NC1=NC=C(S1)C2=CC(=NC(=N2)C3=NC=CN=C3)C4=C(C=C(C=C4C)OC)C. Drug target is LIMK1. Drug target pathway is Cytoskeleton.
Drug 3: The drug is TIVOZANIB. The drug SMILES structure is CC1=CC(=NO1)NC(=O)NC2=C(C=C(C=C2)OC3=C4C=C(C(=CC4=NC=C3)OC)OC)Cl. Drug target is VEGFR1, VEGFR2, VEGFR3, PDGFR, KIT. Drug target pathway is RTK signaling.
The mutations of the cell line are ATM, BCOR, BRCA2, BRD4, EMSY, CEBPA, CIC, FANCA, GABRA6, HNF1A, MLL, MLL2, MAPK1, PARP1, PIK3CA, PPP2R1A, RAD21, ROS1, STAT3, TERT, TGFBR2, TP53, ZNF703.
Best drug option: ?",LIMK1 INHIBITOR BMS4
ACH-000929,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KOBE2602. The drug SMILES structure is C1=CC(=CC=C1NC(=S)NNC2=C(C=C(C=C2[N+](=O)[O-])C(F)(F)F)[N+](=O)[O-])F. Drug target is RAS effector. Drug target pathway is RTK signaling.
Drug 2: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 3: The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ABL1, ARID1A, ASXL1, ATM, AXIN1, CARD11, DAXX, DNMT3A, EPHA3, ERBB2, ERBB3, FANCC, FBXW7, FGF12, FGFR4, FOXL2, GABRA6, GRM3, KEAP1, MERTK, MRE11A, MTOR, MUTYH, MYCL1, NOTCH1, NTRK3, PAX5, PDGFRA, POLD1, RB1, SDHC, SETD2, TEK, TNFAIP3, TP53.
Best drug option: ?",KIN001-135
ACH-000930,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
Drug 2: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 3: The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ALOX12B, ARFRP1, ARID1A, ATM, BARD1, BRCA2, CARD11, CD274, CDC73, DIS3, EPHB1, EZH2, FANCA, FGF10, FH, FLCN, GABRA6, HGF, HNF1A, IKBKE, JAK3, MLL2, MAF, MAP2K4, MDM2, MDM4, MST1R, MTOR, NF1, PIK3C2B, PTCH1, PTEN, PTPRO, RAD52, ROS1, SMARCA4, SNCAIP, SPEN, STAG2, TBX3, TIPARP, TP53, WHSC1L1.
Best drug option: ?",WYE-125132
ACH-000932,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is JNJ-38877605. The drug SMILES structure is CN1C=C(C=N1)C2=NN3C(=NN=C3C(C4=CC5=C(C=C4)N=CC=C5)(F)F)C=C2. Drug target is Unknown. Drug target pathway is Unknown.
Drug 2: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
Drug 3: The drug is IMATINIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5. Drug target is ABL, KIT, PDGFR. Drug target pathway is Other, kinases.
The mutations of the cell line are AKT2, FAM123B, ARID1A, ATM, AXL, BCOR, BRAF, BRCA2, BTG2, CIC, CSF3R, EPHB1, ERBB4, ESR1, FANCL, FGF10, FUBP1, GNAS, GRM3, GSK3B, IDH2, JAK1, KIT, MLL, MLL2, KRAS, MED12, MEF2B, MLH1, MSH3, MTOR, MYB, NFE2L2, NUTM1, PARP1, PBRM1, PIK3CB, POLD1, PRKCI, RAD51C, RAD52, RICTOR, RPTOR, SMAD4, SMO, STAT3, TBX3, TGFBR2.
Best drug option: ?",WYE-125132
ACH-000934,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
Drug 2: The drug is CAY10566. The drug SMILES structure is CC1=NN=C(O1)C2=NN=C(C=C2)N3CCC(CC3)OC4=C(C=CC(=C4)F)Cl. Drug target is Stearoyl-CoA desaturase. Drug target pathway is Other.
Drug 3: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are AKT1, ARID1A, ATRX, BAP1, BRAF, BRCA2, BRIP1, CDKN1B, CDKN2A, CYP17A1, DOT1L, EGFR, ETV5, ETV6, FGF10, FGF19, GABRA6, GNA13, KDM5C, MAP2K2, MAP3K13, MTOR, NF1, NOTCH1, NUTM1, PIK3C2G, PIK3CA, PPARG, PTCH1, RAD21, SDHA, SF3B1, SGK1, SMAD2, SPEN, SUFU, TP53.
Best drug option: ?",WYE-125132
ACH-000935,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is GSK2606414. The drug SMILES structure is CN1C=C(C2=C(N=CN=C21)N)C3=CC4=C(C=C3)N(CC4)C(=O)CC5=CC(=CC=C5)C(F)(F)F. Drug target is PERK. Drug target pathway is Metabolism.
Drug 2: The drug is YK-4-279. The drug SMILES structure is COC1=CC=C(C=C1)C(=O)CC2(C3=C(C=CC(=C3NC2=O)Cl)Cl)O. Drug target is RNA helicase A. Drug target pathway is Other.
Drug 3: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are ALK, APC, BRAF, CDK6, CDKN2A, CSF3R, DIS3, GSK3B, IKZF1, KDR, NOTCH3, PTEN.
Best drug option: ?",KIN001-135
ACH-000937,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is FORETINIB. The drug SMILES structure is COC1=CC2=C(C=CN=C2C=C1OCCCN3CCOCC3)OC4=C(C=C(C=C4)NC(=O)C5(CC5)C(=O)NC6=CC=C(C=C6)F)F. Drug target is MET, KDR, TIE2, VEGFR3/FLT4, RON, PDGFR, FGFR1, EGFR. Drug target pathway is RTK signaling.
Drug 2: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
Drug 3: The drug is IMATINIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5. Drug target is ABL, KIT, PDGFR. Drug target pathway is Other, kinases.
The mutations of the cell line are AKT2, ALK, APC, ARID1A, ATM, ATRX, AXIN1, BCORL1, BCR, BRD4, CARD11, CCND3, CD79B, CDH1, CDK8, CREBBP, CSF1R, CSF3R, CTCF, CTNNA1, CTNNB1, CUL3, CUL4A, DAXX, DIS3, DNMT3A, DOT1L, EP300, EPHB1, ERBB3, ERG, ETV6, FANCA, FGFR4, FUBP1, GATA4, GNAQ, GNAS, HNF1A, IDH2, JAK1, JAK2, KDM5A, KDM5C, KDM6A, KDR, KLHL6, MLL, MLL2, MAP2K1, MAP3K1, MAP3K13, MED12, MRE11A, MSH6, MYC, NF1, NOTCH1, NOTCH3, NRAS, NTRK2, NTRK3, P2RY8, PARK2, PIK3R1, POLD1, PPP2R1A, PRKAR1A, PRKCI, PTCH1, PTEN, PTPRO, RAD54L, RPTOR, SDHA, SETD2, SMARCA4, SOX9, SPEN, SPOP, STAG2, STAT3, SUFU, SYK, TEK, TNFAIP3, TP53, TSC2, TYRO3, XPO1, ZNF703.
Best drug option: ?",IMATINIB
ACH-000938,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
Drug 2: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 3: The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are FAM123B, APC, BAP1, BCL6, BCORL1, BRCA2, BRIP1, CD22, CD70, CHEK2, CIC, CREBBP, EGFR, EP300, ERBB2, FAM46C, FANCC, FGF14, INPP4B, KDM5A, KEAP1, MPL, MSH3, MTOR, MUTYH, NOTCH2, NRAS, NTRK3, PALB2, PARK2, QKI, RARA, RSPO2, SDHA, SMARCA4, SPEN, SUFU, TET2, TIPARP, TSC2, WHSC1L1.
Best drug option: ?",KIN001-135
ACH-000939,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is CAY10566. The drug SMILES structure is CC1=NN=C(O1)C2=NN=C(C=C2)N3CCC(CC3)OC4=C(C=CC(=C4)F)Cl. Drug target is Stearoyl-CoA desaturase. Drug target pathway is Other.
Drug 2: The drug is FR-180204. The drug SMILES structure is C1=CC=C(C=C1)C2=NN3C=CC=CC3=C2C4=CC5=C(NN=C5N=N4)N. Drug target is ERK1, ERK2. Drug target pathway is ERK MAPK signaling.
Drug 3: The drug is AGI-5198. The drug SMILES structure is CC1=CC=CC=C1C(C(=O)NC2CCCCC2)N(C3=CC(=CC=C3)F)C(=O)CN4C=CN=C4C. Drug target is IDH1 (R132H). Drug target pathway is Metabolism.
The mutations of the cell line are ABL1, ACVR1B, ALK, APC, ARID1A, ATM, CDC73, CDK12, CIC, CREBBP, CTCF, DOT1L, EGFR, GATA3, GNA13, GNAS, GRM3, HRAS, IGF1R, IRF2, KDM6A, MLL, MLL2, MAP3K1, MSH2, MTOR, NOTCH1, NOTCH2, PALB2, PIK3C2B, PIK3CA, POLE, PTEN, RAC1, RAD51B, RB1, RBM10, RNF43, SDHA, SETD2, SOCS1, SPEN, SPOP, TBX3, TP53, TSC2, XRCC2.
Best drug option: ?",CAY10566
ACH-000940,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 2: The drug is JNJ-38877605. The drug SMILES structure is CN1C=C(C=N1)C2=NN3C(=NN=C3C(C4=CC5=C(C=C4)N=CC=C5)(F)F)C=C2. Drug target is Unknown. Drug target pathway is Unknown.
Drug 3: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ALOX12B, FAM123B, ARAF, ARID1A, ATRX, BARD1, BCORL1, BCR, CCND1, CIC, CREBBP, CTCF, DOT1L, EED, EWSR1, FBXW7, FGF14, FGF23, FGF3, FGFR2, GNA11, GNA13, GNAS, HRAS, IKBKE, IKZF1, IRS2, JAK1, KDM5A, KDM5C, MAP3K1, MET, MSH6, MTOR, MUTYH, MYCN, NOTCH1, NOTCH2, NOTCH3, NTRK1, PIK3C2G, PIK3R1, POLD1, POLE, PPP2R1A, PRDM1, PTEN, ROS1, RPTOR, SETD2, SLC34A2, SMARCA4, STAT3, TERT, TP53, WHSC1L1, ZNF217.
Best drug option: ?",WYE-125132
ACH-000943,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 2: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
Drug 3: The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ABL1, AKT3, ALOX12B, AR, ARFRP1, ARID1A, AURKA, BAP1, BCORL1, BCR, BRAF, BRCA1, BRCA2, BRD4, CASP8, CDK4, CREBBP, CTNNA1, CXCR4, DDR1, DOT1L, EP300, EPHB1, ERBB2, EZH2, FANCA, FGF14, FGFR1, GATA3, GNAS, GRM3, HNF1A, IDH1, IDH2, KEAP1, KIT, KLHL6, MLL, MLL2, MAP3K1, MED12, MEF2B, MERTK, MLH1, MSH6, MYC, MYCN, NF1, NF2, NOTCH1, NOTCH3, NT5C2, NTRK3, PARP1, PBRM1, PIK3CA, POLE, RAD51B, RNF43, RPTOR, SDC4, SDHA, SLC34A2, SOX9, STAT3, TET2, TNFAIP3, TNFRSF14, TSC2, U2AF1, WHSC1, ZNF217.
Best drug option: ?",KIN001-135
ACH-000944,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 2: The drug is EPZ004777. The drug SMILES structure is CC(C)N(CCCNC(=O)NC1=CC=C(C=C1)C(C)(C)C)C[C@@H]2[C@H]([C@H]([C@@H](O2)N3C=CC4=C(N=CN=C43)N)O)O. Drug target is DOT1L. Drug target pathway is Chromatin histone methylation.
Drug 3: The drug is JQ1-(+). The drug SMILES structure is CC1=C(SC2=C1C(=N[C@H](C3=NN=C(N32)C)CC(=O)OC(C)(C)C)C4=CC=C(C=C4)Cl)C. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ARID1A, ATRX, BCOR, BCR, EMSY, CDKN2A, CTCF, ETV4, FH, ID3, MSH3, MYC, P2RY8, PARK2, SLC34A2, SPEN, TP53.
Best drug option: ?",KIN001-135
ACH-000945,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 2: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
Drug 3: The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ALK, APC, AR, ASXL1, ATM, BCORL1, BRCA2, CD70, CDK4, CREBBP, CSF3R, ETV6, FGF12, FLT1, FLT3, GNAS, IKZF1, KDM5A, KIT, MLL, KRAS, MED12, MRE11A, MSH6, MST1R, MTOR, MYCL1, NBN, NTRK1, NUTM1, PBRM1, PDGFRB, PIK3C2B, PIK3R1, POLE, PTCH1, QKI, REL, RSPO2, SF3B1, SMARCA4, SYK, TBX3, TEK, TERT, TP53, WT1.
Best drug option: ?",KIN001-135
ACH-000947,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is DACINOSTAT. The drug SMILES structure is C1=CC=C2C(=C1)C(=CN2)CCN(CCO)CC3=CC=C(C=C3)C=CC(=O)NO. Drug target is HDAC1. Drug target pathway is Chromatin histone acetylation.
Drug 2: The drug is GSK2606414. The drug SMILES structure is CN1C=C(C2=C(N=CN=C21)N)C3=CC4=C(C=C3)N(CC4)C(=O)CC5=CC(=CC=C5)C(F)(F)F. Drug target is PERK. Drug target pathway is Metabolism.
Drug 3: The drug is IMATINIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5. Drug target is ABL, KIT, PDGFR. Drug target pathway is Other, kinases.
The mutations of the cell line are ACVR1B, FAM123B, ARAF, ARID1A, ATR, BARD1, CCND1, CDK12, CIC, CREBBP, CSF3R, CTCF, DAXX, DDR1, DDR2, DIS3, EPHB1, FANCC, FLCN, FLT1, JAK2, KDM5A, KDM6A, MLL2, KRAS, MEF2B, MRE11A, MSH3, MTOR, MYCL1, NTRK3, PARP3, PIK3C2B, PIK3C2G, PIK3CB, PIK3R1, PTCH1, PTEN, PTPN11, RET, SDHA, SMAD2, SMARCA4, SOCS1, SOX2, SPEN, TBX3, TET2, TNFAIP3, TP53, TSC2, ZNF217, ZNF703.
Best drug option: ?",IMATINIB
ACH-000948,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
Drug 2: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
Drug 3: The drug is IMATINIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5. Drug target is ABL, KIT, PDGFR. Drug target pathway is Other, kinases.
The mutations of the cell line are AKT1, AKT3, ARID1A, AXIN1, BARD1, BRD4, BTG1, EMSY, CARD11, CBL, CCND2, CD79A, CD79B, CDH1, CDK8, CDKN1A, CHEK2, CIC, CSF3R, CTCF, ERBB3, ERBB4, ESR1, EZH2, EZR, FGFR2, JAK1, KIT, MLL, MLL2, LTK, MEF2B, MTOR, NOTCH1, NTRK1, PARK2, PIK3C2B, PPARG, PRDM1, PTCH1, QKI, RICTOR, RNF43, ROS1, SETD2, SGK1, SMAD2, SMARCA4, SOX2, SOX9, SPEN, STAG2, STK11, WHSC1L1, ZNF217.
Best drug option: ?",IMATINIB
ACH-000949,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
Drug 2: The drug is JNJ-38877605. The drug SMILES structure is CN1C=C(C=N1)C2=NN3C(=NN=C3C(C4=CC5=C(C=C4)N=CC=C5)(F)F)C=C2. Drug target is Unknown. Drug target pathway is Unknown.
Drug 3: The drug is AZD8931. The drug SMILES structure is CNC(=O)CN1CCC(CC1)OC2=C(C=C3C(=C2)C(=NC=N3)NC4=C(C(=CC=C4)Cl)F)OC. Drug target is EGFR, ERBB2, ERBB3. Drug target pathway is RTK signaling.
The mutations of the cell line are ABL1, ALK, FAM123B, APC, ATM, BCL6, EMSY, CREBBP, CTCF, CTNNA1, DAXX, FBXW7, HNF1A, IKBKE, MLL2, KRAS, MAP3K13, MSH2, MSH3, NOTCH1, NOTCH3, PIK3C2G, PIK3CA, POLE, PTCH1, RNF43, ROS1, RPTOR, SPEN, TET2, TGFBR2, TIPARP, TNFAIP3, TP53, TSC2.
Best drug option: ?",WYE-125132
ACH-000951,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 2: The drug is CAY10566. The drug SMILES structure is CC1=NN=C(O1)C2=NN=C(C=C2)N3CCC(CC3)OC4=C(C=CC(=C4)F)Cl. Drug target is Stearoyl-CoA desaturase. Drug target pathway is Other.
Drug 3: The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ACVR1B, ATR, AURKB, AXL, BCL2L2, BCORL1, CBL, CDK12, CREBBP, CSF1R, DDR2, EPHB1, ERBB2, ERBB4, FBXW7, GABRA6, GNAS, GRM3, IKZF1, IRF2, KDM5A, MLL, MLL2, MAP2K4, MED12, MEN1, MET, MLH1, NF1, NTRK2, PARK2, PMS2, PTCH1, QKI, RPTOR, SDHB, SF3B1, SMARCA4, SMARCB1, SPEN, SPOP, SUFU, TGFBR2, TP53, TSC2, WT1.
Best drug option: ?",BRYOSTATIN-1
ACH-000955,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is IMATINIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5. Drug target is ABL, KIT, PDGFR. Drug target pathway is Other, kinases.
Drug 2: The drug is EPOTHILONE-B. The drug SMILES structure is CC1CCCC2(C(O2)CC(OC(=O)CC(C(C(=O)C(C1O)C)(C)C)O)C(=CC3=CSC(=N3)C)C)C. Drug target is Unknown. Drug target pathway is Unknown.
Drug 3: The drug is YK-4-279. The drug SMILES structure is COC1=CC=C(C=C1)C(=O)CC2(C3=C(C=CC(=C3NC2=O)Cl)Cl)O. Drug target is RNA helicase A. Drug target pathway is Other.
The mutations of the cell line are ACVR1B, ASXL1, ATRX, BCOR, BRAF, BRCA2, CASP8, CBFB, CCNE1, CHEK2, CIC, CTCF, CTNNB1, CXCR4, DDR1, EGFR, EP300, EPHB1, ERBB3, ERBB4, ERCC4, ETV4, FANCA, FANCC, FANCG, FAS, FBXW7, GATA3, IKBKE, INPP4B, IRS2, JAK3, KDM5C, KDR, KLHL6, MLL2, KRAS, LTK, MSH2, MTAP, NOTCH1, NOTCH2, NTRK1, PARP1, PBRM1, PIK3C2B, PIK3CA, POLD1, POLE, PTCH1, RAD51, SF3B1, SMARCA4, SMO, SPOP, STAT3, TP53, TSC2, WHSC1, XRCC2, ZNF217.
Best drug option: ?",IMATINIB
ACH-000956,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
Drug 2: The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
Drug 3: The drug is GSK2606414. The drug SMILES structure is CN1C=C(C2=C(N=CN=C21)N)C3=CC4=C(C=C3)N(CC4)C(=O)CC5=CC(=CC=C5)C(F)(F)F. Drug target is PERK. Drug target pathway is Metabolism.
The mutations of the cell line are AR, ARID1A, ASXL1, ATM, AXIN1, AXL, BARD1, BRAF, BRCA2, CALR, CBFB, CD22, CIC, CREBBP, CSF3R, CYP17A1, DDR1, EP300, EPHA3, EPHB4, ERBB3, ERBB4, FBXW7, FLT1, FLT3, GATA4, GNAS, JAK1, JAK2, KDM5A, KDM5C, KEAP1, MLL2, MAP3K13, MEN1, MITF, MSH3, MTOR, NBN, NOTCH1, NOTCH2, NUTM1, P2RY8, PALB2, PDGFRA, PDGFRB, PIK3CA, PTCH1, PTPRO, ROS1, RPTOR, SPEN, STK11, TERT, TET2, TIPARP, TP53, TSC1, WHSC1, XRCC2.
Best drug option: ?",YM-201636
ACH-000957,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
Drug 2: The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
Drug 3: The drug is YK-4-279. The drug SMILES structure is COC1=CC=C(C=C1)C(=O)CC2(C3=C(C=CC(=C3NC2=O)Cl)Cl)O. Drug target is RNA helicase A. Drug target pathway is Other.
The mutations of the cell line are ABL1, APC, ARID1A, BRAF, BRCA1, CBFB, CCND3, CD70, CDK6, CEBPA, CIC, CTCF, CTNNA1, CTNNB1, CUL4A, DDR2, EP300, FANCA, FGFR1, GATA3, GSK3B, IRS2, JAK1, KDM5A, KDM6A, KDR, MLL2, KRAS, LYN, MEN1, MLH1, MRE11A, MSH6, NOTCH3, PDGFRB, PIK3CA, POLD1, PPP2R1A, PPP2R2A, PTEN, QKI, RNF43, RPTOR, SGK1, SOX9, SPEN, STK11, SUFU, SYK, TEK, TIPARP, TNFAIP3, TSC1, TYRO3.
Best drug option: ?",YM-201636
ACH-000958,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is CAY10566. The drug SMILES structure is CC1=NN=C(O1)C2=NN=C(C=C2)N3CCC(CC3)OC4=C(C=CC(=C4)F)Cl. Drug target is Stearoyl-CoA desaturase. Drug target pathway is Other.
Drug 2: The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
Drug 3: The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ACVR1B, AKT2, AKT3, ALK, APC, AR, ARAF, ARID1A, ATR, ATRX, AURKB, BCL6, BCORL1, BRCA2, BRD4, CARD11, CASP8, CREBBP, CSF3R, CTCF, CTNNA1, CTNNB1, CYP17A1, DDR1, DOT1L, EGFR, EP300, EPHA3, EPHB4, ERBB4, EZH2, FAS, FBXW7, FGF10, FGFR1, FGFR3, FLT1, GNAS, HDAC1, IGF1R, IKZF1, KDM5C, KDM6A, MLL2, LTK, MAP2K1, MAP3K13, MED12, MERTK, MSH6, MST1R, MTOR, NOTCH1, NOTCH2, NOTCH3, NTRK1, P2RY8, PARP1, PDGFRA, PDK1, PIK3C2B, PIK3CA, POLD1, PTCH1, QKI, RAD54L, RBM10, REL, RET, RICTOR, RNF43, SETD2, SF3B1, SMARCA4, SMO, SNCAIP, SOX9, SPEN, STAT3, TBX3, TET2, TNFAIP3, TSC1, WHSC1, WHSC1L1.
Best drug option: ?",BRYOSTATIN-1
ACH-000960,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
Drug 2: The drug is CAY10566. The drug SMILES structure is CC1=NN=C(O1)C2=NN=C(C=C2)N3CCC(CC3)OC4=C(C=CC(=C4)F)Cl. Drug target is Stearoyl-CoA desaturase. Drug target pathway is Other.
Drug 3: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are ACVR1B, ALK, ARID1A, ATRX, BCL2L2, BCOR, CHEK1, CIC, CUL4A, ERBB4, ESR1, EWSR1, FANCA, GATA3, GATA6, IGF1R, IKBKE, IKZF1, JAK3, KDM5A, MLL2, MCL1, MDM2, MEN1, MLH1, MST1R, MTOR, MYB, MYD88, NOTCH1, PALB2, PDGFRA, PDK1, PIK3R1, PIM1, PMS2, PRDM1, PTEN, RAC1, RARA, SPEN, SYK, TERT, TIPARP, TMPRSS2, TP53, XPO1, ZNF703.
Best drug option: ?",KIN001-135
ACH-000962,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 2: The drug is GSK2606414. The drug SMILES structure is CN1C=C(C2=C(N=CN=C21)N)C3=CC4=C(C=C3)N(CC4)C(=O)CC5=CC(=CC=C5)C(F)(F)F. Drug target is PERK. Drug target pathway is Metabolism.
Drug 3: The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ALK, ARID1A, ATM, ATRX, BARD1, BCL6, BCORL1, BRAF, BRCA2, BTK, CARD11, CASP8, CD274, CD79A, CIC, CREBBP, EP300, EPHB1, ERBB2, ERBB3, ESR1, FANCA, FANCG, FBXW7, FGF10, FGF12, FGFR4, FLT1, GNAS, HNF1A, IKZF1, JAK1, KDM5A, KDM5C, KEL, MLL, MLL2, MAP3K1, MAP3K13, MED12, MSH2, MSH3, MTAP, MYCL1, NOTCH1, NOTCH2, PARP2, PBRM1, PIK3CA, PTPRO, RBM10, RSPO2, SDHB, SMARCA4, SPEN, STAG2, STK11, TBX3, TEK, TNFRSF14, TP53, WHSC1.
Best drug option: ?",KIN001-135
ACH-000963,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is TIVOZANIB. The drug SMILES structure is CC1=CC(=NO1)NC(=O)NC2=C(C=C(C=C2)OC3=C4C=C(C(=CC4=NC=C3)OC)OC)Cl. Drug target is VEGFR1, VEGFR2, VEGFR3, PDGFR, KIT. Drug target pathway is RTK signaling.
Drug 2: The drug is GDC-0068. The drug SMILES structure is CC1CC(C2=C1C(=NC=N2)N3CCN(CC3)C(=O)C(CNC(C)C)C4=CC=C(C=C4)Cl)O. Drug target is AKT1, AKT, AKT3. Drug target pathway is PI3K/MTOR signaling.
Drug 3: The drug is QL-VIII-58. The drug SMILES structure is NC1=NC=C(C=N1)C1=CC=C2N=CC3=C(N(C(=O)C=C3)C3=CC(Cl)=C(C=C3)N3CCNCC3)C2=C1. Drug target is MTOR, ATR. Drug target pathway is Other.
The mutations of the cell line are ABL1, APC, ARAF, ATRX, BAP1, BRAF, BRCA1, BRCA2, BRD4, BTK, EMSY, CALR, CDC73, CDK8, CHEK2, CIC, CREBBP, CTCF, CTNNB1, DNMT3A, DOT1L, EGFR, EPHA3, EPHB4, ERBB2, ERBB4, EZR, FANCA, FBXW7, FGF12, FLCN, FLT1, GRM3, IKBKE, IRS2, JAK1, JAK3, KDM5A, KLHL6, MLL, MLL2, MAP3K1, MDM4, MERTK, MKNK1, MLH1, MSH2, MSH3, MTOR, MUTYH, NF2, NOTCH1, NOTCH2, NOTCH3, NTRK3, NUTM1, PALB2, PARP1, PAX5, PDGFRA, PIK3C2B, PIK3CA, POLE, PRDM1, PTCH1, PTPRO, RICTOR, RNF43, RPTOR, SDHA, SGK1, SMARCA4, SMO, SOX9, STAT3, TBX3, TEK, TET2, TP53, TSC2, U2AF1, XRCC2.
Best drug option: ?",QL-VIII-58
ACH-000965,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 2: The drug is IMATINIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5. Drug target is ABL, KIT, PDGFR. Drug target pathway is Other, kinases.
Drug 3: The drug is FORETINIB. The drug SMILES structure is COC1=CC2=C(C=CN=C2C=C1OCCCN3CCOCC3)OC4=C(C=C(C=C4)NC(=O)C5(CC5)C(=O)NC6=CC=C(C=C6)F)F. Drug target is MET, KDR, TIE2, VEGFR3/FLT4, RON, PDGFR, FGFR1, EGFR. Drug target pathway is RTK signaling.
The mutations of the cell line are FAM123B, AR, ARID1A, ASXL1, ATM, BRAF, BRCA2, BTK, CASP8, CBL, CCND1, CDKN1B, CIC, CSF3R, CTCF, CUL4A, DOT1L, EGFR, EP300, ERBB2, ERBB4, FLT3, GATA3, GNAS, HRAS, IDH2, JAK1, JAK2, KDR, KEAP1, KEL, MLL2, MAF, MED12, MPL, MSH2, MSH3, MSH6, MST1R, MYC, NF2, NOTCH1, NT5C2, NUTM1, PAX5, PIK3C2G, PIK3R1, PRDM1, PTEN, RAC1, RAD21, RAF1, RARA, RPTOR, SDHC, SLC34A2, SMARCA4, SOCS1, SPEN, TERT, TP53.
Best drug option: ?",IMATINIB
ACH-000966,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 2: The drug is YK-4-279. The drug SMILES structure is COC1=CC=C(C=C1)C(=O)CC2(C3=C(C=CC(=C3NC2=O)Cl)Cl)O. Drug target is RNA helicase A. Drug target pathway is Other.
Drug 3: The drug is PYRIMETHAMINE. The drug SMILES structure is CCC1=C(C(=NC(=N1)N)N)C2=CC=C(C=C2)Cl. Drug target is Dihydrofolate reductase (DHFR). Drug target pathway is Other.
The mutations of the cell line are ABL1, ACVR1B, AR, ARAF, ARID1A, ATM, AXIN1, BCL6, BCOR, BCORL1, BRCA1, BRCA2, BTG1, BTK, EMSY, CARD11, CASP8, CBL, CD22, CDK12, CDK6, CDK8, CDKN1B, CDKN2C, CIC, CREBBP, CTCF, CTNNA1, CUL3, CUL4A, DDR1, EP300, ERBB3, FAM46C, FANCA, FGF3, FGF4, FGFR1, FH, FLCN, FLT3, FUBP1, GATA3, IGF1R, IKZF1, IRS2, JAK1, JAK3, KDR, MLL, MLL2, MAP3K1, MED12, MLH1, MRE11A, MSH3, MSH6, MTAP, MYB, NF2, NKX2-1, NOTCH1, NOTCH3, NUTM1, PALB2, PAX5, PIK3C2G, PIK3CA, PIK3CB, POLD1, PRDM1, PRKCI, PTEN, PTPN11, QKI, RB1, RET, RICTOR, RPTOR, SDHA, SETD2, SF3B1, SMAD2, SMAD4, SMARCA4, SNCAIP, SOX9, STAG2, TEK, TIPARP, TP53, TSC2, TYRO3.
Best drug option: ?",KIN001-135
ACH-000968,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
Drug 2: The drug is SB-505124. The drug SMILES structure is CC1=NC(=CC=C1)C2=C(N=C(N2)C(C)(C)C)C3=CC4=C(C=C3)OCO4. Drug target is Unknown. Drug target pathway is Unknown.
Drug 3: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are ABL1, ALOX12B, AR, ARID1A, BCOR, BRCA2, EMSY, CBL, CD22, CREBBP, CSF1R, DNMT3A, EP300, EPHA3, ERBB4, ETV6, FGFR1, FGFR2, FGFR3, IKZF1, KDM5A, KDR, KEL, MAP2K2, MEN1, MERTK, MPL, MST1R, MTOR, NF1, NOTCH2, PAX5, PBRM1, PRKCI, PTPN11, RAF1, RBM10, SDHD, SNCAIP, SOX9, U2AF1, XRCC2, ZNF703.
Best drug option: ?",KIN001-135
ACH-000969,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is SNX-2112. The drug SMILES structure is CC1(CC2=C(C(=O)C1)C(=NN2C3=CC(=C(C=C3)C(=O)N)NC4CCC(CC4)O)C(F)(F)F)C. Drug target is HSP90. Drug target pathway is Protein stability and degradation.
Drug 2: The drug is YK-4-279. The drug SMILES structure is COC1=CC=C(C=C1)C(=O)CC2(C3=C(C=CC(=C3NC2=O)Cl)Cl)O. Drug target is RNA helicase A. Drug target pathway is Other.
Drug 3: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are ACVR1B, ALK, FAM123B, APC, ARID1A, ATM, AXIN1, AXL, BCORL1, BRAF, BRCA1, BRCA2, BRD4, CD79A, CDK12, CDKN1A, CHEK2, CIC, CREBBP, CSF3R, CUL3, DOT1L, EGFR, EP300, ERBB2, ERBB4, FANCA, FGF3, FGFR3, GNA13, GNAS, GRM3, GSK3B, HDAC1, IKZF1, IRS2, KDM5A, KDM6A, KDR, KEAP1, MLL, MLL2, LTK, LYN, MDM4, MPL, MSH2, MSH3, MSH6, MST1R, MTOR, MYB, MYD88, NF1, NOTCH1, NOTCH2, NOTCH3, PARP1, PDCD1LG2, POLD1, POLE, PRDM1, PTCH1, PTEN, RAD51D, REL, RNF43, SF3B1, SOCS1, SPEN, SRC, SYK, TGFBR2, TP53, TSC1, TSC2, VEGFA.
Best drug option: ?",YK-4-279
ACH-000970,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is YK-4-279. The drug SMILES structure is COC1=CC=C(C=C1)C(=O)CC2(C3=C(C=CC(=C3NC2=O)Cl)Cl)O. Drug target is RNA helicase A. Drug target pathway is Other.
Drug 2: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 3: The drug is IMATINIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5. Drug target is ABL, KIT, PDGFR. Drug target pathway is Other, kinases.
The mutations of the cell line are ACVR1B, APC, ARID1A, ATM, AXL, BAP1, BCOR, BCORL1, BRAF, BRCA2, BRIP1, BTK, CD79B, CDKN1A, CHEK2, CREBBP, CRKL, CTCF, CTNNA1, DDR2, DNMT3A, DOT1L, EP300, ERBB3, ETV6, FANCC, FBXW7, FGFR3, GNAS, GRM3, IKZF1, JAK3, KDM5A, KEL, KIT, KLHL6, MLL2, MAP2K2, MAP2K4, MDM2, MEN1, MET, MITF, MST1R, MTOR, MYC, MYCL1, MYD88, NFE2L2, NOTCH2, NOTCH3, NTRK3, PIK3CA, PMS2, POLD1, PRKCI, RAD52, RNF43, ROS1, SLC34A2, SNCAIP, SOX2, STAG2, SYK, TNFRSF14, TP53, TSC2, U2AF1, WT1.
Best drug option: ?",KIN001-135
ACH-000971,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is AVAGACESTAT. The drug SMILES structure is C1=CC(=CC=C1S(=O)(=O)N(CC2=C(C=C(C=C2)C3=NOC=N3)F)[C@H](CCC(F)(F)F)C(=O)N)Cl. Drug target is Amyloid beta20, Amyloid beta40. Drug target pathway is Other.
Drug 2: The drug is YK-4-279. The drug SMILES structure is COC1=CC=C(C=C1)C(=O)CC2(C3=C(C=CC(=C3NC2=O)Cl)Cl)O. Drug target is RNA helicase A. Drug target pathway is Other.
Drug 3: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are ABL1, ARAF, ATM, ATRX, AXL, BCOR, BCORL1, BCR, BRCA2, CALR, CDH1, CDK12, CDK8, CDKN2A, CHEK2, CTNNB1, CUL4A, CXCR4, DDR2, EP300, EPHB1, ERBB3, ERCC4, FAM46C, FANCA, FGF4, FGFR1, FGFR2, FLT1, FLT3, GNAQ, GNAS, HDAC1, IDH1, KDM5A, KIT, MLL2, KRAS, MAP3K1, MDM4, MED12, MERTK, MET, MLH1, MSH3, MSH6, MTAP, NF1, NOTCH1, NOTCH2, NTRK3, NUTM1, PARK2, PIK3CA, POLD1, PPP2R1A, PRDM1, PRKCI, REL, RNF43, ROS1, SETD2, SMARCA4, SMO, SOX2, TERT.
Best drug option: ?",KIN001-135
ACH-000973,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
Drug 2: The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
Drug 3: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are ABL1, APC, AR, ARID1A, ATM, BAP1, BCORL1, BCR, BRD4, BRIP1, CALR, CDKN1A, CDKN2A, CREBBP, CTNNB1, EP300, FGFR3, FUBP1, GNAS, IGF1R, IKZF1, KDM5C, KDR, MLL2, KRAS, MAP2K2, MED12, MET, MLH1, MSH2, MSH6, MYCN, NOTCH1, NOTCH2, NPM1, NRAS, NTRK1, PALB2, PAX5, PDGFRA, PDGFRB, PIK3C2B, PIK3CA, POLD1, PTCH1, PTEN, RAD21, RAD54L, RB1, RBM10, ROS1, SMAD4, SMARCA4, SPEN, TERT, TP53, TSC1.
Best drug option: ?",KIN001-135
ACH-000974,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 2: The drug is LENALIDOMIDE. The drug SMILES structure is C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N. Drug target is CRBN. Drug target pathway is Protein stability and degradation.
Drug 3: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are AKT3, ALOX12B, APC, ARFRP1, ARID1A, ATM, ATRX, BAP1, BCORL1, BRD4, BRIP1, EMSY, CARD11, CASP8, CCND1, CDK12, CDKN2C, CIC, CREBBP, CTCF, CTNNB1, DDR2, DNMT3A, EP300, EPHB4, FANCA, FANCG, FGFR3, FLT1, FLT3, GATA3, GNAS, H3F3A, HGF, IGF1R, IRS2, KDM5A, KDM6A, MLL, MLL2, KRAS, LTK, MAP2K1, MAP3K1, MED12, MEF2B, MEN1, MKNK1, MRE11A, MSH3, MSH6, MST1R, MTOR, NTRK1, NUTM1, PARK2, PBRM1, PDCD1, PIK3CA, PIK3CB, POLE, PPP2R1A, PRDM1, PTCH1, PTEN, QKI, SDHA, SMARCA4, SMO, SNCAIP, SPEN, TEK, TSC1, XRCC2.
Best drug option: ?",LENALIDOMIDE
ACH-000976,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
Drug 2: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 3: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are BRCA2, DIS3, ERBB3, FBXW7, FGF23, MLL2, KRAS, MAP2K2, MSH6, QKI, RAD51, RB1, SDHA, SETD2, SRC, TP53.
Best drug option: ?",KIN001-135
ACH-000977,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is YK-4-279. The drug SMILES structure is COC1=CC=C(C=C1)C(=O)CC2(C3=C(C=CC(=C3NC2=O)Cl)Cl)O. Drug target is RNA helicase A. Drug target pathway is Other.
Drug 2: The drug is PAZOPANIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC2=NC=CC(=N2)N(C)C3=CC4=NN(C(=C4C=C3)C)C)S(=O)(=O)N. Drug target is CSF1R, KIT,  PDGFRA, PDGFRB. Drug target pathway is RTK signaling.
Drug 3: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are ABL1, FAM123B, APC, AR, ARID1A, ATM, ATR, ATRX, AXL, BCOR, BRIP1, BTK, CARD11, CD74, CDH1, CDK4, CHEK2, CREBBP, CSF3R, CTCF, CTNNB1, CXCR4, DNMT3A, DOT1L, EP300, EPHA3, EPHB4, ERBB3, ERBB4, FANCA, FGFR1, FLT1, FLT3, GNA11, GNAS, HDAC1, HGF, IRF4, IRS2, JAK1, JAK2, KDM5A, KDM6A, KEAP1, KLHL6, MLL, LTK, MAP2K1, MAP3K13, MEN1, MLH1, MPL, MSH3, MYC, MYCN, NF1, NOTCH1, NOTCH2, NOTCH3, PARP2, PBRM1, PIK3R1, POLD1, PPP2R1A, PRKAR1A, PTEN, RAD54L, RET, ROS1, RSPO2, SETD2, SF3B1, SMARCA4, SMO, SPEN, STAG2, TERT, TET2, TNFRSF14, TSC1.
Best drug option: ?",YK-4-279
ACH-000978,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is AZD8931. The drug SMILES structure is CNC(=O)CN1CCC(CC1)OC2=C(C=C3C(=C2)C(=NC=N3)NC4=C(C(=CC=C4)Cl)F)OC. Drug target is EGFR, ERBB2, ERBB3. Drug target pathway is RTK signaling.
Drug 2: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
Drug 3: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are ACVR1B, AKT1, ALOX12B, FAM123B, APC, ARID1A, ASXL1, ATM, ATR, ATRX, AURKA, AXIN1, BARD1, BCR, BRAF, BRCA2, EMSY, CD70, CDC73, CDK12, CDKN2A, CDKN2C, CHEK2, CIC, CREBBP, CUL3, CXCR4, CYP17A1, DAXX, DIS3, DNMT3A, DOT1L, EGFR, EP300, EPHB4, FANCA, FBXW7, FGF14, FGFR2, FGFR3, FH, FLCN, FLT3, GABRA6, GNA11, IDH1, IGF1R, IKBKE, IRF2, IRS2, JAK1, JAK2, KDM5A, KDM5C, KDM6A, MLL, MLL2, MAP2K4, MCL1, MEF2B, MET, MSH3, MSH6, MTAP, MTOR, MYCN, NBN, NF1, NKX2-1, NOTCH1, NOTCH3, NTRK1, NUTM1, PALB2, PARP1, PBRM1, PIK3C2B, PIK3CA, PIK3CB, PIK3R1, PMS2, POLD1, PPARG, PRKAR1A, PRKCI, PTCH1, PTPRO, RAD21, RAD51, RAD51C, RAD52, RAD54L, RARA, RET, RNF43, ROS1, RPTOR, SDHA, SETD2, SMAD2, SMARCA4, SNCAIP, SOX9, SPEN, SPOP, STAG2, STAT3, SUFU, TET2, TGFBR2, TNFAIP3, TP53, TSC1, TSC2, WHSC1L1, ZNF217.
Best drug option: ?",KIN001-135
ACH-000980,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 2: The drug is IMATINIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5. Drug target is ABL, KIT, PDGFR. Drug target pathway is Other, kinases.
Drug 3: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ABL1, AKT3, APC, ATRX, BCORL1, CARD11, CDKN1B, CIC, DDR1, DDR2, DIS3, DOT1L, EP300, EPHB4, EZH2, GATA6, INPP4B, JAK2, JAK3, KDM5C, MLL2, KRAS, LYN, MCL1, MDM4, MET, MRE11A, MSH6, MST1R, MUTYH, NF2, NUTM1, PARP1, PAX5, PDCD1, PIK3CA, PRKCI, PTCH1, PTEN, RB1, SF3B1, SMAD4, SMO, SPEN, STAG2, TP53, ZNF217.
Best drug option: ?",IMATINIB
ACH-000981,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is CAY10566. The drug SMILES structure is CC1=NN=C(O1)C2=NN=C(C=C2)N3CCC(CC3)OC4=C(C=CC(=C4)F)Cl. Drug target is Stearoyl-CoA desaturase. Drug target pathway is Other.
Drug 2: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
Drug 3: The drug is NIRAPARIB. The drug SMILES structure is C1C[C@H](CNC1)C2=CC=C(C=C2)N3C=C4C=CC=C(C4=N3)C(=O)N. Drug target is PARP1, PARP2. Drug target pathway is Genome integrity.
The mutations of the cell line are ALK, ALOX12B, ASXL1, BAP1, BCL2L1, BCORL1, BRCA1, BRCA2, BTK, CARD11, CHEK2, CREBBP, CSF3R, CTCF, DAXX, DOT1L, EGFR, EP300, ERBB3, ETV6, EWSR1, FANCL, FUBP1, GNA11, GNA13, HDAC1, IDH1, IGF1R, IRS2, KDM6A, KLHL6, MLL, MLL2, KRAS, LTK, MAP2K4, MKNK1, MLH1, MRE11A, MSH3, NBN, NFE2L2, NFKBIA, NOTCH1, NRAS, NTRK1, PALB2, PBRM1, PDGFRB, PIM1, POLD1, PRDM1, PRKCI, PTCH1, PTEN, RAD21, RB1, RET, RICTOR, SDHA, SF3B1, SMARCA4, SMARCB1, SPEN, STK11, TNFAIP3, TP53, TSC2, ZNF217, ZNF703.
Best drug option: ?",CAY10566
ACH-000983,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is PI-103. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)O. Drug target is PI3Kalpha, DAPK3, CLK4, PIM3, HIPK2. Drug target pathway is Other, kinases.
Drug 2: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
Drug 3: The drug is IMATINIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5. Drug target is ABL, KIT, PDGFR. Drug target pathway is Other, kinases.
The mutations of the cell line are ABL1, ACVR1B, ASXL1, AXIN1, BRAF, BRCA1, BRCA2, CALR, CD74, CD79A, CDH1, CEBPA, CIC, CREBBP, CTCF, DNMT3A, EWSR1, FGF23, FGFR3, FGFR4, FLCN, GATA6, IKZF1, IRS2, JAK3, KEAP1, MLL2, MAP3K1, MEN1, MLH1, MSH6, MST1R, MTOR, MUTYH, MYCN, NOTCH1, NOTCH2, NOTCH3, PBRM1, PDGFRB, PIK3C2B, PIK3CA, POLE, RICTOR, RPTOR, SETD2, SOCS1, SPEN, STAT3, STK11, SYK, TEK, TNFRSF14, TP53, TSC2, TYRO3.
Best drug option: ?",PI-103
ACH-000985,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is ARA-G. The drug SMILES structure is C1=NC2=C(N1[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)N=C(NC2=O)N. Drug target is Anti-metabolite. Drug target pathway is Other.
Drug 2: The drug is CAY10566. The drug SMILES structure is CC1=NN=C(O1)C2=NN=C(C=C2)N3CCC(CC3)OC4=C(C=CC(=C4)F)Cl. Drug target is Stearoyl-CoA desaturase. Drug target pathway is Other.
Drug 3: The drug is PAZOPANIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC2=NC=CC(=N2)N(C)C3=CC4=NN(C(=C4C=C3)C)C)S(=O)(=O)N. Drug target is CSF1R, KIT,  PDGFRA, PDGFRB. Drug target pathway is RTK signaling.
The mutations of the cell line are ACVR1B, ALK, ALOX12B, APC, AR, ARID1A, ASXL1, ATM, ATRX, BARD1, BCL6, BCOR, BCORL1, BCR, BRAF, BRCA1, BRCA2, BRD4, BRIP1, BTK, EMSY, CARD11, CASP8, CCND2, CDC73, CDK4, CHEK1, CHEK2, CIC, CREBBP, CSF1R, CTCF, CTNNA1, CUL4A, DNMT3A, DOT1L, EGFR, EPHB1, ERBB2, ERBB3, ERBB4, ERG, FANCA, FBXW7, FGF19, FGF23, FGFR1, FLT1, FLT3, GNA11, GNAS, HNF1A, IDH1, IGF1R, IKZF1, INPP4B, IRS2, JAK2, JAK3, KDM5A, KEAP1, MLL, MLL2, LYN, MAP2K4, MAP3K13, MCL1, MDM2, MET, MLH1, MRE11A, MSH3, MST1R, MUTYH, MYCN, NBN, NF1, NOTCH1, NOTCH2, NOTCH3, NT5C2, NTRK1, NTRK2, NTRK3, NUTM1, P2RY8, PIK3C2B, PIK3C2G, PIK3CB, POLD1, PRDM1, PTCH1, PTEN, RAD21, RAD51B, RAD54L, RARA, RBM10, RET, RNF43, RPTOR, SF3B1, SNCAIP, SRC, STAG2, STAT3, TEK, TERT, TET2, TNFRSF14, TP53, TSC2, TYRO3, WHSC1, XRCC2, ZNF217.
Best drug option: ?",PAZOPANIB
ACH-000986,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is SB-505124. The drug SMILES structure is CC1=NC(=CC=C1)C2=C(N=C(N2)C(C)(C)C)C3=CC4=C(C=C3)OCO4. Drug target is Unknown. Drug target pathway is Unknown.
Drug 2: The drug is AVAGACESTAT. The drug SMILES structure is C1=CC(=CC=C1S(=O)(=O)N(CC2=C(C=C(C=C2)C3=NOC=N3)F)[C@H](CCC(F)(F)F)C(=O)N)Cl. Drug target is Amyloid beta20, Amyloid beta40. Drug target pathway is Other.
Drug 3: The drug is ARA-G. The drug SMILES structure is C1=NC2=C(N1[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)N=C(NC2=O)N. Drug target is Anti-metabolite. Drug target pathway is Other.
The mutations of the cell line are ALK, FAM123B, APC, AR, ASXL1, ATM, ATR, ATRX, BCL2L1, BCL2L2, BCL6, BRAF, BRCA1, BRCA2, BRIP1, CASP8, CBL, CDC73, CDH1, CDK12, CDK8, CHEK2, CREBBP, CSF1R, CTNNA1, DDR1, DNMT3A, EP300, EPHB1, EPHB4, ERBB4, ERCC4, ESR1, ETV5, EZH2, FANCC, FANCL, FBXW7, FGF12, FGF14, FGF19, FLT1, FLT3, GNAQ, GNAS, GRM3, HGF, INPP4B, JAK2, JAK3, KDM5A, KDR, KEL, KLHL6, MLL, MLL2, MDM2, MDM4, MET, MPL, MSH3, MSH6, MTOR, NF1, NOTCH2, NTRK1, NTRK3, PALB2, PBRM1, PDGFRA, PDGFRB, PIK3C2G, PIK3CA, PIK3CB, PMS2, POLD1, POLE, PPP2R2A, PRKCI, PTPN11, RAD21, RAD51D, RNF43, SETD2, SF3B1, SMAD2, SMARCA4, SMO, SPEN, SRC, TERT, TET2, TGFBR2, TP53, TSC1, WHSC1L1, XPO1, ZNF217.
Best drug option: ?",ARA-G
ACH-000987,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 2: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
Drug 3: The drug is JNJ-38877605. The drug SMILES structure is CN1C=C(C=N1)C2=NN3C(=NN=C3C(C4=CC5=C(C=C4)N=CC=C5)(F)F)C=C2. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are FAM123B, AR, ATR, BCOR, BCORL1, BCR, BRD4, CD22, CD79A, CDC73, CDK12, CDKN2A, CTNNA1, DAXX, DOT1L, EPHA3, EPHB4, ERBB4, ERG, ESR1, FAM46C, FANCA, FGFR1, FGFR2, FLT1, GNAS, GRM3, HGF, HSD3B1, IGF1R, IKBKE, KDR, KLHL6, MLL, MLL2, MET, MLH1, MSH6, NF1, NOTCH1, NOTCH3, NUTM1, PARP3, PDGFRA, PDGFRB, PIK3C2B, PPP2R1A, PTCH1, PTPRO, RBM10, ROS1, RSPO2, SF3B1, SMO, SPEN, SRC, SYK, TEK, TP53.
Best drug option: ?",KIN001-135
ACH-000988,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
Drug 2: The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
Drug 3: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are ABL1, AKT1, APC, ARID1A, ATM, BCOR, BCORL1, BCR, BRAF, BRCA2, BRD4, EMSY, CD22, CD274, CD79B, CDKN2A, CIC, CREBBP, CSF1R, CTCF, CTNNA1, DAXX, DDR2, EP300, EPHA3, EPHB4, ERBB2, ERBB3, ERBB4, ERRFI1, ETV5, ETV6, FANCA, FBXW7, FGF4, FGFR2, FLCN, FLT1, GATA3, GATA4, GATA6, GNA13, GNAS, HGF, HNF1A, IKZF1, IRF2, IRS2, JAK1, JAK2, KDM5A, KDR, KEAP1, MLL2, LYN, MAP2K4, MAP3K1, MAP3K13, MET, MPL, MRE11A, MSH2, MSH6, MST1R, MTOR, MYB, NF2, NFE2L2, NOTCH1, NOTCH3, PARP1, PARP3, PBRM1, PDGFRB, PIK3C2G, PIK3R1, PMS2, POLD1, PRKCI, PTEN, RBM10, REL, RICTOR, ROS1, SMARCB1, SPEN, SRC, SUFU, TERT, TET2, TNFAIP3, TP53, TSC2, WHSC1, XPO1.
Best drug option: ?",KIN001-135
ACH-000991,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is AZD8931. The drug SMILES structure is CNC(=O)CN1CCC(CC1)OC2=C(C=C3C(=C2)C(=NC=N3)NC4=C(C(=CC=C4)Cl)F)OC. Drug target is EGFR, ERBB2, ERBB3. Drug target pathway is RTK signaling.
Drug 2: The drug is JNJ-38877605. The drug SMILES structure is CN1C=C(C=N1)C2=NN3C(=NN=C3C(C4=CC5=C(C=C4)N=CC=C5)(F)F)C=C2. Drug target is Unknown. Drug target pathway is Unknown.
Drug 3: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are AKT3, ALK, ALOX12B, APC, AR, ARID1A, ASXL1, ATM, ATR, ATRX, AXIN1, AXL, BARD1, BCL6, BRCA1, BRCA2, BRIP1, CARD11, CBL, CD22, CDK12, CDKN1B, CHEK2, CREBBP, CRKL, CTCF, CTNNA1, CTNNB1, CUL3, CYP17A1, DDR1, DDR2, DNMT3A, DOT1L, EED, EGFR, EP300, EPHA3, ERBB4, ERRFI1, ESR1, EZH2, FANCA, FANCC, FANCL, FAS, FBXW7, FGF14, FGF23, FH, FLT1, FLT3, FUBP1, GATA6, GNAQ, GNAS, HDAC1, IGF1R, IRF4, KDM5A, KDR, KEL, KIT, KLHL6, MLL, KRAS, LYN, MAP2K4, MDM2, MERTK, MET, MITF, MLH1, MPL, MRE11A, MSH6, MTOR, MYD88, NF1, NFE2L2, NRAS, NTRK1, NTRK3, NUTM1, PBRM1, PDGFRA, PIK3C2G, PIK3CA, PIK3CB, PIK3R1, POLE, PPARG, PRKAR1A, PTEN, PTPRO, RAD51C, RBM10, REL, ROS1, RSPO2, SETD2, SGK1, SMAD2, SMARCA4, SPEN, SPOP, STAG2, STAT3, TBX3, TET2, TNFAIP3, TP53, TSC1, TYRO3, WHSC1, WHSC1L1, XPO1, ZNF217.
Best drug option: ?",WYE-125132
ACH-000995,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is IMATINIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5. Drug target is ABL, KIT, PDGFR. Drug target pathway is Other, kinases.
Drug 2: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 3: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are AKT1, APC, AR, ARID1A, ATM, ATR, AURKB, AXIN1, AXL, BCL2, BCORL1, BRAF, BRCA1, BRD4, EMSY, CALR, CARD11, CASP8, CD74, CDK12, CIC, CREBBP, CSF3R, CTCF, CUL4A, CYP17A1, DAXX, DNMT3A, DOT1L, EGFR, EP300, EPHB4, ERBB2, ERBB3, ERBB4, ETV6, EWSR1, FANCA, FANCC, FANCG, FBXW7, FGF19, FGF23, FGFR1, FGFR3, FLCN, FLT1, FLT3, FUBP1, GATA6, GNA11, HDAC1, ID3, IKBKE, IKZF1, IRF4, JAK3, KEAP1, MLL, MLL2, MAP3K13, MDM4, MED12, MEF2B, MET, MSH2, MSH6, MST1R, NFE2L2, NOTCH1, NTRK2, PALB2, PIK3C2B, POLE, PPP2R2A, PRKCI, PTEN, QKI, RAC1, RAD51C, RAD51D, RAF1, RARA, RB1, RPTOR, SF3B1, SMARCA4, SMARCB1, STAT3, STK11, TERT, TET2, TNFAIP3, TP53, TSC1, TSC2.
Best drug option: ?",IMATINIB
ACH-000997,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is CAY10566. The drug SMILES structure is CC1=NN=C(O1)C2=NN=C(C=C2)N3CCC(CC3)OC4=C(C=CC(=C4)F)Cl. Drug target is Stearoyl-CoA desaturase. Drug target pathway is Other.
Drug 2: The drug is AVAGACESTAT. The drug SMILES structure is C1=CC(=CC=C1S(=O)(=O)N(CC2=C(C=C(C=C2)C3=NOC=N3)F)[C@H](CCC(F)(F)F)C(=O)N)Cl. Drug target is Amyloid beta20, Amyloid beta40. Drug target pathway is Other.
Drug 3: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are ACVR1B, ALK, ALOX12B, FAM123B, APC, ARID1A, ASXL1, ATM, ATR, ATRX, AURKA, AXIN1, AXL, BAP1, BARD1, BCOR, BCORL1, BCR, BRCA1, BRCA2, BRD4, EMSY, CALR, CASP8, CBL, CCND2, CCND3, CDC73, CDK8, CHEK2, CIC, CREBBP, CSF3R, CTNNA1, DAXX, DDR1, DDR2, DIS3, DNMT3A, EP300, ERBB3, ERBB4, ERCC4, ETV4, ETV5, EWSR1, EZH2, EZR, FANCA, FANCG, FGF6, FGFR1, GABRA6, GATA4, GATA6, GNAS, HNF1A, IDH1, IGF1R, IKBKE, IRF2, IRF4, IRS2, JAK2, JAK3, KDR, KEAP1, KEL, KIT, MLL, MLL2, KRAS, LTK, MAP2K4, MAP3K1, MAP3K13, MDM4, MED12, MLH1, MSH3, MSH6, MST1R, MYCN, NBN, NF1, NFKBIA, NOTCH1, NOTCH2, NOTCH3, NT5C2, NTRK1, PALB2, PARK2, PARP2, PARP3, PDCD1LG2, PIK3C2B, PIK3CA, PIK3CB, PIK3R1, POLD1, POLE, PPARG, PPP2R1A, PTCH1, QKI, RAD21, RBM10, RET, RNF43, RPTOR, SETD2, SF3B1, SGK1, SLC34A2, SMARCA4, SMO, SOX9, SPEN, SPOP, SYK, TBX3, TEK, TGFBR2, TNFAIP3, TP53, TSC2, TYRO3, VEGFA, XPO1, ZNF217, ZNF703.
Best drug option: ?",CAY10566
ACH-000998,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is YK-4-279. The drug SMILES structure is COC1=CC=C(C=C1)C(=O)CC2(C3=C(C=CC(=C3NC2=O)Cl)Cl)O. Drug target is RNA helicase A. Drug target pathway is Other.
Drug 2: The drug is PAZOPANIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC2=NC=CC(=N2)N(C)C3=CC4=NN(C(=C4C=C3)C)C)S(=O)(=O)N. Drug target is CSF1R, KIT,  PDGFRA, PDGFRB. Drug target pathway is RTK signaling.
Drug 3: The drug is VE-822. The drug SMILES structure is CC(C)S(=O)(=O)C1=CC=C(C=C1)C2=CN=C(C(=N2)C3=CC(=NO3)C4=CC=C(C=C4)CNC)N. Drug target is ATR. Drug target pathway is Genome integrity.
The mutations of the cell line are ABL1, AKT2, ALK, APC, AR, ARAF, ARID1A, ASXL1, ATM, ATR, ATRX, AURKB, AXIN1, AXL, BAP1, BCL2, BCORL1, BCR, BRCA2, BRIP1, BTK, CARD11, CBL, CD74, CDC73, CDH1, CDK12, CDK8, CHEK2, CIC, CREBBP, CSF3R, CTCF, CTNNA1, CTNNB1, CUL3, DDR2, DOT1L, EGFR, EP300, EPHB1, EPHB4, ERBB2, ERBB3, ERCC4, ERRFI1, ESR1, EWSR1, EZH2, FANCC, FANCG, FANCL, FGFR1, FGFR4, FH, FLCN, FLT1, FUBP1, GABRA6, GATA3, GATA6, GNAS, HGF, IDH2, IKBKE, INPP4B, IRS2, JAK1, JAK3, JUN, KDM6A, KDR, KEL, KIT, KLHL6, MLL, MLL2, KRAS, MAP2K4, MAPK1, MDM2, MED12, MERTK, MLH1, MSH3, MSH6, MTOR, MUTYH, MYCN, MYD88, NF1, NFE2L2, NKX2-1, NOTCH1, NOTCH2, NOTCH3, NTRK3, NUTM1, PARP1, PARP2, PARP3, PAX5, PBRM1, PDCD1, PDGFRA, PIK3C2B, PIK3C2G, PIK3CA, PIK3R1, POLD1, POLE, PPP2R2A, PRDM1, PTCH1, PTEN, PTPRO, RARA, RBM10, REL, RET, ROS1, RPTOR, SDHA, SETD2, SGK1, SMARCA4, SNCAIP, SPEN, SPOP, STAG2, SUFU, TEK, TGFBR2, TSC1, TSC2, TYRO3, U2AF1, WHSC1.
Best drug option: ?",VE-822
ACH-001016,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 2: The drug is AVAGACESTAT. The drug SMILES structure is C1=CC(=CC=C1S(=O)(=O)N(CC2=C(C=C(C=C2)C3=NOC=N3)F)[C@H](CCC(F)(F)F)C(=O)N)Cl. Drug target is Amyloid beta20, Amyloid beta40. Drug target pathway is Other.
Drug 3: The drug is GSK2606414. The drug SMILES structure is CN1C=C(C2=C(N=CN=C21)N)C3=CC4=C(C=C3)N(CC4)C(=O)CC5=CC(=CC=C5)C(F)(F)F. Drug target is PERK. Drug target pathway is Metabolism.
The mutations of the cell line are CUL4A, KDR, MET, ROS1, TP53.
Best drug option: ?",KIN001-135
ACH-001075,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is GSK2606414. The drug SMILES structure is CN1C=C(C2=C(N=CN=C21)N)C3=CC4=C(C=C3)N(CC4)C(=O)CC5=CC(=CC=C5)C(F)(F)F. Drug target is PERK. Drug target pathway is Metabolism.
Drug 2: The drug is BORTEZOMIB. The drug SMILES structure is B([C@H](CC(C)C)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O. Drug target is Proteasome. Drug target pathway is Protein stability and degradation.
Drug 3: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are AR, GNAS, MLL, MRE11A, NF2, SF3B1.
Best drug option: ?",KIN001-135
ACH-001086,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is AVAGACESTAT. The drug SMILES structure is C1=CC(=CC=C1S(=O)(=O)N(CC2=C(C=C(C=C2)C3=NOC=N3)F)[C@H](CCC(F)(F)F)C(=O)N)Cl. Drug target is Amyloid beta20, Amyloid beta40. Drug target pathway is Other.
Drug 2: The drug is JNJ-38877605. The drug SMILES structure is CN1C=C(C=N1)C2=NN3C(=NN=C3C(C4=CC5=C(C=C4)N=CC=C5)(F)F)C=C2. Drug target is Unknown. Drug target pathway is Unknown.
Drug 3: The drug is IMATINIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5. Drug target is ABL, KIT, PDGFR. Drug target pathway is Other, kinases.
The mutations of the cell line are ALK, BCOR, CARD11, CIC, EGFR, FGF6, NOTCH1, PTCH1.
Best drug option: ?",JNJ-38877605
ACH-001193,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is QS-11. The drug SMILES structure is C1CC2=C(C1)C=C(C=C2)OC3=NC(=C4C(=N3)N(C=N4)CC5=CC=C(C=C5)C6=CC=CC=C6)NC(CC7=CC=CC=C7)CO. Drug target is Unknown. Drug target pathway is Unknown.
Drug 2: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
Drug 3: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are ATM, ATR, AXL, BCR, CREBBP, MUTYH, RB1, RPTOR, TP53.
Best drug option: ?",WYE-125132
ACH-001274,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is FR-180204. The drug SMILES structure is C1=CC=C(C=C1)C2=NN3C=CC=CC3=C2C4=CC5=C(NN=C5N=N4)N. Drug target is ERK1, ERK2. Drug target pathway is ERK MAPK signaling.
Drug 2: The drug is AGI-5198. The drug SMILES structure is CC1=CC=CC=C1C(C(=O)NC2CCCCC2)N(C3=CC(=CC=C3)F)C(=O)CN4C=CN=C4C. Drug target is IDH1 (R132H). Drug target pathway is Metabolism.
Drug 3: The drug is JNJ-38877605. The drug SMILES structure is CN1C=C(C=N1)C2=NN3C(=NN=C3C(C4=CC5=C(C=C4)N=CC=C5)(F)F)C=C2. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are AKT3, AXIN1, BCORL1, BRAF, CSF1R, GNA13, MLL, MLL2, MED12, MTOR, NF2, NOTCH3, SNCAIP.
Best drug option: ?",JNJ-38877605
ACH-001306,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 2: The drug is CAY10566. The drug SMILES structure is CC1=NN=C(O1)C2=NN=C(C=C2)N3CCC(CC3)OC4=C(C=CC(=C4)F)Cl. Drug target is Stearoyl-CoA desaturase. Drug target pathway is Other.
Drug 3: The drug is JNJ-38877605. The drug SMILES structure is CN1C=C(C=N1)C2=NN3C(=NN=C3C(C4=CC5=C(C=C4)N=CC=C5)(F)F)C=C2. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ATM, BRAF, CDKN2A, FANCA, MET, PBRM1, TP53.
Best drug option: ?",KIN001-135
ACH-001307,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is JNJ-38877605. The drug SMILES structure is CN1C=C(C=N1)C2=NN3C(=NN=C3C(C4=CC5=C(C=C4)N=CC=C5)(F)F)C=C2. Drug target is Unknown. Drug target pathway is Unknown.
Drug 2: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
Drug 3: The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are BRAF, FGFR3, NF2, PDGFRB, SMARCA4, STK11, TP53.
Best drug option: ?",BRYOSTATIN-1
ACH-001328,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is JNJ-38877605. The drug SMILES structure is CN1C=C(C=N1)C2=NN3C(=NN=C3C(C4=CC5=C(C=C4)N=CC=C5)(F)F)C=C2. Drug target is Unknown. Drug target pathway is Unknown.
Drug 2: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 3: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ALK, ASXL1, AXL, BTK, CASP8, EP300, FBXW7, MSH3, PARP2, ROS1, TP53, ZNF703.
Best drug option: ?",KIN001-135
ACH-001332,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is ARA-G. The drug SMILES structure is C1=NC2=C(N1[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)N=C(NC2=O)N. Drug target is Anti-metabolite. Drug target pathway is Other.
Drug 2: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 3: The drug is CETUXIMAB. The drug SMILES structure is CC1(C(=C)N(C2=CC=CC=C21)CCCCCC(=O)O)C. Drug target is EGFR. Drug target pathway is EGFR signaling.
The mutations of the cell line are FBXW7, JAK3, TET2, TP53.
Best drug option: ?",KIN001-135
ACH-001333,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is FORETINIB. The drug SMILES structure is COC1=CC2=C(C=CN=C2C=C1OCCCN3CCOCC3)OC4=C(C=C(C=C4)NC(=O)C5(CC5)C(=O)NC6=CC=C(C=C6)F)F. Drug target is MET, KDR, TIE2, VEGFR3/FLT4, RON, PDGFR, FGFR1, EGFR. Drug target pathway is RTK signaling.
Drug 2: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
Drug 3: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are AKT2, AR, ARAF, ARID1A, BCORL1, BRAF, BRCA2, CD22, CDH1, CHEK2, CREBBP, CTCF, CTNNB1, DAXX, DDR1, DDR2, DIS3, EGFR, EPHA3, ERBB4, ERCC4, ETV4, FAS, FBXW7, FLT1, IKBKE, KEAP1, MLL2, MAP3K13, MDM4, MED12, MRE11A, MSH2, MSH3, PALB2, PIK3CA, POLD1, PTEN, RAD54L, RB1, SGK1, SMARCA4, TBX3, TIPARP, TNFAIP3, TP53, TSC1, WT1, XRCC2.
Best drug option: ?",FORETINIB
ACH-001334,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
Drug 2: The drug is AZ960. The drug SMILES structure is CC1=CC(=NN1)NC2=C(C=C(C(=N2)N[C@@H](C)C3=CC=C(C=C3)F)C#N)F. Drug target is JAK2, JAK3. Drug target pathway is Other, kinases.
Drug 3: The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are BRCA2, CASP8, NT5C2, SMARCA4, STK11.
Best drug option: ?",WYE-125132
ACH-001336,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
Drug 2: The drug is GW-2580. The drug SMILES structure is COC1=CC=C(C=C1)COC2=C(C=C(C=C2)CC3=CN=C(N=C3N)N)OC. Drug target is CSF1R. Drug target pathway is RTK signaling.
Drug 3: The drug is JNJ-38877605. The drug SMILES structure is CN1C=C(C=N1)C2=NN3C(=NN=C3C(C4=CC5=C(C=C4)N=CC=C5)(F)F)C=C2. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ARID1A, EP300, ERCC4, FGF14, FGF4, MLL2, PIK3CA, RAD52, SETD2, STAG2.
Best drug option: ?",WYE-125132
ACH-001341,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is CAY10566. The drug SMILES structure is CC1=NN=C(O1)C2=NN=C(C=C2)N3CCC(CC3)OC4=C(C=CC(=C4)F)Cl. Drug target is Stearoyl-CoA desaturase. Drug target pathway is Other.
Drug 2: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 3: The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are BCL2L1, BRCA2, BTK, CDK12, FBXW7, JAK1, JAK3, MLL2, MTOR, MYB, NFE2L2, NOTCH3, NTRK1, STAG2, WHSC1L1, ZNF703.
Best drug option: ?",KIN001-135
ACH-001344,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is IMATINIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5. Drug target is ABL, KIT, PDGFR. Drug target pathway is Other, kinases.
Drug 2: The drug is GSK2606414. The drug SMILES structure is CN1C=C(C2=C(N=CN=C21)N)C3=CC4=C(C=C3)N(CC4)C(=O)CC5=CC(=CC=C5)C(F)(F)F. Drug target is PERK. Drug target pathway is Metabolism.
Drug 3: The drug is JNJ-38877605. The drug SMILES structure is CN1C=C(C=N1)C2=NN3C(=NN=C3C(C4=CC5=C(C=C4)N=CC=C5)(F)F)C=C2. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are BARD1, BRCA1, CRKL, PIK3CA, SETD2, SLC34A2.
Best drug option: ?",IMATINIB
ACH-001345,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
Drug 2: The drug is AVAGACESTAT. The drug SMILES structure is C1=CC(=CC=C1S(=O)(=O)N(CC2=C(C=C(C=C2)C3=NOC=N3)F)[C@H](CCC(F)(F)F)C(=O)N)Cl. Drug target is Amyloid beta20, Amyloid beta40. Drug target pathway is Other.
Drug 3: The drug is YK-4-279. The drug SMILES structure is COC1=CC=C(C=C1)C(=O)CC2(C3=C(C=CC(=C3NC2=O)Cl)Cl)O. Drug target is RNA helicase A. Drug target pathway is Other.
The mutations of the cell line are ABL1, AKT1, FAM123B, APC, AR, ARID1A, ASXL1, ATR, ATRX, AURKA, AXL, BAP1, BCR, BRAF, BRCA2, BRD4, BRIP1, CALR, CARD11, CDC73, CDH1, CDKN2A, CHEK1, CIC, CREBBP, CSF1R, CTCF, DAXX, DNMT3A, EED, EP300, EPHA3, EPHB1, ESR1, FANCG, FBXW7, FGF12, FGFR1, FGFR2, FLCN, FLT3, FOXL2, FUBP1, GATA4, GATA6, GNA13, GNAS, GRM3, HDAC1, HNF1A, IDH2, IGF1R, IKZF1, INPP4B, IRS2, JAK2, JAK3, KDM5A, KDM5C, KDM6A, KDR, KIT, MLL2, KRAS, MAP3K1, MDM2, MED12, MET, MSH2, MSH3, MSH6, MST1R, MTAP, MTOR, MYCN, NKX2-1, NOTCH1, NOTCH3, NT5C2, NTRK3, P2RY8, PARP2, PDCD1LG2, PDGFRA, PIK3C2B, PIK3C2G, PIK3CA, PIK3CB, PMS2, POLD1, PRDM1, PTCH1, PTEN, PTPRO, QKI, RBM10, RNF43, RPTOR, SDHA, SETD2, SF3B1, SMAD2, SMARCA4, SPEN, SPOP, SRC, STAT3, TEK, TERT, TET2, TSC1, TSC2, WHSC1L1, ZNF703.
Best drug option: ?",AVAGACESTAT
ACH-001360,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 2: The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
Drug 3: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are EWSR1, FOXL2, MPL, NF2, RICTOR.
Best drug option: ?",WYE-125132
ACH-001368,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is AT13148. The drug SMILES structure is C1=CC(=CC=C1C2=CNN=C2)[C@@](CN)(C3=CC=C(C=C3)Cl)O. Drug target is AKT1. Drug target pathway is PI3K/MTOR signaling.
Drug 2: The drug is QS-11. The drug SMILES structure is C1CC2=C(C1)C=C(C=C2)OC3=NC(=C4C(=N3)N(C=N4)CC5=CC=C(C=C5)C6=CC=CC=C6)NC(CC7=CC=CC=C7)CO. Drug target is Unknown. Drug target pathway is Unknown.
Drug 3: The drug is XMD13-2. The drug SMILES structure is O=C(C1CC1)NC2=NNC3=CC(C4=CC(C(NC5CC5)=O)=CC=C4)=CC=C32. Drug target is MRCKB. Drug target pathway is Cytoskeleton.
The mutations of the cell line are CCND2, ERBB2, MTOR, REL, TP53, WHSC1.
Best drug option: ?",XMD13-2
ACH-001373,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 2: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
Drug 3: The drug is PAZOPANIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC2=NC=CC(=N2)N(C)C3=CC4=NN(C(=C4C=C3)C)C)S(=O)(=O)N. Drug target is CSF1R, KIT,  PDGFRA, PDGFRB. Drug target pathway is RTK signaling.
The mutations of the cell line are CYP17A1, PPP2R1A, PTPRO, QKI, TP53.
Best drug option: ?",KIN001-135
ACH-001384,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is ARA-G. The drug SMILES structure is C1=NC2=C(N1[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)N=C(NC2=O)N. Drug target is Anti-metabolite. Drug target pathway is Other.
Drug 2: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 3: The drug is GSK2606414. The drug SMILES structure is CN1C=C(C2=C(N=CN=C21)N)C3=CC4=C(C=C3)N(CC4)C(=O)CC5=CC(=CC=C5)C(F)(F)F. Drug target is PERK. Drug target pathway is Metabolism.
The mutations of the cell line are KDR, MEN1, STAT3, TP53.
Best drug option: ?",GSK2606414
ACH-001385,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 2: The drug is PANOBINOSTAT. The drug SMILES structure is CC1=C(C2=CC=CC=C2N1)CCNCC3=CC=C(C=C3)C=CC(=O)NO. Drug target is HDAC. Drug target pathway is Chromatin histone acetylation.
Drug 3: The drug is CAY10566. The drug SMILES structure is CC1=NN=C(O1)C2=NN=C(C=C2)N3CCC(CC3)OC4=C(C=CC(=C4)F)Cl. Drug target is Stearoyl-CoA desaturase. Drug target pathway is Other.
The mutations of the cell line are LTK, SPEN, STK11.
Best drug option: ?",KIN001-135
ACH-001398,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is PARTHENOLIDE. The drug SMILES structure is CC1=CCCC2(C(O2)C3C(CC1)C(=C)C(=O)O3)C. Drug target is HDAC1. Drug target pathway is Chromatin histone acetylation.
Drug 2: The drug is KOBE2602. The drug SMILES structure is C1=CC(=CC=C1NC(=S)NNC2=C(C=C(C=C2[N+](=O)[O-])C(F)(F)F)[N+](=O)[O-])F. Drug target is RAS effector. Drug target pathway is RTK signaling.
Drug 3: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ALOX12B, ERBB3, KDM5C, KLHL6, MLH1, NFE2L2, PDGFRA, SMO, VHL.
Best drug option: ?",KOBE2602
ACH-001399,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
Drug 2: The drug is SB-505124. The drug SMILES structure is CC1=NC(=CC=C1)C2=C(N=C(N2)C(C)(C)C)C3=CC4=C(C=C3)OCO4. Drug target is Unknown. Drug target pathway is Unknown.
Drug 3: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are APC, AXIN1, HNF1A, KDM6A, KRAS, MAF, MAP2K4, NOTCH2, SMAD4, SPEN, TP53.
Best drug option: ?",KIN001-135
ACH-001400,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is FORETINIB. The drug SMILES structure is COC1=CC2=C(C=CN=C2C=C1OCCCN3CCOCC3)OC4=C(C=C(C=C4)NC(=O)C5(CC5)C(=O)NC6=CC=C(C=C6)F)F. Drug target is MET, KDR, TIE2, VEGFR3/FLT4, RON, PDGFR, FGFR1, EGFR. Drug target pathway is RTK signaling.
Drug 2: The drug is CAY10566. The drug SMILES structure is CC1=NN=C(O1)C2=NN=C(C=C2)N3CCC(CC3)OC4=C(C=CC(=C4)F)Cl. Drug target is Stearoyl-CoA desaturase. Drug target pathway is Other.
Drug 3: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are AKT3, ASXL1, CIC, KLHL6, MLL2, RBM10, RET, RICTOR, SMAD4, TP53.
Best drug option: ?",KIN001-135
ACH-001401,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is YK-4-279. The drug SMILES structure is COC1=CC=C(C=C1)C(=O)CC2(C3=C(C=CC(=C3NC2=O)Cl)Cl)O. Drug target is RNA helicase A. Drug target pathway is Other.
Drug 2: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 3: The drug is CAY10566. The drug SMILES structure is CC1=NN=C(O1)C2=NN=C(C=C2)N3CCC(CC3)OC4=C(C=CC(=C4)F)Cl. Drug target is Stearoyl-CoA desaturase. Drug target pathway is Other.
The mutations of the cell line are APC, BCL2L1, CDKN1A, FGFR3, PTPRO, SMARCA4, STK11, TP53.
Best drug option: ?",KIN001-135
ACH-001402,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is AZ960. The drug SMILES structure is CC1=CC(=NN1)NC2=C(C=C(C(=N2)N[C@@H](C)C3=CC=C(C=C3)F)C#N)F. Drug target is JAK2, JAK3. Drug target pathway is Other, kinases.
Drug 2: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 3: The drug is LY2109761. The drug SMILES structure is C1CC2=C(C(=NN2C1)C3=CC=CC=N3)C4=C5C=CC(=CC5=NC=C4)OCCN6CCOCC6. Drug target is TGFB1. Drug target pathway is Other.
The mutations of the cell line are ARID1A, ATRX, BCOR, EMSY, CARD11, CREBBP, CTCF, EP300, EPHA3, ETV6, KDR, KRAS, MET, NF1, NUTM1, ROS1, SMO, SOX9, SPEN, STK11.
Best drug option: ?",KIN001-135
ACH-001418,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 2: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
Drug 3: The drug is GW-2580. The drug SMILES structure is COC1=CC=C(C=C1)COC2=C(C=C(C=C2)CC3=CN=C(N=C3N)N)OC. Drug target is CSF1R. Drug target pathway is RTK signaling.
The mutations of the cell line are BRCA1, KLHL6, NF1, PPP2R1A, PRDM1, TP53.
Best drug option: ?",WYE-125132
ACH-001442,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is PANOBINOSTAT. The drug SMILES structure is CC1=C(C2=CC=CC=C2N1)CCNCC3=CC=C(C=C3)C=CC(=O)NO. Drug target is HDAC. Drug target pathway is Chromatin histone acetylation.
Drug 2: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 3: The drug is FORETINIB. The drug SMILES structure is COC1=CC2=C(C=CN=C2C=C1OCCCN3CCOCC3)OC4=C(C=C(C=C4)NC(=O)C5(CC5)C(=O)NC6=CC=C(C=C6)F)F. Drug target is MET, KDR, TIE2, VEGFR3/FLT4, RON, PDGFR, FGFR1, EGFR. Drug target pathway is RTK signaling.
The mutations of the cell line are ARID1A, CASP8, CTCF, EGFR, MSH6, NOTCH1, PBRM1, PIK3CA, SPOP, TP53.
Best drug option: ?",FORETINIB
ACH-001443,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 2: The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
Drug 3: The drug is GSK2606414. The drug SMILES structure is CN1C=C(C2=C(N=CN=C21)N)C3=CC4=C(C=C3)N(CC4)C(=O)CC5=CC(=CC=C5)C(F)(F)F. Drug target is PERK. Drug target pathway is Metabolism.
The mutations of the cell line are ALK, ATR, INPP4B, JUN, KEL, NOTCH2, NRAS, PRDM1, TP53, XPO1.
Best drug option: ?",BRYOSTATIN-1
ACH-001453,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
Drug 2: The drug is CAY10566. The drug SMILES structure is CC1=NN=C(O1)C2=NN=C(C=C2)N3CCC(CC3)OC4=C(C=CC(=C4)F)Cl. Drug target is Stearoyl-CoA desaturase. Drug target pathway is Other.
Drug 3: The drug is FILANESIB. The drug SMILES structure is CN(C(=O)N1C(SC(=N1)C2=C(C=CC(=C2)F)F)(CCCN)C3=CC=CC=C3)OC. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are BCR, HSD3B1, MLL, MPL.
Best drug option: ?",CAY10566
ACH-001494,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 2: The drug is CAY10566. The drug SMILES structure is CC1=NN=C(O1)C2=NN=C(C=C2)N3CCC(CC3)OC4=C(C=CC(=C4)F)Cl. Drug target is Stearoyl-CoA desaturase. Drug target pathway is Other.
Drug 3: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ACVR1B, BRIP1, CCND2, EP300, EPHB1, GABRA6, GNAS, KRAS, MSH3, NOTCH1, PDGFRA, TP53.
Best drug option: ?",WYE-125132
ACH-001497,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is BOSUTINIB. The drug SMILES structure is CN1CCN(CC1)CCCOC2=C(C=C3C(=C2)N=CC(=C3NC4=CC(=C(C=C4Cl)Cl)OC)C#N)OC. Drug target is SRC, ABL, TEC. Drug target pathway is Other, kinases.
Drug 2: The drug is IMATINIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5. Drug target is ABL, KIT, PDGFR. Drug target pathway is Other, kinases.
Drug 3: The drug is ABT-737. The drug SMILES structure is CN(C)CC[C@H](CSC1=CC=CC=C1)NC2=C(C=C(C=C2)S(=O)(=O)NC(=O)C3=CC=C(C=C3)N4CCN(CC4)CC5=CC=CC=C5C6=CC=C(C=C6)Cl)[N+](=O)[O-]. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are CARD11, ETV5, FGF6, MLL2, MTAP, PMS2, TET2, TP53.
Best drug option: ?",IMATINIB
ACH-001498,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is AVAGACESTAT. The drug SMILES structure is C1=CC(=CC=C1S(=O)(=O)N(CC2=C(C=C(C=C2)C3=NOC=N3)F)[C@H](CCC(F)(F)F)C(=O)N)Cl. Drug target is Amyloid beta20, Amyloid beta40. Drug target pathway is Other.
Drug 2: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 3: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ALK, ASXL1, AXIN1, BCL6, BCOR, BCORL1, CASP8, CDK12, CDKN1A, CDKN2A, CIC, CREBBP, DOT1L, EP300, ERBB2, ERCC4, ESR1, FGF12, FLT3, FOXL2, GABRA6, HDAC1, KDM6A, MLL, LYN, MAP2K2, POLE, PRDM1, PTCH1, PTPRO, QKI, SETD2, SOCS1, STAG2, TGFBR2, TP53, XPO1, ZNF217.
Best drug option: ?",KIN001-135
ACH-001500,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is AVAGACESTAT. The drug SMILES structure is C1=CC(=CC=C1S(=O)(=O)N(CC2=C(C=C(C=C2)C3=NOC=N3)F)[C@H](CCC(F)(F)F)C(=O)N)Cl. Drug target is Amyloid beta20, Amyloid beta40. Drug target pathway is Other.
Drug 2: The drug is PF-4708671. The drug SMILES structure is CCC1=CN=CN=C1N2CCN(CC2)CC3=NC4=C(N3)C=C(C=C4)C(F)(F)F. Drug target is S6K1. Drug target pathway is PI3K/MTOR signaling.
Drug 3: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are BRCA2, FGF14, PIK3C2G, SPEN, TP53.
Best drug option: ?",KIN001-135
ACH-001517,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
Drug 2: The drug is IMATINIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5. Drug target is ABL, KIT, PDGFR. Drug target pathway is Other, kinases.
Drug 3: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are ABL1, AKT2, ARID1A, ATM, AXL, BAP1, BCOR, BRCA2, CARD11, CASP8, CBL, CD22, CD274, CD70, CIC, CSF3R, CTCF, CUL3, DAXX, DDR1, DOT1L, EP300, ERBB2, ERBB3, ERBB4, ETV6, FLT3, GATA6, HRAS, IKBKE, IKZF1, INPP4B, JAK3, JUN, KDM6A, KEAP1, MLL2, KRAS, LYN, MAF, MAP2K2, MAP3K1, MAP3K13, MET, MRE11A, MSH6, MYCL1, NF1, NF2, NFE2L2, NOTCH1, NOTCH3, NTRK1, PARP1, PARP3, PAX5, PBRM1, PDGFRB, PIK3C2B, PIK3C2G, PIK3CA, POLD1, PPP2R1A, RAD54L, RARA, RICTOR, RPTOR, SMAD4, SNCAIP, SOX2, SPEN, STAG2, TBX3, TERT, TNFRSF14, TP53, TSC1, U2AF1, XPO1, ZNF703.
Best drug option: ?",IMATINIB
ACH-001519,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is FORETINIB. The drug SMILES structure is COC1=CC2=C(C=CN=C2C=C1OCCCN3CCOCC3)OC4=C(C=C(C=C4)NC(=O)C5(CC5)C(=O)NC6=CC=C(C=C6)F)F. Drug target is MET, KDR, TIE2, VEGFR3/FLT4, RON, PDGFR, FGFR1, EGFR. Drug target pathway is RTK signaling.
Drug 2: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 3: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ERBB4, MLL2, NF2, NOTCH2, POLE, SDHC, SMARCB1.
Best drug option: ?",KIN001-135
ACH-001526,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is VE-822. The drug SMILES structure is CC(C)S(=O)(=O)C1=CC=C(C=C1)C2=CN=C(C(=N2)C3=CC(=NO3)C4=CC=C(C=C4)CNC)N. Drug target is ATR. Drug target pathway is Genome integrity.
Drug 2: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
Drug 3: The drug is JNJ-38877605. The drug SMILES structure is CN1C=C(C=N1)C2=NN3C(=NN=C3C(C4=CC5=C(C=C4)N=CC=C5)(F)F)C=C2. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are BTK, EGFR, IKBKE, KDM5C, LTK, MYCL1, PARP3, PTPRO, RB1, RNF43, STAG2, ZNF217.
Best drug option: ?",WYE-125132
ACH-001528,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is GW-2580. The drug SMILES structure is COC1=CC=C(C=C1)COC2=C(C=C(C=C2)CC3=CN=C(N=C3N)N)OC. Drug target is CSF1R. Drug target pathway is RTK signaling.
Drug 2: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
Drug 3: The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are AKT1, ASXL1, BRAF, CREBBP, EP300, ERBB4, FOXL2, IKBKE, NOTCH3, RAC1, SMARCA4, SPEN.
Best drug option: ?",WYE-125132
ACH-001529,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is AT13148. The drug SMILES structure is C1=CC(=CC=C1C2=CNN=C2)[C@@](CN)(C3=CC=C(C=C3)Cl)O. Drug target is AKT1. Drug target pathway is PI3K/MTOR signaling.
Drug 2: The drug is LENALIDOMIDE. The drug SMILES structure is C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N. Drug target is CRBN. Drug target pathway is Protein stability and degradation.
Drug 3: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are BRCA2, CDK6, DDR2, EPHA3, EPHB1, ERBB4, HGF, IDH2, IRF2, KDM5A, KDR, MLL, NTRK3, PPP2R1A, RAD51C, RAD51D, TEK.
Best drug option: ?",KIN001-135
ACH-001542,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
Drug 2: The drug is CAY10566. The drug SMILES structure is CC1=NN=C(O1)C2=NN=C(C=C2)N3CCC(CC3)OC4=C(C=CC(=C4)F)Cl. Drug target is Stearoyl-CoA desaturase. Drug target pathway is Other.
Drug 3: The drug is PANOBINOSTAT. The drug SMILES structure is CC1=C(C2=CC=CC=C2N1)CCNCC3=CC=C(C=C3)C=CC(=O)NO. Drug target is HDAC. Drug target pathway is Chromatin histone acetylation.
The mutations of the cell line are ATRX, CEBPA, ERCC4, GNAQ, KDM6A, KEAP1, MDM4, MSH2, MTAP, MYB, PIK3C2G, SPEN, TP53, TSC1.
Best drug option: ?",PANOBINOSTAT
ACH-001549,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
Drug 2: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 3: The drug is IMATINIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5. Drug target is ABL, KIT, PDGFR. Drug target pathway is Other, kinases.
The mutations of the cell line are BRCA1, CTNNA1, DIS3, EP300, ERBB3, ERBB4, FUBP1, KEAP1, PARK2, PRKAR1A, SF3B1, SPEN, TEK, TP53.
Best drug option: ?",YM-201636
ACH-001578,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 2: The drug is YK-4-279. The drug SMILES structure is COC1=CC=C(C=C1)C(=O)CC2(C3=C(C=CC(=C3NC2=O)Cl)Cl)O. Drug target is RNA helicase A. Drug target pathway is Other.
Drug 3: The drug is PACLITAXEL. The drug SMILES structure is CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@](C3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C. Drug target is TTK and microtubules. Drug target pathway is Unclassified.
The mutations of the cell line are CD79B, KDM5A, MPL, MYC, NPM1, PMS2, PTEN, TP53.
Best drug option: ?",KIN001-135
ACH-001603,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is JNJ-38877605. The drug SMILES structure is CN1C=C(C=N1)C2=NN3C(=NN=C3C(C4=CC5=C(C=C4)N=CC=C5)(F)F)C=C2. Drug target is Unknown. Drug target pathway is Unknown.
Drug 2: The drug is PAZOPANIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC2=NC=CC(=N2)N(C)C3=CC4=NN(C(=C4C=C3)C)C)S(=O)(=O)N. Drug target is CSF1R, KIT,  PDGFRA, PDGFRB. Drug target pathway is RTK signaling.
Drug 3: The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ABL1, APC, AR, BCR, GATA3, NF1, SETD2.
Best drug option: ?",JNJ-38877605
ACH-001605,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is GSK2606414. The drug SMILES structure is CN1C=C(C2=C(N=CN=C21)N)C3=CC4=C(C=C3)N(CC4)C(=O)CC5=CC(=CC=C5)C(F)(F)F. Drug target is PERK. Drug target pathway is Metabolism.
Drug 2: The drug is GDC-0941. The drug SMILES structure is CS(=O)(=O)N1CCN(CC1)CC2=CC3=C(S2)C(=NC(=N3)C4=C5C=NNC5=CC=C4)N6CCOCC6. Drug target is PI3K (class 1). Drug target pathway is PI3K/MTOR signaling.
Drug 3: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are ATR, EPHA3, GABRA6, MLL, MEN1, RAF1, RB1, RET, SPEN, TP53.
Best drug option: ?",KIN001-135
ACH-001617,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is TASELISIB. The drug SMILES structure is CC1=NN(C(=N1)C2=CN3CCOC4=C(C3=N2)C=CC(=C4)C5=CN(N=C5)C(C)(C)C(=O)N)C(C)C. Drug target is PI3K (beta sparing). Drug target pathway is PI3K/MTOR signaling.
Drug 2: The drug is DACINOSTAT. The drug SMILES structure is C1=CC=C2C(=C1)C(=CN2)CCN(CCO)CC3=CC=C(C=C3)C=CC(=O)NO. Drug target is HDAC1. Drug target pathway is Chromatin histone acetylation.
Drug 3: The drug is GSK2606414. The drug SMILES structure is CN1C=C(C2=C(N=CN=C21)N)C3=CC4=C(C=C3)N(CC4)C(=O)CC5=CC(=CC=C5)C(F)(F)F. Drug target is PERK. Drug target pathway is Metabolism.
The mutations of the cell line are BCL6, CCND3, ERBB4, ETV5, IDH1, SMARCA4, TP53, WT1.
Best drug option: ?",GSK2606414
ACH-001625,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is PANOBINOSTAT. The drug SMILES structure is CC1=C(C2=CC=CC=C2N1)CCNCC3=CC=C(C=C3)C=CC(=O)NO. Drug target is HDAC. Drug target pathway is Chromatin histone acetylation.
Drug 2: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 3: The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ATM, FAM46C, HNF1A, MYCL1, NOTCH2, PTPRO, TP53.
Best drug option: ?",KIN001-135
ACH-001626,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is LESTAURTINIB. The drug SMILES structure is C[C@@]12[C@](C[C@@H](O1)N3C4=CC=CC=C4C5=C6C(=C7C8=CC=CC=C8N2C7=C53)CNC6=O)(CO)O. Drug target is FLT3, JAK2, NTRK1, NTRK2, NTRK3. Drug target pathway is Other, kinases.
Drug 2: The drug is JNJ-38877605. The drug SMILES structure is CN1C=C(C=N1)C2=NN3C(=NN=C3C(C4=CC5=C(C=C4)N=CC=C5)(F)F)C=C2. Drug target is Unknown. Drug target pathway is Unknown.
Drug 3: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are BRCA1, CDKN2A, CHEK2, ETV4, KDM6A, PIK3CA, TBX3, TP53.
Best drug option: ?",JNJ-38877605
ACH-001630,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is JQ1-(+). The drug SMILES structure is CC1=C(SC2=C1C(=N[C@H](C3=NN=C(N32)C)CC(=O)OC(C)(C)C)C4=CC=C(C=C4)Cl)C. Drug target is Unknown. Drug target pathway is Unknown.
Drug 2: The drug is GSK2606414. The drug SMILES structure is CN1C=C(C2=C(N=CN=C21)N)C3=CC4=C(C=C3)N(CC4)C(=O)CC5=CC(=CC=C5)C(F)(F)F. Drug target is PERK. Drug target pathway is Metabolism.
Drug 3: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are CDK12, CREBBP, MSH3, POLE, TBX3, TP53.
Best drug option: ?",GSK2606414
ACH-001638,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is YK-4-279. The drug SMILES structure is COC1=CC=C(C=C1)C(=O)CC2(C3=C(C=CC(=C3NC2=O)Cl)Cl)O. Drug target is RNA helicase A. Drug target pathway is Other.
Drug 2: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 3: The drug is IMATINIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5. Drug target is ABL, KIT, PDGFR. Drug target pathway is Other, kinases.
The mutations of the cell line are BRCA2, BTK, CALR, DOT1L, ETV5, EWSR1, IKZF1, IRS2, MAP3K1, MPL, NF1, NFKBIA, PIK3C2G, RAD21, RAD51B, RNF43, SDHD, SGK1, TNFAIP3.
Best drug option: ?",KIN001-135
ACH-001641,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is ARA-G. The drug SMILES structure is C1=NC2=C(N1[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)N=C(NC2=O)N. Drug target is Anti-metabolite. Drug target pathway is Other.
Drug 2: The drug is TIVOZANIB. The drug SMILES structure is CC1=CC(=NO1)NC(=O)NC2=C(C=C(C=C2)OC3=C4C=C(C(=CC4=NC=C3)OC)OC)Cl. Drug target is VEGFR1, VEGFR2, VEGFR3, PDGFR, KIT. Drug target pathway is RTK signaling.
Drug 3: The drug is LIMK1 INHIBITOR BMS4. The drug SMILES structure is CCNC(=O)NC1=NC=C(S1)C2=CC(=NC(=N2)C3=NC=CN=C3)C4=C(C=C(C=C4C)OC)C. Drug target is LIMK1. Drug target pathway is Cytoskeleton.
The mutations of the cell line are ASXL1, EGFR, IRF2, MAP3K1, MAP3K13, MSH6, NTRK3, NUTM1, PBRM1, TGFBR2, TP53.
Best drug option: ?",TIVOZANIB
ACH-001642,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is AVAGACESTAT. The drug SMILES structure is C1=CC(=CC=C1S(=O)(=O)N(CC2=C(C=C(C=C2)C3=NOC=N3)F)[C@H](CCC(F)(F)F)C(=O)N)Cl. Drug target is Amyloid beta20, Amyloid beta40. Drug target pathway is Other.
Drug 2: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 3: The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are BTG2, EPHB1, ERBB3, MAP2K1, MED12, MSH3, NOTCH3, SPEN.
Best drug option: ?",KIN001-135
ACH-001650,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
Drug 2: The drug is IMATINIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5. Drug target is ABL, KIT, PDGFR. Drug target pathway is Other, kinases.
Drug 3: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are ABL1, BCOR, FGFR3, KRAS, MYCN, RB1.
Best drug option: ?",YM-201636
ACH-001653,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is AVAGACESTAT. The drug SMILES structure is C1=CC(=CC=C1S(=O)(=O)N(CC2=C(C=C(C=C2)C3=NOC=N3)F)[C@H](CCC(F)(F)F)C(=O)N)Cl. Drug target is Amyloid beta20, Amyloid beta40. Drug target pathway is Other.
Drug 2: The drug is PF-4708671. The drug SMILES structure is CCC1=CN=CN=C1N2CCN(CC2)CC3=NC4=C(N3)C=C(C=C4)C(F)(F)F. Drug target is S6K1. Drug target pathway is PI3K/MTOR signaling.
Drug 3: The drug is DASATINIB. The drug SMILES structure is CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)N4CCN(CC4)CCO)C. Drug target is ABL, SRC, Ephrins, PDGFR, KIT. Drug target pathway is RTK signaling.
The mutations of the cell line are ABL1, AR, AXL, CASP8, FGFR2, KEAP1, MET, MST1R, PIM1, TP53.
Best drug option: ?",AVAGACESTAT
ACH-001655,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 2: The drug is GW-2580. The drug SMILES structure is COC1=CC=C(C=C1)COC2=C(C=C(C=C2)CC3=CN=C(N=C3N)N)OC. Drug target is CSF1R. Drug target pathway is RTK signaling.
Drug 3: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ABL1, BCOR, HGF, IGF1R, INPP4B, NUTM1, PTEN, TP53.
Best drug option: ?",KIN001-135
ACH-001674,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is AVAGACESTAT. The drug SMILES structure is C1=CC(=CC=C1S(=O)(=O)N(CC2=C(C=C(C=C2)C3=NOC=N3)F)[C@H](CCC(F)(F)F)C(=O)N)Cl. Drug target is Amyloid beta20, Amyloid beta40. Drug target pathway is Other.
Drug 2: The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
Drug 3: The drug is ARA-G. The drug SMILES structure is C1=NC2=C(N1[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)N=C(NC2=O)N. Drug target is Anti-metabolite. Drug target pathway is Other.
The mutations of the cell line are ALK, AURKB, CTNNA1, ERBB4, KDM5C, KIT, MED12, NF1, POLD1, RAC1, STAT3, TP53.
Best drug option: ?",ARA-G
ACH-001702,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
Drug 2: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 3: The drug is CAY10566. The drug SMILES structure is CC1=NN=C(O1)C2=NN=C(C=C2)N3CCC(CC3)OC4=C(C=CC(=C4)F)Cl. Drug target is Stearoyl-CoA desaturase. Drug target pathway is Other.
The mutations of the cell line are IRS2, MLL2, NF2, TNFAIP3.
Best drug option: ?",KIN001-135
ACH-001703,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is FORETINIB. The drug SMILES structure is COC1=CC2=C(C=CN=C2C=C1OCCCN3CCOCC3)OC4=C(C=C(C=C4)NC(=O)C5(CC5)C(=O)NC6=CC=C(C=C6)F)F. Drug target is MET, KDR, TIE2, VEGFR3/FLT4, RON, PDGFR, FGFR1, EGFR. Drug target pathway is RTK signaling.
Drug 2: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 3: The drug is YK-4-279. The drug SMILES structure is COC1=CC=C(C=C1)C(=O)CC2(C3=C(C=CC(=C3NC2=O)Cl)Cl)O. Drug target is RNA helicase A. Drug target pathway is Other.
The mutations of the cell line are BCL2, BCL6, BCORL1, BCR, BRCA2, CCND3, CD79B, CREBBP, ERBB4, EZH2, FLT1, FUBP1, GNA13, KDR, KLHL6, MLL2, MYB, MYC.
Best drug option: ?",KIN001-135
ACH-001711,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
Drug 2: The drug is GSK2606414. The drug SMILES structure is CN1C=C(C2=C(N=CN=C21)N)C3=CC4=C(C=C3)N(CC4)C(=O)CC5=CC(=CC=C5)C(F)(F)F. Drug target is PERK. Drug target pathway is Metabolism.
Drug 3: The drug is FORETINIB. The drug SMILES structure is COC1=CC2=C(C=CN=C2C=C1OCCCN3CCOCC3)OC4=C(C=C(C=C4)NC(=O)C5(CC5)C(=O)NC6=CC=C(C=C6)F)F. Drug target is MET, KDR, TIE2, VEGFR3/FLT4, RON, PDGFR, FGFR1, EGFR. Drug target pathway is RTK signaling.
The mutations of the cell line are CDH1, CIC, RSPO2, SPEN, TP53.
Best drug option: ?",FORETINIB
ACH-001715,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
Drug 2: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 3: The drug is YK-4-279. The drug SMILES structure is COC1=CC=C(C=C1)C(=O)CC2(C3=C(C=CC(=C3NC2=O)Cl)Cl)O. Drug target is RNA helicase A. Drug target pathway is Other.
The mutations of the cell line are ALK, EMSY, GATA3, MAP3K13, MSH3, MST1R.
Best drug option: ?",KIN001-135
ACH-001716,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is IMATINIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5. Drug target is ABL, KIT, PDGFR. Drug target pathway is Other, kinases.
Drug 2: The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
Drug 3: The drug is GW-2580. The drug SMILES structure is COC1=CC=C(C=C1)COC2=C(C=C(C=C2)CC3=CN=C(N=C3N)N)OC. Drug target is CSF1R. Drug target pathway is RTK signaling.
The mutations of the cell line are ATM, BRCA1, CHEK2, FGF14, IDH1, KDM5C, MKNK1, NRAS, PPP2R2A, TBX3, TET2, TSC1.
Best drug option: ?",IMATINIB
